Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
To buy and sell shares in this company via JP Jenkins, you will need to use a regulated UK stockbroker.
For a comprehensive list of brokers click here.
Over 40 UK brokers regularly connect with our platform. If you are based overseas and are interested in participating then please contact us directly by emailing info@jpjenkins.com or by calling 0207 469 0937 Trades take place through our central counterparty partner. There is a fee of 1.5% of the transaction price which is charged to both buyers and sellers and a £25 transaction fee. Your broker may also apply charges.
Please note, when purchasing shares Stamp Duty Reserve Tax (“SDRT”) may be applicable.
Connected Kerb, the British born and based electric vehicle (EV) smart charging infrastructure specialist, today announced it has secured a £65 million equity investment to support its plans of expanding the UK’s on-street EV charging network.
The fundraise sees NWF commit a £55m ordinary equity investment alongside a further £10m ordinary equity investment from Aviva Investors, the global asset management business of Aviva plc.
This substantial investment into the UK’s public charging infrastructure is critical for delivering the forecast requirement of at least 300,000 public EV chargers by 2030.
Chris Pateman-Jones, CEO of Connected Kerb, said:
“This investment combines Connected Kerb’s proven hardware and advanced software infrastructure with the financial resources of NWF and Aviva to deploy public charging at scale, to all corners of the UK. This is a game-changing investment that will give individuals and businesses the confidence to make the switch to driving electric, dramatically reducing carbon emissions and air pollution. We are delighted to have such high-profile investors who are deeply aligned with our sustainability and ethical goals.”

John Flint, National Wealth Fund, said:
“To get to net zero we need to make it as easy as possible for people to change the way they do things. Providing convenient and reliable on-street charging is key to helping those without driveways make the switch to electric vehicles. Our investment in Connected Kerb will support one of the UK’s leading public charge point operators to continue its network expansion and deploy this much-needed EV charging infrastructure at pace and at scale to homes and businesses across the country.”
Angenika Kunne, Head of Infrastructure Equity, Aviva Investors said:
”We are pleased to extend our relationship with Connected Kerb and to back its continued growth plans. This is an ambitious company which we believe is leading the way in helping the UK get ready for the future and supporting the transition towards a low-carbon economy. With plans to roll-out an extensive EV charging network, it is well-positioned to create infrastructure which can support the adoption of electric vehicles for the mass market. The unique offer of Connected Kerb’s advanced site selection and user software provides a compelling proposition for both Aviva Investors clients and the end user.”
Future of Roads Minister, Lilian Greenwood said:
“Our charge point network is going from strength to strength, and it’s brilliant to see Connected Kerb secure a £65m boost to expand its charging network – a great vote of confidence in the EV transition. The funding follows a record of nearly 20k public charge points added last year. With a further £6bn in the pipeline from industry by 2030, the switch to EVs is driving investment across the country, supporting jobs and making the UK a clean energy superpower to deliver our plan for change.”
Juliet Davenport, Connected Kerb Chair said:
“We are incredibly proud to receive this substantial investment from the National Wealth Fund and Aviva Investors. This funding will enable us to significantly expand our EV charging network, making electric vehicle charging accessible to everyone, especially those without driveways. This investment not only supports our growth but also aligns with our commitment to reducing carbon emissions and promoting flexibly clean energy solutions across the UK.”
EV ownership continues to rise fast with over 30% of new vehicles sold last December# being pure battery EVs. However, there’s a growing gap between EV ownership where drivers can charge their vehicle on their own driveway or garages and where they cannot, as is the case in 55% of dwellings in urban areas##.
By boosting public charging infrastructure, Connected Kerb’s public/private partnership model, enabled by NWF and Aviva Investors, is rebalancing this inequality. The company’s chargers are manufactured in the UK, supporting the government’s drive for green job creation.
Connected Kerb was advised in this transaction by Cameron Barney Herbst Hilgenfeldt (CBHH).
ENDS
About Connected Kerb
Connected Kerb is is on a mission to change the world for good. We aim to make EV charging inclusive, convenient, and reliable, and are committed to sustainable mobility. We work with local authorities to build and operate community EV charging in residential streets and local public car parks, and also install future-proof EV charging infrastructure at workplaces, retail destinations, car parks, commercial real estate, and for residential developers.
As smart cities of the future develop, Connected Kerb’s charge points support smart charging technology and other future technologies designed to have a positive impact on people and the planet. The company is committed to ensure that no one in the UK lives further than a five-minute walk from a charger.
About The National Wealth Fund
The National Wealth Fund (NWF) is an investor, operating as a bank, to drive private sector investment into the UK’s clean energy and growth industries in support of government policy.
Created in October 2024 from the UK Infrastructure Bank, the NWF aims to mobilise private capital around the government’s strategic priorities, including delivery of the forthcoming industrial strategy.
The NWF is based in Leeds and has £27.8bn to deploy across the capital structure, including loans, equity investments, and guarantees.
The NWF also provides commercial and financial advisory services and market leading lending to local authorities across the UK. The Fund is wholly owned by HM Treasury but is operationally independent from government.
Data sources:
# SMMT vehicles sales statistics December 2024
November 6, 2025
27th March 2025
CMO:JPJ
ISIN: GB00BMB5Y385
CMO Group
(“CMO” or “the Company”)
CMO Group shares are now trading on JP Jenkins
London, UK – 27th March 2025 – CMO Group (CMO:JPJ) is pleased to announce that its shares have been admitted for trading on the JP Jenkins share dealing platform. The company is registered at Burrington Business Park, Burrington Way, Plymouth, United Kingdom, PL5 3LX (Company No. 13451589).
Founded in 2008 as Construction Materials Online, CMO is an online-only retailer of building materials. CMO has a range of listings with over 140,000 products through its many specialist websites which recently underwent rebranding. It‘s unique digital hybrid service model, developed over more than 10 years, combines specialist advice and expertise tailored to category and customer needs online, to service the next generation of digital natives by bridging the gap between traditional bricks and mortar retailers and pureplay digital retailing.
JP Jenkins provides a share trading venue for unlisted or unquoted companies, enabling shareholders and prospective investors to trade equity on a matched bargain basis. JP Jenkins operates as a trading name of InfinitX Limited and is an Appointed Representative of Prosper Capital LLP (FRN 453007). The indicative pricing for the ordinary shares, along with transaction history, will be available on the JP Jenkins website: https://jpjenkins.com.
For further information, please contact:
CMO Group
Email: investor@cmogroup.com
JP Jenkins Ltd
Veronika Oswald / Mason Doick
Tel: +44 (0) 207 469 0937
October 27, 2025
Cambria Africa PLC
11 October 2024
Cambria Africa Plc
(“Cambria” or the “Company”)
Interim Results (the “Results”)
Loss per share of 0.01 US cents and NAV 1.12 US cents
For the 6 Months ended 28 February 2024
Cambria Africa PLC (AIM:CMB) (“Cambria” or the “Company”) is pleased to announce its interim results for the six months ended 28 February 2024 (the “Period”). A copy of this announcement is available on the Company’s website (www.cambriaafrica.com). With the publishing of the Group`s FY 2023 and HY 2024 results, the suspension of the Company`s shares on the AIM will be lifted at 7.30am on 11 October 2024.
A circular to shareholders was issued on 23 September 2024 convening a general meeting to be held on 10 October 2024 to seek shareholder approval for the proposed Cancellation and to amend the Company’s Articles of Association. As announced on 10 October 2024 all Resolutions were passed. Accordingly, cancellation of admission of the Company’s ordinary shares to trading on AIM will become effective at 7.00 a.m. on 22 October 2024.
The suspension of the Company’s Ordinary Shares is due to be lifted shortly on publication of these results, as a result Shareholders will only have the day to trade their Cambria Ordinary Shares on AIM, before the Company will again be suspended at 7.00am on 14 October 2024. As announced on 23 September 2024, the Company will cease to have a nominated adviser with effect from 8.00 a.m. on 14 October 2024. As a result, the Company will again be suspended as of 7:00 a.m. on 14 October 2024, pursuant to AIM Rule 1, for failing to retain a Nominated Adviser. As the Company have decided not to appoint a new Nominated Adviser the suspension will remain in place until the cancellation of admission of the Company’s ordinary shares to trading on AIM at 7.00 a.m. on 22 October 2024.
The Group realised a loss after tax of US$44,000 for the 6 months ended 28 February 2023 compared to $99,000 achieved in the same period in 2022. This was due to a decline in revenue and earnings contributions from Tradanet. Tradanet`s performance was impacted by the slower growth in the US dollar value of its loan processing portfolio which value slowed as a consequence of inflation and the devaluation of Zimbabwe’s currency (ZWL). Tradanet’s revenues were further adversely impacted by liquidity constraints in the banking sector. Autopay also experienced a decline in the real value of its Payroll processing revenues caused by the depreciation of ZWL relative to the US dollar.
The Group’s Net asset value of $6.12 million remained in line with the audited NAV reported for the financial year ended
31 August 2023 of $6.1 million.
Half Year 2024 Results Highlights 6 Months ended 28 February 2024 (US$’000)20242023Change– Revenue185451(59%)– Operating costs192 323(41%)– Consolidated EBITDA(18) 128(114%)– Consolidated Profit after tax (PAT)(44)99(144%)– (Loss)/Profit attributable to owners of the Company (58)28(307%)– Central costs73 21248%– EPS – cents(0.01)0.01–– NAV6,119 5,7636%– NAV per share – cents1.12 1.066%– Weighted average of shares in issue544,576544,576–– Shares in issue at year end544,576544,576–Divisional: – Payserv – consolidated PAT40121(67%)– Payserv – consolidated EBITDA66 149(56%)– Millchem – EBITDA–––Group Highlights HY 2024:
· Net Equity (NAV) increased by 6% from US $5.763 million (1.06 US cents per share) in HY 2023 to $6.119 million (1.12 US cents per share) in HY 2024.
· Group revenue decreased by 59% compared to the prior period from $451,000 to $185,000. This is mainly due to Tradanet revenues decreasing as a result of declining loan advances by CABS in United States dollar terms during the period. The operations in Zimbabwe, despite challenging market and currency devaluation conditions, operate at break even with minimal impact at the holding level.
Net Equity (Net Asset Value)
The company’s net asset value increased by 6% from $5.763 million at HY 2023 to $6.119 million at HY 2024. The HY2024 NAV corresponds with the audited NAV at 31 August 2023 of $6,104 million.
Components of NAV at 28 February 2024
The Group NAV of $6.119 million as at the end of HY 2024 consists of the following tangible and intangible assets:
Building and properties valued at $2.3 million – The Company`s real estate holding company, Lonzim Holdings Limited, has received multiple offers, with a transaction yet to be finalised.
Investment in Radar Holdings Limited – 9.74% or 4.98 million shares valued at US $1.743 million (net of minority interests) based on 35 US cents per equivalent Radar share. In the post balance sheet period, the sale of the Group`s 78.2% shareholding in A.F Philips (Pvt) Ltd (“AFP”) (which holds the Investment in Radar Holdings Limited) has been concluded with all conditions precedent to the deal being successfully completed. The purchasers have settled $1.1 million of the purchase price (after HY 2024) with the balance, which accrues interest at a rate of 10% per annum, expected to be settled by the end of the calendar year.
USD Cash and Cash Equivalents – US dollar cash totalling $1.56 million.
Old Mutual and Nedbank shares – the Company holds 204,047 Old Mutual Limited shares and 2,692 Nedbank shares valued on at US $156,971 based on the closing price of the shares on the Johannesburg Stock Exchange at the interim period end.
Goodwill – The Company has a goodwill value of $717,000 on its Statement of Financial Position relating to its investment in the Payserv group of Companies. The Company believes this is a fair assessment of the intangible asset despite the impact of the decisions made by Zimbabwe`s banking institutions against using its payment platforms. Turnaround opportunities are being explored as evidenced by the recent granting to Multi-Pay Solutions (Pvt) Ltd (Multi-Pay Solutions) the exclusive rights to use, distribute, and operate Paynet Software in the Southern African Development Community (SADC). Payserv Africa will continue to operate Paynet outside of the SADC. Tradanet, in which the Company holds an effective 51% interest, is the largest contributor to the Company’s earnings. Tradanet processes microloans on behalf of CABS, Zimbabwe’s largest Building Society. At their peak in 2019, these microloans comprised about a third of the banks assets and the Directors believe that a return to those levels is fully conceivable. Accordingly, the Company continues to believe that Payserv’s intellectual property value and the amalgamation of the above exceeds the book value of the goodwill.
Chief Executive’s Report
The Company has released its Annual Report for the financial year ended 31 August 2023 simultaneously with its 2024 half year results. As covered in my CEO report attached to the audited year end results, Cambria’s story is now focused on realizing its NAV. Investors might find value in examining our estimate of realizable NAV at US $7.2 million (1.3 US cents per share). Our estimate draws from the following actual and anticipated components:
· Cash: As at the half year ended 2023, the Group held cash reserves of US$1.56 million. As at 30 September 2024, in addition to Zimbabwe-held US dollar-denominated cash, shares and gold coins, the Company holds Fixed Deposits of $2.4 million in the United Kingdom.
· Commercial Property: This is represented by the prominently located Mt. Pleasant Business Park Commercial Property valued at $2.3 million.
· Recovery of Legacy Debts: The Company is actively pursuing the recovery of “Legacy Debts” or “Blocked Funds” owed by our Zimbabwe subsidiaries to the holding companies. As at 31 August 2023, we’ve successfully recovered US$407,350, leaving an outstanding balance of $1.2 million held by the Ministry of Finance. These funds, initially held by the Reserve Bank in ZWL on a one-to-one basis with the USD, were marked down to a negligible value in previous financial years based on the annual official exchange rate. However, post FY 2022, the Ministry of Finance began repaying these debts and assures us of the balance, as funds become available. As a result, our NAV after the financial year end will see an increase, accounting for the recovered debts.
· Listed Portfolio Value: We aim to realise the value of the 204,047 Old Mutual shares and 2,692 Nedbank shares by transferring these shares to the South African register. The total value of this portfolio was $192,469 based on JSE closing prices on 10 October 2024.
· Sale of Radar equivalent shares: At the holding Company level, we will realise $1.743 million from the sale of our indirect stake in Radar after the fulfilment of all conditions precedent to the agreement of sale. $1.1 million has been received, with the balance accruing 10% interest, expected to be settled by the end of the calendar year.
· Intellectual Property Value: The Board is committed to deriving maximum value from our intellectual property, both in our current operations and future endeavours. The Company’s Statement of Financial Position lists a goodwill value of $717,000.
These estimates, culminating in a projected NAV of US $7.2 million, come with the following considerations:
1. Maintenance of stable commercial real estate prices in Harare and successful sales realization at the holding Company level.
2. Repayment of US $1.2 million in Legacy Debts.
3. Effective utilization of intellectual properties for profit.
4. The resumption of fungibility of dual-listed shares.
We remain cautiously optimistic about achieving full value for the Company’s assets beyond its NAV.
With the publishing of the Group`s FY 2023 and HY 2024 results, the suspension of the Company’s Ordinary Shares has been lifted and as a result Shareholders will have one day to trade their Cambria Ordinary Shares on AIM, before the Company will again be suspended at 7.00am on 14 October 2024. As announced on 23 September 2024, the Company will cease to have a nominated adviser with effect from 8.00 a.m. on 14 October 2024. As a result, the Company will again be suspended as of 7:00 a.m. on 14 October 2024, pursuant to AIM Rule 1, for failing to retain a Nominated Adviser. As the Company have decided not to appoint a new Nominated Adviser the suspension will remain in place until the cancellation of admission of the Company’s ordinary shares to trading on AIM at 7.00 a.m. on 22 October 2024.
Albeit for one day only, the lifting of the suspension should enable shareholders to trade with a comprehensive understanding of the updated financial position and the investment landscape confronting Cambria. At the time of suspension, Cambria shares were valued at 0.225p, contrasting with a book NAV of 0.88p and our estimate of 1.3 US cents per share or 1.07p per share. Shareholders must determine whether the market has aptly gauged the discount to the Company’s book NAV and management’s estimates of realizable NAV, which we are committed to achieving.
Samir Shasha
10 October 2024
Contacts Cambria Africa Plcwww.cambriaafrica.comSamir Shasha+44 (0)20 3287 8814WH Ireland Limitedwww.whirelandplc.com/capital-marketsJames Joyce / Sarah Mather+44 (0) 20 7220 1666Cambria Africa Plc
Interim consolidated income statement
For the six month period ended 28 February 2024
Unaudited Unaudited Audited 6 months to 6 months to Year to 28-Feb-24 28-Feb-23 31-Aug-23 US$’000 US$’000US$’000 Revenue185 451 922 Cost of sales(11)–(53) Gross profit174 451 869 Operating costs(192)(323)(585) Other income––7 Exceptionals(11)–13 Operating (loss)/profit(29) 128 304 Finance income101131 Finance costs––– Net finance income101131 (Loss)/Profit before tax(19) 139 335 Income tax(25)(40)(70) (Loss)/Profit for the period(44) 99 265 Attributable to: Owners of the company(58) 28 156 Non-controlling Interests1471109 (Loss)/Profit for the period(44) 99 265 (Loss)/earnings per share Basic and diluted (loss)/earnings per share (cents)(0.01c)0.01c0.03c (Loss)/Earnings per share – continuing operations Basic and diluted (loss)/earnings per share (cents)(0.01c)0.01c0.03c Weighted average number of shares for EPS544,576 544,576 544,576Cambria Africa Plc
Interim consolidated statement of comprehensive income
For the six month period ended 28 February 2024
Unaudited Unaudited Audited 6 months to 6 months to Year to 28-Feb-24 28-Feb-23 31-Aug-23 US$’000 US$’000 US$’000 (Loss)/Profit for the period (44) 99 265 Other comprehensive income Items that will not be reclassified to Statement of Profit or Loss: Legacy debt recoveries407Foreign currency translation differences for overseas operations88(10)(219)Total comprehensive profit for the period 44 89 453 Attributable to: Owners30 18 344 Non-controlling interests1471109Total comprehensive profit for the period 44 89 453Cambria Africa Plc
Interim consolidated statement of financial position
As at 28 February 2024
Unaudited Unaudited Audited Group Group Group 28-Feb-24 28-Feb-23 31-Aug-23 US$’000 US$’000US$’000 Property, plant and equipment2,3002,3052,308Goodwill717717717Intangible assets–––Financial assets at fair value through profit and loss157152168Total non-current assets 3,174 3,174 3,193 Inventories–8–Financial assets at fair value through profit and loss111534Trade and other receivables7517288Cash and cash equivalents1,5671,3611,552Assets classified as held for sale 2,228 2,2282,228Total current assets 3,881 3,784 3,902 Total assets 7,055 6,958 7,095 Equity Issued share capital777777Share premium account88,45988,45988,459Revaluation reserve(190)(190)(190)Foreign exchange reserve(10,852)(11,138)(10,940)Non- distributable reserves2,3712,3712,371Accumulated losses(73,746)(73,816)(73,688)Equity attributable to owners of the company 6,119 5,763 6,089 Non-controlling interests413496454Total equity 6,532 6,259 6,543 Liabilities Trade and other payables–40–Deferred tax liabilities174189153Total non-current liabilities 174 229 153 Current tax liabilities47134104Trade and other payables302336295Liabilities for discontinued operation–––Total current liabilities 349 470 399 Total liabilities 523 699 552 Total equity and liabilities 7,055 6,958 7,095Cambria Africa Plc
Interim consolidated statement of changes in equity
For the six month period ended 28 February 2024
US$’000Share CapitalShare PremiumRevaluation ReserveForeign Exchange ReserveAccumulated LossesNon-distributable ReserveTotalNon-controlling InterestTotal Balance at 1 September 2022 7788,459(190)(11,128)(73,844)2,3715,7454256,170Profit for the period––––28–287199Legacy Debt Revaluation 757575Foreign currency translation differences for overseas operations–––(85)––(85)–(85)Total comprehensive loss for the year –––(10)28–187189Contributions by/distributions to owners of the Company recognised directly in equity Dividends paid–––––––––Total contributions by and distributions to owners of the Company –––––––––Balance at 28 February 2023 7788,459(190)(11,138)(73,816)2,3715,7634966,259US$000Share Capital Share premium Revaluation reserve Foreign exchange reserve Accumulated lossesNDRTotalNon-Controlling interestsTotal Balance at 1 September 2022 77 88,459 (190) (11,128) (73,844) 2,371 5,745 425 6,170 Profit/(loss) for the year––––156–156109265 Foreign currency translation differences for overseas operations–––(219)––(219)(24)(243) Legacy debt recoveries–––407 – –407–407 Total comprehensive income for the year77 88,459 (190) (10,940) (73,688)2,3716,0895106,599 Contributions by/distributions to owners of the Company recognised directly in equity Dividends paid to minorities–––––––(56)(56) Total contributions by and distributions to owners of the Company– – – – –– –(56)(56) Balance at 31 August 202377 88,459 (190) (10,940) (73,688)2,3716,0894546,543 US$’000Share CapitalShare PremiumRevaluation ReserveForeign Exchange ReserveAccumulated LossesNon-distributable ReserveTotalNon-controlling InterestTotal Balance at 1 September 2023 7788,459(190)(10,940)(73,688)2,3716,0894546,543Loss for the period––––(58)–(58)14(44)Foreign currency translation differences for overseas operations–––88––88(51)37Total comprehensive (loss)/income for the period –––88(58)–30(37)(138)Contributions by/distributions to owners of the Company recognised directly in equity Dividends paid–––––––(4)(4)Total contributions by and distributions to owners of the Company –––––––––Balance at 28 February 2024 7788,459(190)(10,852)(73,746)2,3716,1194136,532Cambria Africa Plc
Interim consolidated statement of cash flows
For the six month period ended 28 February 2024
Unaudited28-Feb-24US$’000 Unaudited 28-Feb-23 US$’000Audited 31-Aug-23US$’000 Cash generated from operations 33 128 307Taxation paid(61)(43)(142)Cash generated from operating activities (28) 85 165 Cash flows from investing activitiesProceeds on disposal of property, plant and equipment – 15–Purchase of property, plant and equipment––(5)Purchase of gold coins––(31)Dividends received–6 Interest received101131Net cash (utilized in)/ generated investing activities 10 26 1 Cash flows from financing activitiesDividends paid to non-controlling interests(4)–(56)Legacy debt received–75407Loans repaid–––Net cash (utilized) by financing activities (4) 75 351 Net (decrease)/ increase in cash and cash equivalents (22) 186 517Cash and cash equivalents at the beginning of the period1,5521,2631,263Foreign exchange37(88)(228)Net cash and cash equivalents at the end of the period 1,567 1,361 1,552 Cash and cash equivalents as above comprise the followingCash and cash equivalents attributable to continuing operations1,5671,3611,263Net cash and cash equivalents at 31 August 1,567 1,361 1,263* Amounts include both continuing and discontinued operations.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
October 11, 2025
9th Sep 2025
MBT:JPJ
ISIN: GB00B01RQV23
Mobile Tornado Group PLC
(“Mobile Tornado” or “the Company”)
Shares trading on JP Jenkins
London, UK, 9 September 2025 – Mobile Tornado Group plc (MBT:JPJ), today announces its shares have been admitted to trade on JP Jenkins share dealing platform. The Company’s registered address is Copthall Bridge, 59 Station Parade, Harrogate, North Yorkshire, England, HG1 1TT and company number is 05136300.
Mobile Tornado Group plc sells software licences and services to enterprises and operators worldwide through several distribution partners. It specialises in providing platforms and applications in the mobile data services market including presence-based messaging, Push to Talk, Push to Locate, Push to Alert and related services.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
The indicative pricing for the ordinary shares as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/).
For further information, please contact:
Mobile Tornado Group plc
Investor Relations
Tel. +44 (0) 142 351 1900
Email: sales@mobiletornado.com
JP Jenkins Ltd
Veronika Oswald / Mason Doick
Tel. +44 (0) 207 469 0937
Email: info@jpjenkins.com
– ENDS –
September 9, 2025
27 August 2025
Quantum Group is proud to announce it has successfully become a carbon neutral business in 2025, working with Carbon Neutral Britain to develop sustainable policies and introduce carbon offsetting. This announcement comes as the UK’s leading fintech and security incubator – which includes companies Volopa, Verve, Valkyrie and Forensic Control in its growing portfolio – scales towards a public listing planned for 2026.
Floyd Woodrow MBE DCM LLB, Quantum Group Co-Founder and CEO, said: “Developing a robust environmental policy is vital for any forward-facing enterprise. Therefore, we are delighted to announce that Quantum Group has achieved carbon neutral certification ahead of our anticipated schedule.
"In addition to building sustainable practices into all areas of the Group to reduce carbon emissions and increase eco-responsible operation, we are proud to work with Carbon Neutral Britain to support wider projects that have a positive impact on climate change within our local and international communities."
Carbon Neutral Britain is the UK's leading carbon offsetting initiative that is helping British businesses and individuals make an impact on climate change. Increased emissions of carbon dioxide and other greenhouse gases is the leading cause of global warming in the world. When a business or individual offsets their carbon footprint (through planting trees, funding renewable energy and forest projects that absorb carbon dioxide from the atmosphere), they can balance out their emissions to become what is known as carbon neutral.
By becoming carbon neutral certified, Quantum Group has taken a proactive approach to tackle climate change and reverse the impact of emissions created in the world. This is just one of the many ways that the company is building sustainable practices within the Group.
Each month, Carbon Neutral Britain purchases carbon credits based on the number of tonnes of greenhouse gases required for their individual and business customers. From mangrove restoration in Mozambique to the Marston Valley forest creation in England, in addition to planting trees, the organisation also funds projects in the developing world that help provide education, employment, clean water, energy and a positive impact on the local wildlife and ecology.
Visit www.quantumgroup.uk to find out more
August 27, 2025
August 21, 2025
August 13, 2025
Mobile Tornado Group PLC
11 August 2025
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
11 August 2025
Mobile Tornado Group plc
(“Mobile Tornado“, the “Company” or the “Group“)
Proposed cancellation of admission of the Ordinary Shares to trading on AIM
Proposed re-registration as a private limited company and adoption of New Articles
and
Notice of General Meeting
Mobile Tornado (AIM: MBT), a leading provider of resource management mobile solutions to the enterprise market, announces the proposed cancellation of admission of its Ordinary Shares to trading on AIM, its proposed re-registration as a private limited company and the proposed adoption of new articles of association.
As detailed further below, the Directors consider that it is in the best interests of the Company and its Shareholders taken as a whole to cancel the admission of the Ordinary Shares to trading on AIM. A circular (the “Circular”) will be sent to Shareholders today and will shortly be available on the Company’s website, www.mobiletornado.com, setting out the background to and reasons for the proposed Cancellation and Re-Registration and containing a notice of General Meeting. Extracts from the Circular are set out, without material amendment, below.
The Cancellation is conditional upon the approval of not less than 75 per cent of the votes cast by Shareholders (whether present in person or by proxy) in respect of the Cancellation Resolution at the General Meeting. The General Meeting is being convened at the offices of Mobile Tornado at Copthall Bridge, 59 Station Parade, Harrogate, HG1 1TT at 10:00 a.m. UK time on 1 September 2025.
Pursuant to Rule 41 of the AIM Rules, the Company through its nominated adviser, Allenby Capital Limited, has notified the London Stock Exchange of the date of the proposed Cancellation which is expected to become effective at 7.00 a.m. on 9 September 2025 if the Cancellation Resolution is passed at the General Meeting.
Enquiries:
EXTRACTS FROM THE CIRCULAR
EXPECTED TIMETABLE OF PRINCIPAL EVENTS
Each of the dates in the above timetable is subject to change at the absolute discretion of the Company.
References to time in this Document and in the Form of Proxy are to UK time.
The timetable above assumes that the Resolutions set out in the Notice of General Meeting will be passed.
Events listed in the above timetable following the General Meeting are conditional on the Resolutions being passed at the General Meeting without amendment.
If any of the above times and/or dates change, the revised time(s) and/or date(s) will be notified to Shareholders by announcement through a Regulatory Information Service.
August 11, 2025
July 25, 2025
K3 Business Technology Group PLC
21 July 2025
This release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation (2014/596/EU), or EU MAR, and of the UK version of EU MAR as it forms part of UK law by virtue of the European Union (Withdrawal) Act (as amended).
K3 BUSINESS TECHNOLOGY GROUP PLC
(“K3” or “the Group” or “the Company”)
Result of Tender Offer
K3, which provides business-critical software solutions focused on fashion and apparel brands, announces the results of the Tender Offer set out in the circular published by the Company on 2 July 2025 (the “Circular”), which closed at 1.00 p.m. on 18 July 2025. The Tender Price was 85 pence per Share.
The Company offered to purchase up to a maximum of 34,117,647 Shares (being approximately 74.3 per cent. of the Company’s existing issued share capital) under the Tender Offer. In total, 33,797,331 Shares were validly tendered under the Tender Offer through Qualifying Shareholders’ Basic Entitlements as well as excess applications received in respect of 10,144,370 Shares through excess tenders. As such, the total number of Shares being acquired by the Company is the maximum of 34,117,647. All valid tenders were satisfied in full pursuant to their Basic Entitlement (rounded down to the nearest whole number of Shares) and excess applications were satisfied based on a percentage proportion of the total excess tenders received, with 320,316 Shares accepted pursuant to excess tenders.
It is expected that cheques will be despatched and CREST accounts will be credited with proceeds in respect of successfully tendered shares on or before 28 July 2025.
The 34,117,647 Shares tendered under the Tender Offer will be repurchased by the Company under the Repurchase Agreement and cancelled.
The ordinary issued share capital of the Company following the purchase will be 11,814,732 (with no ordinary shares held in treasury). The total voting rights in the Company following the purchase and cancellation will be 11,814,732.
The figure of 11,814,732 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.
The Company reminds Shareholders of the expected timetable of principal events as follows:
CREST accounts settled in respect of unsold tendered Shares held in uncertificated form 22 JulyPayments through CREST made in respect of Shares held in uncertificated form successfully tenderedby 28 JulyCheques despatched in respect of Shares held in certificated form successfully tenderedby 28 JulyBalancing certificates despatched in respect of unsold tendered Shares held in certificated formby 28 JulyLast day of dealings in the Shares on AIM29 JulyCancellation of admission of the Shares to trading on AIM30 JulyUnless otherwise defined, capitalised terms in this announcement shall have the meaning set out in the Circular.
Enquiries:
K3 Business Technology Group plcOliver Scott, ChairmanT: c/o 020 3178 6378www.k3btg.comEric Dodd, Chief Executive Officer Cavendish Capital Markets(NOMAD & Broker)Julian Blunt/ Callum Davidson/Trisyia Jamaludin(Corporate Finance)Sunila De Silva(Corporate Broking)T: 020 7220 0500This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
July 21, 2025
18th July 2025
PMGL:JPJ
ISIN: GB00BPNWR625
Powder Monkey Group Limited
(“Powder Monkey” or “the Company”)
Powder Monkey Group Acquires Akasha & Wayward Brewing Co.
Sydney, Australia & Gosport, UK – Powder Monkey Group, an independent craft brewing and hospitality collective with operations across the UK and Australia, has officially acquired the brands of Wayward Brewing Company and Akasha Brewing Company, two of Sydney’s most celebrated craft breweries. The move is a major step in Powder Monkey’s global expansion strategy and further consolidates its operations alongside Southern Highlands Brewing Co. and Willie the Boatman and the Powder Monkey brand in Australia and Asia.
This acquisition brings together five award-winning breweries, uniting operational scale, local authenticity, brand strength, and innovative brewing under a single, independent global platform. It adds an additional $AUD5.5m revenue to the Group turnover and provides the capacity and capability for a series of significant new ventures.
Powder Monkey Group’s Australian based Director Ben Twomey said “This was about extending the international ‘buy and build’ value strategy as well as creating a sizeable central brewing engine in Australia. High asset utilisation is a key measure which is supported by the multiple brand wholesale businesses”
With this acquisition, the combined Australian team will operate from four high-performing venues:
Dave Padden will be appointed General Manager Powder Monkey Australia, overseeing a team of combined talent from the previous independent entities.
“Akasha and Wayward are two of the most respected names in independent Australian brewing, and I am excited about the experience Dave Padden provides to the Group” said Andy Burdon, Group CEO. “This acquisition brings strength, scale, and storytelling power to our portfolio—and positions us to lead in craft beer not just in Australia and the UK, but across global markets.”
About Powder Monkey Group
Founded in 2021 in Gosport, UK, Powder Monkey Group operates breweries, taprooms, and hospitality venues across the UK and Australia. With a focus on craft, community, and quality, the group now includes:
In 2025, the group listed on the JP Jenkins secondary market and continues to pursue targeted acquisitions and partnerships across Europe, Australia, and Southeast Asia.
About Akasha & Wayward
Founded by close friends Pete Philip (Wayward) and Dave Padden (Akasha), the two Sydney breweries have long been mainstays of Australia’s independent beer scene. Their partnership—now supercharged by Powder Monkey—unlocks significant opportunity for growth, innovation, and efficiency.
Wayward is known for its bold creativity, pioneering category moves like sparkling hop waters, hard seltzer and better-for-you beers, while Akasha brings technical precision and mastery of hop-forward, core-range beers like Hopsmith IPA and Freshwater Pale Ale. Together, they boast decades of brewing experience and a trophy cabinet full of gold medals from the AIBAs, The Indies, and Sydney Royal.
“This is about more than joining forces—it’s about doing more of what we love, better,” said Pete Philip, Founder of Wayward. “We’ve always believed in independent beer with soul and integrity. Powder Monkey brings the backing and structure to take that spirit global—without compromising what made our brands special in the first place.”
Dave Padden, Founder of Akasha, added: “We’ve always brewed with precision, but now we have a platform to scale that quality. Partnering with Powder Monkey means better beer, broader reach, and more capacity to innovate.”
Contacts
July 18, 2025
(Alliance News) – Superdry PLC on Friday said it will begin trading on the JP Jenkins securities matching platform following its delisting in London.
In April, the Cheltenham, England-based clothing retailer announced its intention to delist from the London Stock Exchange as part of wider restructuring plans which were subsequently approved by shareholders and sanctioned by the court in June.
Superdry cited the “significant annual cost savings from the delisting” as the reason behind the decision.
In the last reported full year that ended April 29 2023, Superdry swung to a pretax loss of GBP78.5 million from a GBP17.6 million profit a year prior, as selling and distribution costs grew by 13% to GBP306.6 million.
Interim results for the six months ending October 28 revealed a 24% fall in revenue to GBP219.8 million from GBP287.2 million the previous year.
The restructuring plan will primarily focus on amending Superdry’s leasehold obligations to reduce losses and property-related liabilities with rent reductions expected at 39 of its UK sites.
Meanwhile the maturity of loans with Bantry Bay Capital Ltd and Hilco Capital Ltd are to be extended.
An equity raise via a placing of shares at 5 pence each totalling GBP10 million is to provide liquidity headroom to implement the plan.
The company’s stock price has been trending downwards falling 97% over the past five years.
Superdry shares were up 8.8% to 3.70 pence each in London on Friday morning.
On Friday, the company’s last day of trading on the London Stock Exchange, Superdry said its shares are to be admitted to trading on the JP Jenkins securities matching platform from July 15 onwards.
The platform provides a venue for unlisted or unquoted assets in companies, and shareholders wishing to trade these securities will be able to do so through their stockbroker.
By Elijah Dale, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
July 15, 2025
08 July 2025
For immediate release
ADVFN LIMITED
(ADVFN)
Result of General Meeting
The Board of ADVFN announces that at the General Meeting held on Monday, 7 July 2025, theResolution was passed. The voting was determined by a poll and the results in respect of theResolution was as follows:
ResolutionsVotes For%Votes Against% Ordinary Resolution – authority to allot15,341,53899.957,2360.05
The Resolution was proposed as an ordinary resolution to authorise directors to allot shares pursuant to section 551 of the Companies Act 2006 in connection with the Open Offer, particulars of which are set out in a circular issued by ADVFN on 19 June 2025.
Expected Open Offer timetable
The dates and times given below are as previously announced and are based on the current expectations and may be subject to change. If any of the below times and/or dates change, the revised time(s) and/or date(s) will be notified to Shareholders. All references to time are to London time unless otherwise stated.
Event2025Latest time and date for receipt of completed Application Forms and payment in full under the Open Offer or settlement of the relevant CREST instructions (as appropriate)11:00 a.m. on 15 JulyExpected date of announcement of the results of the Open Offer16 July
A copy of this announcement is available on the Company’s website, www.advfnplc.com, and the website of JP Jenkins, https://jpjenkins.com/company/advfn-plc/.
For further information please contact:
ADVFN LimitedAmit Tauman (CEO)+44 (0) 203 8794 460
July 8, 2025
TALLY CENTRAL LTD
(“Tally Central”, “TAL” or the “Company”)
Tally Central Ltd (TAL : JPJ), the money innovator and central authority of the Tally full-reserve physical gold monetary system, with milligrams of gold branded as tally®, is pleased to update shareholders about the Company’s Q2 activities.
Tally Central’s monetary system enables people to use sound money in an everyday account and TallyMoney debit Mastercard®, and provides transparent and inexpensive gold ownership, with real- time spending. Every unit of tally (the currency, spelt with a lowercase ‘t’) represents 1 milligram of ethically sourced physical gold from London Bullion Market Association (LBMA)-accredited brokers that is vaulted in Switzerland on behalf of Tally customers with LBMA-accredited high security provider, Brinks®. Tally’s standalone monetary system operates independently to the debt-based fiat- currency fractional-reserve banking system but seamlessly works with that established funds transfers and merchant payments infrastructure. Tally is the first in the world to offer individual customer IBANs (International Bank Account Numbers) to access a currency that is not issued by a government.
Cameron Parry, Founder and Chief Executive Officer, commented: “Tally is on a mission to provide sound money for the people, that benefits and protects depositors and savers, and can be used as an alternative to the local currency issued by a government’s central bank.
Combining the value of gold with our innovative payments technology, we deliver sound money for individual financial wellbeing and to promote savings and productivity in society. The TallyMoney App provides a transparent and inexpensive way for customers to own gold in seconds, with instant access and the familiar use of an everyday account and debit card.
The second quarter of 2025 saw the completion of behind-the-scenes operational improvements and automations necessary to scale, and the finalisation of a comprehensive multi-layered marketing plan that just went live on the 1st of July. The campaign is a bold, rebellious and a cheeky call to action for the establishment challenger audience, targeting their frustrations with the fiat currency banking system. By using the phrase “Up yours!”, the campaign is both calling out common pain points such as inflation, low savings returns, and loss of financial independence, as well as showing a way to ‘up’ what they are searching for: self-sovereignty, financial resilience, and personal control of their money. TallyMoney offers a solution by providing savings held in physical gold with real-time spending, encouraging people to up your savings, up your gold, and up your financial freedom with TallyMoney.
As shareholders know, Tally Central’s shares commenced trading on the JP Jenkins platform in London (TAL : JPJ) on the 1st of February this year. Although we are not conducting investor relations yet and the first financial performance reporting (following shares being admitted to trading) is not due until the Company releases its end of financial year audited accounts (scheduled for late October 2025), since TAL shares have been tradable (1 February), TAL has been the 2nd most traded stock by value, and 1st in most traded by number of shares, on the JP Jenkins platform.
Tally is well underway now into its roadmap and regulatory strategy for calendar years 2025 & 2026, with our target of achieving operating profitability by the end of December 2026. We continue to currently focus resources on growing the core business, increasing customer acquisition and transaction volumes, and promoting the Company’s core products and completion of our sub products suite. And with our well-funded establishment challengers marketing campaign now live in the UK, we should be in for an exciting second half of 2025.”
For further information:
Email: corporate@tallymoney.com
Tel: +44 (0) 20 3858 0373
About TALLY
July 3, 2025
02 July 2025
2 July 2025
THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION IN WHOLE OR IN PART IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE ITS RELEASE, PUBLICATION OR DISTRIBUTION IS OR MAY BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN INVITATION TO PARTICIPATE IN THE TENDER OFFER (AS DEFINED HEREIN) IN OR FROM ANY JURISDICTION IN OR FROM WHICH, OR TO OR FROM ANY PERSON TO OR FROM WHOM, IT IS UNLAWFUL TO MAKE SUCH OFFER UNDER APPLICABLE SECURITIES LAWS OR OTHERWISE.
K3 BUSINESS TECHNOLOGY GROUP PLC
(“K3” or “the Group” or “the Company”)
Proposed Return of up to £29.0 million to Shareholders by Way of a Tender Offer for up to 34,117,647 Shares at 85 pence per Share
and
Cancellation of Admission of Shares to Trading on AIM
Publication of Circular and Notice of General Meeting
K3, which provides business-critical software solutions focused on fashion and apparel brands, announces that it will shortly be posting a Circular (the “Circular“) setting out the details of a proposed return of capital to Shareholders of up to £29.0 million as distribution from the proceeds of the Nexsys Disposal (the “Tender Offer“) and the proposed cancellation of admission of shares to trading on AIM (the “De-Listing” and, together with the proposed Tender Offer, the “Proposals”).
Further to its announcement on 3 April 2025, the Company is seeking to return up to approximately £29.0 million of cash to Qualifying Shareholders by way of the Tender Offer. The Tender Offer will be conducted at a fixed price of 85 pence per Ordinary Share (the “Tender Price“), which represents the closing mid-market price of an Ordinary Share on 1 July 2025 (being the “Latest Practicable Date“) and will be subject to the passing of the Tender Offer Resolution.
If the maximum number of Ordinary Shares under the Tender Offer is acquired, this would result in the purchase of approximately 74.3 per cent. of the Company’s current issued share capital. The Tender Offer and De-Listing remain subject to approval by Shareholders at the General Meeting, to be held at the offices of Cavendish Financial plc at One Bartholomew Close, London EC1A 7BL 11.00 a.m. on 18 July 2025.
The Circular sets out the background to and reasons for the Proposals, terms and conditions of the Tender Offer and explains how Qualifying Shareholders may tender Shares, should they wish to do so. The Circular will be published on the Company’s website at https://www.k3btg.com/investor-centre/regulatory-news/#circulars.
Unless otherwise defined, capitalised terms in this announcement shall have the meaning set out in the Circular.
Enquiries:
K3 Business Technology Group plcOliver Scott, ChairmanT: c/o 020 3178 6378www.k3btg.comEric Dodd, Chief Executive Officer Cavendish Capital Markets(NOMAD & Broker)Julian Blunt/Callum Davidson/Trisyia Jamaludin(Corporate Finance)Sunila De Silva(Corporate Broking)T: 020 7220 0500KTZ CommunicationsKatie Tzouliadis/ Robert MortonT: 020 3178 6378Expected Timetable
Announcement of Tender Offer and De-ListingPosting of the Circular20252 July2 JulyTender Offer opens2 JulyLatest time and date for receipt of CREST Proxy Instructions for the General Meeting11.00 a.m. on 16 JulyLatest time and date for receipt of Forms of Proxy for the General Meeting11.00 a.m. on 16 JulyGeneral Meeting11.00 a.m. on 18 JulyLatest time and date for receipt of Tender Forms or for settlement of TTE Instructions in respect of the Tender Offer1.00 p.m. on 18 JulyRecord Date for participation in Tender Offer6.00 p.m. on 18 JulyResult of Tender Offer announced21 JulyCREST accounts settled in respect of unsold tendered Shares held in uncertificated form22 JulyPayments through CREST made in respect of Shares held in uncertificated form successfully tenderedby 28 JulyCheques despatched in respect of Shares held in certificated form successfully tenderedby 28 JulyBalancing certificates despatched in respect of unsold tendered Shares held in certificated formby 28 JulyLast day of dealings in the Shares on AIM29 JulyCancellation of admission of the Shares to trading on AIM30 JulyNotes:
1 Each of the times and dates referred to in the expected timetable above and elsewhere in this announcement may be extended or brought forward at the discretion of the Company. If any of the above times and/or dates change, the revised time(s) and/or date(s) will be notified to Shareholders by an announcement through a Regulatory Information Service.
2 All times referred to in this announcement are, unless otherwise stated, references to London time.
K3 BUSINESS TECHNOLOGY GROUP PLC
(“K3” or “the Group” or “the Company”)
Proposed Return of up to £29.0 million to Shareholders by Way of a Tender Offer for up to 34,117,647 Shares at 85 pence per Share
and
Cancellation of Admission of Shares to Trading on AIM
Publication of Circular and Notice of General Meeting
1. Introduction
Following on from the Company’s sale of NexSys Solutions Limited (“Nexsys“) which was completed on 6 January 2025 for cash consideration of approximately £36 million (the “Nexsys Disposal“), and the capital reorganisation as approved by the Court on 11 June 2025, the Company now intends to return up to approximately £29.0 million of cash to Qualifying Shareholders by way of a tender offer and subsequent repurchase from Cavendish of the Shares successfully tendered (the “Tender Offer“). The Tender Offer will be conducted at a fixed price of 85 pence per Share (the “Tender Price“). Once the Tender Offer is completed the Directors are also proposing to de-list the Company from AIM.
The Tender Offer is being made available to all Shareholders who are on the Register at the close of business on 18 July 2025, with the exception of holders in certain overseas jurisdictions. Qualifying Shareholders can decide whether they want to tender some or (subject to scale back) all of their Shares at a price of 85 pence per Share, being the closing mid-market price on the Latest Practicable Date.
The Tender Offer is being made by Cavendish, the Company’s corporate broker, as principal on the basis that all Shares that it buys under the Tender Offer will be purchased from it by the Company. The Company requires the authority from Shareholders to purchase any such Shares and this is being sought at the General Meeting to be held at the offices of Cavendish Financial Plc, One Bartholomew Close, London, EC1A 7BL at 11.00 a.m. on 18 July 2025. The General Meeting will also seek Shareholder approval for the Delisting Resolution.
The purpose of the Circular is to explain the terms and conditions of the Tender Offer and subsequent repurchase of Shares and to explain how Qualifying Shareholders may tender Shares, should they wish to do so, and the background to and reasons for the Delisting and why the Board unanimously recommends that Shareholders vote in favour of the Resolutions to be proposed at the General Meeting, notice of which is set out in Part 9 of the Circular.
The Board is unanimously recommending Shareholders to vote in favour of the Resolutions to be proposed at the General Meeting, as the Directors intend to do in respect of their own beneficial holdings of Shares amounting to 0.14 per cent. in aggregate of the Company’s issued share capital. The Directors also intend to tender for no less than their Basic Entitlements in the Tender Offer.
Further, both Kestrel Partners LLP (“Kestrel“) and PJ Claesson have irrevocably undertaken to tender for no less than their Basic Entitlements in the Tender Offer and to vote in favour of the Tender Offer Resolution in respect of their holdings of 13,274,493 Shares and 11,321,780 Shares, respectively, amounting to 53.5 per cent. in aggregate of the issued share capital.
When the Company announced the conditional sale of NexSys on 2 December 2024 the Board was clear that it anticipated returning a substantial proportion of the net proceeds of the disposal to Shareholders. Since completion of the NexSys Disposal the Board has focused on:
• stabilising the Group’s remaining businesses, comprising the K3 Products Division and the Third Party Solutions Division (the “Remaining Group“) with a view to returning the Group’s continuing operations to a month on month cashflow breakeven position from March 2025 onwards. In this regard we are pleased to report that, with ongoing focus on cost discipline and cash management, month on month cashflow breakeven was achieved in April and May 2025;
• reorganising the Company’s balance sheet in order to permit a lawful distribution of capital by way of a process such as the Tender Offer; and
• assessing the different options through which it may distribute capital to Shareholders, with the Board concluding that the Tender Offer is the most suitable way of doing so quickly and efficiently, taking into account the relative costs, complexity and timeframes of other possible methods, as well as the likely tax treatment for and equality of treatment of Shareholders.
Integral to the above has been assessment of the quantum of the NexSys Disposal proceeds considered appropriate to be retained within the Group to leave it with sufficient working capital and restructuring funding to operate debt free. This amount is expected to be approximately £6.0 million (including £3.3 million of restricted cash, restricted until July 2026), leaving approximately £29.0 million (after costs) to be returned by way of the Tender Offer, equating to approximately 4 per cent. more than the entire market capitalisation of K3 prior to the announcement of the sale of NexSys.
As the Group stated in its final results announcement for the year ended 30 November 2024 (“FY24“) on 27 February 2025, FY24 was a challenging year, especially at Global Accounts (the predominant part of the Third-Party Solutions Division) whose revenue fell by approximately 41.4 per cent. Whilst FY24 results were nonetheless in line with Board’s expectations, with Third Party Solutions’ revenue now holding at a significantly reduced level with no expectation of return to previous levels, the rate of deal closure in the K3 Products Division is slowing and further restructuring is still required. In light of these prospects and the factors described below, the Board does not believe that K3’s future is best served by its continued admission to AIM. Accordingly, the Board has now concluded that the De-Listing, following completion of the Tender Offer, is in the best interests of the Company and its Shareholders as a whole.
Whether or not the De-Listing Resolution is approved, the Board’s focus remains on delivering value to Shareholders. It is expected that this will be achieved by maintaining strong financial discipline, continuing to simplify the Group, as appropriate, through the sale of non-core businesses and to judiciously invest in profitable growth opportunities. As further value is realised and cash generated, the Board intends to return this to Shareholders on a timely basis.
In reaching its conclusion in relation to the De-Listing, in addition to the Group’s trading prospects described above, the Board has also considered the following factors:
• the scale and structure of the UK Small Cap market has changed for the foreseeable future and K3 is too small to be of interest to the vast majority of a reducing number of investors in UK publicly-quoted companies;
• In the opinion of the Board, the Tender Offer represents a near term opportunity for Qualifying Shareholders to realise a large part of the current value of their investment in the Company for cash;
• in the opinion of the Board, the level of free float in the shares of the Company is not of a scale to attract sufficient interest from institutional and other investors and it is difficult therefore to create a more liquid market for its Shares to effectively or economically utilise its AIM quotation;
• in light of the limited trading in the Shares, the costs associated with maintaining the AIM quotation are considered by the Directors to be disproportionately high when compared to the benefits, and the Board believes that these funds could be better utilised; and
• the management time and the legal and regulatory burden associated with maintaining the Company’s admission to trading on AIM is, in the Directors’ opinion, disproportionate to the benefits to the Company.
If the De-Listing Resolution is not approved by Shareholders the Company will remain liable for the ongoing professional and related costs associated with maintaining its admission to AIM, which amounted to approximately £0.3 million during FY24.
Further information in relation to the proposed De-Listing is set out in paragraph 5 below.
The Tender Offer will be implemented on the basis that Cavendish will acquire, as principal, the successfully tendered Shares from all Shareholders (other than certain Overseas Shareholders) (“Tendered Shares“). Full details of the Tender Offer, including the terms and conditions on which it is being made, are set out in Part 3 of the Circular and, in relation to Shareholders holding Shares in a certificated form, on the Tender Form to be sent to them.
The Tender Offer is conditional on the passing of Resolution 1 (which will be proposed as an ordinary resolution) set out in the notice of General Meeting at the end of the Circular and the satisfaction of the other Conditions specified in Part 3 of the Circular.
The Tender Offer (subject to the overriding terms and conditions set out in Part 3 of the Circular) involves the following:
• The Tender Offer is being made to all Shareholders (other than certain Overseas Shareholders) for the purchase of up to 34,117,647 Shares. Under the Tender Offer, each Shareholder is entitled to have up to 74.3 per cent. of his or her shareholding (representing his/her Basic Entitlement) purchased by Cavendish at the Tender Price together with potentially further purchases depending on the number of Shares tendered by other Shareholders. Basic Entitlements will be calculated by the Receiving Agent as at the Record Date by reference to the Qualifying Shareholder’s holding of Shares as at that date.
• The Tender Offer is being made at a price of 85 pence per Share, being the closing mid-market price on the Latest Practicable Date, for a maximum aggregate consideration of approximately £29.0 million.
• Successfully Tendered Shares will be purchased free of commission and dealing charges.
• Shareholders (other than certain Overseas Shareholders) will be able to decide to tender none, some or all of their Shares within the overall limits of the Tender Offer.
• Tenders in excess of a Shareholders’ Basic Entitlement can only be accepted to the extent that other Shareholders tender less than their Basic Entitlement or do not tender any Shares.
• All Shares validly tendered by any Shareholder up to their Basic Entitlement are intended to be accepted in full.
• The Tender Form to be completed by Shareholders who hold their Shares in certificated form contains a box to enable those Shareholders who wish to tender their Basic Entitlement to do so (Box 2A). If Shares are held in certificated form and this box is ticked, the Receiving Agent will calculate Basic Entitlements on the Record Date. If Shareholders wish to tender a different number of Shares to their Basic Entitlement, such number of Shares can be inserted in the alternate box provided on the Tender Form (Box 2B).
• Shareholders who hold their Shares in uncertificated form (i.e. in CREST) and who wish to tender their Basic Entitlement should send a TTE instruction through CREST to the member account set out in paragraph 3.3(v) of Part 3 of the Circular. The Receiving Agent will calculate Basic Entitlements on the Record Date and return any excess Shares. If Shareholders wish to tender a different number of Shares to their Basic Entitlement, they should send a TTE Instruction through CREST to the same member account specifying such number of Shares that they wish to tender.
• If the total number of Shares validly tendered by all Shareholders equates to a number greater than 34,117,647 Shares, tenders are intended to be accepted in the order set out below:
– all Shares validly tendered by any Shareholder up to their Basic Entitlement are intended to be accepted in full; and
– all Shares validly tendered by Shareholders in excess of their Basic Entitlements will be satisfied at the discretion of the Board. The number of Shares to be purchased in the Tender Offer will not, in any event, exceed 34,117,647 Shares.
• All successfully Tendered Shares purchased by Cavendish will be repurchased from Cavendish by the Company pursuant to the Repurchase Agreement and will be immediately cancelled and will not rank for any future dividends.
• Any rights of Shareholders who choose not to tender their Shares will be unaffected, however, the reduction in the Company’s issued share capital is likely to result in a further reduction in the liquidity of the Shares in the secondary market. Attention is also drawn to section 5 below regarding the effects of the De-Listing.
4. Repurchase Agreement
Under the Repurchase Agreement, the parties have agreed that, subject to, amongst other things, the sum of approximately £29.0 million (equal to the Tender Price multiplied by the maximum number of Shares that could be repurchased under the Tender Offer) being received by Cavendish (or its custodian) by no later than 5.00 p.m. on 23 July 2025 (or such later time and/or date as may be agreed by Cavendish and the Company) and the Tender Offer becoming unconditional in all respects and not lapsing or terminating in accordance with its terms, Cavendish shall, as principal, purchase, “on exchange”, at the Tender Price, Shares successfully tendered to it, up to a maximum aggregate value, at the Tender Price, of approximately £29.0 million.
The Company has agreed that, immediately following the purchase by Cavendish of all Shares which it has agreed to purchase as principal under the terms of the Tender Offer, the Company will purchase from Cavendish all such Shares at a price per Share equal to the Tender Price. All transactions will be carried out on the London Stock Exchange.
Under the Repurchase Agreement, the Company has agreed to cancel any Shares purchased by it under the Tender Offer. The Repurchase Agreement contains certain warranties from Cavendish in favour of the Company concerning its authority to enter into the Repurchase Agreement and to make the purchase of Shares pursuant thereto. The Repurchase Agreement also contains warranties and undertakings from the Company in favour of Cavendish and incorporates an indemnity in favour of Cavendish in respect of any liability which it may suffer in relation to the performance of its obligations under the Tender Offer. The Company will also be liable to pay Cavendish’s fees, costs and expenses under the terms of Cavendish’s engagement by the Company in connection with the Tender Offer.
The principal effects of the De-Listing will be that:
• there will not be a formal market mechanism enabling the Shareholders to trade Shares;
• while the Shares will remain freely transferrable, it is possible that the liquidity and marketability of the Shares will, in the future, be more constrained than at present and the value of such shares may be adversely affected as a consequence. Shareholders will note however, as set out above, that the Directors believe that the existing liquidity in the Shares is, in any event, limited. Shareholders should also note that the Directors intend to establish the Matched Bargain Facility with effect from De-Listing, as referred to below, though no representation is made that this will guarantee liquidity in the future;
• in the absence of a formal market and quote, it may be more difficult for Shareholders to determine the market value of their investment in the Company at any given time;
• the regulatory and financial reporting regime applicable to companies whose shares are admitted to trading on AIM will no longer apply and the Company will no longer be subject to UK MAR or the Disclosure Guidance and Transparency Rules and so will therefore no longer be required to disclose significant shareholdings in the Company;
• Shareholders will no longer be afforded the protections given by the AIM Rules and the requirement that the Company seek Shareholder approval for certain corporate actions, where applicable, including substantial transactions, reverse takeovers, and fundamental changes in the Company’s business;
• the levels of transparency and corporate governance within the Company may not be as stringent as for a company quoted on AIM;
• Cavendish will cease to be the Company’s nominated adviser and the Company will cease to have a broker;
• stamp duty will be payable on transfers of Shares as the Shares will no longer be traded on AIM; and
• the De-Listing may have personal taxation consequences for Shareholders. Shareholders who are in any doubt about their tax position should consult their own professional independent tax adviser.
Shareholders should note that the Takeover Code will continue to apply to the Company provided its registered office is in the UK, the Channel Islands or the Isle of Man for a period of two years following the date of the De-Listing. After this period, the Code will cease to apply to the Company. Further details regarding the scope and applicability of the Takeover Code are set out in paragraph 8 below.
The Company will also continue to be bound by the Companies Act (which requires shareholder approval for certain matters) following the De-Listing.
The above considerations are not exhaustive, and Shareholders should seek their own independent advice when assessing the likely impact of the De-Listing on them.
Under the AIM Rules, the De-Listing can only be effected by the Company after securing a special resolution of Shareholders in a general meeting and the expiry of a period of 20 clear Business Days from the date on which notice of the De-Listing is given to the London Stock Exchange. In addition, a period of at least five clear Business Days following Shareholders’ approval of the De-Listing is required before the De-Listing may become effective. The Notice of General Meeting contains a special resolution which seeks the approval of Shareholders for the De-Listing. Assuming that the De-Listing Resolution is approved, the De-Listing is expected to take place at 7.00 a.m. on 30 July 2025.
The Company currently intends to continue to provide certain information, services and facilities to Shareholders following the De-Listing. The Company intends to:
• continue to communicate information about the Company (including annual accounts) to its Shareholders, as required by the Companies Act;
• continue, for at least 12 months following the Cancellation, to maintain its website, www.k3btg.com and to post updates on the website from time to time, although Shareholders should be aware that there will be no obligation on the Company to include all of the information required under the Disclosure Guidance and Transparency Rules, AIM Rule 26, UK MAR or to update the website as currently required by the AIM Rules; and
• make available to Shareholders, by way of J P Jenkins’ Matched Bargain Facility, the means to buy and sell Shares on a matched bargain basis following the De-Listing. J P Jenkins is an appointed representative of Prosper Capital LLP, which is authorised and regulated by the FCA.
It is intended that the Matched Bargain Facility will operate for a minimum of 12 months after the De-Listing. The Directors’ current intention is that it will continue beyond that time but Shareholders should note that it could be withdrawn and therefore inhibit the ability to trade the Shares. Further details will be communicated to the Shareholders at the relevant time.
The attention of Qualifying Shareholders who are citizens, residents or nationals of countries outside the UK wishing to participate in the Tender Offer is drawn to paragraph 6 (entitled “Overseas Shareholders”) in Part 3 of the Circular.
Qualifying Shareholders should be aware that there may be tax considerations that they should take into account when deciding whether or not and/or the extent to which to participate in the Tender Offer. A summary of the taxation consequences of the Tender Offer for UK resident Shareholders is set out in Part 5 of the Circular. It should be noted that this tax summary is merely a guide to current tax law and practice in the UK. Shareholders are advised to consult their own professional advisers regarding their own tax position.
The Code is issued and administered by the Panel. The Code currently applies to the Company and, accordingly, Shareholders are entitled to the protections afforded by the Code.
The Code and the Panel operate principally to ensure that shareholders in an offeree company are treated fairly and are not denied an opportunity to decide on the merits of a takeover and that shareholders in the offeree company of the same class are afforded equivalent treatment by an offeror. The Code also provides an orderly framework within which takeovers are conducted. In addition, it is designed to promote, in conjunction with other regulatory regimes, the integrity of the financial markets.
The Code is based upon a number of General Principles, which are essentially statements of standards of commercial behaviour. The General Principles apply to takeovers and other matters to which the Code applies. They are applied by the Panel in accordance with their spirit in order to achieve their underlying purpose.
In addition to the General Principles, the Code contains a series of rules. Like the General Principles, the rules are to be interpreted to achieve their underlying purpose. Therefore, their spirit must be observed as well as their letter. The Panel may derogate or grant a waiver to a person from the application of a rule in certain circumstances.
The Takeover Code applies to any company which has its registered office in the UK, the Channel Islands or the Isle of Man if any of its equity share capital or other transferable securities carrying voting rights are admitted to trading on a UK regulated market, a UK MTF, or a stock exchange in the Channel Islands or the Isle of Man. The Code therefore applies to the Company as its securities are admitted to trading on AIM, which is a UK multilateral trading facility (“MTF“).
The Code also applies to any company which has its registered office in the UK, the Channel Islands or the Isle of Man if any of its securities were admitted to trading on a UK regulated market, a UK MTF, or a stock exchange in the Channel Islands or the Isle of Man at any time during the preceding two years.
Accordingly, if the De-Listing is approved by Shareholders at the General Meeting and becomes effective, the Code will continue to apply to the Company for a period of two years after the De-Listing, following which the Code will cease to apply to the Company.
While the Code continues to apply to the Company, a mandatory cash offer will be required to be made if either:
(a) any person acquires an interest in shares which (taken together with the shares in which the person or any person acting in concert with that person is interested) carry 30 per cent. or more of the voting rights of the company; or
(b) any person, together with persons acting in concert with that person, is interested in shares which in the aggregate carry not less than 30 per cent. of the voting rights of a company but does not hold shares carrying more than 50 per cent. of such voting rights and such person, or any person acting in concert with that person, acquires an interest in any other shares which increases the percentage of shares carrying voting rights in which that person is interested.
Brief details of the Takeover Panel, and of the protections afforded by the Code, are set out in Part 6 of the Circular.
Before voting on the De-Listing, Shareholders may want to take independent professional advice from an appropriate independent financial adviser.
Cavendish will purchase, as principal, voting shares under the Tender Offer which could result in Cavendish acquiring an interest in Shares carrying 30 per cent. or more of the voting rights of the Company. Promptly following such purchase, under the terms of the Repurchase Agreement, Cavendish will sell all such Shares to the Company and the Company will buy and thereafter cancel all such Shares. Accordingly, a waiver has been obtained from the Panel on Takeovers and Mergers in respect of the application of Rule 9 to the purchase by Cavendish of the voting shares under the Tender Offer.
Whether or not Shareholders intend to attend the General Meeting in person, they are encouraged to submit a proxy vote online.
Shareholders can appoint proxies electronically via the MUFG Corporate Markets Investor Centre app or via the web browser at https://uk.investorcentre.mpms.mufg.com/ so that the instruction is received by MUFG Corporate Markets by not later than 11.00 a.m. on 16 July 2025. CREST members can also appoint proxies by using the CREST electronic proxy appointment service and transmitting a CREST Proxy Instruction in accordance with the procedures set out in the CREST Manual so that it is received by MUFG Corporate Markets (under CREST participant RA10) by not later than 11.00 a.m. on 16 July 2025. The time of receipt will be taken to be the time from which MUFG is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST. An institutional investor may also be able to appoint a proxy electronically via the Proxymity platform, a process which has been agreed by the Company and approved by the Registrar. For further information regarding Proxymity, please go to www.proxymity.io.
If Shareholders are in any doubt as to the action they should take, they are recommended to seek their own independent advice.
Only Qualifying Shareholders whose names appeared on the Register as at 6.00 p.m. on the Record Date are able to participate in the Tender Offer in respect of the Shares held as at that date. Qualifying Shareholders who hold Shares in certificated form who have acquired Shares in the period between the date of the Circular and the Record Date can obtain a Tender Form by contacting the Receiving Agent as set out on page 15 of the Circular.
Qualifying Shareholders who hold Shares in certificated form and who wish to participate in the Tender Offer should follow the instructions on the Tender Form provided to them and return it to the Receiving Agent, together with their share certificates or other document(s) of title, to arrive by no later than 1.00 p.m. on 18 July 2025. Qualifying Shareholders who hold their Shares in certificated form should also send their original share certificate(s) in respect of the Shares tendered with their Tender Form.
Qualifying Shareholders who hold their Shares in uncertificated form (that is, in CREST) and who wish to participate in the Tender Offer should tender electronically through CREST so that the TTE Instruction settles no later than 1.00 p.m. on 18 July 2025.
Further details of the procedures for tendering and settlement are set out in Part 3 of the Circular.
Shareholders who do not wish to participate in the Tender Offer should not complete the Tender Form and should not make or arrange for a TTE Instruction.
Any repurchase of Shares pursuant to the Repurchase Agreement will be financed solely from the Company’s existing cash resources. No borrowings will be incurred by the Company in respect of any repurchase of Shares pursuant to the Repurchase Agreement.
If Shareholders choose not to tender their Shares under the Tender Offer, their holding will be unaffected, save for the fact that, assuming the successful completion of the Tender Offer and subsequent repurchase of Shares by the Company, they will end up holding a greater percentage of the issued share capital of the Company than they did before the Tender Offer as there will be fewer Shares in issue after completion of the Tender Offer and subsequent repurchase of Shares. Attention is also drawn to section 5 above regarding the De-Listing.
The Company has received irrevocable undertakings to tender Shares under the Tender Offer from Kestrel and PJ Claesson pursuant to which they have each committed to tender for no less than their Basic Entitlements in the Tender Offer and to vote in favour of the Tender Offer Resolution in respect of their current holdings of 13,274,493 Shares and 11,321,780 Shares respectively amounting to 53.5 per cent. in aggregate of the current issued share capital.
The entering into by the Company of the undertakings referred to in paragraph 11 above constitute related party transactions under AIM Rule 13. Both Kestrel and PJ Claesson are substantial shareholders of the Company as defined in the AIM Rules for Companies. The independent Directors consider that, having consulted with the Company’s nominated adviser, Cavendish, the terms of these undertakings are fair and reasonable insofar as Shareholders are concerned. As a partner of and being beneficially interested in Kestrel and in 355,360 Shares held within funds managed by Kestrel, Oliver Scott is not deemed to be an independent Director for these purposes.
Assuming that the maximum number of Shares under the Tender Offer are bought back by the Company and cancelled, the Company’s issued share capital will be reduced by 34,117,647 Shares to 11,814,732 Shares. An announcement setting out the Company’s new issued share capital for the purposes of making DTR 5.1.2 notifications will be made following any purchase by the Company of Shares from Cavendish in relation to the Tender Offer.
Shareholders’ attention is drawn to the information contained in the rest of the Circular, including, in particular, the terms and conditions of the Tender Offer in Part 3 of the Circular.
15. Recommendation
The Board considers the Resolutions to be in the best interests of Shareholders as a whole. Accordingly, the Board recommends that Shareholders vote in favour of the Resolutions to be proposed at the General Meeting, as the Directors intend to do for their respective individual beneficial holdings of, in aggregate, 65,286 Shares, representing approximately 0.14 per cent. of the Company’s issued share capital as at the Latest Practicable Date.
Oliver Scott, Tom Crawford and Lavinia Alderson also intend to tender for no less than their Basic Entitlements in respect of their current shareholdings (amounting to 0.14 per cent. in aggregate of the current issued share capital).
The Directors are making no recommendation to Qualifying Shareholders in relation to participation in the Tender Offer itself. If Shareholders are in any doubt as to the action they should take, they are recommended to seek their own independent advice.
DEFINITIONS
“AIM“the AIM Market operated by the London Stock Exchange“AIM Rules“the AIM Rules for Companies published by the London Stock Exchange from time to time“Basic Entitlement”74.3 per cent. (rounded down to the nearest whole number) of the Shares held by the Qualifying Shareholder on the Record Date“Board“the board of Directors, including any duly constituted committee thereof“Business Day“any day other than a Saturday, Sunday or public holiday in England and Wales and Jersey on which clearing banks in London and St Helier are open for general banking business“Cavendish“Cavendish Capital Markets Limited, nominated adviser and broker to the Company“certificated” orThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
July 2, 2025
ADVFN PLC
Introduction
ADVFN Ltd is pleased to announce it has signed a binding agreement to acquire Capital Market Group from Gumtree Australia Markets Ltd (ASX: GUM). Capital Market Group (CMG) is the owner of two leading investor platforms:
– The leading online community for Australian retail investors, focused on ASX-listed stocks and market discussions.
– Stockhouse (Canada) – one of Canada’s most recognized digital investor communities
The agreed purchase price is $4.43 million USD on a cash-free, debt-free basis. Completion is expected by the first week of Q3 2025.
Strategic Rationale
This acquisition brings together ADVFN, iHub, HotCopper, and Stockhouse to create the largest global network of small-cap retail investors, with over 3 million unique monthly usersacross multiple key markets, including a large base of high-net-worth individuals.
Key Benefits:
– Expands ADVFN’s reach into Australia and North America
– Creates one of the world’s largest investor communities for small-cap equities
– Combines complementary capabilities:
ADVFN: real-time market data, subscription products, investor tools
CMG: high-performing issuer advertising and content marketing model
CMG Financial Snapshot
CMG FY2024 (Actuals):
–
• Revenue: $7 million
• Expenditure: $7.6 million
• EBITDA: -$600,000
• Net Loss: -$1.5 million
CMG FY2025(Forecast)
• Revenue: $6.1 million
• Expenditure: $5.9 million
• EBITDA: $200,000
• Net Loss: -$510,000
*Forecast is based on internal management projections and subject to final audit.
* All calculations were made based on The AUD to USD exchange rate at 0.65.
* FY: June 2024- June 2025
Post-Merger Strategy & Synergies
We are confident in our ability to unlock both top-line and bottom-line improvements following integration. There are clear synergies to work on. Our roadmap includes:
Cross-Platform Integration:
– Introduce ADVFN’s subscription data tools into HotCopper and Stockhouse
– Expand CMG’s issuer advertising and IR solutions across ADVFN and iHub
– Launch the new Deal Room product for small-cap issuers across multiple markets.
Operational Consolidation:
– Unify infrastructure, vendor contracts, and key operational functions
– Align SEO, marketing, and product roadmaps
– Implement shared editorial and content model
-Unified subscription model embedded across all platforms
Financial Upside:
– Significant revenues synergies identified.
– Cost efficiencies between both entities.
– Combined group positioned to drive margin expansion and shareholder value.
– Focus on driving meaningful progress toward achieving profitability in FY26.
Transaction & Funding Summary
1. Purchase Price
• Base Transfer Price to Seller: $3,592,971
• Assumed Debt (RBC Loan Facility): $837,395
• Total Purchase Price (including assumed debt): $4,430,366
2. Cash Balances at Completion
• Australian & Canadian Group Companies: $214,500
3. Retention Amount
• A total of $97,500 has been placed in a Retention Account.
• This amount is excluded from the purchase price and will be held until 31 December 2026, subject to potential claims or adjustments.
4. Transaction Structure
• The acquisition was completed on a debt-free, cash-free basis, subject to the following conditions:
o A defined Net Working Capital target, with true-up adjustments based on the final audited accounts.
o Provisions were made for debt-like items identified during the due diligence process and reflected in the purchase price.
o A full suite of warranties and indemnities was provided by the Seller.
Funding Structure
• Open offer of up to 30,856,808 shares at £0.12/share (£3.7 million GBP)
• Offer Record Date: 17 June 2025
• Deadline: 15 July 2025 at 11:00 a.m.
• Open to external investors for a 15-day window
CEO Statement
“We are excited to welcome Capital Market Group into the ADVFN family. Together, we are creating the most complete platform for retail investors in the small-cap space, combining advanced market data tools with a vision to connect companies and their shareholders.”
– Amit Tauman, CEO, ADVFN Limited
Conclusion
This acquisition marks a transformative step in ADVFN’s evolution as a global investor engagement platform. With expanded reach, a balanced revenue model, and clear post-merger synergies, we are positioned to scale both investor value and issuer services while creating a more connected and efficient capital markets ecosystem.
Further details can be found in the shareholder circular issued on 19 June 2025, including notice of the general meeting on 7 July 2025 at 10:00 a.m. to approve the fundraising authorities.
For enquiries: ir@advfnplc.com
* All calculations were made based on The AUD to USD exchange rate at 0.65.
*Disclaimer: Some of the figures are approximate estimates and should be very close to the actual targets, subject to minor
July 1, 2025
Welcome back to our monthly round up!
A hot June brought about a number of events, clients and new contacts.
Momentum slowed post easter, which gave our team some well earned respite and now back to business with the flurry of new admissions pending for the rest of 2025.
In the past month, we saw another company leave Aquis and join JP Jenkins – Walls and Futures REIT plc (our first REIT, of many we hope).
Many more exciting developments feature below, from our partnership with Euroclear, the updated JPJ index and new admissions.
We are delighted to announce the following new admissions to JP Jenkins:
Walls & Futures REIT plc:
Walls & Futures REIT plc (WAFR:JPJ), announced its shares have been admitted to trade on JP Jenkins share dealing platform. Walls & Futures REIT plc is embarking on an exciting new chapter, transitioning to an evergreen investment company structure. We will be partnering with institutional investors and co-invests into individual and portfolio investments across a range of commercial and real estate opportunities in the UK and Western Europe.
Please see the full press release below:
4Global PLC:
4GLOBAL PLC announced that their AGM was duly passed and they will leave AIM to join JP Jenkins on the 8th July.
To read the full press release, see below:
Issuer news – Check out the latest updates, awards and news from our clients:
Prax Group:
Prax recently competed in the Dragon Boat Race! Last Sunday, a team from across the Prax Group took to the water at Goldsworth Park Lake, Woking. The team raised funds for Woking & Sam Beare Hospice and Wellbeing Care. Prax is one of the most actively traded securities on our platform and continues to match every week with orders daily. Well done team Prax to all who participated and the monies that was raised.
My Club Group:
My Club Group announced a new strategic partnership with Pitchero as its official teamwear partner. The partnership combines My Club’s technology first approach to enable Pitchero’s 70,000+ registered teams direct access to My Club’s fully customisable performance kits, bringing elite-quality design and delivery to teams of all levels. Please see the full release below: https://lnkd.in/eSppYfJ9
GS Verde Group:
GS Verde Group, a company trading its share on JP Jenkins, have been highly ranked across UK & Ireland deal making tables by Experian’s Market IQ Report, as well as high listings in Wales, South West and Midlands regional tables also. Full story on their website here: https://lnkd.in/e9-SAxtmSource
Nigel Greenaway the CEO of GS Verde Group has been shortlisted for Equity-Backed Entrepreneur of the Year 2025. Read more here: https://lnkd.in/e9emxtYD
Cardiff-based GS Verde Group, the award-winning multi-discipline dealmaking business, has just announced the opening of its new, larger office in Bristol’s Temple Quay.
Innovation Agritech Group:
Innovation Agritech Group (IAG), a leading British agricultural technology company, is proud to announce its latest collaboration with Sparsholt College Group’s University Centre Sparsholt (UCS). This collaboration has seen the installation of IAG’s flagship aeroponic vertical farming system, the GrowFrame360™, on the Sparsholt campus. To read the full article, please check out their page here – https://lnkd.in/eAjKhsZU
JPJ news – Check out the latest updates, awards and news:
Our Head of Corporate Mason Doick attended the European Mediscience Awards 2025 last night held at the InterContinental, London.
Winners:
We have a variety of bio, pharma and life science businesses on JP Jenkins, notably Redx Pharma, BiVictriX Therapeutics Ltd, e-therapeutics PLC, Deltex Medical, LPM & Biome Technologies plc.
Euroclear Partnership:
Our clients are increasingly seeking greater control over their cap tables, and our partnership with Euroclear delivers exactly that. Whether it’s growth-stage companies offering liquidity while retaining control, or private equity funds exploring partial exits, this solution meets the needs of both issuers and institutional investors who require securities to be settled within an established infrastructure such as CREST. THG Ingenuity is already leveraging this innovative approach following its demerger from THG plc demonstrating how this solution can support sophisticated capital strategies. To read the full article, please click the link below:https://lnkd.in/eSryMYBY
LSE Partnership:
JP Jenkins continues to enhance its reach through data providers and media outlets like London South East. To learn more about our companies through the LSE page, please click the link below:https://lnkd.in/eV73GzZF
JP Jenkins May Index:
This month’s review of the index recorded a slight loss of less than 1%. The JP Jenkins proprietary index covers the performance of the 15 largest companies.This was calculated after the close on 6th June 2025. This shows the index trading at 1053.11, down 0.69% from the previous calculation on 2nd May. The index will next be calculated using closing prices from Friday, 4th July. The index is market cap weighted, with the maximum weighting capped at 20%. Please see the RNS announcements and link below:https://lnkd.in/eQjCZdjU
Private Markets & Pisces:
The FCA and HMT, created the PISCES initiative to support and regulate trading in private companies shares. The LSE, JP Jenkins and any other provider can launch their own PISCES market. The Private Intermittent Securities and Capital Exchange System will periodically offer liquidity to shareholding employees and existing investors with less onerous rules around market abuse than public trading. A five-year “sandbox” for the Financial Conduct Authority to test its regulatory framework is expected to launch in the autumn. Read the full article below:https://lnkd.in/e4xJiAJj
What is PISCES?
Is Pisces a market?
No. Pisces is a regulatory sandbox in which those wishing to set up a market can do so in an experimental way for a period of five years.
Can you raise money through Pisces?
No. A Pisces regulated platform will be a platform for trading existing shares – a secondary market only.
Is Pisces an initiative of the London Stock Exchange?
No. The LSE is one of several organisations that have expressed an interest in launching a platform under Pisces regulations, JP Jenkins being one of them, of which has been enabling the trading of private company shares for years. JP Jenkins has supported the majority of companies that delisted this year and last with 54 new admissions (both private and previously public) over a two year period.
Please read the full article below:https://lnkd.in/eBh3WH-U
Learning 101 with JP Jenkins – Check out our latest videos here on:
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
June 30, 2025
Powering the Future of Grassroots Sports; New strategic partnershipprovides direct access to high–quality custom sportswear to 70,000+ teams across the UK
My Club (JPJ:MCE), one of the UK’s fastest-growing providers of custom teamwear, today announced a new strategic partnership with Pitchero as its official teamwear partner.
The partnership combines My Club’s technology first approach to enable Pitchero’s 70,000+ registered teams direct access to My Club’s fully customisable performance kits, bringing elite-quality design and delivery to teams of all levels.
Through Pitchero’s platform, clubs can now access high-quality teamwear at better value and with kit cost still one of the biggest barriers to grassroots participation – a 2024 Sported survey found that 87% of UK families view sportswear as a key obstacle, with 74% believingchildren are less likely to take part without it – this partnership provides a smarter, more accessible solution.
“Grassroots clubs already wear so many hats; managers, fundraisers, community leaders. The last thing they need is stress over kit,” said Chris Flood, CEO of My Club. “My Club takes that pressure off, and this partnership with Pitchero means clubs can now handle everything from fixtures to teamwear in one place without compromise.”
“We’re always looking for ways to add real, tangible value to the clubs we support,” said Mark Fletcher, CEO of Pitchero. “My Club understands the challenges grassroots teams face, and their approach to custom kit is affordable, efficient and designed with clubs in mind.”
My ClubChief Executive Officer – Chris FloodVia focusIRInvestor RelationsDirector – Kat PerezKat.Perez@focusir.comMedia RelationsAbout My Club
My Club is a UK-based sportswear brand creating high-performance custom kits at all levels across all sports. By fusing cutting-edge design, AI digital innovation and sustainable practices they deliver apparel that performs under pressure and looks the part. From local clubs to national tournaments, and partnerships with well-known brands like Decathlon, each team’s kit is tailored to their identity.
Trusted by over 4,000 teams across the UK, everything from accessible standard kits to a fully bespoke Elite range is offered. Beyond sport, causes that matter are always at the front of mind: rewilding with Make it Wild and global initiatives like Game4Ukraine. My Club believes teamwear should work harder for players, for communities, and for the planet.
https://myclubgroup.co.uk / Instagram: @myclubgroup / LinkedIn: My Club Group
About Pitchero
Pitchero is the UK’s leading sports club website platform, powering over 70,000 teams and 1.5 million active users across football, rugby, hockey, cricket and netball. From websites and apps to payments and fixtures, Pitchero helps clubs manage everything in one place.
https://www.pitchero.com / Instagram: @bepitchero / LinkedIn: Pitchero
June 26, 2025
25th June 2025
PMGL:JPJ
ISIN: GB00BPNWR625
POWDER MONKEY GROUP AGREES HEADS OF TERMS FOR ANOTHER ACQUISITION
Powder Monkey Group LLC (JP Jenkins PMGL:JPJ) has agreed a Heads of Terms for the acquisition of Akasha and Wayward Brewing’s renowned businesses in Australia. This includes selected assets and retail ventures all in Australia.
The respective brands join the Australasian brands Southern Highlands Brewing, Powder Monkey and Willie the Boatman. The deal will see the consolidation of staff, management and most importantly brewing assets into a centralised facility in Five Dock.
This has followed the recent acquisition of Goddards and Castle Eden Breweries in the UK and is a pre-cursor to the Powder Monkey Taphouse due to open in Camden NSW in October. The closure of the deal is looking to take place in the coming month.
The Group has hospitality interests in both the UK and Australia including 8 brewing operations and venues. It provides beer in mainland Europe, APAC and the UK. It continues to seek growth by means of strategic alignments plus acquisitions of assets and brands. The Shares are available on both the JP Jenkins Traded Platform or directly from the Company in the first instance.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
…
For further information, please contact:
Powder Monkey Group
Investor Relations:
Email: hello@powdermonkeygroup.com
Tel: 02392 522126
JP Jenkins Ltd
Veronika Oswald / Mason Doick
Tel: +44 (0) 207 469 0937
– END –
June 25, 2025
4GLOBAL PLC
25 June 2025
4GLOBAL PLC
(“4GLOBAL”, the “Group” or the “Company”)
Result of General Meeting
4GLOBAL, a UK-based data and technology company focused on providing customers in the sport and fitness sector with business-critical insights about their customers, operations, and investments, announces that, at the general meeting of the Company held earlier today (the “General Meeting“), all resolutions put to the Company’s shareholders (“Shareholders“) were duly passed.
The proxy votes by resolution is shown below.
Resolution NumberResolution NameVotes ForVotes AgainstNo. of shares% of shares votedNo. of shares% of shares voted1Cancellation Resolution19,257,59892%1,687,8658%2Re-registration and change of Articles Resolution19,257,59892%1,687,8658%
The full text of the Resolutions proposed and passed at the General Meeting can be found in the Circular containing, inter alia, the Notice of General Meeting, which was published at 7.00 a.m. on 4 June 2025 and is available on the Company’s website https://investors.4global.com
AIM Cancellation
Following approval by Shareholders at the General Meeting, the admission of the Ordinary Shares to trading on AIM will be cancelled. The AIM Cancellation is expected to take place at 7:00 a.m. on 7 July 2025 and, accordingly, the last day of dealings in Ordinary Shares on AIM is expected to be 4 July 2025.
Re-registration as a private company
In accordance with the passing of Resolution 2, the Company will re-register as a private limited company and adopt new articles of association, which is expected to take place by 28 July 2025.
Exchange Facility and Matched Bargain Facility
To facilitate future shareholder transactions in the Company’s Ordinary Shares, the Company has appointed JP Jenkins to provide a share Exchange Facility and Matched Bargain Facility. The Exchange Facility will become available on the date of Cancellation and will remain in place for an extended period thereafter. While the exact duration may vary, the Board currently expects it to be available for at least one year following Cancellation. The Matched Bargain Facility will be available following expiry of the Exchange Facility. Upon Cancellation, full details of the Exchange Facility and Matched Bargain Facility will be made available to Shareholders on the Company’s website https://investors.4global.com.
Capitalised terms used but not defined in this announcement shall have the same meaning given to such terms in the Circular.
Contacts:
4GLOBAL PLCEloy Mazon (CEO) via AlmaSpark Advisory Partners – Nominated AdviserNeil Baldwin +44 (0)20 3368 3554Canaccord Genuity – BrokerBobbie Hilliam +44 (0)20 7523 8000Alma Strategic Communications
Josh RoystonRebecca Sanders-Hewett David IsonLouisa El-Ahwal
June 25, 2025
Samarkand Group Ltd
10th June 2025
(“Samarkand”, the “Company” or together with its subsidiaries the “Group”)
Samarkand Group (JPJ: SMK), the consumer brand owner, provides a trading update for the year ended 31st March 2025 (“FY25”).
Group top line revenues are expected to have decreased in the range of 30% to 35% vs prior year as the Group reconfigured its operations around its profitable owned brands and withdrew from unprofitable and non-strategic activities. Adjusted EBITDA losses are expected to be in line with prior year, despite lower revenues as a result of extensive restructuring actions which took place in the year.
The Group undertook significant restructuring and reconfiguration in the course of FY25 as it shifted focus to concentrate on its owned brands which are sold primarily in the UK and withdrew from Chinese cross border eCommerce distribution activities for third party brands. Underlying growth in our portfolio of owned brands in the UK was in the range of 30% to 35% vs prior year.
The Group is now clearly positioned as a brand owner and is fully focused on growing its portfolio of differentiated, high growth, owned brands, Napiers the Herbalists, Zita West and Natures Greatest Secret. Our portfolio of owned consumer brands has maintained strong momentum with sales growth in the region of 30% across the portfolio vs prior year and contribution margins improved materially as a result of gross margin improvements and operating leverage across the portfolio.
Napiers the Herbalists, our natural herbal health and healing apothecary brand grew revenues in the UK, in the range of 40% to 50% vs prior year, boosted by natural herbal skin care innovation and the establishment of a strong omni-channel presence spanning our original Apothecary store in Edinburgh, Napiers DTC eCommerce site, social commerce channels and eCommerce marketplaces such as Amazon. Zita West our specialist supplement product line for fertility and reproductive health, grew revenues in the UK in the range of 20% to 25% vs prior year as a result of high levels of customer retention and higher growth in new customers engaging with the Zita West DTC proposition as well as the incremental contribution from new products targeted at specific fertility needs introduced in the period.
Natures Greatest Secret, our specialist colloidal silver-based brand which was acquired in May 2024 performed strongly in the year with growth in the range of 80% to 90% as we made improvements to the DTC site and Amazon marketplace operations. The Group cash position has remained stable in recent months as a result of strong growth in our owned brands, withdrawal from unprofitable operations, and other actions taken to improve working capital across the business.
(2) Future Outlook
With a clear focus on our profitable owned brands, encouraging top line momentum and improvements in gross margins and a restructured cost base as well as higher levels of operating efficiency, we enter FY26 in a better position than prior year. Reaching consistent monthly profitability remains our primary goal and early indications are that we are on track to achieve this in FY26.
We estimate that April 2025, the first month of our new financial year, will be a breakeven month as a standalone brand owning business, operating as a private company and expect May to follow a similar pattern. David Hampstead, Chief Executive Officer of Samarkand Group, commented: “I am very pleased with the growth momentum we are generating on our owned brands and our progress towards overall profitability.
We are now a simpler, more focused business, fully concentrated on driving profitable growth in our owned brands. Our brands resonate with consumers and customers, are meaningfully differentiated vs the competition, are well positioned on long term growth segments and enjoy healthy unit economics. Run rate revenues for our owned brand portfolio are in the range of £8.0 to £9.0 million and we see strong potential for further growth and development in our portfolio of owned brands.”
For more information, please contact:
Samarkand Group https://samarkand.global/
David Hampstead, Chief Executive Officer- david@samarkand.global
Eva Hang, Chief Financial Officer- eva@samarkand.global
Samarkand is a consumer brand owner operating a scale up platform for meaningful different, high growth, high potential health and healing brands. Owned brands include Napiers the Herbalists, Scotland’s oldest natural herbal apothecary brand and Zita West, a leading specialist supplement line for fertility and reproductive health as well as Natures Greatest Secret a leading colloidal silver-based health and healing brand. Founded in 2016, Samarkand is headquartered in Tonbridge, UK
For further information please visit https://www.samarkand.global/
END
June 10, 2025
Bracknell, UK – June 2025– Innovation Agritech Group (IAG), a leading British agricultural technology company, is proud to announce its latest collaboration with Sparsholt College Group’s University Centre Sparsholt (UCS), one of the UK’s premier land-based education institutions. This collaboration has seen the installation of IAG’s flagship aeroponic vertical farming system, the GrowFrame360™, on the Sparsholt campus, marking a significant milestone in the Sparsholt College Group’s commitment to pioneering sustainable agriculture and advanced crop science education.
The installation is housed within a repurposed single-story agricultural building on the Sparsholt College and University Centre Sparsholt campus. This state-of-the-art system is the first of its kind at Sparsholt, setting a new direction for the college and providing students with cutting-edge tools and hands-on experience in modern agricultural practices.
The GrowFrame360™ is an innovative, modular system designed to revolutionise traditional farming methods by offering a sustainable alternative that operates without sunlight, soil, or pesticides. This advanced system allows for year-round crop production and research, independent of seasonal or climate restrictions, making it an ideal platform for both educational and research purposes.
Key Features of the Sparsholt Installation:
Innovative Farming Technology: The GrowFrame360™ features a closed loop aeroponic irrigation system that uses significantly less water than traditional farming methods. Each GrowFrame can grow up to 3,250 plants, including a wide variety of leafy greens, herbs, microgreens, and specialty crops such as medicinal plants, making it a highly efficient solution for sustainable food production.
Academic Install Package: The academic installation package will include a single GrowFrame360™ room and dedicated spaces for germination, propagation, and essential operational activities, providing a comprehensive environment for students and faculty to engage with the technology.
Educational Impact: The GrowFrame360™ will primarily be used by students aged 16 and above, offering them hands-on experience with advanced agricultural technologies. Additionally, it will serve as a showcase for local schools and support University Centre Sparsholt’s newly funded PhD program.
The installation was funded by a grant from the Department for Education’s Local Skills Improvement Fund (LSIF), with additional support from University Centre Sparsholt for building modifications.
This collaboration follows IAG’s successful installation at the University of Essex, where the GrowFrame360™ has become an integral part of the university’s research and educational initiatives. The collaboration with Sparsholt College Group further cements IAG’s position asa leader in providing vertical farming solutions tailored to the education and research sectors.
Julie Milburn, Principal and CEO at Sparsholt College Group, commented:
“The addition of our vertical farming unit, along with our existing green technology, ensures that Sparsholt remains at the forefront of innovation. We are proud to be redefining the student experience through the integration of cutting-edge technology, creating dynamic and engaging learning environments.“
Jaz Singh, Founder and CEO, commented:
“We’re incredibly proud to see our GrowFrame360™ installed at University Centre Sparsholt. This collaboration represents exactly what we set out to achieve with IAG educate, providing future farmers, scientists, and agritech leaders with hands-on access to cutting-edge technology. This installation is a real milestone, and we’re excited to see how it continues to grow with Sparsholt’s academic ambitions.”
– END –
About IAG
British agricultural technology company that builds world-class aeroponic vertical farming systems using exclusive patented technology. Revolutionising agriculture by achieving exceptional crop yields, locally and sustainably, whilst eliminating seasonal constraints of traditional farming. IAG’s mission is to deliver innovative farming solutions to growers, making food production sustainable and accessible for all. IAG is Red Tractor and Global GAP accredited.
About the IAG GrowFrame360™
IAG’s flagship tech, the IAG GrowFrame360™ , is a closed loop modular system which uses automatic aeroponic irrigation resulting in significantly less water uses than traditional farming, producing up to 17 harvest cycles per year. The GrowFrame360™ does not require soil, as perfectly balanced pH nutrient solutions and H2O are sprayed directly on the crop’s roots. Eliminating the need for pesticides and other chemicals. The simple to use scalable system has automated features, allowing crops to be monitored and grown successfully to order.
For further information, visit: www.innovationagritech.com /
www.iagri-tech.com/iag-educate
About Sparsholt College Group (incorporating Andover College, Sparsholt College, and University Centre Sparsholt): University Centre Sparsholt, a leading provider of higher education in land-based specialisms
Dedicated to fostering innovation and research to drive advances within the rural sector and to promote sustainability thereby equipping our graduates to be the future leaders in the sector. We offer a broad range of land-based subjects including animal and zoomanagement, equine science, sustainable agriculture, fisheries and wildlife and ecology. Courses range from Access to Higher Education and undergraduate degree studies to Masters and PhDs, alongside a growing number of higher apprenticeships to meet the changing needs of industry.
Sparsholt Campus, the specialist land-based college set in rural Hampshire
Delivering the full spectrum of land-based subjects and technical qualifications. With access to high specification equipment and industry standard facilities to enrich the learning experience, learners are well prepared to serve the land-based industry or progress to higher level studies. An extensive range of apprenticeship programmes serve industry needs alongside a comprehensive full-cost course portfolio to upskill individuals for technical competencies and skills required to work within the sector.
Contact information:
Name: PR Team
Email: marketing@iagri-tech.com
June 10, 2025
(Alliance News) – Lords Group Trading PLC on Monday said it has bought CMO Group Ltd for around GBP1.8 million.
The London-based distributor of building materials took ownership of all CMO’s trade and assets, following a pre-pack administration process. CMO posted revenue of GBP52 million in 2024. Back in March, CMO shareholders backed a resolution to delist from AIM and re-register as a private company, after which the CMO’s shares were cancelled on London’s junior market.
Originally called Construction Materials Online, CMO is a Plymouth, England-based online-only retailer of construction products, which “has brought true disruption” to the sector, according to Lords.
“The acquisition brings together Lords’s infrastructure and merchanting expertise with CMO’s digital-first online model and reflects Lords’ continued focus on growth, diversification, and digital innovation in the construction materials distribution sector,” Lords said.
Around 120 CMO staff will join Lords as part of the merger. Lords noted the lead-up to Monday’s acquisition may have impacted stakeholders such as creditors and suppliers.
The firm insisted that CMO’s administration process was carried out “with the intention of preserving as much business continuity, employment, and value as possible”. Lords did not provide further details on CMO staff cuts. Instead Lords insisted that “all trading activity continues under the new ownership without interruption”.
CMO’s Chief Executive Dean Murray commented: “We have built a strong, digitally-led business over the past 15 years, and in Lords we have found a partner that not only understands our model but shares our ambition.”
“CMO brings a well-established digital platform, strong customer reach, and a specialist product-led approach that complements our own. This partnership allows us to blend traditional merchanting strengths with cutting-edge digital capabilities,” added Lords CEO Shanker Patel.
Lords shares rose 16% to 40.00 pence each on Monday afternoon in London.
By Holly Munks, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2025 Alliance News Ltd. All Rights Reserved.
June 9, 2025
Experian’s Market IQ Report for Quarter 1 2025 has been published this week, with M&A advisory rankings announced across the UK on a regional and national basis.
The published rankings have seen disruptive dealmaking business GS Verde achieve national growth by ranking in the top 15 UK advisors, as well as various placements across regional tables.
With a significant increase in deal activity across the UK & Ireland, GS Verde’s growth has been recognised with being ranked in the Top 15 (joint 13th) of M&A advisors across the UK in Experian’s latest Market IQ rankings, the only Wales based business to be ranked in the national positions. The Group were also ranked in the top 5 advisors in the South West regional ranking (joint 4th), the top 10 in the Midlands table (joint 6th), while also continuing to be ranked number 1 in Wales.
GS Verde Group, who are headquartered in Wales, have been ranked number 1 advisory business in Wales for the previous 3 years in a row, and continue that form with retaining top spot in the latest rankings, however it is the growth outside of Wales that is even more notable.
The disruptive advisory business, take a unique ‘one team’ approach to advising on M&A transactions. Where traditionally a business owner would need to seek and engage several disparate advisors covering the many facets of legal, financial, tax and origination aspects of a transaction, GS Verde provide an end to end solution, combining multiple disciplines into one advisory team.
Speaking on the success, Nigel Greenaway, Group CEO, said: “I am delighted with the results, and proud of our team for the growth we have achieved in recent years. We have big ambition at GS Verde and have grown our regional footprint both organically and through acquisition, and the results we are seeing across the UK are reflected by that”.
GS Verde, who advise business owners on growth strategies, such as acquisition and business exits, have themselves grown through acquisition and regional expansion. Having acquired Astrum Accountants in Bristol in 2021 and expanding with a new office in Bristol in 2022, the Group followed this up with acquisitions in Ireland in 2023, and in 2024 opened a new Cheltenham office, alongside the acquisition of Anderson Shaw Corporate Finance in the East Midlands.
Mr Greenaway added: “The ‘One Team’ approach was cemented as our model as a strategic decision which followed with a re-branding exercise in October 2021. In less than 4 years since, to be ranked in the top 15 of UK M&A advisors and ranked highly in 3 of the regions we have expanded into, is testament to the great team we have, and we take great satisfaction in supporting our fantastic clients to achieve their own company ambitions through our advisory support”.
Read the full report here: Experian
June 3, 2025
#16th Edition
Welcome back to our monthly round up!
JP Jenkins has continued its momentum from 2024 with 30 new admissions and increased through the start of 2025 with 24 more in the first 3 months.
This past month, we saw 4 more companies join with My Club Group , ADVFN , The Brighton Pier Group PLC and Samarkand Group join the platform to trades its companies shares.
Since Jan, there have been 249 matches completed so far this year with over £4m traded We also successfully facilitated the share-for-share exchange of 5.5 million Hornby shares, totalling over £1 million in value, across 12 leading brokers, including Hargreaves Lansdown, AJ Bell, ii, Canaccord, and many more.
We are delighted to announce the following new admissions to JP Jenkins:
My Club Europe PLC (MCE:JPJ):
My Club Europe PLC is a custom sports kit company based in Oxted, Surrey, specialising in creating personalised teamwear for sports teams of all sizes, and all sports. My Club deliver performance-driven sportswear that meets the unique needs of each team. Our AI-driven approach allows them to design and produce high-quality kits at high volumes with fast turnarounds, while maintaining affordable prices. With nearly 4,000 clients to-date, My Club provide kit for all sports, including football, rugby, cricket, and netball, and serve a diverse range of clients, from sports clubs, schools to universities, corporates, and charities.
Please see below the full press release:
https://www.lse.co.uk/rns/my-club-europe-plc-shares-trading-on-jp-jenkins-0orikpj3lz64s28.html
ADVFN PLC (AFN:JPJ):
ADVFN is a global stock, shares and crypto information website providing market-leading financial tools and data to private investors around the world. Offering real-time share prices, news feeds, charting, portfolio management, monitor lists, financials, data from global stock exchanges, Level 2 and the most active financial bulletin board in the UK, the site is the destination of choice for day traders and retail investors. The site currently has approximately 36 million users worldwide and a billion-page impressions a year. Originally a UK-based site, the company currently operates in the US, UK, Brazil, Japan and Dubai.
Please see below the full press release:
Samarkand (SMK:JPJ):
Samarkand is a consumer brand owner operating a scale up platform for meaningful different, high growth, high potential health and healing brands. Owned brands include Napiers the Herbalists, Scotland’s oldest natural herbal apothecary brand and Zita West, a leading specialist supplement line for fertility and reproductive health as well as Natures Greatest Secret a leading colloidal silver-based health and healing brand. Brands are marketed on an omnichannel basis with strong DTC and social commerce capabilities.
Please see below the full press release:
The Brighton Pier Group (PIER:JPJ):
The Brighton Pier Group PLC owns and trades Brighton Palace Pier, as well as five premium bars nationwide, eight indoor mini-golf sites and the Lightwater Valley Family Adventure Park in North Yorkshire. Brighton Palace Pier welcomes up to four million visitors per year and offers a wide range of attractions including two arcades (with over 300 machines) and nineteen funfair rides, together with a variety of on-site hospitality and catering facilities.
Please see below the full press release:
Issuer news – Check out the latest updates, awards and news from our clients:
IAGT have received some very exciting media coverage over the last couple of weeks. BBC South visited IAG’s HQ facility in Bracknell and interviewed Dean Barron as part of a segment for the Politics South show.
You can view the BBC South Interview on the below link: https://www.youtube.com/watch?si=OOsZhhMSd_1w3HKC&v=gykN8QSekq4&feature=youtu.be
Jaz Singh, the CEO and founder of IAGT, sat down with Edison Group to discuss what the company does, its unique technology in the vertical farming sector, as well as IAG’s decision to join our share-matching platform.
Please find the full interview here: https://www.edisongroup.com/edison-tv/innovation-agritech-group-executive-interview/BM-1566/
A leading supplier of security, cleaning and retail support services (who trade their companies shares on JP Jenkins) had their largest Innovation Lab to date last month. This year’s event hosted over 600 delegates for a day of solution exploration, professional development and peer-to-peer networking. They continue to support some of the largest brands and football clubs in the UK, with a fantastic management team behind them.
To learn more, please see their corporate profile here: https://jpjenkins.com/company/carlisle-support-services-group-limited/
Renewable energy investment company, Thrive Renewables plc has just launched its new £5 million share offer.The share offer via Triodos Bank Crowdfunding platform will be to fund the construction of two new onshore wind farms, plus a pipeline of solar and community-owned projects.
The key terms include: £247 minimum investment (100 shares), Long term equity investment, Thrive shares can qualify for inheritance tax relief.
2024 annual results highlights include:
Please see the full release below: https://www.investegate.co.uk/index.php/announcement/ias/thrive-renewables-plc–thrv/thrive-renewables-plc-new-share-offer-and-topline-2024-annual-results/8866210
Thrive Renewables recently released its annual results. £11.3m operating profits and £20.6m in cash allocated to build new clean energy projects.
Check out the latest report here: https://www.thriverenewables.co.uk/news/2025/05/thrive-announces-11-3-million-operating-profit-for-2024-with-20-6-million-cash-allocated-to-build-new-clean-energy-projects
We’re proud to share that JP Jenkins successfully facilitated the share-for-share exchange of 5.5 million Hornby shares—totalling over £1 million in value—across 12 leading brokers, including Hargreaves Lansdown, AJ Bell, ii, Canaccord, and more.This was no ordinary corporate action. With Hornby delisting from AIM, we delivered a unique, seamless solution that ensured shareholders could retain exposure via Castelnau—a listed vehicle—through our agile and tech-driven platform.
To read the full press release, use the link below: https://www.londonstockexchange.com/news-article/CGL/further-issue-of-equity-in-relation-to-hornby/17032549
Founder of THG, Matthew Moulding said that “the demerger of THG Ingenuity at the start of 2025 was by far their biggest initiative”. JP Jenkins is incredibly proud to have worked on THG with the team at TheHut.com on this initiative. There is still incredible demand for the shares, which are tradable on JP Jenkins.
To learn more, please see their corporate profile here: https://jpjenkins.com/company/thg-ingenuity/
Fantastic news from one of our clients Powder Monkey Group (PMG), who have just acquired Castle Eden Brewery (CEB).Powder Monkey shares are trading on JP Jenkins, to learn more, see their page here: https://jpjenkins.com/company/powder-monkey-group-limited/
Andy Burdon, CEO of Powder Monkey Group said, “We are constantly looking at great opportunities to expand the Powder Monkey portfolio…coupled with a superb facility and great operation..”Mike McGeever Chairman of PMG, added “This has given further reinforcement to the ‘buy and build’ strategy of Powder Monkey and the outlook for significant further growth..”See the full press release below: https://www.londonstockexchange.com/news-article/market-news/acquisition-of-castle-eden-brewery/17049088
JPJ news – Check out the latest updates, awards and news:
PISCES takes another step closer with the relevant Statutory Instrument being laid down in parliament yesterday. Great piece by Simon Hunt at City AM as the media start to digest what this means for issuers and prospective PISCES market operators alike.
Read the full article below: https://www.cityam.com/pisces-regulations-have-arrived-heres-what-you-need-to-know/
As the PISCES rollout gathers momentum, City AM provide a great illustration of what the market potential is.
Read the full article via the link below: https://www.cityam.com/pisces-has-the-potential-to-flourish-if-the-fca-plays-its-cards-right/
Private market structures provide ideal proving ground ahead of potential IPOs.Decades ago, business schools used to teach the mantra that an owner would aim to sell an asset when it had achieved maximum valuation. That ethos has been played out in a number of recent IPOs, as illustrated in this article from Simon Hunt at City AM today.
Read the full article below: https://www.cityam.com/firms-staying-private-for-longer-as-listing-drought-set-to-continue-baillie-gifford-says/
Fantastic morning at our inaugural Private Markets Breakfast!Thank you again to all the team at our sponsor and host Howard Kennedy LLP. Thank you also to our key speakers and panel members: Steve Banfield, ACG, Ashley Reeback and Peter Gouw.We had a fabulous turn out with a tight squeeze to fit everyone in – thank you for all that attended and we hope it was very insightful. Finally compliments to the JP Jenkins team for bringing this together, especially Andrew Foster and Veronika Oswald.
Our corporate team Charlie Duffy and Mason Doick thoroughly enjoyed this afternoon at the Guernsey Finance Funds Forum.Interesting debates around the political landscape, trade tariffs and positioning the UK as an attractive environment for investment. A focus also on fund administration, global regulation and AI developments. Relatable conversations for the JPJ Team from Ed Hammond discussing secondary markets and liquidity for funds in particular. Thank you Adam Knight for the invite.
Thank you to RGH-Global | People Services for the kind invitation to the London City 7s yesterday!Our Head of Corporate Mason Doick and Associate Charlie Duffy thoroughly enjoyed the event where RGH sponsored Shogun RFC. Top-tier rugby, with Shogun RFC going head-to-head with Saracens, Harlequins, Spain, and many more. RGH-Global | People Services trades its shares on JP Jenkins, see their page here for further information: https://jpjenkins.com/company/resource-group-holdings-plc-2/
Last week, JP Jenkins hosted our inaugural brokers drinks! We were joined by over 20 retail and institutional brokers who we work with closely on behalf of their shareholders and investors. A city venue on the river Thames with the sun beaming through the windows and onto the terrace – can’t complain. Thank you to all who attended and see you next time
Learning 101 with JP Jenkins – Check out our latest videos here on:
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
May 30, 2025
23 May 2025
Sportech Ltd
(‘Sportech’ or the ‘Group’)
FY 2024 Annual Report Results
Sportech, an international betting and hospitality business is pleased to release its Annual Report and Accounts for the financial year ended 31 December 2024 (‘FY 2024’). These can be located on the Sportech website and on JP Jenkins website: www.sportechplc.com/investors/results/ www.jpjenkins.com/company/Sportech/
FY ’24 Financial Overview
Revenue £23.1m (2023 £26.5m )
Gross Profit £12.7m (2023 £14.1m )
Adjusted EBITDA1 £1.5m (2023 £ 1.6m )
Loss before Tax £0.1m (2023 £(0.8)m)
Cash2 £3.6m (2023 £ 3.8m )
Performance Overview
The revenue decline in 2024 was primarily driven by a lower Pari-Mutuel (Tote) betting handle, as competition for discretionary wagering dollars intensified with the continued expansion of Sports Betting, iCasino gaming, and the launch of online lotteries in Connecticut. Additionally, Food and Beverage sales at three locations noted a slight dip, while adverse weather conditions in the early and late parts of the financial year impacted both the quality of available betting products available and customer footfall at physical venues.
Despite these challenges, Sportech was successful in largely mitigating the impact through growth in Sports Betting net commission, growth in other diversified income streams and aggressively managed costs, resulting in only a modest reduction in reported EBITDA. Sportech continues to establish new business partnerships, building on its solid foundation, seeking to deliver future shareholder returns. Sportech remains committed to maximizing shareholder value, fostering growth in the US gaming sector, and leveraging its exclusive licenses to drive innovation and customerengagement. Potential Assets sale
During 2024, the an independent party approached the Company, expressing interest in acquiring significant Group assets. Despite significant work by both parties, these negotiations have now ended without a binding offer being presented.
Corporate Initiatives
Sportech’s strategic initiatives included a successful transition to Fanatics. Sportsbook across all locations as its sports betting provider under an agreementwith the Connecticut Lottery Corporation (CLC). The Group also entered new commercial arrangements with leading U.S. betting operators, strengthening its market position. The company also completed the sale and leaseback of its Windsor Locks, CT property, contributing to a £3.4 million capital distribution to shareholders, bringing total returns to shareholders of £124.6 million, since 2017. Financial Position The Groups cash position remains stable at approximately £3.6m at 31 December 2024 (c. 37 pence per share). The Group will continue to balance investment opportunities and capital returns where possible and remains focused on creating tangible increased value for shareholders in 2025.
About Sportech:
Sportech is an international betting and hospitality business, known for its innovative solutions in the sports betting industry. With a strong presence across multiple locations, Sportech is committed to providing exceptional service and cutting-edge technology to its retail customers.
Chairman comments
“We are proud of our resilience in navigating competitive and environmental challenges while delivering value to shareholders and enhancing our offerings for customers,” said Chairman Richard McGuire “Our focus on operational efficiency, strategic partnerships, and innovative betting platforms positions us for sustained success in 2025.”
For More Information: www.sportechplc.com or richard.mcguire@sportech.net Note: This press release is for informational purposes and may include forward- looking statements that involve risks and uncertainties.
May 23, 2025
Released 07:00:10 22 May 2025
RNS Number : 7600J
Powder Monkey Group Limited
22nd May 2025
PMGL:JPJ
ISIN: GB00BPNWR625
Powder Monkey Group Limited
(“Powder Monkey” or “the Company”)
Acquisition of Castle Eden Brewery
London, UK, 22nd May 2025 – Powder Monkey Group Limited (PMGL:JPJ), today announces 100% acquisition of Castle Eden Brewery Ltd (CEB) and associated Companies for an undisclosed sum.
Andy Burdon, CEO of Powder Monkey Group commented: “Castle Eden Brewery was first established in County Durham in 1826 and has joined PMG after a series of owners after its near 200yr history.
CEB to-date has concentrated on contract brewing. PMG intend to maintain those relationships as well as adding in brewing for their existing product lines and importantly resurrecting the Castle Eden Brewing name throughout the area. This increases focus on the beers that made CEB an important piece of local beer history.”
Cliff Walker Joint Managing Director of CEB added “We’re absolutely delighted to join PMG and look forward to the additional exciting opportunities for growth”
“This has given further reinforcement to the ‘buy and build’ strategy of Powder Monkey and the outlook for significant further growth. With our forthcoming fund raise for both the UK, Australia and regions in between this acquisition adds significant capacity and a broad base for the next acquisitions” added Mike McGeever Chairman of PMG.
For further information, please contact:
Powder Monkey Group Limited Investor RelationsJP Jenkins Ltd Veronika Oswald / Mason Doick Email: mike.mcgeever@powdermonkeybrewing.comTel. +44 (0) 207 469 0937Email: info@jpjenkins.comThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
May 22, 2025
May 21, 2025
8th May 2025
AFN: JPJ
ISIN: GB00BPT24C10
ADVFN PLC
(“AFN” or “The Company”)
Shares now trading on JP Jenkins
London, UK, 8th May 2025 – ADVFN PLC (AFN:JPJ), today announces its shares have been
admitted to trade on JP Jenkins share dealing platform. The Company’s registered address is
167-169 Great Portland Street, 5th Floor, London W1W 5PF and company number is
02374988.
ADVFN is a global stock, shares and crypto information website providing market-leading
financial tools and data to private investors around the world. Offering real-time share prices,
news feeds, charting, portfolio management, monitor lists, financials, data from global stock
exchanges, Level 2 and the most active financial bulletin board in the UK, the site is the
destination of choice for day traders and retail investors. The site currently has approximately
36 million users worldwide and a billion-page impressions a year. Originally a UK-based site,
the company currently operates in the US, UK, Brazil, Japan and Dubai.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies,
enabling shareholders and prospective investors to buy and sell equity on a matched bargain
basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of
Prosper Capital LLP (FRN453007).
Shareholders wishing to trade these securities can do so through their stockbroker. Trades
will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer.
Trades can be conducted, and limits can be accepted, during normal business hours.
Shareholders or potential investors can place limits via their existing UK regulated stockbroker.
The indicative pricing for the ordinary shares as well as the transaction history, will be available
on the JP Jenkins website at (https://jpjenkins.com/).
For further information, please contact:
ADVFN PLC
Investor Relations
Tel. +44 (0) 203 8794 460
Email: ir@advfnplc.com
JP Jenkins Ltd
Veronika Oswald / Mason Doick
Tel. +44 (0) 207 469 0937
Email: info@jpjenkins.com
-ENDS-
May 8, 2025
7th May 2025
SMK: JPJ
ISIN: GB00BLH1QT30
SAMARKAND GROUP
(“SMK” or “The Company”)
Shares now trading on JP Jenkins
London, UK, 7th May 2025 – Samarkand Group (SMK:JPJ), today announces its shares have
been admitted to trade on JP Jenkins share dealing platform. The Company’s registered
address is Unit 13 Tonbridge Trade Park, Ingot Way, Tonbridge, England, TN9 1GN and
company number is 13127277.
Samarkand is a consumer brand owner operating a scale up platform for meaningful different,
high growth, high potential health and healing brands. Owned brands include Napiers the
Herbalists, Scotland’s oldest natural herbal apothecary brand and Zita West, a leading
specialist supplement line for fertility and reproductive health as well as Natures Greatest
Secret a leading colloidal silver-based health and healing brand. Brands are marketed on an
omnichannel basis with strong DTC and social commerce capabilities. In addition to specialist
brand and marketing teams, the Company’s brands benefit from shared operational resources
including shared warehousing and logistics and pick pack ship services from the Company’s
own warehouse and in house manufacturing from the Company’s own specialist production
facilities.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies,
enabling shareholders and prospective investors to buy and sell equity on a matched bargain
basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of
Prosper Capital LLP (FRN453007).
Shareholders wishing to trade these securities can do so through their stockbroker. Trades
will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer.
Trades can be conducted, and limits can be accepted, during normal business hours.
Shareholders or potential investors can place limits via their existing UK regulated stockbroker.
The indicative pricing for the ordinary shares as well as the transaction history, will be available
on the JP Jenkins website at (https://jpjenkins.com/).
For further information, please contact:
Samarkand Group
Investor Relations
Tel. 020 3740 3933
Email: info@samarkand.global
JP Jenkins Ltd
Veronika Oswald / Mason Doick
Tel. +44 (0) 207 469 0937
May 7, 2025
6th May 2025
PIER: JPJ
ISIN: GB00BG49KW66
Brighton Pier Group PLC
(“PIER” or “The Company”)
Shares now trading on JP Jenkins
London, UK, 6th May 2025 – Brighton Pier Group PLC (PIER:JPJ), today announces its
shares have been admitted to trade on JP Jenkins share dealing platform. The Company’s
registered address is 36 Drury Lane, London, England, WC2B 5RR and company number is
08687172.
The Brighton Pier Group PLC owns and trades Brighton Palace Pier, as well as five premium
bars nationwide, eight indoor mini-golf sites and the Lightwater Valley Family Adventure Park
in North Yorkshire. Brighton Palace Pier welcomes up to four million visitors per year and
offers a wide range of attractions including two arcades (with over 300 machines) and nineteen
funfair rides, together with a variety of on-site hospitality and catering facilities.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies,
enabling shareholders and prospective investors to buy and sell equity on a matched bargain
basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of
Prosper Capital LLP (FRN453007).
Shareholders wishing to trade these securities can do so through their stockbroker. Trades
will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer.
Trades can be conducted, and limits can be accepted, during normal business hours.
Shareholders or potential investors can place limits via their existing UK regulated stockbroker.
The indicative pricing for the ordinary shares as well as the transaction history, will be available
on the JP Jenkins website at (https://jpjenkins.com/).
For further information, please contact:
Brighton Pier Group PLC
Investor Relations
Tel. 020 7376 6300
Email: coysec@brightonpiergroup.com
JP Jenkins Ltd
Veronika Oswald / Mason Doick
Tel. +44 (0) 207 469 0937
Email: info@jpjenkins.com
-ENDS-
May 6, 2025
#15th Edition
Welcome back to our monthly round up!
New companies joined in March: 10
Aggregate Market Cap: £1.84 billion
Benchmark index drops 0.5% – March/April Index update
The JP Jenkins (www.jpjenkins.com) proprietary index covering the performance of the venue’s 15 largest stocks has been calculated after the close on 7th April 2025. This shows the index trading at 1061.24, down 0.5% from the previous calculation on 7th March.
The index will next be calculated using closing prices from Friday, 2nd May. The index is market cap weighted, with the maximum weighting capped at 20%.
Since the last newsletter, we announced 4 new companies / clients with CMO Group, Biome Technologies plc, Corre Energy and Hornby Hobbies Ltd all going live for trading.
We also have Samarkand Group, Celadon Pharmaceuticals Plc, ADVFN, My Club Group and The Brighton Pier Group PLC going live with us very shortly.
There are several more awaiting to be announced.
We are delighted to announce the following new admissions to JP Jenkins:
Biome Technologies PLC:
Biome Technologies plc (BIOM:JPJ) is pleased to announce that its shares have been admitted for trading on the JP Jenkins share dealing platform. Biome Technologies Ltd is a United Kingdom-based technology company. The Company’s operations are focused on two divisions, Bioplastics and Radio Frequency (RF) Technologies.
See the full press release below:
Hornby PLC
Hornby Hobbies Ltd (HRN:JPJ) is pleased to announce that its shares have been admitted for trading on the JP Jenkins share dealing platform. Hornby Plc is a United Kingdom-based models and collectibles company. The company is engaged in the development, design, sourcing and distribution of hobby and interactive home entertainment products. Its principal business is the development, production and supply of toy and hobby products.
Please see the full press release below:
Corre Energy B.V
Corre Energy B.V (CORRE:JPJ) is pleased to announce that its shares have been admitted for trading on the JP Jenkins share dealing platform. Corre Energy is one of the few established millisecond to multi – day long duration energy storage (‘LDES’) developers globally, having spent the last 10+ years building its pipeline, cultivating supply chain and on -the -ground relationships, and building in – house IP that is critical to delivering projects of this scale.
See full press release below:
CMO Group
CMO Group (CMO:JPJ) is pleased to announce that its shares have been admitted for trading on the JP Jenkins share dealing platform. Founded in 2008 as Construction Materials Online, CMO is an online-only retailer of building materials. CMO has a range of listings with over 140,000 products through its many specialist websites which recently underwent rebranding. It‘s unique digital hybrid service model, developed over more than 10 years, combines specialist advice and expertise tailored to category and customer needs online, to service the next generation of digital natives by bridging the gap between traditional bricks and mortar retailers and pure play digital retailing.
Read the full press release below:
We are delighted to announce the following intend to join JP Jenkins shortly:
My Club Europe
My Club Europe PLC announced early this year, they intend to join JP Jenkins in the next step of their growth journey.
Celadon Pharma
Celadon Pharmaceuticals Plc announced their intentions to move from AIM to JP Jenkins post the GM being duly passed.
Please see the full RNS below:
Samarkand Global
Samarkand Global announced their intention to move from AQUIS to JP Jenkins. The trading of Samarkand shares will commence from the 7th May, following the GM being duly passed.
Please see the full RNS press release below:
The Brighton Pier Group
The Brighton Pier Group PLC announced their intention to move from AIM to JP Jenkins, post their GM being passed. If the GM is passed, trading of the company’s share will commence from the 2nd May.
Please see the full RNS press release below:
Issuer news – Check out the latest updates, awards and news from our clients:
Thrive Renewables PLC
Check out Edison Group latest video and report on Thrive Renewables PLC:
Thrive is a privately owned UK-based renewable energy company that consists of 33 sustainable energy projects across the UK, with a total capacity of around 142MW – https://www.edisongroup.com/research/empowering-a-positive-change/34077/
Its shares trade on the JP Jenkins share trading venue, via monthly intermittent auctions. The Directors Valuation was recently increased to £2.55 per share in February. Thrive Renewables operates a twice yearly buy-back scheme at 90% of Directors’ Valuation for eligible shareholders.
Tally Central / Money
TallyMoney‘s CEO Cameron Parry was on GB News this morning discussing a poll that reveals 71 per cent of over 55s feel that their financial security is under threat. Tally Money is trading on JP Jenkins, to learn more, please see here: https://jpjenkins.com/company/tally-central-limited/
Check out the full video below:
JPJ news – Check out the latest updates, awards and news:
JP Jenkins continues to partner with various advisors and institutions within the UK and further afield. We have confirmed our partnership with Earth Capital to support sustainable investment opportunities, connecting innovative, impact-driven businesses with a broad network of investors.
Read the full announcement here – https://www.earthcapital.net/earth-capital-partners-with-jp-jenkins-to-expand-sustainable-investment-opportunities/
JP Jenkins is excited to announce our strategic partnership with London South East! Through this partnership, London South East will provide its users with comprehensive price, news and trade data from companies on the JP Jenkins venue.
View here – https://www.lse.co.uk/private-markets/markets/jp-jenkins/
Our Commercial Director Veronika Oswald recently appeared on the latest Hardman & Co episode in the series of The Private Company Valuation Forum, bringing insights into how to value private businesses. In this episode, we explore the evolving landscape of private company valuations as we move into an uncertain but opportunity-filled 2025, where investor power is growing.
Please watch the episode in full below: https://www.youtube.com/watch?si=VdY-zUoyYS5mCZUh&v=v_rH-B4ursQ&feature=youtu.be
Our team enjoyed the launch of UK Fast Growth Index 2025 at UBS! Featuring 350 dynamic companies, last year’s Index showcased a collective turnover of £15.1 billion, marking a staggering growth of £9.6 billion from 2021 to 2023—an impressive 173% increase. Among them, 162 companies surpassed a turnover of £20 million, underscoring their substantial impact on the UK business landscape. It was so good to meet so many great founders, advisors and contacts.
Learning 101 with JP Jenkins – Check out our latest videos here on:
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
April 20, 2025
Brighton Pier Group PLC (The)
02 April 2025
This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.
Brighton Pier Group PLC
Proposed Cancellation of Admission of the Ordinary Shares to trading on AIM
Re-registration as a Private Limited Company
Adoption of New Articles
Notice of General Meeting
and
Trading Update
Brighton Pier Group PLC, a diversified UK leisure and entertainment business, today announces the proposed voluntary cancellation of the admission of its ordinary shares of £0.25 each (“Ordinary Shares“) from trading on AIM (the “Cancellation“), pursuant to Rule 41 of the AIM Rules for Companies (the “AIM Rules“), re-registration of the Company as a private limited company (the “Re-registration“) and adoption of new articles of association (the “New Articles“) (the “Proposals“).
The Directors have conducted a careful review of the benefits and drawbacks to the Company and the Shareholders in retaining the Company’s quotation on AIM and believe that seeking Shareholder approval for the proposed Cancellation and Re-registration at the earliest opportunity in line with AIM Rule 41 and the Companies Act is in the best interests of the Company and the Shareholders as a whole. In addition, in connection with the Re-registration, it is proposed that the New Articles be adopted to reflect the change in the Company’s status to a private company limited by shares.
A circular (the “Circular“) will be posted to Shareholders later today, and includes notice of a general meeting of the Company which is being convened for 10 a.m. on 22 April 2025 (the “General Meeting“) at Cavendish Capital Markets Limited at One Bartholomew Close, London, EC1A 7BL, for the purposes of considering and, if thought fit, passing the requisite shareholder resolution to approve the proposed Cancellation (the “Cancellation Resolution“) and Re-registration (the “Re-registration Resolution“, together the “Resolutions“). In accordance with the requirements of Rule 41 of the AIM Rules and the Companies Act 2006, the Cancellation and Re-Registration, respectively, are each conditional upon the approval of not less than 75 per cent of the votes cast by Shareholders (whether present in person or by proxy) at the General Meeting.
If the Cancellation Resolution is passed at the General Meeting, it is anticipated that the Cancellation will become effective at 7.00 a.m. on 2 May 2025. Approval of the Re-registration Resolution is conditional upon the passing of the Cancellation Resolution. If both resolutions are passed, it is anticipated that the Re-registration will become effective in the week commencing 12 May 2025.
If the Cancellation becomes effective, Cavendish will cease to be the nominated adviser of the Company pursuant to the AIM Rules and the Company will no longer be required to comply with the AIM Rules. However, the Company will remain subject to the Takeover Code for a period of two years after the Cancellation, details of which are set out in the Circular.
Should the Resolutions be passed, and for the period of time that the Company continues to be supported by a wide shareholder base, the Company intends to continue to provide certain facilities and services to Shareholders that they currently enjoy as shareholders of an AIM company. The Company will:
· continue to communicate information about the Company (including annual accounts) to its Shareholders, as required by the Companies Act; and
· implement the Matched Bargain Facility which would facilitate Shareholders buying and selling Ordinary Shares on a matched bargain basis following Cancellation.
Further information on the Cancellation, Re-registration, the General Meeting and the New Articles is set out below or in the Circular.
The Board urges Shareholders that they are not required, if they do not wish, to dispose of their Ordinary Shares in any manner. However, Shareholders should note that, despite the measures the Company shall establish, if the Cancellation proceeds, their ability to trade their Ordinary Shares may be reduced.
Should the Resolutions be passed, a Shareholder has three options with respect to its shareholding in the Company:
1. remain a continuing Shareholder of the following the Cancellation and Re-registration of the Company as a private entity;
2. sell Ordinary Shares prior to the Cancellation, which will occur following the proposed last day of trading on 1 May 2025; or
3. sell Ordinary Shares via the Matched Bargain Facility, for which further details are provided below.
The Board can make no recommendation as to whether or not individual Shareholders should seek to sell their Ordinary Shares in light of the proposed Cancellation. Shareholders should carefully consider the advantages and disadvantages of tendering Ordinary Shares into the exchange facility. Shareholders who are in any doubt as to what they should do are advised to seek their own independent advice from a professional adviser duly authorised and regulated by the FCA. This is a matter for individual Shareholders and will depend on their personal, financial and fiscal circumstances.
Current trading
The Company trading results (on a pre-highlighted items basis) for the 12 month period ended 29 December 2024 are in line with current market expectations.
In the first 12 weeks of the current reporting period, total Group sales of £4.2 million were £0.1 million lower than the equivalent weeks trading in the previous year (2024: total Group sales of £4.3 million). A warm weather spell during March, combined with the introduction of the higher £2 admissions charge for non-residents, resulted in total sales at the Pier of £1.8 million, which were £0.1 million higher year-on-year (2024: total sales of £1.7 million). Conversely, trading in the Bars and Golf divisions has seen a slow start, with total sales of £1.0 million and £1.4 million respectively, each £0.1 million lower than the prior weeks’ equivalent in 2024 (2024: Bars total sales of £1.1 million, Golf total sales of £1.5 million). As in previous years, there are no sales for Lightwater Valley in the first 12 weeks of the financial year, due to the normal seasonal winter closure of the park.
Background and reasons for proposed Cancellation, Re-registration and adoption of New Articles
Over the past several years, the Company has faced persistent challenging trading conditions, impacted by, inter alia, COVID-19, repeat bad weather during peak summer trading periods, recent significant Budget increases in National Insurance to commence from 6 April 2025, pressures on consumer discretionary spending and a change in consumer behaviours. Accordingly, the Company has necessarily focused its strategy on cost savings, disposals of underperforming assets and health of the balance sheet, limiting its ability to invest in growing the business. Whilst the Directors believe that the Company has been effective in this regard, trading challenges have continued and the Board has accordingly been undertaking a review of its strategic options.
Government increases in the National Minimum Wage, high interest rates, together with increases in energy and other costs flowing from the events in Ukraine has significantly increased the Group’s cost base.
This cost of living crisis is also having a material impact on how consumers purchase. As prices rise, consumers are cutting back on non-essential spending which is impacting all parts of the Hospitality and Leisure industry which includes most of the Group’s business activities.
In reaching its conclusion to pursue the Cancellation, the Board has consulted certain Shareholders and has considered the following key factors amongst others:
a) Costs and regulatory burden: The considerable cost and management time and the legal and regulatory burden associated with maintaining the Company’s admission to trading on AIM are, in the Board’s opinion, disproportionate to the benefits of the Company’s continued admission to trading on AIM. Given the lower costs associated with unquoted company status, it is estimated that the Cancellation will materially reduce the Company’s recurring administrative and adviser costs by between £250,000 and £300,000 per annum, which the Board believes would be a significant reduction in overhead cost burden that in turn would allow for cash to be invested directly into supporting the longer-term growth strategy of the business. The Company expects to realise additional cost savings from reduced regulatory expenses.
b) Refinancing: Post the Cancellation, the board intends to actively pursue a partial refinancing of the bank debt. The board are in early stage discussions with the two major shareholders regarding this refinancing. The professional fees involved in any such possible transaction will be significantly lower if the business is unquoted than if it is done as a quoted company. There can be no certainty any such refinancing will take place.
c) Lack of liquidity: There continues to be limited liquidity in the Ordinary Shares on Aim and, as a result, the Board believes that Shareholders are not provided with opportunities to trade in meaningful volumes or with frequency in an active market in Ordinary Shares.
d) Market volatility: As a result of the limited liquidity of Ordinary Shares described above, small trades in Ordinary Shares can have a significant impact on price and, therefore, market valuation which, the Board believes, in turn has a materially adverse impact on: (a) the Company’s status within its industry; (b) the perception of the Company among its customers, suppliers and other partners; (c) staff morale; and (d) the Company’s ability to seek appropriate financing or realise an appropriate value for any material future sales or disposals.
e) Challenges related to the Company’s position as a micro-cap stock: Growing the company, a UK micro-cap stock, comes with a range of challenges, which, in the Board’s view, stem from the Company’s small market valuation, limited resources, and the dynamic nature of the market. These challenges include, but are not limited to: (i) access to capital; (ii) a lack of visibility amongst analysts, media and potential investors; (iii) increased volatility in Company valuation unrelated to Company performance leading to higher risk perception; and (iv) an aversion from potential new investors seeking stability and a valuation that aligns with Company performance. For these reasons, the Board believes that the Company is unlikely to attract the material investment it requires from third party equity investors whilst current market conditions continue to prevail, and does not see such conditions changing in the medium term. Consequently, the Board believes that the most likely source of future funds would be through private capital and debt funding. Furthermore, the UK small and micro-cap markets have changed significantly since the Company’s IPO and the Directors believe that the Company’s current public market valuation reflects neither the current status of the business nor its underlying potential.
f) Strategic flexibility: The Board believes that an unquoted company can take and implement decisions more quickly than a company which is publicly traded as a result of the more flexible regime that is applicable to a private company; and
g) Future trading of shares: The Board believes that it can make satisfactory arrangements for Shareholders to transfer their shares periodically via a matched bargain trading facility.
A summary of the principal effects of the Cancellation can be found in Part 2 of the Circular.
Therefore, as a result of this review, the Board has unanimously concluded that the proposed Cancellation and Re-registration is in the best interests of the Company and its Shareholders as a whole. The Board makes no recommendation as to whether or not individual Shareholders should seek to sell their Ordinary Shares in light of the proposed Cancellation either pursuant to the exchange facility or otherwise. Shareholders should carefully consider the advantages and disadvantages of tendering Ordinary Shares into the exchange facility as set out in the Circular.
Exchange Facility and Matched Bargain Facility
The Directors are aware that certain Shareholders may wish to acquire or dispose of Ordinary Shares in the Company following the Cancellation.
Therefore, the Company has made arrangements for the Matched Bargain Facility to assist Shareholders to trade in the Ordinary Shares to be put in place from the day of Cancellation if the Resolution is passed. The Matched Bargain Facility will be provided by J P Jenkins Limited (“JP Jenkins”). JP Jenkins is a liquidity venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
Under the Matched Bargain Facility, Shareholders or persons wishing to acquire or dispose of Ordinary Shares will be able to leave an indication with JP Jenkins, through their stockbroker (JP Jenkins is unable to deal directly with members of the public), of the number of Ordinary Shares that they are prepared to buy or sell at an agreed price. In the event that JP Jenkins is able to match that order with an opposite sell or buy instruction, they would contact both parties and then effect the bargain. Should the Cancellation become effective and the Company put in place the Matched Bargain Facility, details will be made available to Shareholders on the Company’s website at www.brightonpiergroup.com and directly by letter or e-mail (where appropriate).
Following Cancellation, the provision of the Matched Bargain Facility will be kept under review by the Board and, in determining whether to continue to offer a Matched Bargain Facility, the Company shall consider expected (and communicated) Shareholder demand for such a facility as well as the composition of the Company’s register of members and the costs to the Company and Shareholders. Shareholders should therefore note that there can be no certainty that the Matched Bargain Facility will continue to be in place for an extended period of time following Cancellation although it is the Board’s expectation that this will be in place for at least five years following Cancellation.
There can be no guarantee as to the level of the liquidity or marketability of the Ordinary Shares under the Matched Bargain Facility, or the level of difficultly for Shareholders seeking to realise their investment under the Matched Bargain Facility.
Before giving your consent to the Cancellation, you may want to take independent professional advice from an appropriate independent financial adviser.
If Shareholders wish to buy or sell Ordinary Shares on AIM they must do so prior to the Cancellation becoming effective. As noted above, in the event that Shareholders approve the Cancellation, it is anticipated that the last day of dealings in the Ordinary Shares on AIM will be 1 May 2025 and that the effective date of the Cancellation will be 2 May 2025.
There can be no guarantee as to the level of the liquidity or marketability of the Ordinary Shares under the Matched Bargain Facility, or the level of difficulty for Shareholders seeking to realise their investment under the Matched Bargain Facility.
Before giving your consent to the Cancellation, you may want to take independent professional advice from an appropriate independent financial adviser.
A copy of this announcement and the Circular will be made available on the Company’s website at www.brightonpiergroup.com. Shareholders are strongly encouraged to read the Circular in full.
Capitalised terms used but not defined in this announcement shall have the same meanings as are given to such terms in the Circular.
Enquiries: The Brighton Pier GroupTel: 020 7376 6300Anne Ackord, Chief Executive OfficerTel: 012 7360 9361John Smith, Chief Financial OfficerTel: 020 7376 6300
Cavendish Capital Markets Limited (Nominated Adviser and Broker)
Stephen Keys (Corporate Finance)Tel: 020 7397 8926Callum Davidson (Corporate Finance)Tel: 020 7397 8923
Appendix 1
EXTRACTS FROM THE CIRCULAR
3. Process for, and principal effects of, the CancellationUnder the AIM Rules, it is a requirement that the Cancellation must be approved by Shareholders holding not less than 75 per cent. of votes cast by Shareholders at the General Meeting. Accordingly, the Notice of General Meeting set out in this Circular contains a special resolution to approve the Cancellation. Furthermore, Rule 41 of the AIM Rules requires any AIM company that wishes the London Stock Exchange to cancel the admission of its shares to trading on AIM to notify shareholders and to separately inform the London Stock Exchange of its preferred cancellation date at least 20 clear Business Days prior to such date. Additionally, the Cancellation will not take effect until at least five clear Business Days have passed following the passing of the Cancellation Resolution.If the Cancellation Resolution is passed at the General Meeting, it is proposed that the last day of trading in the Ordinary Shares on AIM will be 1 May 2025 and that the Cancellation will take effect at 7:00 a.m. on 2 May 2025.If the Cancellation becomes effective, Cavendish will cease to be the nominated adviser of the Company pursuant to the AIM Rules and the Company will no longer be required to comply with the AIM Rules. However, the Company will remain subject to the Takeover Code for a period of two years after the Cancellation, details of which are set out below.The principal effects of the Cancellation will include the following:§ there will be no formal market mechanism enabling the Shareholders to trade Ordinary Shares, save for the Matched Bargain Facility referred to in paragraph 4.2 below, and no other recognised market or trading facility is intended to be put in place to facilitate trading in the Ordinary Shares;§ while the Ordinary Shares will remain freely transferable, it is possible that, following the publication of this Document, the liquidity and marketability of the Ordinary Shares will be further reduced and their value adversely affected (however, as set out above, the Directors believe that the existing liquidity in the Ordinary Shares is limited in any event);§ the Ordinary Shares may be more difficult to sell compared to shares of companies traded on AIM (or any other recognised market or trading exchange);§ in the absence of a formal market and quote, it may be difficult for Shareholders to determine the market value of their investment in the Company at any given time;§ the regulatory and financial reporting regime applicable to companies whose shares are admitted to trading on AIM will no longer apply;§ Shareholders will no longer be afforded the protections given by the AIM Rules, such as the requirement to be notified of price sensitive information or certain events and the requirement that the Company seek shareholder approval for certain corporate actions, where applicable, including substantial transactions, reverse takeovers, related party transactions and fundamental changes in the Company’s business, including certain acquisitions and disposals;§ the levels of disclosure and corporate governance within the Company will not be as stringent as for a company quoted on AIM;§ the Company will no longer be subject to UK MAR regulating inside information and other matters;§ the Company will no longer be required to publicly disclose any change in major shareholdings in the Company under the Disclosure, Guidance and Transparency Rules;§ the Company will no longer be required to have an independent nominated adviser and broker;§ whilst the Company’s CREST facility will remain in place immediately post the Cancellation, the Company’s CREST facility may be cancelled in the future and, although the Ordinary Shares will remain transferable, they may cease to be transferable through CREST (in which case, Shareholders who hold Ordinary Shares in CREST will receive share certificates);§ stamp duty will become due on transfers of shares and agreements to transfer shares unless a relevant exemption or relief applies to a particular transfer; and§ the Cancellation and Re-registration may have personal taxation consequences for Shareholders. Shareholders who are in any doubt about their tax position should consult their own professional independent tax adviser.The Directors are aware that certain Shareholders may be unable or unwilling to hold Ordinary Shares in the event that the Cancellation is approved and becomes effective. Shareholders should take independent advice about retaining their interests in Ordinary Shares prior to the Cancellation becoming effective.The above considerations are not exhaustive, and Shareholders should seek their own independent advice when assessing the likely impact of the Cancellation on them.For the avoidance of doubt, the Company will remain registered with the Registrar of Companies in England and Wales in accordance with and, subject to the Companies Act, notwithstanding the Cancellation and Re-registration.The Company currently intends to continue to provide certain facilities and services to Shareholders that they currently enjoy as shareholders of an AIM company. The Company will:§ continue to communicate information about the Company (including annual accounts) to its Shareholders, as required by the Companies Act; and§ implement the Matched Bargain Facility which would facilitate Shareholders buying and selling Ordinary Shares on a matched bargain basis following Cancellation.The Resolutions to be proposed at the General Meeting include the adoption of the New Articles, with effect from the Re-registration. A summary of the principal differences between the Current Articles and the proposed New Articles is included in Part 2 of this Document. A copy of the New Articles and a copy marked up to show changes from the Current Articles can be viewed on the Company’s website at https://www.brightonpiergroup.com/.4. Transactions in the Ordinary Shares prior to and post the proposed Cancellation4.1. Prior to CancellationShareholders should note that they are able to continue trading in the Ordinary Shares on AIM prior to Cancellation.4.2. Dealing and settlement arrangementsThe Directors are aware that certain Shareholders may wish to acquire or dispose of Ordinary Shares in the Company following the Cancellation.Therefore, the Company has made arrangements for the Matched Bargain Facility to assist Shareholders to trade in the Ordinary Shares to be put in place from the day of Cancellation if the Resolution is passed. The Matched Bargain Facility will be provided by J P Jenkins Limited (“JP Jenkins“). JP Jenkins is a liquidity venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).Under the Matched Bargain Facility, Shareholders or persons wishing to acquire or dispose of Ordinary Shares will be able to leave an indication with JP Jenkins, through their stockbroker (JP Jenkins is unable to deal directly with members of the public), of the number of Ordinary Shares that they are prepared to buy or sell at an agreed price. In the event that JP Jenkins is able to match that order with an opposite sell or buy instruction, they would contact both parties and then effect the bargain. Should the Cancellation become effective and the Company put in place the Matched Bargain Facility, details will be made available to Shareholders on the Company’s website at https://www.brightonpiergroup.com/ and directly by letter or e-mail (where appropriate).Following Cancellation, the provision of the Matched Bargain Facility will be kept under review by the Board and, in determining whether to continue to offer a Matched Bargain Facility, the Company shall consider expected (and communicated) Shareholder demand for such a facility as well as the composition of the Company’s register of members and the costs to the Company and Shareholders. Shareholders should therefore note that there can be no certainty that the Matched Bargain Facility will continue to be in place for an extended period of time following Cancellation although it is the Board’s expectation that this will be in place for at least five years following Cancellation.There can be no guarantee as to the level of the liquidity or marketability of the Ordinary Shares under the Matched Bargain Facility, or the level of difficultly for Shareholders seeking to realise their investment under the Matched Bargain Facility.Before giving your consent to the Cancellation, you may want to take independent professional advice from an appropriate independent financial adviser.If Shareholders wish to buy or sell Ordinary Shares on AIM they must do so prior to the Cancellation becoming effective. As noted above, in the event that Shareholders approve the Cancellation, it is anticipated that the last day of dealings in the Ordinary Shares on AIM will be 1 May 2025 and that the effective date of the Cancellation will be 2 May 2025.9. RecommendationThe Directors consider that the Proposals are in the best interests of the Company and its Shareholders as a whole and, therefore, unanimously recommend that you vote in favour of the Resolutions at the General Meeting as each of the Directors intends to vote, or procure the vote, in respect of, in aggregate, 11,384,185 Ordinary Shares to which they or their connected persons are beneficially entitled.
Appendix 2
EXPECTED TIMETABLE OF PRINCIPAL EVENTSEventTime and/or date*Notice provided to the London Stock Exchange of the proposed Cancellation under AIM Rule 41 2 April 2025Publication and posting of this Document to Shareholders 2 April 2025Latest time and date for receipt of proxy votes in respect of the General Meeting10 a.m. on 16 April 2025General Meeting 10 a.m. on 22 April 2025Expected last day of dealings in Ordinary Shares on AIM 1 May 2025Time and date of Cancellation 7.00 a.m. on 2 May 2025Matched Bargain Facility for Ordinary Shares expected to commence7.00 a.m. on 6 May 2025Re-registration as a private companyBy 12 May 2025Notes:1. References to times in this Document are to London time, unless otherwise stated.2. Each of the times and dates in the above timetable is subject to change. If any of the above times and/or dates change, the revised times and dates will be notified to Shareholders by an announcement through a Regulatory Information Service. 3. The Cancellation requires the approval of not less than 75 per cent. of the votes cast (in person or by proxy) by Shareholders at the General Meeting. 4. The Re-registration requires the approval of not less than 75 per cent. of the votes cast (in person or by proxy) by Shareholders at the General Meeting.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
April 2, 2025
April 2, 2025
Corre Energy B.V
(“CORRE” or “the Company”)
Corre Energy B.V shares are now trading on JP Jenkins
London, UK – 28th March 2025 – Corre Energy B.V (CORRE:JPJ) is pleased to announce that its shares have been admitted for trading on the JP Jenkins share dealing platform. The company is registered at Helperpark 278 3, 9723ZA Groningen (Company No. 82068046).
Corre Energy is one of the few established millisecond to multi – day long duration energy storage (‘LDES’) developers globally, having spent the last 10+ years building its pipeline, cultivating supply chain and on -the ground relationships, and building in – house IP that is critical to delivering projects of this scale
JP Jenkins provides a share trading venue for unlisted or unquoted companies, enabling shareholders and prospective investors to trade equity on a matched bargain basis. JP Jenkins operates as a trading name of InfinitX Limited and is an Appointed Representative of Prosper Capital LLP (FRN 453007). The indicative pricing for the ordinary shares, along with transaction history, will be available on the JP Jenkins website: https://jpjenkins.com.
For further information, please contact:
Corre Energy B.V
Email: ir@corre.energy
Tel: +31 50 799 5060
JP Jenkins Ltd
Veronika Oswald / Mason Doick
Tel: +44 (0) 207 469 0937
March 28, 2025
#14th Edition
Welcome back to our monthly newsletter!
In the past month we announced 9 more companies / clients with Innovation Agritech Group (IAG), Gusbourne, Connected Kerb, Powder Monkey Brewing Co, Eresos CBD, Deltex Medical, Tribe Tech Group, Eurovestech PLC and Studio Stays Hotel Group PLC.
We also have Corre Energy, CMO Group, Biome Technologies plc, Hornby Hobbies Ltd going live with us very shortly.
There are several more awaiting to be announced.
We are delighted to announce the following new admissions to JP Jenkins:
Innovation Agritech Limited:
Innovation Agritech Group (IAG) Limited (Ticker – IAGT:JPJ), is a UK-based company that specializes in vertical farming products and protocols, announces its shares have been admitted to trade on JP Jenkins share dealing platform. Innovation Agritech Group (IAG) is a pioneering British company transforming the agricultural industry through advanced vertical farming technology. Specialising in aeroponic systems, IAG’s proprietary GrowFrame360™ technology enables sustainable, local, year-round crop production without the need for sunlight, soil, or pesticides.
Please see the full press release below:
Gusbourne PLC:
Gusbourne PLC (GUS:JPJ) is pleased to announce that its shares have been admitted for trading on the JP Jenkins share dealing platform. Gusbourne first vines were planted in 2004 with a single-minded vision: to craft the world’s finest sparkling wines. They are detail-focused and quality obsessed, pushing the boundaries of what’s possible in English wine. They are also unwavering in what makes them special – crafting vintage-only bottlings from estate-grown, hand harvested grapes.
Please see the full press release below:
Connected Kerb Limited:
The founders of Connected Kerb Limited (CKB:JPJ) are pleased to announce that their shares have been admitted for trading on the JP Jenkins, to run a bespoke secondary sale. Connected Kerb is a company focused on providing electric vehicle (EV) charging infrastructure, particularly on-street charging solutions for residents without home charging access, by partnering with local councils to install charging points in public areas, making EV charging more accessible to everyone; they also offer charging solutions for businesses, retail spaces, and residential developments, aiming to democratize the EV industry and contribute to sustainable mobility through reliable and convenient charging options.
Please see the full press release announcement below:
Powder Monkey Group Limited:
Powder Monkey Group Limited (PMGL:JPJ), announces its shares have been admitted to trade on JP Jenkins share dealing platform. Powder Monkey Group was created in 2023 to bring together several brewing and hospitality operations under one roof, creating a Powerhouse of Brands with grain to glass margins across a Global landscape. The Group has just acquired its second UK brewing and hospitality site. In Australia the Group has two production facilities, a hospitality offering and an additional site locked in for Q3 2025. The Group is continuing with its growth strategy, with targets and opportunities identified in UK, APAC, US and Europe.
Please see the full press release announcement below:
Eresos Holdings PLC:
Eresos CBD Holdings PLC (ERS:JPJ), announces its shares are trading on JP Jenkins share dealing platform. Eresos is a company that makes CBD-infused skincare, cosmetics, and nutraceutical products. Their products are based on ancient Greek botanical science and are designed to improve health and wellbeing.
Please see the full press release announcement below:
Eurovestech PLC:
Eurovestech PLC (EVT:JPJ) is pleased to announce that its ordinary shares have been admitted for trading on the JP Jenkins share dealing platform. Eurovestech plc is a pan-European venture capital firm established in January 2000. The focus of the fund is on early stage investments in software and technology businesses throughout the UK and Europe.
Please see the full press release announcement below:
Studio Stays Hotel Group PLC:
Studio Stays Hotel Group PLC (SSHG:JPJ) is pleased to announce that its shares have been admitted and are now live for trading on the JP Jenkins share dealing platform. The Studio Stays Hotel Group PLC is a hotel chain operator deriving revenue from traditional Hotel stays, AIRBNB and longer stays.
Please see the full press release announcement below:
Deltex Medical Group PLC:
Deltex Medical Group plc (JPJ:DEMG) is pleased to announce that its ordinary shares will be admitted for trading on the JP Jenkins share dealing platform. Deltex Medical uses proprietary haemodynamic monitoring technology to assist clinicians to improve outcomes for patients as well as increase throughput and capacity for hospitals. The Group’s flagship, world-leading, ultrasound-based oesophageal doppler monitoring (“ODM”) is supported by 24 randomised control trials conducted on anaesthetised patients.
Please see the full press release announcement below:
Tribe Tech Group PLC:
Tribe Tech Group PLC (JPJ:TRYB) is pleased to announce that its shares have admitted for trading on the JP Jenkins share dealing platform.Tribe Technology PLC is a disruptive developer and manufacturer of autonomous mining equipment. The group’s core activities are the development, in-house manufacturing, and sale of its autonomous RC Drill Rigs incorporating its core proprietary intellectual property, the Tribe Technology Drilling System (“TTDS”). Tribe Technology was founded in late 2019 in Western Australia and has since established a headquarters and manufacturing facility in Northern Ireland.
Please see the full press release announcement below:
We are delighted to announce the following intend to join JP Jenkins shortly:
Biome Technologies PLC:
Biome Technologies plc announcement confirmed the result of the GM was duly passed. Biome will be joining JP Jenkins for trading of its shares from the 24th March.
Please see the full RNS below:
https://www.londonstockexchange.com/news-article/BIOM/result-of-gm-update-on-cancellation/16939900
Corre Energy B.V.:
Corre Energy B.V. announced its intentions to move from Euronext to JP Jenkins post the AGM results being duly passed.
Please see the full RNS below:
CMO Group PLC:
CMO Group PLC announced their results of the GM were duly passed and the company will be joining JP Jenkins for trading from the 27th March.
See the full RNS release below:
https://www.investegate.co.uk/announcement/rns/cmo-group–cmo/result-of-general-meeting/8782988
Hornby PLC:
Hornby PLC announced its intentions to move from AIM to JP Jenkins post the AGM results being duly passed.
For the full RNS announcement, please see below:
Issuer news – Check out the latest updates, awards and news from our clients:
Powder Monkey Group:
Powder Monkey acquires Empress Ale Powder Monkey Group (PMGL:JPJ) announced the acquisition of Midlands based, Empress Ale (Empress). The group has 4 brewing facilities, together with 3 Hospitality outlets in the UK & Australia, with further acquisitions planned. This acquisition provides Powder Monkey with not only top-quality additional beers for its “direct to consumer” portfolio but also a notable established client base in some of London’s prime restaurants and Grocers such as Waitrose and Ocado.
See the full release below:
Carlisle Support Services:
Carlisle Support Services announced this week that they have won the OSPAs of Security Company of the year! Carlisle is currently trading on JP Jenkins, to find out more check out our website, www.jpjenkins.com
Redx Pharma:
Redx Pharma (JPJ:REDX), the clinical-stage, small molecule biotechnology company, announced on Monday the presentation of results from a RXC008 Phase 1 clinical trial by lead investigator, Dr Florian Rieder at the 20th Congress of European Crohn’s and Colitis Organisation Conference (ECCO) on Friday February 21, 2025, Berlin, Germany.
To read the full announcement, please see below:
GS Verde Group:
Nigel Greenaway – CEO of GS Verde Group (One of the many fantastic companies to trade on JP Jenkins), is set to embark on a series of four extraordinary challenges in aid of St David’s Hospice Care. The JP Jenkins team wish you well and best of luck!
Read more here: https://www.gsverde.group/nigel-greenaway-takes-on-four-extreme-challenges-in-aid-of-st-davids-hospice-care
Learning 101 with JP Jenkins – Check out our latest videos here on:
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
March 20, 2025
20th March 2025
IAGT:JPJ
ISIN: GB00BRQPCZ68
Innovation Agritech Group Limited
(“IAGT” or “the Company”)
Shares now trading on JP Jenkins
London, UK, 20th March 2025 – Innovation Agritech Group Limited (IAGT:JPJ), is a UK-based company that specializes in vertical farming products and protocols, today announces its shares have been admitted to trade on JP Jenkins share dealing platform. IAGT is based at The AeroBarn, Heathley Hall Farm, Bracknell Road, Bracknell, England, RG42 6BN and is registered as a company in England and Wales under Companies House, company number 10570531.
Innovation Agritech Group (IAG) is a pioneering British company transforming the agricultural industry through advanced vertical farming technology. Specialising in aeroponic systems, IAG’s proprietary GrowFrame360™ technology enables sustainable, local, year-round crop production without the need for sunlight, soil, or pesticides. Founded in 2017, IAG’s mission is to empower growers with technology solutions that maximise crop yields and minimise resource usage while eliminating the seasonal constraints of traditional farming, ultimately contributing to global food security. IAGT’s believe that embracing the synergy of science and technology can lead to a more sustainable and progressive future for agriculture.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007). Jaz Singh, Innovation Agritech Group’s Founder & CEO, commented: “We are pleased to announce that our shares are now trading on JP Jenkins. As part of our company’s growth trajectory, we see this as a vital step in the right direction for both the company and its shareholders. JP Jenkins provides our shareholders with an efficient, simple and effective platform to trade.”
Veronika Oswald, Commercial Director of JP Jenkins, commented: “JP Jenkins are delighted to welcome IAGT to our platform and continuously growing list of companies. The board is very happy to see yet another fantastic private business benefit from our platform, utilising the access and services we offer. We look forward to supporting IAGT in their next stage of growth.”
Shareholders wishing to trade these securities can do so through their stockbroker. Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer. Trades can be conducted, and limits can be accepted, during normal business hours. Shareholders or potential investors can place limits via their existing UK regulated stockbroker. The indicative pricing for the ordinary shares, as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/).
For further information, please contact:
Innovation Agritech Group Limited
Investor Relations
JP Jenkins Ltd
Veronika Oswald / Mason Doick
Tel. +44 (0) 203 883 5532 Tel. +44 (0) 207 469 0937
Email: replies@iagri-tech.com Email: info@jpjenkins.com
ENDS
March 20, 2025
19th March 2025
GUS:JPJ
ISIN: GB00B8TS4M09
Gusbourne PLC
(“GUS” or “the Company”)
Gusbourne PLC shares are now trading on JP Jenkins
London, UK – 19th March 2025 – Gusbourne PLC (GUS:JPJ) is pleased to announce that its shares have been admitted for trading on the JP Jenkins share dealing platform. Gusbourne PLC, registered at Gusbourne, Kenardington Road, Appledore, Ashford, Kent, England, TN26 2BE (Company No. 08225727).
Gusbourne’s first vines were planted in 2004 with a single-minded vision: to craft the world’s finest sparkling wines. They are detail-focused and quality obsessed, pushing the boundaries of what’s possible in English wine. They are also unwavering in what makes them special – crafting vintage-only bottlings from estate-grown, handharvested grapes.
JP Jenkins provides a share trading venue for unlisted or unquoted companies, enabling shareholders and prospective investors to trade equity on a matched bargain basis. JP Jenkins operates as a trading name of InfinitX Limited and is an Appointed Representative of Prosper Capital LLP (FRN 453007). The indicative pricing for the ordinary shares, along with transaction history, will be available on the JP Jenkins website: https://jpjenkins.com.
For further information, please contact:
Gusbourne PLC
Investor Relations:
Email: investorrelations@gusbourne.com
Tel: 01622 809763
JP Jenkins Ltd
Veronika Oswald / Mason Doick
Tel: +44 (0) 207 469 0937
Email: info@jpjenkins.com
– END –
March 19, 2025
18th March 2025
PMGL:JPJ
ISIN: GB00BPNWR625
Powder Monkey Group (PMG) of Priddy’s Hard, Gosport, is delighted to announce the acquisition of Midlands based, Empress Ale (Empress). Empress supplies beers to some of the finest Michelin starred restaurants, gastro pubs and up-and-coming eateries across the UK.
This acquisition provides Powder Monkey with not only top-quality additional beers for its “direct to consumer” portfolio but also a notable established client base in some of London’s prime restaurants and Grocers such as Waitrose and Ocado. Surj Virk, Founder of Empress said: “I’m delighted that Empress has joined the PMG family. To join powerhouse brands already within the group is an exciting step for the Empress story. PMG strongly aligns with our ethos as a business, and we share the same vision for future growth. We are very excited to be part of the PMG journey”.
Andy Burdon, CEO of Powder Monkey Group, said: “I am excited to welcome Empress on board, a fantastic addition to our expanding Group. It’s also a pleasure to welcome Surj to join our senior management team, adding in his years of sales expertise which he has utilised to create and drive the Empress brand to date”.
Mike McGeever, Chairman Powder Monkey Group, said: “Absolutely delighted to welcome Surj and the team at Empress to the PMG. This acquisition complements the current UK offering and enhances the Group’s capacity and capability.”
Powder Monkey Group Limited (PMGL:JPJ), shares are trading on the JP Jenkins share dealing venue. For further information, please review their page via the link – https://jpjenkins.com/company/powder-monkey-group-limited/. JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
For further information, please contact:
Powder Monkey Group
Investor Relations:
Email: hello@powdermonkeygroup.com
Tel: 02392 522126
JP Jenkins Ltd
Veronika Oswald / Mason Doick
Tel: +44 (0) 207 469 0937
March 18, 2025
Connected Kerb Limited
(“CKB” or “the Company”)
Connected Kerb Limited shares are now trading on JP Jenkins
London, UK – March 2025 – Connected Kerb Limited (JPJ:CKB) is pleased to announce that its shares will be admitted for trading on the JP Jenkins share dealing platform. Connected Kerb Limited, registered at 2 Communications Road, Greenham Business Park, Newbury, Berkshire, United Kingdom, RG19 6AB (Company No. 11062616).
Connected Kerb is a company focused on providing electric vehicle (EV) charging infrastructure, particularly on-street charging solutions for residents without home charging access, by partnering with local councils to install charging points in public areas, making EV charging more accessible to everyone; they also offer charging solutions for businesses, retail spaces, and residential developments, aiming to democratize the EV industry and contribute to sustainable mobility through reliable and convenient charging options.
JP Jenkins provides a share trading venue for unlisted or unquoted companies, enabling shareholders and prospective investors to trade equity on a matched bargain basis. JP Jenkins operates as a trading name of InfinitX Limited and is an Appointed Representative of Prosper Capital LLP (FRN 453007). The indicative pricing for Connected Kerb Limited ordinary shares, along with transaction history, will be available on the JP Jenkins website: https://jpjenkins.com.
For further information, please contact:
Connected Kerb Limited
Investor Relations:
Stephen Richardson
Tel: +44 (0)7947 529 848
JP Jenkins Ltd
Veronika Oswald / Mason Doick
Tel: +44 (0) 207 469 0937
– END –
March 17, 2025
13th March 2025
PMGL:JPJ
ISIN: GB00BPNWR625
Powder Monkey Group Limited
(“Powder Monkey” or “the Company”)
Shares now trading on JP Jenkins
London, UK, 13th March 2025 – Powder Monkey Group Limited (PMGL:JPJ), today
announces its shares have been admitted to trade on JP Jenkins share dealing
platform. The Company’s registered address is Priddys Hard, Heritage Way, Gosport,
England, PO12 4FL and company number is 14805370.
Powder Monkey Group was created in 2023 to bring together several brewing and hospitality
operations under one roof, creating a Powerhouse of Brands with grain to glass margins
across a Global landscape. The Group has just acquired its second UK brewing and
hospitality site. In Australia the Group has two production facilities, a hospitality offering and
an additional site locked in for Q3 2025. The Group is continuing with its growth strategy,
with targets and opportunities identified in UK, APAC, US and Europe.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies,
enabling shareholders and prospective investors to buy and sell equity on a matched
bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative
of Prosper Capital LLP (FRN453007).
Shareholders wishing to trade these securities can do so through their stockbroker. Trades
will be conducted at a level that JP Jenkins is able to match a willing seller and a willing
buyer. Trades can be conducted, and limits can be accepted, during normal business hours.
Shareholders or potential investors can place limits via their existing UK regulated
stockbroker. The indicative pricing for the ordinary shares as well as the transaction history,
will be available on the JP Jenkins website at (https://jpjenkins.com/).
For further information, please contact:
Powder Monkey Group Limited
Investor Relations
Email: mike.mcgeever@powdermonkeybrewing.com
JP Jenkins Ltd
Veronika Oswald / Mason Doick
Tel. +44 (0) 207 469 0937
Email: info@jpjenkins.com
ENDS
March 13, 2025
5th March 2025
EVT:JPJ
ISIN: GB0002292810
Eurovestech PLC
(“Eurovestech” or the “Group”)
Eurovestech PLC ordinary shares are admitted to JP Jenkins
London, UK – 5th March 2025 – Eurovestech PLC (EVT:JPJ) is pleased to announce
that its ordinary shares will be admitted for trading on the JP Jenkins share dealing
platform. Eurovestech PLC, registered at 164 Field End Road, Eastcote, England,
HA5 1RH (Company No. 03913197).
Eurovestech plc is a pan-European venture capital firm established in January 2000.
The focus of the fund is on early stage investments in software and technology
businesses throughout the UK and Europe.
JP Jenkins provides a share trading venue for unlisted or unquoted companies,
enabling shareholders and prospective investors to trade equity on a matched
bargain basis. JP Jenkins operates as a trading name of InfinitX Limited and is an
Appointed Representative of Prosper Capital LLP (FRN 453007). The indicative
pricing for the ordinary shares, along with transaction history, will be available on the
JP Jenkins website: https://jpjenkins.com.
For further information, please contact:
Eurovestech PLC
Investor Relations:
enquiries@eurovestech.com
+44 (0)20 7478 9070
JP Jenkins Ltd
Veronika Oswald / Mason Doick
info@jpjenkins.com
Tel: +44 (0) 207 469 0937
March 5, 2025
4 March 2025
Great Eastern Energy Corporation Limited
(“Great Eastern” or “Company”)
Announcement for appointment of Additional Director (Independent)
Great Eastern Energy Corporation Limited, the fully integrated gas production, development, and exploration Company in India, announces that the Board of Directors have approved the appointment of Mrs. Ambika Sharma as an Additional Director (Independent) of the Company with effect from February 28, 2025.
For further information, please contact:J P Jenkins Ltd. Veronika OswaldDirector +44 (0) 20 7469 0937 Great Eastern Energy Corporation Limited Jonathan KeelingVP – Investor Relations jkeeling@geecl.comAbout the Company
Great Eastern is a fully integrated gas production, development, and exploration Company in India. Gas is being produced from the Raniganj (South) block in West Bengal, which covers 210 sq. km with 10.62 TCF of Original gas in place. The Company’s second license is the Mannargudi block in Tamil Nadu, which covers 667 sq. km with 0.98 TCF of Original gas in place.
March 4, 2025
Welcome back to our monthly newsletter!
In the past month we announced a few more new clients with QUIZ Clothing, HVS (Hydrogen Vehicle Systems) & TallyMoney.
We also have Tribe Tech Group, Deltex Medical, Powder Monkey Brewing Co, Studio Stays Hotel Group PLC & Gusbourne going live with us very shortly.
There are several more awaiting to be announced.
We are delighted to announce the following new admissions to JP Jenkins:
Tally Central Ltd:
TallyMoney Central Ltd (TAL: JPJ), announces its shares are to be admitted to trade on the JP Jenkins share dealing platform. An admission price of 3p per share giving an indicative market capitalisation c.£23m.
Tally Central is a London-based fintech company incorporated in Guernsey, that developed a gold-based standalone monetary system that operates independently to the fiat-currency fractional-reserve banking system, but seamlessly works with established merchant payment and funds transfer infrastructure.
See the full announcement below:https://lnkd.in/eupegFfq
Quiz PLC:
QUIZ Clothing (QUIZ:JPJ), announces its shares are to be admitted to trade on JP Jenkins share dealing platform. Quiz was founded in 1993 and began trading with 3 stores in Scotland. Quiz has now grown to over 150 stores and concessions in most of the major shopping centres and high streets across the UK.
With over 60 franchises in Europe and Asia the Quiz brand has also grown worldwide. The company employs more than 1000 members of staff in the UK alone. QUIZ PLC is an omni-channel fast fashion women’s wear brand. It focusses on occasion wear and dressy casual wear offering clothes, footwear and accessories.
See the full announcement below:https://lnkd.in/d-dTMxpU
Hydrogen Vehicle Systems Limited:
HVS (Hydrogen Vehicle Systems) Limited (HVS:JPJ), announces its shares are to be admitted to trade on JP Jenkins share dealing platform. HVS is a UK-based AI climate tech company specialising in the design and manufacture of hydrogen-powered trucks.
Its AI-SEMAS™ vehicle control technology optimises performance in diesel, battery, and hydrogen trucks. Developed by nuclear physicist Dr. Telford, HVS’s patented system boosts efficiency and lowers emissions.
See the full announcement below:https://lnkd.in/eeFsPjEG
We are delighted to announce the following intend to join JP Jenkins shortly:
Deltex & Tribe Tech:
Recently we saw two companies announce their results of the AGM were duly passed, they will be leaving AIM and joining JP Jenkins. Please see the RNS announcements below:
Deltex Medical:https://lnkd.in/eTjaPxAG
Tribe Tech Group:https://lnkd.in/eq58gGDi
We have another several public companies and private companies looking to join our platform very shortly
Studio Stays Hotel Group PLC:
Studio Stays Hotel Group PLC (JPJ:SSHG) is pleased to announce that its shares will be admitted for trading on the JP Jenkins share dealing platform. The Studio Stays Hotel Group PLC is a hotel chain operator deriving revenue from traditional Hotel stays, AIRBNB and longer stays.
Full announcement here: https://www.investegate.co.uk/announcement/ias/studio-stays-hotel-group-plc–sshg:jpj/studio-stays-hotel-group-plc-to-join-jp-jenkins-trading-platform/8740341
Gusbourne PLC:
Gusbourne PLC announced this morning its intention to move from AIM to JP Jenkins, for continued share trading post cancellation.
Please read the full announcement here:https://lnkd.in/ept3k4WQ
Issuer news – Check out the latest updates, awards and news from our clients:
Carlisle Support Services
Don’t miss the latest Innovation Labs event due to take place on Thursday 27th March at Excel London. With over 700 decision makers in attendance from across our market leading portfolio of clients, contract management teams and wider senior industry stakeholders, the event poses excellent business opportunities you wouldn’t want to miss.
Click the link below to find out more, discover organisations expected in attendance and register to capitalise on this opportunity: https://innovationlab.carlislesupportservices.com/
Thrive Renewables
Thrive Renewables closed its latest auction (Jan), trading 17,050 shares at an average price of £1.90.
Thrive shares are trading on JP Jenkins via monthly auctions – They paid a 12p dividend this year and provide a buy back policy for all qualifying shareholders at 90% of the directors valuations, currently at £2.43.
The company is planning to complete another buy back in line with their buy back policy here: https://www.thriverenewables.co.uk/investors/buy-and-sell-shares/share-buy-back-policy
To learn more, please visit: https://lnkd.in/e78GMxfa
Check out the latest research report produced by Edison Group below:https://lnkd.in/e7Rmai7t
Check out the latest news, events and webinars:
JP Jenkins embraces AI tech for ESG reporting
JP Jenkins, the private platform for trading in unlisted securities, has announced its first deployment of AI technology. The solution, from data science specialists Insig AI, provides access to the company’s Transparency and Disclosure Index (TDI) reports.
Read the full announcement below:
https://www.investments.halifax.co.uk/research-centre/news-centre/article/?id=18914976&type=bsmNew Starter – Head of Dealing
JP Jenkins is delighted to welcome Kerry Dyce as our New Head of Dealing. We are super excited to have Kerry support all our clients / companies with further liquidity and connectivity with all UK regulated brokers that are trading with JP Jenkins. Our platform continues to improve with increased liquidity, new growth companies joining and potentially a few more hires in due course!
The Investors’ Circle Dinner at the East India Club
Our Commercial Director Veronika Oswald presented to a full room this week at The Investors’ Circle Dinner at the East India Club. Discussing the challenges facing many private companies and their shareholders in the current economic conditions. Lack of liquidity and exit options is a particular concern of many investors. Thank you again for having us Richard Angus!
New Update!
At JP Jenkins, we continue to improve and enhance our platform. We have now added Offer / Bid Interest information to each trading company. Brokers are able to Request For Quote using their trading terminals and our platform showcases what the price is for any Offer or Bid we receive. We also have some very exciting developments with a new Head of Trading joining us very soon to manage further increased demand in trading volumes.
To learn more, please visit: www.jpjenkins.com
Learning 101 with JP Jenkins – Check out our latest videos here on:
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
February 26, 2025
QUIZ Clothing
(“QUIZ” or “the Company”)
Administration of Zandra Retail Limited
QUIZ confirms that Teneo have been appointed as Administrators to the Company’s wholly owned subsidiary, Zandra Retail Limited (“Zandra”), which operates QUIZ’s standalone UK and Ireland retail stores. This decision was taken by the Board to put the business in a more sustainable position in the context of continuing challenging trading conditions negatively impacting the Group’s performance.
Following the appointment of Teneo as Administrators to Zandra Retail Limited, Orion Retail Limited (“Orion”), a subsidiary of the Company, has agreed to immediately acquire from Zandra (acting through its Administrators) certain assets of Zandra, including the right to occupy and to continue to trade from 42 stores operated by Zandra. This will preserve the majority of the Group’s retail employees.
Regrettably, 23 stores deemed to be loss-making or unsustainable will not be operated by Orion and were closed by the Administrators soon after the appointment.
QUIZ’s online business, concessions and international operations are operated by other Group subsidiaries and are unaffected by this announcement.
Sheraz Ramzan, CEO of QUIZ commented: “The Board took the difficult decision to appoint administrators to Zandra Retail Limited in light of the continuing challenging trading conditions impacting the Group’s performance.
We are deeply sorry to those affected by the store closures, including our retail colleagues. However, this decision will put the business in a more sustainable footing for the future and protect several hundred jobs as a result.”
February 24, 2025
QUIZ Clothing
(“QUIZ” or “the Company”)
Change to Limited Company and Director Resignations
QUIZ PLC confirms that further to the delisting of the Company from AIM, the Company was re-registered as a private registered company and renamed QUIZ Limited on 28 January 2025.
Further to this, Peter Cowgill and Roger Mather have resigned as directors of QUIZ effective on 29 January 2025.
Sheraz Ramzan, CEO of QUIZ commented: “I would like to thank Peter and Roger for their commitment and considerable contribution to the QUIZ business since their appointment in 2017. We wish them well in their future endeavours.”
20 February 2025
February 20, 2025
17th Feb 2025
SSHG:JPJ
Studio Stays Hotel Group PLC
(“SSHG” or “the Company”)
Studio Stays Hotel Group PLC to Join JP Jenkins Trading Platform
London, UK – February 2025 – Studio Stays Hotel Group PLC (JPJ:SSHG) is pleased to announce that its shares will be admitted for trading on the JP Jenkins share dealing platform. Studio Stays Hotel Group PLC, registered at 27 Old Gloucester Street, London, United Kingdom, WC1N 3AX (Company No. 16236213). The Studio Stays Hotel Group PLC is a hotel chain operator deriving revenue from traditional Hotel stays, AIRBNB and longer stays.
Grant Bovey, CEO of Studio Stays Hotel Group PLCcommented:
“This marks a significant milestone for the company as it embarks on an innovative growth strategy within the UK hotel sector. Studio Stays has assembled an experienced management team with an exceptional track record in the hospitality industry. The company’s leadership has successfully built and scaled large businesses and is now set to revolutionise the UK hotel market with its pioneering hybrid business model.
JP Jenkins provides a trading venue for unlisted or unquoted companies, enabling shareholders and prospective investors to trade equity on a matched bargain basis. JP Jenkins operates as a trading name of InfinitX Limited and is an Appointed Representative of Prosper Capital LLP (FRN 453007). The indicative pricing for its ordinary shares, along with transaction history, will be available on the JP Jenkins website: https://jpjenkins.com.
For further information, please contact:
Studio Stays Hotel Group PLC
Investor Relations:
Grant Bovey CEO
Tel : +447710421345
Email : grant@studio-stays.com
JP Jenkins Ltd
Veronika Oswald / Mason Doick
Tel: +44 (0) 207 469 0937
– END –
February 17, 2025
February 17, 2025
Connected Kerb, the British born and based electric vehicle (EV) smart charging infrastructure specialist, today announced it has secured a £65 million equity investment to support its plans of expanding the UK’s on-street EV charging network.
The fundraise sees NWF commit a £55m ordinary equity investment alongside a further £10m ordinary equity investment from Aviva Investors, the global asset management business of Aviva plc.
This substantial investment into the UK’s public charging infrastructure is critical for delivering the forecast requirement of at least 300,000 public EV chargers by 2030.
Chris Pateman-Jones, CEO of Connected Kerb, said:
“This investment combines Connected Kerb’s proven hardware and advanced software infrastructure with the financial resources of NWF and Aviva to deploy public charging at scale, to all corners of the UK. This is a game-changing investment that will give individuals and businesses the confidence to make the switch to driving electric, dramatically reducing carbon emissions and air pollution. We are delighted to have such high-profile investors who are deeply aligned with our sustainability and ethical goals.”
John Flint, National Wealth Fund, said:
“To get to net zero we need to make it as easy as possible for people to change the way they do things. Providing convenient and reliable on-street charging is key to helping those without driveways make the switch to electric vehicles. Our investment in Connected Kerb will support one of the UK’s leading public charge point operators to continue its network expansion and deploy this much-needed EV charging infrastructure at pace and at scale to homes and businesses across the country.”
Angenika Kunne, Head of Infrastructure Equity, Aviva Investors said:
”We are pleased to extend our relationship with Connected Kerb and to back its continued growth plans. This is an ambitious company which we believe is leading the way in helping the UK get ready for the future and supporting the transition towards a low-carbon economy. With plans to roll-out an extensive EV charging network, it is well-positioned to create infrastructure which can support the adoption of electric vehicles for the mass market. The unique offer of Connected Kerb’s advanced site selection and user software provides a compelling proposition for both Aviva Investors clients and the end user.”
Future of Roads Minister, Lilian Greenwood said:
“Our charge point network is going from strength to strength, and it’s brilliant to see Connected Kerb secure a £65m boost to expand its charging network – a great vote of confidence in the EV transition. The funding follows a record of nearly 20k public charge points added last year. With a further £6bn in the pipeline from industry by 2030, the switch to EVs is driving investment across the country, supporting jobs and making the UK a clean energy superpower to deliver our plan for change.”
Juliet Davenport, Connected Kerb Chair said:
“We are incredibly proud to receive this substantial investment from the National Wealth Fund and Aviva Investors. This funding will enable us to significantly expand our EV charging network, making electric vehicle charging accessible to everyone, especially those without driveways. This investment not only supports our growth but also aligns with our commitment to reducing carbon emissions and promoting flexibly clean energy solutions across the UK.”
EV ownership continues to rise fast with over 30% of new vehicles sold last December# being pure battery EVs. However, there’s a growing gap between EV ownership where drivers can charge their vehicle on their own driveway or garages and where they cannot, as is the case in 55% of dwellings in urban areas##.
By boosting public charging infrastructure, Connected Kerb’s public/private partnership model, enabled by NWF and Aviva Investors, is rebalancing this inequality. The company’s chargers are manufactured in the UK, supporting the government’s drive for green job creation.
Connected Kerb was advised in this transaction by Cameron Barney Herbst Hilgenfeldt (CBHH).
ENDS
About Connected Kerb
Connected Kerb is is on a mission to change the world for good. We aim to make EV charging inclusive, convenient, and reliable, and are committed to sustainable mobility. We work with local authorities to build and operate community EV charging in residential streets and local public car parks, and also install future-proof EV charging infrastructure at workplaces, retail destinations, car parks, commercial real estate, and for residential developers.
As smart cities of the future develop, Connected Kerb’s charge points support smart charging technology and other future technologies designed to have a positive impact on people and the planet. The company is committed to ensure that no one in the UK lives further than a five-minute walk from a charger.
About The National Wealth Fund
The National Wealth Fund (NWF) is an investor, operating as a bank, to drive private sector investment into the UK’s clean energy and growth industries in support of government policy.
Created in October 2024 from the UK Infrastructure Bank, the NWF aims to mobilise private capital around the government’s strategic priorities, including delivery of the forthcoming industrial strategy.
The NWF is based in Leeds and has £27.8bn to deploy across the capital structure, including loans, equity investments, and guarantees.
The NWF also provides commercial and financial advisory services and market leading lending to local authorities across the UK. The Fund is wholly owned by HM Treasury but is operationally independent from government.
Data sources:
# SMMT vehicles sales statistics December 2024
February 11, 2025
31st Jan 2025
TAL: JPJ
ISIN: GG00B3M9KL68
Tally Central Ltd.
(“Tally Central”, “TAL” or “the Company”)
Shares to be trading on JP Jenkins
London, UK, 31st January 2025 – Tally Central Ltd, today announces its shares are to be admitted to trade on the JP Jenkins share dealing platform (TAL: JPJ) with an admission price of 3p per share giving an indicative market capitalisation c.£23m.
Tally Central is a London-based fintech company incorporated in Guernsey, that developed a gold-based standalone monetary system that operates independently to the fiat-currency fractional-reserve banking system, but seamlessly works with established merchant payment and funds transfer infrastructure. Only currently available for UK residents and marketed through the Company’s wholly owned subsidiary, TallyMoney UK Ltd (“Tally UK”), it is the first in the world to offer individual customer IBANs (International Bank Account Numbers) denominated in a currency that is not issued by a government. Every unit of tally® (the currency, spelt with a lowercase ‘t’) represents 1 milligram of ethically sourced physical gold from London Bullion Market Association (LBMA)-accredited brokers and stored with LBMA-accredited high security vault providers, held on behalf of Tally customers.
In addition to its core operational business, the Company holds strategic investments of 5% or more in Bombay Stock Exchange-listed gold mining company, Deccan Gold Mines Limited and travel industry SaaS (Software-as-a-Service) company, Journey Mentor Ltd. Tally Central’s audited accounts for financial year end 30 June 2024 that were completed and published at the end of October 2024, which shows the Company’s total net assets in excess of £9 million at financial year end. The audited financial accounts can be found at tallymoney.com/investors/reports
Cameron Parry, Chief Executive Officer and Founder, commented: “Tally is on a mission to provide people with sound money, that benefits and protects depositors and savers, and can be used as an alternative to their local currency issued by the government’s central bank. Combining the value of gold with payments innovation, we deliver sound money which is foundational to individual financial wellbeing and promotes savings and productivity in society. Tally Central’s monetary system enables people to use tally as their everyday money, for savings and payments. The TallyMoney App also provides a transparent and inexpensive way to own gold in seconds, with instant access through an everyday account and debit card.
Tally Central’s subsidiary, Tally UK, currently has a base of several thousand UK customers, and now with the focus moving to growing that customer base significantly over 2025 and 2026, it is timely for TAL shares to be admitted to trading and we’re pleased to be joining the JP Jenkins platform.
From first concept through to initial product release in June 2019, through to the proprietary technology platform build going live in May 2023 and building out the organisation to a team of 30, which has been paid for through previous capital raisings and investment returns of circa £15 million to date. Tally Central now has a scalable monetary technology with potential global application and all the necessary operational resources in place, to focus on revenue growth and achieving profitability of the core business over the next two years. With the Company able to fund itself through its realisable investments during this period, admission of TAL shares tradeable on the JP Jenkins platform provides an avenue for those looking to depart or join this exciting new stage of Tally Central’s journey.”
JP Jenkins
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
The indicative pricing for the ordinary shares as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/).
For further information, please contact:
Tally Central Ltd Investor RelationsJP Jenkins Ltd Veronika Oswald / Mason Doick Tel: +44 (0) 20 3858 0373Tel. +44 (0) 207 469 0937 Email: corporate@tallymoney.com Email: info@jpjenkins.comENDS
January 31, 2025
23rd Jan 2025
QUIZ:JPJ
ISIN: JE00BZ00SF59
Quiz PLC
(“QUIZ” or “the Company”)
Shares to be trading on JP Jenkins
London, UK, 23rd Jan 2025 – Quiz PLC (QUIZ:JPJ), today announces its shares are to be admitted to trade on JP Jenkins share dealing platform. The Company’s registered address is 61 Hydepark Street, Glasgow, G3 8BW.
Quiz was founded in 1993 and began trading with 3 stores in Scotland. Quiz has now grown to over 150 stores and concessions in most of the major shopping centres and high streets across the UK. With over 60 franchises in Europe and Asia the Quiz brand has also grown worldwide. The company employs more than 1000 members of staff in the UK alone. QUIZ PLC is an omni-channel fast fashion women’s wear brand. It focusses on occasion wear and dressy casual wear offering clothes, footwear and accessories.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
The indicative pricing for the ordinary shares as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/).
For further information, please contact:
ENDS
January 23, 2025
Happy New Year! (Yes a tad late, but unfortunately we only send these once a month)
In the past month we announced another four more clients with Parsley Box, THG Ingenuity, SCHOLIUM GROUP PLC and OMEGA MINERALS PLC.
We also have QUIZ Clothing going live on Friday this week and another two companies have announced this week they are moving from AIM to JP Jenkins.
There are several more awaiting to be announced.
We hope that 2025 can be even better than last year!
We are delighted to announce the following new admissions to JP Jenkins:
The Hut com Limited
The Hut com Limited t/a THG Ingenuity (INGT:JPJ), announced its shares have been admitted to trade on JP Jenkins share dealing platform. THG Ingenuity comprises leading digital marketing, technology and fulfilment capabilities. THG Ingenuity utilises its experience in building category-leading digital brands to offer end-to-end ecommerce solutions for brand owners and retailers.
Full announcement can be found here: https://lnkd.in/eXktK6XZ
Scholium Group PLC
Scholium Group PLC (SCHO:JPJ), announced its shares are to be admitted to trade on JP Jenkins share dealing platform. Scholium Group PLC is a holding company that trades and retails rare books, works on paper, and fine art in the United Kingdom. The company also deals with other third-party dealers in the arts and collectibles.
Full announcement can be found here: https://lnkd.in/eFDCWq8U
Parsley Box Group Ltd
Parsley Box Group Ltd (MEAL:JPJ), announced its shares have been admitted to trade on JP Jenkins share dealing platform.Parsley Box is a direct-to-consumer provider of ready meals that are prepared in UK kitchens. Their meals are cooked using a process similar to home pressure cooking, which gives them a longer shelf life and locks in flavor. The meals are vacuum sealed and can be stored in a cupboard for up to six months without needing to be refrigerated or frozen.
Full announcement can be found here: https://lnkd.in/eNfUnfCB
Omega Minerals PLC
OMEGA MINERALS PLC (OMM:JPJ), announced its shares have been admitted to trade on JP Jenkins share dealing platform. Founded in 2020, Omega Minerals PLC is a mining exploration company that acquires and develops mineral and alluvial gold projects in Canada. Omega is focused on gold resources within the historic gold belt in British Columbia, Canada.
Omega Minerals Plc board commented,
Full announcement can be found here: https://lnkd.in/e5Yd95pr
We are delighted to announce the following intend to join JP Jenkins shortly:
Quiz Clothing PLC:
QUIZ Clothing announced the results of their general meeting were duly passed on a poll. Following approval by Shareholders at the General Meeting, the admission of the ordinary shares to trading on AIM will be cancelled on 23 January 2025. To facilitate future shareholder transactions in the Company’s Ordinary Shares, the Company has appointed JP Jenkins to provide a matched bargain facility, which will be available upon the date of Cancellation.
Full announcement can be found here: https://lnkd.in/ecMUwsfQ
Deltex Medical PLC
Deltex Medical announces its intention to move from AIM and join JP Jenkins.
Full details of the announcement are below: https://lnkd.in/e26wsYyh
Tribe Tech Group PLC
Tribe Tech Group announced this morning its intention to move from AIM and join JP Jenkins.
Full details of the announcement are below: https://lnkd.in/eFyjzxmb
JP Jenkins has another several new admissions / companies to announce in February!
Issuer news – Check out the latest updates, awards and news from our clients:
Cafédirect
The Cafédirect Board welcome Silvia Herrera. “Silvia is a coffee farmer from Mexico’s UES cooperative, one of the first groups we partnered with back in 1991. She’s joining us as one of two producer directors on our eight-person board, bringing years of hands-on experience and deep knowledge of coffee farming.” Cafédirect is working to change how coffee is bought and sold, so farmers always receive a steady price that’s enough to live on. It’s the only way to guarantee the future of high-quality coffee.
Molecular Energies
Molecular Energies has released an update to shareholders on its activities for the quarter ending 30 June 2024.
Read the update here https://lnkd.in/eHjTs-GD
Leeds Group Limited
Leeds Group Limited announced its re-registration as a private company and new articles of association.
Carlisle Support Services
Don’t miss the latest Innovation Labs event due to take place on Thursday 27th March at Excel London. With over 700 decision makers in attendance from across our market leading portfolio of clients, contract management teams and wider senior industry stakeholders, the event poses excellent business opportunities you wouldn’t want to miss.
Click the link below to find out more, discover organisations expected in attendance and register to capitalise on this opportunity: https://innovationlab.carlislesupportservices.com/
THG Ingenuity
THG Ingenuity are delighted to welcome their new Chief Commercial Officer, Lucy Cooper. “Lucy joins us from Microsoft, bringing over 15 years’ experience spanning growth strategy, transformation, and technology commercialisation. With strong expertise in AI, digital platforms and M&A, with a strong focus on customer-centric strategies, Lucy brings a track record of identifying and delivering innovative growth opportunities to this new era for THG Ingenuity.”
Read more here: https://lnkd.in/eJx3b2_d
GS Verde Group
GS Verde Group announced its latest deal – An established Telecommunications company has successfully completed an Employee Ownership Trust (EOT), in a deal advised on by GS Verde Group. With over 20 years of experience installing and maintaining Fibre Optic networks for its customers, the Wales-based company provides various services such as Fibre testing, splicing and cabling.
Find out more about the deal here: https://lnkd.in/eMGYr6ZM
Thrive Renewables
Thrive Renewables closed its latest auction (Dec), trading 2,100 shares at an average price of £1.88. In the latest buy back the company runs each year, 90,406 shares were bought at an average price of £2.19. Thrive shares are trading on JP Jenkins via monthly auctions – They paid a 12p dividend this year and provide a buy back policy for all qualifying shareholders at 90% of the directors valuations, currently at £2.43.
To learn more, please visit: https://lnkd.in/e78GMxfa
Check out the latest research report produced by Edison Group below:https://lnkd.in/e7Rmai7t
Events – Check out the latest events and webinars:
Unfortunately given the Christmas and New Year break there were no events to report, but lots pending for 2025!
Learning 101 with JP Jenkins – Check out our latest videos here on:
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
January 20, 2025
Quiz PLC
08 January 2025
8 January 2025
QUIZ Plc
(“QUIZ”, the “Company” or the “Group”)
Result of General Meeting
QUIZ, the omni-channel fashion brand, announces that, at the general meeting of the Company held earlier today (the “General Meeting”), all resolutions put to the Company’s shareholders (“Shareholders”) were duly passed on a poll.
Details of proxy votes received are summarised below:
Resolution NumberResolution NameVotes ForVotes AgainstNo. of shares% of shares votedNo. of shares% of shares voted1Cancellation Resolution85,614,131 98.6 1,254,169 1.4 2Re-registration Resolution85,614,131 98.6 1,254,169 1.4The full text of the Resolutions proposed and passed at the General Meeting can be found in the circular containing, inter alia, the Notice of General Meeting, which was published intraday on 20 December 2024 and is available on the Company’s website www.quizgroup.co.uk (the “Circular”).
AIM Delisting
Following approval by Shareholders at the General Meeting, the admission of the ordinary shares of £0.003 each in the capital of the Company (“Ordinary Shares”) to trading on AIM will be cancelled (the “AIM Delisting”). The AIM Delisting is expected to take place at 7:00 a.m on 23 January 2025 (“Cancellation”) and, accordingly, the last day of dealings in Ordinary Shares on AIM is expected to be 22 January 2025.
Re-registration as a private company
In accordance with the passing of Resolution 2, the Company will re-register as a private limited company and adopt new articles of association, which is expected to take place in or around the week commencing 27 January 2025.
Matched Bargain Facility
To facilitate future shareholder transactions in the Company’s Ordinary Shares, the Company has appointed JP Jenkins to provide a matched bargain facility, which will be available upon the date of Cancellation. Upon Cancellation, full details of the matched bargain facility will be made available to Shareholders on the Company’s website www.quizgroup.co.uk.
Capitalised terms used but not defined in this announcement shall have the same meaning given to such terms in the Circular.
Enquiries:
QUIZ plcVia Hudson SandlerSheraz Ramzan, Chief Executive OfficerGerry Sweeney, Chief Financial Officer Panmure Liberum(Nominated Adviser and Sole Broker)Emma Earl, Ailsa MacmasterRupert Dearden +44 (0) 207 886 2500Hudson Sandler LLP (Public Relations)+44 (0) 207 796 4133Alex BrennanEmily Brooker quiz@hudsonsandler.comThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
January 8, 2025
6th Jan 2025
SCHO:JPJ
ISIN: GB00BJYS2173
Scholium Group PLC
(“SCHO” or “the Company”)
Shares trading on JP Jenkins
London, UK, 6th Jan 2025 – Scholium Group PLC (SCHO:JPJ), today announces its shares are to be admitted to trade on JP Jenkins share dealing platform. The Company’s registered address is 94 New Bond Street, London, England, W1S 1SJ and company number is 8833975.
Scholium Group PLC is a holding company that trades and retails rare books, works on paper, and fine art in the United Kingdom. The company also deals with other third-party dealers in the arts and collectibles.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
The indicative pricing for the ordinary shares as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/).
For further information, please contact:
Scholium Group PLCENDS
January 6, 2025
THG PLC
17 December 2024
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.
FOR IMMEDIATE RELEASE
17 December 2024
THG PLC
(the “Company”)
Ingenuity Shareholders’ Agreement and Ingenuity Articles
As announced by the Company on 28 November 2024, copies of the Ingenuity Shareholders’ Agreement and the Ingenuity Articles were made available to view on the Company’s website on 2 December 2024.
The Company today announces that revised versions of the Ingenuity Shareholders’ Agreement and the Ingenuity Articles, showing all the changes to the versions made available on 2 December 2024, have been made available on the Company’s website and are available to view at: https://www.thg.com/investor-relations/ingenuity-demerger.
The Demerger is anticipated to complete on 2 January 2025, once the Ingenuity Distribution has been made.
The revised versions of the Ingenuity Shareholders’ Agreement and the Ingenuity Articles incorporate certain amendments intended to facilitate the implementation of the matched bargain facility described in paragraph 8 of the Circular (the “Matched Bargain Facility“). InfinitX Limited, trading as JP Jenkins, has been appointed to run the Matched Bargain Facility.
Matched Bargain Facility
In addition, the Company provides the following update in respect of the way in which the Matched Bargain Facility is intended to operate following completion of the Demerger, including in relation to the transfer to escrow of uncertificated Ingenuity Shares:
· Following completion of the Demerger, an Ingenuity Shareholder who has received Ingenuity Shares (ISIN: GB00BR4ZLS43) in uncertificated form pursuant to the Ingenuity Distribution or any person who subsequently receives Ingenuity Shares in uncertificated form in accordance with the Ingenuity Articles or Ingenuity Shareholders’ Agreement will be required to transfer those uncertificated Ingenuity Shares into escrow with Equiniti Limited (“EQ“) by making a CREST Transfer to Escrow (“TTE“) instruction to CREST Participant ID: RA11 and CREST Member Account ID: EQESCROW (the “Escrow Details“).
· The relevant Ingenuity Shares will only be released from escrow once IngenuityCo is satisfied that the relevant requirements for a transfer of Ingenuity Shares set out in the Ingenuity Shareholders’ Agreement and the Ingenuity Articles have been complied with. IngenuityCo would then provide authorisation to EQ (via JP Jenkins) to process a Transfer from Escrow instruction (“TFE“) that would release the relevant number of Ingenuity Shares from escrow to support a trade within the Matched Bargain Facility. EQ reserves the right to request that the CREST participant processes an Escrow Adjustment instruction (“ESA“).
· Following settlement of any authorised trade pursuant to the Matched Bargain Facility, the CREST custodian in receipt of the Ingenuity Shares would be required under the Ingenuity Shareholders’ Agreement and the Ingenuity Articles to make a TTE to the Escrow Details, with such Ingenuity Shares remaining in escrow until authorisation for any further transfer of the Ingenuity Shares is obtained from IngenuityCo.
Capitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Demerger circular, which was made available by the Company to its Shareholders on 28 November 2024 (the “Circular“).
For further information please contact:
Investor enquiries:Greg Feehely, SVP Investor RelationsKate Grimoldby, Director of Investor Relations and Strategic Projects investor.relations@thg.comMedia enquiries:Sodali & Co – Financial PR adviserVictoria Palmer-MooreRuss Lynch Tel: +44 (0) 20 7250 1446thg@sodali.comTHG PLCViki Tahmasebimedia-enquiries@thg.comBarclays (Joint Corporate Broker)Alastair BlackmanCallum WestDominic Harper +44 (0) 20 7623 2323Jefferies International Limited (Joint Corporate Broker)Philip NobletEd MatthewsGavriel Lambert+44 (0) 20 7029 8000Peel Hunt LLP (Joint Corporate Broker)George SellarAndrew ClarkElla Hastings+44 (0) 20 7418 8900Further Information
This announcement is for information purposes only and is not intended to and does not constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell, otherwise dispose of or issue, or any solicitation of any offer to sell, otherwise dispose of, issue, purchase, otherwise acquire or subscribe for, any security.
Barclays Bank PLC, acting through its Investment Bank (“Barclays“), which is authorised by the Prudential Regulation Authority (the “PRA“) and regulated in the United Kingdom by the Financial Conduct Authority (the “FCA“) and the PRA, Jefferies International Limited (“Jefferies“) and Peel Hunt LLP (“Peel Hunt“), each of which is authorised and regulated by the FCA, are acting exclusively for the Company and no one else in connection with the Demerger and will not be responsible to anyone other than the Company for providing the protections afforded to the respective clients of Barclays, Jefferies and Peel Hunt, or for providing advice in connection with the Demerger, the contents of this announcement or any other matter referred to in this announcement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
December 27, 2024
27 December 2024
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.
FOR IMMEDIATE RELEASE
27 December 2024
THG PLC
(the “Company”)
Announcement of results of General Meeting and results of elections for B Shares
Results of General Meeting
Following the General Meeting which was held earlier today, the Company announces that the Resolution relating to the B Share Redesignation and the Ingenuity Distribution, further details of which are contained in the circular relating to the Demerger which was made available to Shareholders on 28 November 2024 (the “Circular“), was duly passed as a special resolution on a poll vote.
The detailed results of the voting are as follows:
FORAGAINSTWITHHELDVOTES CASTResolutionTotal votes in favour% of votes castTotal votes against% of votes castVotes withheld% of votes castTotal number of votes cast% of issued share capitalConditional upon such number of elections having been made as will enable 100 per cent. of the Ingenuity Shares to be distributed, the approval of the redesignation of Ordinary Shares in respect of which valid elections have been made as B Shares and the distribution of Ingenuity Shares to holders of the B Shares by the Company836,746,29688.71106,496,19411.292,833,4960.00943,242,49061.81Notes:
1. Votes in favour include votes in respect of which the Chair of the General Meeting was given discretion regarding how to vote.
2. Percentages of votes in favour and votes against are expressed as a proportion of the total number of votes cast (which does not include votes withheld).
3. A “vote withheld” is not a vote under English law and is not counted in the calculation of votes “for” or “against” the Resolution.
Results of elections for B Shares
Following the Election Return Time and the record date for receipt of B Shares, the Company announces that:
· valid elections have been received in respect of 100 per cent. of the Ingenuity Shares held by the Company;
· valid elections to participate in the B Share Redesignation and Ingenuity Distribution have been made in respect of 424,005,142 Ordinary Shares, including 326,455,745 Ordinary Shares in respect of which over elections were received by the Company;
· as sufficient elections have been received to satisfy the aggregate amount of the Guaranteed Entitlement (being 13.3728458539443 per cent. of the issued share capital of the Company as at 26 November 2024) and following the pro rata scale back of Ordinary Shares in respect of which over elections were received by the Company and the rounding down of any fractional entitlements to the nearest whole number (or to nil as the case may be), 204,081,632 Ordinary Shares will be redesignated as B Shares on 30 December 2024 and 204,081,632 Ingenuity Shares will be distributed to holders of B Shares on 2 January 2025;
· elections were satisfied in respect of 32.63299317 per cent. of the Ordinary Shares in respect of which over elections were received by the Company; and
· once the B Share Redesignation has completed, the number of Ordinary Shares in the capital of the Company will be reduced by 204,081,632 Ordinary Shares to 1,322,058,529 Ordinary Shares and, once the Ingenuity Distribution has been made and the B Shares have been redesignated as Deferred 1 Shares, the number of Deferred 1 Shares in the capital of the Company will be increased by 204,081,632 Deferred 1 Shares.
Transfer to Escrow of uncertificated Ingenuity Shares
Shareholders are reminded that, following completion of the Demerger, the Ingenuity Shareholders’ Agreement requires Ingenuity Shareholders who receive Ingenuity Shares in uncertificated form to transfer those uncertificated Ingenuity Shares into escrow in accordance with the instructions set out under the “Matched Bargain Facility” heading of the Company’s announcement dated 17 December 2024 relating to the Ingenuity Shareholders’ Agreement and Ingenuity Articles.
Expected timetable of principal events
The expected timetable of principal events set out in the announcement released by the Company on 28 November 2024 remains unchanged:
EventTime and/or dateElecting Ordinary Shares redesignated as B Shares30 December 2024CREST accounts credited with unsuccessfully elected Ordinary Shares30 December 2024Payment Date of Ingenuity Distribution2 January 2025CREST accounts of relevant Electing Shareholders credited with Ingenuity Shares2 January 2025B Shares convert into Deferred 1 Shares2 January 2025Return of share certificates or balance share certificates in respect of unsuccessfully elected Ordinary SharesBy 16 January 2025Despatch of share certificates in respect of Ingenuity Shares By 16 January 2025Deferred 1 Shares repurchased by the Company and cancelledNo earlier than 2 January 2026Capitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Circular. All references to times in this announcement are to London time unless stated otherwise.
For further information please contact:
Investor enquiries:Greg Feehely, SVP Investor RelationsKate Grimoldby, Director of Investor Relations and Strategic Projects investor.relations@thg.comMedia enquiries:Sodali & Co – Financial PR adviserVictoria Palmer-MooreRuss Lynch Tel: +44 (0) 20 7250 1446thg@sodali.comTHG PLCViki Tahmasebimedia-enquiries@thg.comBarclays (Joint Corporate Broker)Alastair BlackmanCallum WestDominic Harper +44 (0) 20 7623 2323Jefferies International Limited (Joint Corporate Broker)Philip NobletEd MatthewsGavriel Lambert+44 (0) 20 7029 8000Peel Hunt LLP (Joint Corporate Broker)George SellarAndrew ClarkElla Hastings+44 (0) 20 7418 8900Further Information
This announcement is for information purposes only and is not intended to and does not constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell, otherwise dispose of or issue, or any solicitation of any offer to sell, otherwise dispose of, issue, purchase, otherwise acquire or subscribe for, any security.
Barclays Bank PLC, acting through its Investment Bank (“Barclays“), which is authorised by the Prudential Regulation Authority (the “PRA“) and regulated in the United Kingdom by the Financial Conduct Authority (the “FCA“) and the PRA, Jefferies International Limited (“Jefferies“) and Peel Hunt LLP (“Peel Hunt“), each of which is authorised and regulated by the FCA, are acting exclusively for the Company and no one else in connection with the Demerger and will not be responsible to anyone other than the Company for providing the protections afforded to the respective clients of Barclays, Jefferies and Peel Hunt, or for providing advice in connection with the Demerger, the contents of this announcement or any other matter referred to in this announcement.
Information regarding forward-looking statements
Certain statements made in this announcement are forward-looking statements and, by their nature, all such forward-looking statements involve risk and uncertainty. Forward-looking statements include all matters that are not historical facts and often use words such as “expects”, “may”, “will”, “could”, “should”, “intends”, “plans”, “predicts”, “envisages” or “anticipates” or other words of similar meaning.
These forward-looking statements are based on current beliefs and expectations based on information that is known to the Company at the date of this announcement. Actual results of the THG Group may differ from those expressed or implied in the forward-looking statements as a result of any number of known and unknown risks, uncertainties and other factors, many of which are difficult to predict and are generally beyond the control of the Company and the THG Group (as applicable). Persons receiving this announcement should not place undue reliance on any forward-looking statements. Unless otherwise required by applicable law or regulation, the Company and its advisers disclaim any obligation or undertaking to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
December 27, 2024
24th December 2024
MEAL:JPJ
ISIN: GB00BNK9TZ56
Parsley Box Group Ltd
(“Parsley Box” or “the Company”)
Shares now trading on JP Jenkins
Parsley Box Group Ltd (MEAL:JPJ), today announces its shares have been admitted to trade on JP Jenkins share dealing platform. The Company’s registered address is Orchard Brae House, 30 Queensferry Road, Edinburgh, Scotland, EH4 2HS and company number is SC685656.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
Shareholders wishing to trade these securities can do so through their stockbroker. Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer. Trades can be conducted, and limits can be accepted, during normal business hours. Shareholders or potential investors can place limits via their existing UK regulated stockbroker.
The indicative pricing for the ordinary shares (ISIN:GB00BNK9TZ56) as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/).
For further information, please contact:
Parsley Box Group Ltd Holly McCombJP Jenkins Ltd Veronika Oswald / Mason Doick Tel. +44 (0) 207 469 0937 Email: invest@parsleybox.com Email: info@jpjenkins.comENDS
December 24, 2024
Quiz PLC
20 December 2024
20 December 2024
QUIZ Plc
(“QUIZ”, the “Company” or the “Group”)
Proposed Cancellation of Admission to trading on AIM
Re-registration as a Private Limited Company
Amendment of Articles
Notice of General Meeting
QUIZ, the omni-channel fashion brand, today announces the proposed voluntary cancellation of the admission of its ordinary shares of £0.003 each (“Ordinary Shares”) from trading on AIM (the “Cancellation“), pursuant to Rule 41 of the AIM Rules for Companies (the “AIM Rules“) and re-registration of the Company as a private limited company (the “Re-registration”).
A circular (the “Circular“) will be posted to Shareholders on 23 December 2024, and includes notice of a General Meeting of the Company which is being convened for 11.00am on 8 January 2025 (the the “General Meeting“) at 61 Hydepark Street, Glasgow, G3 8BW for the purposes of considering and, if thought fit, passing the requisite shareholder resolution to approve the Cancellation (the “Cancellation Resolution”). In accordance with the requirements of Rule 41 of the AIM Rules, the Cancellation is conditional upon the approval of not less than 75 per cent. of the votes cast by Shareholders (whether present in person or by proxy) at the General Meeting.
If the Cancellation Resolution is passed at the General Meeting, it is anticipated that the Cancellation will become effective at 7:00 a.m. on 23 January 2025.
The Company has received irrevocable undertakings to vote in favour of the Resolutions from all Directors and family members of Tarak Ramzan, the Group’s founder, including Nusrat Ramzan, Kasim Akram, Omar Aziz, Haris Ramzan and Mussarat Ramzan. In addition the Company has received irrevocable undertakings from Tajveer Gill and Amraj Gill in respect of 21,600,000 Ordinary Shares in which they are legally and beneficially interested. In aggregate, the irrevocable undertakings to vote in favour of the Resolutions set out in the Circular represent approximately 66.74 per cent. of the Company’s issued share capital.
The Company is also seeking Shareholder approval at the General Meeting for the amendment of the Current Articles.
Further information on the proposed Cancellation, the General Meeting and the amendment to the Current Articles is set out below and in the Circular.
Following the Company’s Strategic Review at the end of 2023, continued difficult trading environment and weak share price performance, the Company has conducted a thorough review of the benefits and drawbacks of retaining Quiz’s listing on AIM. The Directors believe that Cancellation will be in the best interests of the Company and its Shareholders. In reaching this conclusion the Board has considered the following key factors.
· The considerable cost, management time and the legal and regulatory burden associated with maintaining the Company’s admission to trading on AIM: The considerable cost associated with maintaining the admission of the Ordinary Shares (such as nominated adviser and broker fees, London Stock Exchange fees and the costs associated with being a quoted company in having perceived higher level of corporate governance and audit scope) are, in the Board’s opinion, disproportionately high, compared to the benefits. The Directors believe the time and cost savings associated with the Cancellation and Re-registration could be better utilised for the benefit of the Company providing an extended cash runway to capitalise on growth opportunities.
· Business cost base: Further to an initial review with its advisors, who the Company has appointed to consider options available to the Group, indications are the business requires to address its cost base to achieve a profitable foundation. The Board therefore believes it is more appropriate and practical to undergo any changes as a private limited company without the constraints of announcement obligations and significant confidentiality constraints.
· Challenging financial market conditions: Macro-economic factors including cost inflationary pressures and low consumer confidence have cultivated a difficult trading environment, with the Company experiencing declines in traffic both in-store and online in recent years. The expected impact of post-Budget higher payroll costs has provided an uncertain economic outlook for the Company, amidst an increasingly competitive fast-fashion retail landscape.
· Limited free float and lack of liquidity of the Ordinary Shares: The Directors believe the current levels of liquidity in trading of the Company’s Ordinary Shares on AIM do not, in itself, offer investors the opportunity to trade in meaningful volumes or with frequency within an active market. In conjunction with the difficult trading environment highlighted in the point above, this has negatively affected the share price of Quiz and therefore its market capitalisation, which the Directors does not believe accurately reflects potential or underlying prospects of the business.
· Board changes: The Group currently operates with a lean board structure with two independent non-executive directors and three executive directors. The Group has previously announced that it was seeking an additional experienced independent non-executive director and that recruitment is underway to replace Gerry Sweeney as Chief Financial Officer when he steps down in 2025. Operating as private company will provide greater flexibility as to board structure potentially including financial benefits.
· Access to capital: Tarak Ramzan, the majority shareholder with a 20.38% shareholding has proposed to provide a £1.0 million loan facility to provide additional liquidity headroom for working capital purposes. However this remains subject to approval from the Group’s main lender. Subject to trading and /or provision of this loan, the Group anticipates that additional funding will be required in the first quarter of 2025 but believe maintaining a listing on AIM is not likely to provide significant additional or more cost effective options for funding.
· Support for delisting: The Company has obtained irrevocable commitments for the Cancellation and Re-registration from certain of its largest Shareholders representing in aggregate approximately 66.74 per cent. of the Company’s current issued share capital.
All current non-executive directors of the Company propose to resign upon Cancellation and Gerry Sweeney, Chief Financial Officer and Company Secretary, intends to step down from his position but will remain with the Company until 31 March 2025 to ensure a steady transition of responsibilities to his successor, as stated in a Company announcement on 11 October 2024.
The Company is seeking to make arrangements for a Matched Bargain Facility to assist Shareholders to trade in the Ordinary Shares to be put in place from the date of the Cancellation, if the Resolutions are passed. The Matched Bargain Facility would be provided by JP Jenkins. JP Jenkins is an appointed representative of Prosper Capital LLP, which is authorised and regulated by the FCA.
A copy of this announcement and the Circular will be made available on the Company’s website at www.quizgroup.co.uk.
Capitalised terms used but not defined in this announcement shall have the same meanings as are given to such terms in the Circular.
Enquiries:
QUIZ plcVia Hudson SandlerSheraz Ramzan, Chief Executive OfficerGerry Sweeney, Chief Financial Officer Panmure Liberum(Nominated Adviser and Sole Broker)Emma Earl, Ailsa MacmasterRupert Dearden +44 (0) 207 886 2500Hudson Sandler LLP (Public Relations)+44 (0) 207 796 4133Alex BrennanEmily Brooker quiz@hudsonsandler.comAppendix 1
Extracts from the Circular
Background and context to the Cancellation
Quiz is an omni-channel women’s fashion brand, specialising in occasion wear and dressy casual wear. The Group’s buying and design team constantly develop its own product line to respond quickly to ever-changing social media fashion trends and deliver stylish and affordable products to consumers. The brand operates through an omni-channel business model, which encompasses online, standalone stores, concessions, international franchises, third party online partners and wholesale. Quiz has more than 60 stores and 40 concessions in the UK.
The Company’s Ordinary Shares have been admitted to trading on AIM since its initial public offering (“IPO”) in July 2017 with the Group’s revenue growing from £89.8m at the time of IPO to £130.8m in 2019. Following the very significant impact of Covid on the Group’s revenue from 2020 and subsequent restructuring of the Group’s store portfolio revenues partially recovered and grew to £91.7m in the year ended 31 March 2023. Subsequently customer demand was impacted by the widely reported cost of living and inflationary pressures with revenue declining to £82.0 million during the 2024 financial year with the Group generating a loss in comparison to a profit in the prior period. Given the ongoing decline in customer demand, revenue in the year ended 31 March 2025 is expected to be below 2024 revenue.
As a consequence of the challenging trading environment and impact on Group revenue, on 5 December 2023, the Company initiated a review of strategic options (the “Strategic Review”) available to the Company to maximise shareholder value. The Strategic Review considered a range of factors, including but not limited to, a refreshed business plan, management team and leadership and funding requirements and availability. On 28 March 2024, the Company announced an update as part of the Strategic Review, Tarak Ramzan, CEO and founder of Quiz, stepped down as CEO to become a non-executive director and Sheraz Ramzan, previously Chief Commercial Officer, was appointed as CEO to implement a turnaround strategy, with the aim to recalibrate the business back into profitable growth. In 2024, the Group implemented a number of strategic initiatives such as restructuring the Buying and Merchandising function and a refreshed marketing brand and social media activity.
Despite the steps taken, since announcing the Strategic Review, the Group has continued to experience a decline in customer traffic both online and instore compared to the same period in the prior year, with a notable decline in traffic and footfall in November a key period for retailers. The Company expects to report an unaudited pre-tax loss prior to any non-recurring charges of c.£ 4.1m for the six months ended 30 September 2024. The Board expect that trading will continue to prove challenging for the sector throughout 2025 calendar year with continuing macro-economic headwinds from the continuation of the cost of living crisis, the ongoing impact of high business rates, above inflation increases to other costs, low consumer confidence as well as the impact of the increase to the National Living Wage and Employer’s National Insurance arrangements.
The Group has continued to proactively manage its cost base and seek further opportunities to improve its financial performance but the cash runway for the business has been impacted by recent performance with revenues having been lower than expected in the period leading up to 30 November 2024, as noted in the Company’s recent announcement on 6 December 2024. As at 5 December 2024, the Group had net borrowings of £2.8 million and total liquidity headroom of £1.2 million. The Group has £4.0 million of bank facilities (which are scheduled to expire on 30 June 2025 and are subject to annual renewal). Subject to the trading performance of the critical pre-and-post-Christmas period, the Group’s existing bank facilities could be fully utilised in the first quarter of 2025.
Although demand in December has shown signs of improvement with online revenues broadly consistent with the prior year on a like-for-like basis, sales in store continue to trend behind those achieved last year. Total revenue to date continues to fall short of management’s expectations and has not compensated for the shortfall in revenue experienced in November.
The Company previously announced, on 29 August 2024, that Tarak Ramzan, the Group’s founder, and largest shareholder, proposed to provide the Company with a £1.0 million secured loan facility to provide additional liquidity headroom for working capital purposes. The agreement in relation to the loan remains outstanding and is awaiting approval from the provider of the Company’s banking facilities, (who are required to approve any subsequent security over the assets of the Group).
Given the decline in revenue during the key trading month of November 2024 and the requirement to improve the liquidity of the business the Board is reviewing the Group’s options and has engaged advisors to consider appropriate options in particular as to the Group’s structure and cost base. The Board is focused on ensuring the Group has sufficient working capital to take the Group through to growth (albeit this cannot be guaranteed). In particular, the Board considers that operating as a private limited company could provide the flexibility and confidentiality necessary to implement these changes effectively as the Company can focus on the long-term transformation of the business without the immediate pressures and scrutiny of public markets.
The Directors are aware that certain Shareholders may be unable or unwilling to hold Ordinary Shares in the event that the Cancellation is approved and becomes effective. Such Shareholders should consider selling their interests in the market prior to the Cancellation becoming effective. However, should the Cancellation become effective, the Company intends to implement a Matched Bargain Facility with a third party which would facilitate Shareholders buying and selling Ordinary Shares on a matched bargain basis following Cancellation.
Under the AIM Rules, the Company is required to give at least 20 clear Business Days’ notice of the Cancellation. Additionally, the Cancellation will not take effect until at least five clear Business Days have passed following the passing of the Cancellation Resolution. If the Cancellation Resolution is passed at the General Meeting, it is proposed that the last day of trading in the Ordinary Shares on AIM will be 22 January 2025 and that the Cancellation will take effect at 7.00 a.m. on 23 January 2025.
If the Cancellation becomes effective, Panmure Liberum will cease to be the nominated adviser of the Company and the Company will no longer be required to comply with the AIM Rules.
Under the AIM Rules, it is a requirement that the Cancellation Resolution must be approved by Shareholders holding not less than 75 per cent. of votes cast by Shareholders at the General Meeting.
Under an existing relationship agreement with Panmure Liberum, the family concert party of the largest shareholder Tarak Ramzan and other members of the Ramzan family (the “Concert Party“) is unable to vote on a delisting resolution (which would require 75% of votes cast) without Panmure Liberum’s consent. Panmure Liberum has accordingly provided consent to the independent directors of Quiz to allow the majority shareholders to vote in favour of the Cancellation Resolution as it believes the Cancellation Resolution is a reasonable step to take for the reasons outlined above.
Accordingly, the Notice of General Meeting, set out in at the end of this Document, contains a special resolution to approve the Cancellation.
The principal effects of the Cancellation will include the following:
• as a private company, there will be no formal market mechanism enabling Shareholders to trade Ordinary Shares (other than any limited off-market mechanism provided by the Matched Bargain Facility), and no price will be publicly quoted for the Ordinary Shares;
• it is possible that, following the publication of this Document, the liquidity and marketability of the Ordinary Shares may be significantly reduced, and their value adversely affected (however, as set out above, the Directors believe that the existing liquidity in the Ordinary Shares is, in any event, limited);
• the Ordinary Shares may be more difficult to sell compared to shares of companies traded on AIM (or any other recognised market or trading exchange);
• in the absence of a formal market and quoted price, it may be difficult for Shareholders to determine the market value of their investment in the Company at any given time;
• the regulatory and financial reporting regime applicable to companies whose shares are admitted to trading on AIM will no longer apply, albeit the Company will remain subject to the Takeover Code for the period, and on the basis;
• Shareholders will no longer be afforded the protections given by the AIM Rules, such as the requirement to be notified of price sensitive information or certain events and the requirement that the Company seek shareholder approval for certain corporate actions, where applicable, including substantial transactions, reverse takeovers, related party transactions and fundamental changes in the Company’s business, including certain acquisitions and disposals;
• the levels of disclosure and corporate governance within the Company may not be as stringent as for a company quoted on AIM;
• the Company will no longer be subject to UK MAR regulating inside information and other matters;
• the Company will no longer be required to publicly disclose any change in major shareholdings in the Company under the Disclosure Guidance and Transparency Rules;
• Panmure Liberum will cease to be nominated adviser to the Company;
• whilst the Company’s CREST facility will remain in place immediately post the Cancellation, the Company’s CREST facility may be cancelled in the future and, although the Ordinary Shares will remain transferable, they may cease to be transferable through CREST (in which case, Shareholders who hold Ordinary Shares in CREST will receive share certificates);
• stamp duty may be due on transfers of shares and agreements to transfer shares unless a relevant exemption or relief applies to a particular transfer; and
• the Cancellation and Re-registration may have personal taxation consequences for Shareholders. Shareholders who are in any doubt about their tax position should consult their own professional independent tax adviser.
For the avoidance of doubt, the Company will remain registered with the Registrar of Companies in Jersey in accordance with and subject to the Companies Law, notwithstanding the Cancellation. The Resolutions to be proposed at the General Meeting include the amendment of the Current Articles, with effect from the Re-registration. A copy of the Amended Articles will be available at www.quizgroup.co.uk and a summary of the key proposed changes is included at Part II of the Circular.
The Company currently intends to continue to provide certain information, services and facilities to Shareholders following the Cancellation. The Company will:
· continue to communicate information about the Company (including annual accounts) to its Shareholders, as required by the Companies Law;
· continue, for at least 12 months following the Cancellation, to maintain its website, www.quizgroup.co.uk and to post updates on the website from time to time, although Shareholders should be aware that there will be no obligation on the Company to include all of the information required under the Disclosure Guidance and Transparency Rules, AIM Rule 26 or to update the website as currently required by the AIM Rules; and
· seek to make available to Shareholders, through JP Jenkins, the Matched Bargain Facility (as further described in the Circular) which would allow Shareholders to buy and sell Ordinary Shares on a matched bargain basis following the Cancellation.
Shareholders should note that they are able to continue trading in the Ordinary Shares on AIM prior to the Cancellation.
The Company is seeking to make arrangements for a Matched Bargain Facility to assist Shareholders to trade in the Ordinary Shares to be put in place from the date of the Cancellation if the Resolutions are passed. The Matched Bargain Facility would be provided by JP Jenkins. JP Jenkins is an appointed representative of Prosper Capital LLP, which is authorised and regulated by the FCA.
Under the Matched Bargain Facility, Shareholders or persons wishing to acquire or dispose of Ordinary Shares would be able to leave an indication with JP Jenkins, through their stockbroker (JP Jenkins is unable to deal directly with members of the public), of the number of Ordinary Shares that they are prepared to buy or sell at an agreed price. In the event that JP Jenkins is able to match that order with an opposite sell or buy instruction, it would contact both parties and then effect the bargain (trade). Shareholdings remain in CREST and can be traded during normal business hours via a UK regulated stockbroker. Should the Cancellation become effective, and the Company puts in place the Matched Bargain Facility, details will be made available to Shareholders on the Company’s website at www.quizgroup.co.uk.
It is intended that the Matched Bargain Facility will operate for a minimum of six months after the Cancellation. The Directors’ current intention is that it will continue beyond that time, but Shareholders should note there remains a risk that the Matched Bargain Facility may not have been put in place at the time of Cancellation, or if it is, it may not remain in place for an extended period of time and therefore inhibit the ability to trade the Ordinary Shares. Further details will be communicated to Shareholders at the relevant time.
The Company has received irrevocable undertakings from the Concert Party and all Directors to vote in favour of the Resolutions, in respect of all Ordinary Shares held by each of them (or in which they are interested) on the date of the General Meeting and currently amounting to 61,309,059 Ordinary Shares in aggregate, representing approximately 49.35 per cent. of the Existing Ordinary Shares. In addition, the Company has received irrevocable undertakings from Tajveer Gill and Amraj Gill in respect of 21,600,000 Ordinary Shares in which they are beneficially interested, representing approximately 17.39 per cent. of the Existing Ordinary Shares.
Accordingly in aggregate, the Company has received irrevocable undertakings to vote in favour of the Resolutions in respect of 82,909,059 Ordinary Shares representing approximately 66.74 per cent. of the Existing Ordinary Shares.
In light of these irrevocable undertakings, the Directors believe it is likely that the Resolutions will be passed at the General Meeting. However Shareholders should be aware that looking ahead, the Group’s financial position is highly dependent on a combination of improved trading conditions and reducing its cost base to achieve a profitable foundation. Given this, the factors highlighted in Going Concern basis adopted in the Group’s annual accounts for the year ended 31 March 2024 remain applicable and there remains a material uncertainty that may cast significant doubt on the Group’s ability to continue as a going concern. In light of the above, the Directors believe that it is important that Shareholders pass the Resolutions.
Pursuant to the terms of the irrevocable undertaking entered into by Tajveer Gill and Amraj Gill, for so long as they remain beneficially interested in Ordinary Shares representing not less than 15% of the Existing Ordinary Shares at the time of Cancellation, they will be entitled to appoint one person as a director of the Company . Such a director will be a non-executive director and not entitled to receive remuneration.
A Form of Proxy will be enclosed with the Circular for use by Shareholders. in connection with the General Meeting. To be valid, Forms of Proxy, completed in accordance with the instructions printed thereon, must be received by the Company’s registrars, Link Group, at PXS 1, Central Square, 29 Wellington Street, Leeds, LS1 4DL, as soon as possible but in any event by no later than 11.00am on 6 January 2025. Shareholders who hold their Ordinary Shares in uncertificated form in CREST may alternatively use the CREST proxy voting service in accordance with the procedures set out in the CREST Manual as explained in the notes accompanying the Notice of General Meeting at the end of this Document. Proxies submitted via CREST must be received by the Company’s registrars, Link Group, by no later than 11.00am on 6 January 2025. Alternatively, you may register your appointment of a proxy electronically by using the Link Investor Centre app or by accessing the web browser at https://investorcentre.linkgroup.co.uk/Login/Login. If you are an institutional investor you may also be able to appoint a proxy electronically via the Proxymity platform, a process which has been agreed by the Company and approved by the Registrar. For further information regarding Proxymity, please go to www.proxymity.io. Electronic proxy appointments must be received by 11.00am on 6 January 2025.
Shareholders are encouraged to appoint the chair of the General Meeting as their proxy with directions as to how to cast their vote on the Resolutions proposed. The appointment of a proxy will not preclude Shareholders from attending and voting at the General Meeting in person should they so wish.
Further details relating to voting will be set out in the Circular.
For the reasons set out in this announcement and the Circular, the Directors consider that the Cancellation is in the best interests of the Company and its Shareholders as a whole. Accordingly, the Directors unanimously recommend that Shareholders vote in favour of the Resolutions as they intend to do in respect of their own shareholdings of 32,731,347 Ordinary Shares, representing approximately 26.35 per cent. of the Existing Ordinary Shares.
Appendix 2
EXPECTED TIMETABLE OF PRINCIPAL EVENTS
EventTime and/or date(1)(2)Announcement of AIM Delisting and Publication of CircularIntraday on 20 December 2024Posting of Circular23 December 2024Latest time for receipt of proxy appointments in respect11.00am on 6 January 2025General Meeting11.00am on 8 January 2025Announcement of result of General Meeting8 January 2025Last day of dealings in Ordinary Shares on AIM22 January 2025Cancellation of admission of the Ordinary Shares to trading on AIM7.00am on 23 January 2025Matched Bargain Facility for Ordinary Shares commences23 January 2025Expected re-registration as a private companyWeek commencing 27 January 2025Notes:
(1) All of the times referred to in this Document refer to London time, unless otherwise stated.
(2) Each of the times and dates in the above timetable is subject to change. If any of the above times and/or dates change, the revised times and dates will be notified to Shareholders by an announcement through a Regulatory Information Service.
Definitions
The following definitions apply throughout this announcement, unless the context requires otherwise:
“AIM”AIM, the market operated by the London Stock Exchange;“Cancellation”the cancellation of admission of the Ordinary Shares to trading on AIM in accordance with Rule 41 of the AIM Rules, subject to passing of the Cancellation Resolution; “Cancellation Resolution”Resolution 1 to be proposed at the General Meeting; “Concert Party”the family concert party of the largest shareholder Tarak Ramzan and other members of the Ramzan family, together holding in aggregate 48.68% of the Ordinary Shares; “Company” or “Quiz”Quiz plc, a company incorporated in the Island of Jersey with registered number 123460; “Directors” or “Board”the directors of the Company, whose names are set out in Part I of this Document; “Existing Ordinary Shares”the 124,230,905 existing Ordinary Shares in the capital of the Company; “General Meeting”the general meeting of the Company convened at 11.00 on 8 January 2025; “Ordinary Shares”the ordinary shares of £0.003 each in the capital of the Company; “Re-registration”the proposed re-registration of the Company as a private limited company; “Resolutions”the resolutions to be proposed at the General Meeting as set out in the notice of the General Meeting; and “Shareholders”holders of Ordinary Shares from time to time. A reference to “£” pounds sterling, being the lawful currency of the UK.This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
December 20, 2024
Eleventh Edition
Merry Christmas To All!
This month we announced another two new clients with Leeds Group PLC and Bibby Line Group going live. There are several coming soon with the likes of Scholium Group, Parsley Box, Omega Minerals, SDX Energy and many more. 2024 has been fantastic, with over 30 new admissions, lots of press releases and over £60m in trading.
We are delighted to announce the following new admissions to JP Jenkins:
Leeds Group (LDSG:JPJ), announced its shares have been admitted to trade on JP Jenkins share dealing platform. Leeds Group plc is a UK based company. Historically, the Group contained both UK and European textile businesses but having divested all its textile trading activities, the Group now owns three properties in Germany, two of which are rented to a former subsidiary and the other is currently being markets for rental.
To read the full announcement, please see the link below: https://lnkd.in/ehkKKHCP
THG Ingenuity
JP Jenkins has been appointed to run the Matched Bargain Facility for the demerger of THG, who recently released its latest update to shareholders regarding the Ingenuity Shareholders’ Agreement and Ingenuity Articles. The Company announces that revised versions of the Ingenuity Shareholders’ Agreement and the Ingenuity Articles, showing all the changes to the versions made available on 2 December 2024, have been made available on the Company’s website and are available to view at: https://lnkd.in/eRaQTFAF.
Scholium Group PLC
Scholium Group announced its results have been passed to move from AIM and join JP Jenkins. The Company is scheduled to have the trading in its shares on AIM cancelled with effect from 7.00am on 6 January 2025.Please see the full announcement here: https://lnkd.in/evM8MPfd. The result of the General Meeting and the Matched Bargain Facility is available on the Company’s website: https://scholiumgroup.com/.
Pending Go Live:
JP Jenkins has another several new admissions / companies to announce in January and our team eagerly await an exciting start to the New Year!
Issuer news – Check out the latest updates, awards and news from our clients:
RGH
Exciting Acquisition News from Resource Group Holdings Plc – Rgh announce their 100% acquisition of HR Tech Company Epitome Global!
To find out more, please use the article below: https://www.linkedin.com/pulse/rgh-announce-100-acquisition-hr-tech-company-ron1c/?trackingId=df3AbgmUQZG6xXu%2FGyS66A%3D%3D
Well done all the team at RGH!
Cafedirect
Cafédirect Group held a site visit for their staff to their roastery last week. To see Grumpy Mule being roasted and packed up. Grumpy Mule has been part of huge social-impact projects in Colombia and Peru.
For further information, please see their page here: https://lnkd.in/eGBSdQ8g
350PPM
350 PPM LTD bolsters balance sheet with c.£500k The environmental incubator and accelerator 350 PPM has bolstered its balance sheet by circa £500,000 thanks to a successful crowdfunding campaign on Crowdcube for the sustainable building board brand, EnviraBoard.
SND
Sondrel announced that Oreste Donzella has joined the board as Non-Executive Director. Sondrel is a UK-based fabless semiconductor company, which trades its shares on JP Jenkins, since moving away from AIM.
THRV
Thrive Renewables closes its last auction of 2024 this month. They have traded just shy of 60,000 shares in the past 10 auctions at an average price of £1.94. In the latest buyback, 90,406 shares were bought at an average price of £2.19. Thrive shares are trading on JP Jenkins via monthly auctions – They paid a 12p dividend this year and provide a buy back policy for all qualifying shareholders at 90% of the directors valuations, currently at £2.43.
To learn more, please visit: https://lnkd.in/e78GMxfa
Check out the latest research report produced by Edison Group below:https://lnkd.in/e7Rmai7t
Events – Check out the latest events and webinars:
Our Head of Corporate, Mason Doick attended the Enterprise Investment Scheme Association (EISA) Christmas Networking Reception hosted by Evelyn Partners in London -Lovely to see everyone as always, good to see RWK Goodman, Hardman & Co and Love Ventures to name a few.
Fantastic evening at GAUCHO for RGH-Global | People Services event last month! JP Jenkins we’re delighted to attend, alongside a number of key clients, stakeholders and contacts of RGH-Global | People Services. Congratulations again all the team at RGH, who have just opened their new office in Sandwich, Kent. They have also opened a new office in Melbourne and on top of this have completed some very large milestones of acquisitions/partnerships.
Thank you to everyone who attended our Liquidity Junction Drinks Event in the city. A lovely evening to catch up with colleagues, contacts and friends. JP Jenkins continues to support companies both leaving public markets and those private companies looking for the next step towards an exit.
Learning 101 with JP Jenkins – Check out our latest videos here on:
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
December 20, 2024
Scholium Group PLC
18 December 2024
Scholium Group plc
(“Scholium Group” or the “Company”)
Result of General Meeting
Scholium Group announces the results of the voting on the special resolutions proposed at the General Meeting held on 18 December 2024 to approve the cancellation of admission of ordinary shares to trading on AIM and amendments to the Company’s Articles of Association.
The resolutions were duly passed. The poll results are set out below.
Special ResolutionsVotes for%Votes against%Votes total% of issued share capitalVotes withheldTo approve the cancellation of admission of the Ordinary Shares to trading on AIM8,827,39879.332,299,71420.6711,127,11281.82–To approve the proposed amended Articles of Association8,827,39879.332,299,71420.6711,127,11281.82–
As a result of Resolution 1 having been passed, the Company is scheduled to have the trading in its shares on AIM cancelled with effect from 7.00am on 6 January 2025.
As a result of Resolution 2 having been passed, the Proposed Articles of Association will immediately be adopted also with effect from 7.00am on 6 January 2025.
The result of the General Meeting will also be made available on the Company’s website: https://scholiumgroup.com/.
The Board urges Shareholders to carefully read the Circular published on 28 November 2024, which provides information about the Matched Bargain Facility available to Shareholders for 12 months following the Cancellation taking effect. The Circular can also be found on the Company’s website: https://scholiumgroup.com/.
Defined Terms
Defined terms in this announcement have the same meaning as in the Circular (unless otherwise specified).
For further information please contact:
Scholium Group plcBernard Shapero, Chief Executive OfficerDavid Harland, Chairman Philip Tansey, Chief Financial Officer +44 (0)20 7493 0876Zeus (Nominated Adviser and Broker)Chris Fielding Tel: +44 (0) 203 829 5000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
December 18, 2024
THG PLC
28 November 2024
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.
FOR IMMEDIATE RELEASE
28 November 2024
THG PLC
(the “Company”)
Posting of Circular and Notice of General Meeting
The Company confirms that the following documents are today being posted or otherwise made available to the Company’s Shareholders:
· a circular dated 28 November 2024 (the “Circular“), incorporating notice of a general meeting of the Company (the “General Meeting“) to be held in connection with the proposed demerger of the Company’s Ingenuity business into an independent private company;
· the associated Form of Proxy; and
· the associated Form of Election.
Copies of each of these documents will today be submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
A copy of the Circular is available to view on the Company’s website at https://www.thg.com/investor-relations/ingenuity-demerger. and copies of the Ingenuity Shareholders’ Agreement and the Ingenuity Articles will also be available to view on the Company’s website at: https://www.thg.com/investor-relations/ingenuity-demerger from 2 December 2024.
Shareholders will be able to participate in the Demerger by electing to redesignate Ordinary Shares as B Shares, with such B Shares giving the holder the right to receive a preferential distribution in specie of Ingenuity Shares (with a Demerger Ratio of one Ingenuity Share for each B Share held). Shareholders should refer to the Circular for the full terms of the Demerger and a description of the action they should take.
Capitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Circular. All references to times in this announcement are to London time unless stated otherwise.
Important information regarding the General Meeting
The General Meeting will be held at the offices of Clifford Chance LLP, 10 Upper Bank Street, London E14 5JJ on Friday 27 December 2024 at 12 p.m.
Details of how to participate in, and the Resolution that will be tabled for Shareholder approval at, the General Meeting are set out in the Notice of General Meeting.
Expected timetable of principal events
The Demerger is anticipated to complete on 2 January 2025, once the Ingenuity Distribution has been made. The expected timetable of principal events is set out below.
EventTime and/or datePublication of Circular 28 November 2024Ex date for receipt of B Shares18 December 2024Election Return Time (being the latest time for return of Forms of Election/settlement of TTE Instructions from CREST holders in respect of the B Shares)1 p.m. on 19 December 2024Record date for receipt of B Shares6 p.m. on 19 December 2024Latest time and date for receipt of Forms of Proxy12 p.m. on 23 December 2024Voting Record Time6.30 p.m. on 23 December 2024General Meeting12 p.m. on 27 December 2024Announcement of the results of the General Meeting and the results of elections for B Shares27 December 2024Electing Ordinary Shares redesignated as B Shares30 December 2024CREST accounts credited with unsuccessfully elected Ordinary Shares30 December 2024Payment Date of Ingenuity Distribution2 January 2025CREST accounts of relevant Electing Shareholders credited with Ingenuity Shares2 January 2025Completion of Demerger2 January 2025B Shares convert into Deferred 1 Shares2 January 2025Return of share certificates or balance share certificates in respect of unsuccessfully elected Ordinary SharesBy 16 January 2025Despatch of share certificates in respect of Ingenuity Shares By 16 January 2025Deferred 1 Shares repurchased by the Company and cancelledNo earlier than 2 January 2026Note: Each of the times and dates set out above is based on current expectations and is subject to change. If any of the above times and/or dates is changed, the revised times and/or dates will be notified to Shareholders by announcement through a regulatory information service.
For further information please contact:
Investor enquiries:Greg Feehely, SVP Investor RelationsKate Grimoldby, Director of Investor Relations and Strategic Projects investor.relations@thg.comMedia enquiries:Sodali & Co – Financial PR adviserVictoria Palmer-MooreRuss Lynch Tel: +44 (0) 20 7250 1446thg@sodali.comTHG PLCViki Tahmasebiviki.tahmasebi@thg.comBarclays (Joint Corporate Broker)Alastair BlackmanCallum WestDominic Harper+44 (0)20 7623 2323Jefferies International Limited (Joint Corporate Broker)Philip NobletEd MatthewsGavriel Lambert+44 (0)20 7029 8000Peel Hunt LLP (Joint Corporate Broker)George SellarAndrew ClarkElla Hastings+44 (0)20 7418 8900Further Information
This announcement is for information purposes only and is not intended to and does not constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell, otherwise dispose of or issue, or any solicitation of any offer to sell, otherwise dispose of, issue, purchase, otherwise acquire or subscribe for, any security.
Prior to making any decision in relation to the Demerger, Shareholders should read the Circular in its entirety. Shareholders must rely upon their own examination, analysis and enquiries of the Company and the terms of the Circular, including the merits and risks involved.
Barclays Bank PLC, acting through its Investment Bank (“Barclays“), which is authorised by the Prudential Regulation Authority (the “PRA“) and regulated in the United Kingdom by the Financial Conduct Authority (the “FCA“) and the PRA, Jefferies International Limited (“Jefferies“) and Peel Hunt LLP (“Peel Hunt“), each of which is authorised and regulated by the FCA, are acting exclusively for the Company and no one else in connection with the Demerger and will not be responsible to anyone other than the Company for providing the protections afforded to the respective clients of Barclays, Jefferies and Peel Hunt, or for providing advice in connection with the Demerger, the contents of this announcement or any other matter referred to in this announcement.
Information regarding forward-looking statements
Certain statements made in this announcement are forward-looking statements and, by their nature, all such forward-looking statements involve risk and uncertainty. Forward-looking statements include all matters that are not historical facts and often use words such as “expects”, “may”, “will”, “could”, “should”, “intends”, “plans”, “predicts”, “envisages” or “anticipates” or other words of similar meaning.
These forward-looking statements are based on current beliefs and expectations based on information that is known to the Company at the date of this announcement. Actual results of the THG Group may differ from those expressed or implied in the forward-looking statements as a result of any number of known and unknown risks, uncertainties and other factors, many of which are difficult to predict and are generally beyond the control of the Company and the THG Group (as applicable). Persons receiving this announcement should not place undue reliance on any forward-looking statements. Unless otherwise required by applicable law or regulation, the Company and its advisers disclaim any obligation or undertaking to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
November 28, 2024
Scholium Group PLC
28 November 2024
This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended (“UK MAR”). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
Scholium Group plc (“Scholium”, the “Company” or the “Group”)
Proposed cancellation of admission of Ordinary Shares to trading on AIM
Scholium Group plc announces the proposed cancellation of the admission of its ordinary shares (“Ordinary Shares”) to trading on AIM (the “Cancellation”) in accordance with Rule 41 of the AIM Rules for Companies (“AIM Rules”), subject to shareholder approval at a General Meeting which is expected to take place on 18 December 2024. The Directors unanimously recommend that Shareholders vote in favour of the Cancellation. It is expected that subject to the resolution being passed, Cancellation will occur on 6 January 2025.
Background to the Proposal
Scholium has been admitted to trading on AIM since March 2014.
As was highlighted in the annual report of the Group for the year ended 31 March 2024, the Group has been bearing the cost of maintaining its public company status. The Board estimates that the Group could, by cancelling the admission of its Ordinary Shares to trading on AIM, reduce its overheads by at least £75,000 per annum, in respect, primarily, of professional adviser fees, stock exchange related expenses and other costs associated with the running of a quoted company. This reduction would have increased profit before taxation in the year ended 31 March 2024 by at least 25 per cent.
Through cancelling the admission of its shares to trading on AIM, the Board is confident that the cost savings so secured will contribute to greater profits, thereby enabling greater investment in the business and an opportunity to pay dividends to Shareholders.
In addition, over the last 30 months the mid-price of each Ordinary Share has not exceeded 45 pence, notwithstanding the significant discount that that price represents to net asset value per share. This discount amounted to over 50 per cent. at 30 September 2024, the date of the Company’s most recent interim statement (based on the closing price per share of 36 pence on 27 November 2024). This has significantly hampered the ability of the Group to grow by acquisition.
The Board has therefore resolved to seek Shareholder approval to cancel the admission of the Ordinary Shares to trading on AIM.
Principal effects of the Proposed Cancellation
The Directors are aware that Shareholders may wish to acquire or dispose of Ordinary Shares in the Company following the Proposed Cancellation, to the extent that they have not sold their shares on AIM before the Proposed Cancellation takes effect. Should the Resolutions be approved by Shareholders at the General Meeting, the Company is seeking to implement a Matched Bargain Facility, which is to be provided by J P Jenkins. J P Jenkins is an appointed representative of Prosper Capital LLP, which is authorised and regulated by the FCA.
Under the Matched Bargain Facility, Shareholders or persons wishing to acquire or dispose of Ordinary Shares will be able to leave an indication with J P Jenkins, through their stockbroker (J P Jenkins is unable to deal directly with members of the public) of the number of Ordinary Shares that they are prepared to buy or sell at an agreed price. In the event that J P Jenkins is able to match that order with an opposite sell or buy instruction, it would contact both parties and then effect the bargain (trade). Shareholdings remaining in CREST can be traded during normal business hours via a UK regulated stockbroker. Should the Proposed Cancellation become effective and the Company put in place the Matched Bargain Facility, details will be made available to Shareholders on the Company’s website at https://scholiumgroup.com/.
The Matched Bargain Facility is expected to operate for 12 months after the Proposed Cancellation takes effect.
If Shareholders wish to buy or sell Ordinary Shares prior to the Proposed Cancellation becoming effective, they can buy or sell shares on or before the last day of dealings in the Ordinary Shares on AIM. As noted above, in the event that Shareholders approve the Proposed Cancellation, it is anticipated that the last day of dealings in the Ordinary Shares on AIM will be 3 January 2025 and that the effective date of the Proposed Cancellation will be 6 January 2025.
Rule 41 of the AIM Rules requires any AIM company that wishes the London Stock Exchange to cancel the admission of its shares to trading on AIM to notify Shareholders and to separately inform the London Stock Exchange of its preferred cancellation date at least 20 clear Business Days prior to such date. In accordance with AIM Rule 41, the Directors have notified the London Stock Exchange of the Company’s intention, subject to the Resolutions approving the Proposed Cancellation being passed at the General Meeting, to cancel the admission of its Ordinary Shares to trading on AIM on 6 January 2025. Accordingly, if the Resolutions are passed at the General Meeting, the Proposed Cancellation will become effective at 7.00 a.m. on 6 January 2025.
If the Proposed Cancellation becomes effective, Zeus Capital Limited (“Zeus”) will cease to be the nominated adviser of the Company pursuant to the AIM Rules and the Company will no longer be required to comply with the AIM Rules, however the Company will remain subject to the City Code on Takeovers and Mergers (the “the Takeover Code”) until 3 February 2027.
Under the AIM Rules, it is a requirement that the Proposed Cancellation must be approved via a special resolution by Shareholders holding not less than 75 per cent. of votes cast by Shareholders (by proxy or in person) at the General Meeting. Accordingly, the Notice of General Meeting set out at the end of this document includes a resolution to approve the Proposed Cancellation.
The principal effects of the Proposed Cancellation would include the following:
• there will be no formal market mechanism enabling Shareholders to trade in the Ordinary Shares (other than any limited off-market mechanism provided by the Matched Bargain Facility);
• there will be no formal market quote or live pricing for the Ordinary Shares, therefore it may be more difficult to sell Ordinary Shares or for Shareholders to determine the market value of their investment in the Company, compared to shares of companies admitted to trading on AIM (or any other recognised market or trading exchange);
• it is possible that immediately following the publication of this document, the liquidity and marketability of the Ordinary Shares may be reduced and their value adversely affected as a result;
• the regulatory and financial reporting regime applicable to companies whose shares are admitted to trading on AIM will no longer apply, albeit the Company will remain subject to the Takeover Code until 3 February 2027;
• Shareholders will no longer be afforded the protections given by the AIM Rules, such as the requirement to be notified of price sensitive information or certain events, and the requirement that the Company seek shareholder approval for certain corporate actions, including reverse takeovers and fundamental changes in the Company’s business;
• the levels of disclosure and corporate governance within the Company will not be as stringent as would otherwise be required for a company whose shares are admitted to trading on AIM;
• the Company will no longer be subject to UK MAR regulating inside information and other matters;
• the Company will no longer be required to publicly disclose any change in major shareholdings in the Company under the Disclosure Guidance and Transparency Rules;
• whilst the Company’s CREST facility will remain in place following the Proposed Cancellation, and it is anticipated that this will be maintained for 12 months, the Company’s CREST facility may be cancelled in the future and, although the Ordinary Shares will remain transferable, they may cease to be transferable through CREST (in which case, Shareholders who hold Ordinary Shares in CREST will receive share certificates);
• stamp duty will be due on transfers of shares and agreements to transfer shares unless a relevant exemption or relief applies to a particular transfer; and
• the Proposed Cancellation may have personal taxation consequences for Shareholders. Shareholders who are in any doubt about their tax position should consult their own professional independent tax adviser.
The above considerations are not exhaustive and Shareholders should seek their own independent advice when assessing the likely impact of the Proposed Cancellation on them.
For the avoidance of doubt, the Company will remain registered with the Registrar of Companies in England & Wales in accordance with, and subject to, the Companies Act, notwithstanding the Proposed Cancellation and adoption of the Proposed Articles of Association.
The Company currently intends to continue to provide certain facilities and services to Shareholders that they currently enjoy as shareholders of an AIM company. The Company intends to:
• continue to communicate information about the Company (including annual accounts) to its Shareholders, as required by the Companies Act; and
• continue, for at least 12 months following the Proposed Cancellation, to maintain its website, www.scholiumgroup.com, and to post updates on the website from time to time, although Shareholders should be aware that there will be no obligation on the Company to include all of the information required under the Disclosure Guidance and Transparency Rules, UK MAR or AIM Rule 26, or to update the website as currently required by the AIM Rules.
Proposed Articles of Association
In the event that the Proposed Cancellation is approved and implemented, the Directors have also resolved to seek Shareholder approval to the adoption of new articles of association appropriate to an unquoted company (“Proposed Articles of Association”). A copy of the Proposed Articles of Association is available at www.scholiumgroup.com.
The Proposed Articles of Association will not contain certain of the provisions of the existing articles of association of the Company which are common for quoted companies, and which will not be necessary for the Company following the Proposed Cancellation.
For example, the existing articles of association of the Company contain provisions requiring a director to retire from office at the third annual general meeting after the general meeting at which that director was appointed. These provisions are not included in the Proposed Articles of Association. The Proposed Articles of Association will also no longer require any director appointed by the Board to be re-appointed by the Shareholders at the next annual general meeting following his or her appointment, as is currently required.
Options
Options over Ordinary Shares granted to certain individuals will remain in situ.
General Meeting
The Company will be circulating to Shareholders a notice convening a General Meeting to be held at 10.30am on 18 December 2024 at 94 New Bond Street, London W1S 1SJ at which the resolutions will be proposed as special resolutions to approve the cancellation of admission of the Ordinary Shares to trading on AIM and the adoption of the Proposed Articles of Association (if such cancellation is approved).
Irrevocable undertakings
The Board has received irrevocable undertakings from Messrs Bernard Shapero, Philip Blackwell, Charles Sebag-Montefiore CBE, Thomas Jennings CBE and Peter Gyllenhammar, and FIJ PTC Limited (representing in aggregate approximately 66.48 per cent. of the Ordinary Shares), to vote in favour of the Resolutions.
The person responsible for arranging the release of this announcement on behalf of the Company is Philip Tansey, Chief Financial Officer of the Company.
For further information please visit www.scholiumgroup.com or contact:
Scholium Group plcBernard Shapero, Chief Executive OfficerDavid Harland, Chairman Philip Tansey, Chief Financial Officer +44 (0)20 7493 0876Zeus (Nominated Adviser and Joint Broker)Chris Fielding Isaac Hooper Tel: +44 (0) 203 829 5000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
November 28, 2024
Scholium Group PLC
28 November 2024
Scholium Group plc
Interim Report & Financial Statements
Six Months ended 30 September 2024
This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended (“MAR”). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
The directors of Scholium Group plc (“Scholium”, the “Company” or, together with its subsidiaries, the “Group”) present their report and financial statements for the Group for the six months ended 30 September 2024.
Six months ended September20242023Change(£000 unless otherwise stated) Revenue4,9703,83530%Gross Profit2,0001,51132%Gross Margin40.3%39.4%Distribution Expenses(202)(231)13%Administrative Expenses(1,489)(1,205)(24)%Employee share option scheme charge(18)––Finance expenses(70)(32)(119)%Pre-Tax Profit before exceptional items22143414%Exceptional items(54)––Profit before tax16743288%Inventories10,62310,2584%Net Cash(433)(274)(58)%Net Assets10,1469,6735%NAV/Issued Share (pence)74.671.15%Earnings per share on a diluted basis (pence)1.230.31297%NAV/Issued Share (pence)74.671.15%David Harland, Chair of Scholium, noted:
“We are very pleased with the performance of the Group in recording its seventh consecutive profitable half-year period, a period that included the transition to our new single flagship property in Bond Street for both books and art which understandably created the exceptional costs incurred in the six month period. The on-going difficult geo-political situation naturally presents a difficult environment in which to plan but we are pleased with the on-going sales at the new property and remain positive about the coming six-month period.
We are announcing immediately after these results a proposal to seek shareholder authority to cancel the admission of our shares to AIM. The value attributed to our shares by the market, relative to the underlying net asset value, has made it difficult to benefit from being quoted, and the Board feels the costs of maintaining that quotation are no longer justified.”
The person responsible for arranging the release of this announcement on behalf of the Company is Philip Tansey, Chief Financial Officer of the Company.
For further information, please contact:
Scholium Group plcDavid Harland, ChairmanBernard Shapero, Chief Executive OfficerPhilip Tansey, Chief Financial Officer+44 (0)20 7493 0876Zeus Capital Markets Ltd – Nominated AdviserChris FieldingIsaac Hooper +44 (020) 7220 1666Scholium is engaged in the business of rare books and modern prints. Its primary operating subsidiary is Shapero Rare Books, one of the leading UK dealers trading internationally in rare and antiquarian books and works on paper, which also trades as Shapero Modern, a leading UK dealer in the growing marketplace of modern and contemporary prints.
The Group earned revenue in the six months to 30 September 2024 from the sale of rare books, prints and works on paper through its wholly owned subsidiary, Shapero Rare Books Limited.
The Group’s strategy is to:
• provide stable asset-backed growth driven by the markets in which the Group operates; and,
• attract individuals or, teams of specialists, in markets complementary to the Group’s existing businesses.
The current principal KPIs are:
• sales, gross profit, gross margin and profit before tax;
• the breadth and distribution of the stock of rare books held by the Group;
• stock turnover;
• cash position;
• net assets per share; and,
• earnings per share.
The Group made a profit before tax and exceptional items of £221k during the six months to 30 September 2024, a 413% increase from the profit of £43k for the corresponding period last year with overall margins continuing to improve.
Overall turnover was 30% higher compared to the same period in the prior year. This was felt across both books and art and the increasingly important shop whose contribution has continued to improve. Books sales were significantly improved at £3,853k (2023: £2,900k) whilst Gallery sales of art through several initiatives and exhibitions improved to £1,086k (2023: £858k). As a result, gross profit of £2,000k compared to the prior period total of £1,511k.
Group costs, including Distribution and Administrative expenses, increased by 18% to £1,691k (2023: £1,436k). This increase resulted from the active decision to increase our number of specialist subject team members in order to raise revenues.
The Group result for the six months was a profit before tax and extraordinary items of £221k (2023: profit of £43k).
Inventories increased by £365k to £10,623k (2023: £10,258k) in line with our expectations with regard to sales activities as witnessed by the increase in revenue. Group cash balances continue to fluctuate monthly in line with stock purchases and trade debtors with net overdraft balances of £(433)k at 30 September 2024 (2023: £(274k)).
Alternative accounting presentation
The Board is focused on demonstrating shareholder return and part of that desire is the analysis of the core performance of the Group’s trading business without costs that are related to the non-trading elements such as quoted status and other non-directly related or one-off costs not typically expected to be incurred in a ‘normal’ year.
Six months ended September (£’000) 20242023Profit before exceptional items22143Add back:Employee share option scheme18–Central costs of the quoted group178197Depreciation & amortisation*323182Finance expenses7132Operating EBITDA811455*inflated in this period on account of the two property leases being surrendered and consolidated into the new single property lease.
The impact of costs associated with our quoted status are the principal reason behind our proposal to shareholders being announced today to approve the cancellation of the trading of our shares on AIM.
The Group retains a strong balance sheet. Net assets of £10,146k (2023: £9,673k) include £10,623k of stock (2023: £10,258k) and a bank position of £(433)k (2023: £(274)k). The Covid loan, drawn down in October 2020 of £250k, has been further reduced by repayment to the current £112k (2023: £162k). As a result, there is an increase to 74.6p of net assets per ordinary share currently in issue (2023: 71.1p).
Shapero Rare Books & Shapero Modern
Shapero Rare Books operates from its new flagship store, gallery and offices at 94 New Bond Street.
Group resources are balanced between its stock of rare books and prints, in order to maximise sales and profit opportunities.
Sales in the period have, as presented in Note 3, shown a healthy rise versus the same period in the prior year across both books and the gallery.
The central costs of the business include all board directors and other Group level costs including those associated with membership of the AIM market. The central costs before exceptional items incurred in the period on account of the property relocation of £14k (2023: £nil) were £196k (2023: £197k).
Total Group Exceptional expense items of £54k (2023: £nil) have been incurred as a result of the fit-out of our new premises into which we moved over the summer months.
The significant increase in the Right of Use asset to 2,488k (2023: £934k) and the corresponding Right-of-use lease liability of less than one year of £426k (2023: £345k) and Right-of-use lease liability of more than one year of £1,493k (2023: £675k) were also on account of the move into our new flagship store, gallery and offices.
The Group continues to focus on its two profitable businesses, rare books and modern prints and is looking to continue the profitable performance of the recent years into the second half of the current financial year.
Looking forward, the Group is viewing its trading for the second half of the year with cautious optimism.
In the event that shareholders approve the Board’s proposal to cancel the admission of the trading of the shares on AIM, we would expect annual savings in excess of £100k.
Like all businesses, the Group faces risks and uncertainties that could impact on the Group’s strategy. The Board recognises that the nature and scope of these risks can change and regularly reviews the risks faced by the Group and the systems and processes to mitigate such risks.
The principal risks and uncertainties affecting the continuing business activities of the Group were outlined in detail in the Strategic Report section of the annual report covering the full year ended 31 March 2024.
In preparing this interim report for the six months ended 30 September 2024, the Board has reviewed these risks and uncertainties and considers that there have been no changes since the publication of the 2024 Annual Report.
We have been engaged by the Company to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 September 2024 which comprises the condensed consolidated statement of comprehensive income, the consolidated statement of changes in equity, the condensed consolidated statement of financial position, the consolidated statement of cash flows and the related explanatory notes.
Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 September 2024 is not prepared, in all material respects, in accordance with UK adopted International Accounting Standard 34 and the AIM Rules.
We conducted our review in accordance with International Standard on Review Engagements (UK) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
As disclosed in note 2, the annual financial statements of the group are prepared in accordance with UK adopted IFRSs. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with UK adopted International Accounting Standard 34, “Interim Financial Reporting”.
This conclusion is based on the review procedures performed in accordance with this ISRE, however future events or conditions may cause the entity to cease to continue as a going concern.
The directors are responsible for preparing the half-yearly financial report in accordance with the AIM rules.
In preparing the half-yearly financial report, the directors are responsible for assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
In reviewing the half-yearly report, we are responsible for expressing to the Company a conclusion on the condensed set of financial statement in the half-yearly financial report. Our conclusion, including our Conclusions Relating to Going Concern, are based on procedures that are less extensive than audit procedures, as described in the Basis for Conclusion paragraph of this report.
This report is made solely to the Company in accordance with International Standard on Review Engagements (UK) 2410 “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by the Financial Reporting Council. Our work has been undertaken so that we might state to the Company those matters we are required to state to it in an independent review report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company, for our review work, for this report, or for the conclusions we have formed.
Ajay Bahl BA BFP FCA
For and on behalf of
Wenn Townsend Chartered Accountants
Oxford, United Kingdom
28 November 2024
Six-month Period Ended (Unaudited)Six-month Period Ended (Unaudited)Year Ended (Audited) 30 Sept30 Sept31 Mar 202420232024 Note£000£000£000 Revenue 34,9703,8359,266 Cost of Sales(2,970)(2,324)(5,618) Gross profit 2,0001,5113,648 Distribution costs(202)(231)(778) Administrative expenses(1,489)(1,205)(2,476) Total costs and expenses (1,691)(1,436)(3,252) Profit from operations 30975394 Charge for share options granted to employees(18)–(31) Financial income––– Financial expense4(70)(32)(63) Other income – Profit before exceptional items 22143300 Exceptional items – New property refit(54)–– Profit before taxation 16743300 Income tax (expense)5––– Profit for the period and total comprehensive income attributable to equity holders of the parent company 16743300 Total earnings per share in pence 61.150.312.2130 Sept30 Sept31 Mar 202420232024 Note£000£000£000 UnauditedUnauditedAuditedAssets Non-current assets Property, plant and equipment2,488934717Intangible assets–––2,488934717Current assets Inventories10,62310,25810,569Trade and other receivables72,3742,1012,760Cash and cash equivalents4–24513,00112,35913,574Total assets 15,48913,29314,291Current liabilities Bank overdrafts 437274262Trade and other payables82,5482,1642,536Loans and borrowings928444523Right-of-use asset lease liabilities10426345188Total current liabilities 3,6952,8273,509 Liabilities due over one yearLoans and borrowings9155118249Right-of-use asset lease liabilities101,493675572 Total liabilities due over one year 1,648 793821Total liabilities 5,3433,6204,330Net assets 10,1469,6739,961Equity and liabilities Equity attributable to owners of the parent Ordinary shares136136136Share premium9,5169,5169,516Merger reserve828282Retained earnings412(61)227Total equity 10,1469,6739,961 Net Asset Value per Share in Issue 74.6p71.1p73.3pThese interim financial statements were approved by the Board of Directors on 28 November 2024 and signed on its behalf by Philip Tansey.
ShareShareMergerRetainedTotal CapitalPremiumreserveearningsequity £000£000£000£000£000 Balance at 30 September 2021 1369,51682(377)9,357 Profit for the period from continued operations 330330Loss for the period from discontinued operations –––(288)(288)Total comprehensive income for the period –––4242 Balance at 31 March 2022 1369,51682(335)9,399 Profit for the period from continued operations –––194194Loss for the period from discontinued operations (15)(15)Total comprehensive income for the period –––179179 Balance at 30 September 2022 1369,51682(156)9,578 Profit for the period from continued operations –––3737Profit for the period from discontinued operations 1515Total comprehensive income for the period 4242 Balance at 31 March 2023 1369,51682(104)9,630 Profit for the period from continued operations –––4343Total comprehensive income for the period –––4343 Balance at 30 September 2023 1369,51682(61)9,673 Profit and total comprehensive income for the period –––257257Employee share option scheme 3131 Balance at 31 March 2024 1369,516822279,961 Profit and total comprehensive income for the period –––167167Employee share option scheme 1818 Balance at 30 September 2024 1369,5168241210,14630 Sept30 Sept31 Mar 202420232024 £000£000£000 Cash flows from operating activities Profit before tax16743301 Employee share option scheme charge18–31 Depreciation of property, plant and equipment323182374 Gain of disposal of lease(82)–– Finance expense703363 496258769 (Increase) / Decrease in inventories(54)(446)(757) (Increase) in trade and other receivables386(43)(702) Increase/(decrease) in trade and other payables12191553 Net cash generated/(used) from operating activities 344(298)(906) Cash flows from investing activities Purchase of property, plant and equipment(451)(11)(21) Net purchase of right to use assets(140)–– Net cash used in investing activities (591)(11)(21) Cash flows from financing activities Lease repayments for right-of-use assets(296)(111)(337) Non-Bank loan financing(437)–634 Loans and borrowings105(25)(49) Interest paid(37)(33)(63) Net cash generated/(used) from financing activities (665)(169)185 Net (decrease) / increase in cash and cash equivalents (416)(220)27(220) Cash and cash equivalents at the beginning of the period(17)(54)(44)(54) Cash and cash equivalents at the end of the period (433)(274)(17)1. General information
Scholium Group plc and subsidiaries (together ‘the Group’) are engaged in the trading and retailing of rare and antiquarian book and, prints and works on paper primarily in the United Kingdom. The Company is a public company domiciled and incorporated in England and Wales (registered number 08833975). The registered address is 94 New Bond Street, London W1S 1DJ.
2. Basis of preparation
These condensed interim financial statements of the Group for the six months ended 30 September 2024 (the ‘Period’) have been prepared using accounting policies consistent with International Financial Reporting Standards (IFRSs) including standards and interpretations issued by the International Accounting Standards Board and in accordance with International Accounting Standards in conformity with the requirements of the Companies Act 2006. The same accounting policies, presentation and methods of computation are followed in these condensed set of financial statements as applied in the Group’s latest audited financial statements for the year ended 31 March 2024. While the financial figures included within this half-yearly report have been computed in accordance with IFRS applicable to interim periods, this half-yearly report does not contain sufficient information to constitute an interim financial report as set out in International Accounting Standard 34 Interim Financial Reporting. These condensed interim financial statements have not been audited, do not include all of the information required for full annual financial statements, and should be read in conjunction with the Group’s consolidated annual financial statements for the year ended 31 March 2024. The auditors’ opinion on these Statutory Accounts was unqualified, did not draw attention to any matters by way of emphasis and did not contain a statement under s498 (2) or s498 (3) of the Companies Act 2006.
3. Revenue
30 Sept30 Sept31 Mar 202420232024 GroupGroupGroup £000£000£000 Sales of stock – Books3,8532,9006,887Sales of stock – Gallery1,0868582,274Commissions221520Other income962854,9703,8359,2664. Financial (expense)
30 Sept30 Sept31 Mar 202420232024 GroupGroupGroup £000£000£000 Interest payable (37) (13) (41)Unwinding of discount on right-to-use liabilities (34) (19) (22)Total financial (expense) (71) (32) (63)5. Income Tax
30 Sept30 Sept31 Mar 202420232024 £000£000£000 Current and deferred tax expense Current tax–––Deferred tax –––Total tax expense ––– The charge for the year is reconciled to the profit per the income statement as follows: 30 Sept30 Sept31 Mar 202420232024 £000£000£000 Profit before tax16743300Applied corporation tax rates:25%19%25%Tax at the UK corporation tax rate of 25%:42875Utilisation of tax losses(42)(8)(75)Current and deferred tax charge –––6. Earnings per Share – pence
30 Sept30 Sept31 Mar 202420232024 GroupGroupGroup £000£000£000 Profit used in calculating basic and diluted earnings per share attributable to the owners of the parentTotal16743300Number of shares (millions)for the calculation of earnings per share: Weighted average number of shares – basic 13.6 13.6 13.6 Weighted average number of shares – options1.00––Total diluted average number of shares14.613.613.6Total basic earnings per share 1.230.322.21Total diluted earnings per share 1.150.312.21The Company announced on 16 June 2023 that it had granted options under the Company’s Enterprise Management Incentive Share Option Scheme (“EMI Option Scheme”) over a total of 1,000,000 ordinary shares of 1 pence in the Company (“Option Shares”) to certain employees including 700,000 to directors of the Company. The Option Shares have an exercise price of 37.5p per share (being the closing mid-market share price on 16 June 2023), vest over the three years from the date of grant (subject to the employees remain in continuous employment within the Group) and once vested, are exercisable at any time up to ten years after the date of grant.
Basic and diluted earnings per share amounts are calculated by dividing net profit for the year or period attributable to ordinary equity holders of the parent by the weighted average number of ordinary shares outstanding during the period or year and, the weighted average number of ordinary shares outstanding during the period combined with the weighted average number of ordinary shares subject to option outstanding during the period or year respectively. No new shares were issued during the period, and the Company had 13.6 million shares in issue and 1.0 million shares subject to option at the end of the period.
7. Trade and Other Receivables
30 Sept30 Sept31 Mar 202420232024 GroupGroupGroup £000£000£000 Trade debtors2,0031,6162,389Other debtors708–Prepayments and accrued income3014773712,3742,1012,7608. Trade and Other Payables
30 Sept30 Sept31 Mar 202420232024 GroupGroupGroup £000£000£000 Trade creditors1,1581,3791,451Other taxes and social security413237Accruals and deferred income1,324727917Other creditors25261312,5482,1642,5369. Loans and Borrowings
30 Sept30 Sept31 Mar 202420232024 GroupGroupGroup £000£000£000 Loans due in less than one year Bank loans 87 4447Non-Bank loans197476Total loans due in less than one year28444523Loan due in more than one yearBank loans15511891Non-Bank loans––158 Total loans due in more than one year15511824910. Right-of-use asset lease liabilities
30 Sept30 Sept31 Mar 202420232024 GroupGroupGroup £000£000£000 Current liabilities426345188 Liabilities due in more than one year1,493675572These liabilities represent the future lease payments due under the Group’s leases of its Mayfair premises and a motor vehicle.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
November 28, 2024
Tenth Edition
This month we announced another new client Cambria Africa plc and several coming soon!
We have Innovation Agritech Group (IAG), Eresos CBD, OMEGA MINERALS PLC and many more to go live in December.
The team is delighted to see that we will onboard over 30 companies this financial year to the JP Jenkins platform.
We are delighted to announce the following new admissions to JP Jenkins:
Cambria Africa plc (CMB:JPJ), announced its shares have been admitted to trade on JP Jenkins share dealing platform. Cambria Africa Plc has actively invested and managed investments in Zimbabwe. Currently, its operations in Zimbabwe are limited to loan processing and payroll management. The company also owns the intellectual property of Paynet Systems, which successfully provided bulk payments and gross settlement services to nearly all Zimbabwean banks.
To read the full announcement, please use the link in the comments.
https://www.eqs-news.com/news/corporate/cambria-africa-plc-shares-now-trading-on-jp-jenkins/2153527
Eresos CBD Holdings PLC (ERS:JPJ), announced this month its shares are soon to be admitted to trade on JP Jenkins share dealing platform. Eresos is a company that makes CBD-infused products for health and wellbeing, including cosmetics, skincare, and nutraceuticals. The proposed plan is to go live for trading on the 2nd Dec 2024.
Carl Jat, CEO of Eresos commented:
To read the full announcement, please use the link here:
Issuer news – Check out the latest updates, awards and news from our clients:
PRAX
Prax Group has recently announced their redesigned site. Check it out for the latest updates, new appointments, announcements, and blog posts. If you are a DCU (Deffered Consideration Unit) holder and would like updates or information on how to trade – check out their dedicated section here: https://lnkd.in/emzw3AQeVisit PRAX at www.prax.com
LOOP
Well done to all the team at LoopUp ! Multinational cloud telephony provider, LoopUp, successfully closes £12 million equity funding.
SDRY
Superdry has just published their 2024 Sustainability Report. Some of Superdry’s key achievements over the past 12 months include:
Well done to all the team at Superdry!
REDX
Congratulations to the Redx Pharma team on their award-winning abstract at UEG – United European Gastroenterology Week 2024.
SND
Sondrel announces CEO transition to lead next phase of growth and Sondrel also announces Mark Julio as new CFO.Sondrel is a leading technology company providing ultra-complex custom chips for leading global technology brands.
Oliver Jones, Sondrel’s CEO, said,
Oliver Jones brings to Sondrel an extensive background in sales, marketing and commercial operations, with experience gained across FTSE-listed engineering companies, private equity-owned businesses, and technology startups. His proven track record in driving growth through nurturing partnerships, enhancing customer experience, and implementing robust commercial management strategies aligns perfectly with Sondrel’s vision for the future.
THRV
Thrive Renewables (THRV) published a research report completed by Edison Group. Since 1994, Thrive Renewables has been working alongside investors, developers, businesses and communities to fund, build and operate sustainable renewable energy projects. Thrive’s aim is to develop the future of UK energy by only investing in clean energy projects that deliver a long-term, measurable environmental impact.
Thrive has funded, built and operated sustainable clean energy generation projects for more than 30 years. To date, it has built, developed or funded 43 renewable energy projects across multiple technologies in the UK, the majority of which it still owns and operates or is currently financing. Thrive’s investor base has grown to more than 6,000 individuals, institutions and organisations. Read the full report below:https://lnkd.in/eAY6r4By
Thrive shares are trading on JP Jenkins via monthly auctions, with the last traded price at £2.15 per share. They paid a 12p dividend this year and provide a buy back policy for all qualifying shareholders at 90% of the directors valuations, currently at £2.43. To learn more, please visit: https://lnkd.in/e78GMxfa
Trading – Check out the latest trading results from the past few weeks:
Molecular Energies PLC:
Date / Quantity / Mid. Price (GBX)
06/11/2024 – 716 – 7.75 GBX
Superdry PLC:
Date / Quantity / Mid. Price (GBX)
21/10/2024 – 95,091 – 3.29 GBX
22/10/2024 – 967 – 3.25 GBX
24/10/2024 – 11,261 – 3.00 GBX
07/11/2024 – 422 – 3.29 GBX
08/11/2024 – 73,316 – 3.29 GBX
Thrive Renewables PLC:
Monthly Auction (Oct)
Volume 10,206
Average price £1.94
Fulcrum (FCRM):
Date / Quantity / Mid. Price (GBX)
31/10/2024 – 476,838 – 0.17 GBX
LPM (LPM):
Date / Quantity / Mid. Price (GBX)
31/10/2024 – 1,170,167 – 45.00 GBX
Prax Exploration (DCU2):
Date / Quantity / Mid. Price (GBX)
25/10/2024 – 43,400 – 2.00 GBX
29/10/2024 – 10,000 – 2.00 GBX
05/11/2024 – 2,053 – 2.00 GBX
08/11/2024 – 288,735 – 2.00 GBX
11/11/2024 – 36,265 – 2.03 GBX
12/11/2024 – 10,170 – 2.00 GBX
20/11/2024 – 7,155 – 2.00 GBX
Events – Check out the latest events and webinars:
JP Jenkins & InfinitX were delighted to be finalists for the Innovation Award at the Great British Entrepreneur Awards & Community. Congratulations to all winners and finalists!
Learning 101 with JP Jenkins – Check out our latest videos here on:
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
November 20, 2024
https://www.investegate.co.uk/announcement/rns/samarkand-group-plc–smk/interim-results/8526678
4th November 2024
Samarkand Group plc
(“Samarkand”, the “Company” or together with its subsidiaries the “Group”)
Interim Results
Shift in Strategy to Owned Brands Progressing Well
Samarkand Group plc, (AQSE:SMK), the consumer brand owner and cross border eCommerce distribution services group announces its unaudited interim results for the half year ending 30 September 2024 (“H1 2025”).
As stated in our annual results FY24, our future is as a scale up platform for meaningfully different, high potential, niche brands in the health and healing space, targeted at specific consumer segments with long term growth potential, specifically natural herbal health and beauty and fertility and reproductive health.
The Group has made strong progress in shifting its strategy to focus on growing our portfolio of owned brands (Napiers the Herbalists, Zita West, Nature’s Greatest Secret and Benatural) and in restructuring our China distribution operations. This is reflected in our first half performance with owned brands growing strongly year over year, particularly in the UK, and China related revenues declining as we focus on a smaller portfolio of third-party brands.
Financial Highlights
· Revenues decreased by 22% to £6.3m (H1 2024: £8.1m)
o Brand Ownership revenues up 14% to £4.1m (H1 2024: £3.6m)
o Brand Acceleration revenues of third party brands decreased by 57% to £1.8m (H1 2024: £4.1m)
o Distribution revenues remained flat at £0.4m (H1 2024: £0.4m)
· Gross margin decreased 22% to £3.8m (H1 2024: £4.9 m) in line with reduction in revenues
· Adjusted EBITDA loss* reduced by 10% to £0.6m (H1 2024: £0.7m)
· Cash and cash equivalents were £0.68m (H1 2024: £1.66m)
*adjusted for restructuring costs, impairment on intangible assets, profit on disposal of Brand Asset and share based payments.
Operational Highlights
· Strong growth in owned brand revenues with H1 sales for our portfolio of owned brands Napiers the Herbalists, Zita West, Nature’s Greatest Secret and Benatural up 64% in the UK over prior year on a like for like basis
· Napiers the Herbalists revenue grew over 100% in the UK vs prior year as a result of product innovation, social commerce activities and expansion in the independent sales channel
· Zita West revenues grew 22% in the UK as a result of new product introductions, upgraded packaging and ongoing investment in education and provision of a high-touch customer experience
· Performance of recently acquired Optimised Energetics Ltd running ahead of expectations with owned brands Natures Greatest Secret and Benatural growing at over 100% and the flexible manufacturing capacity which is now part of the Group improving our speed to market and ability to respond to fast moving consumer trends
· Restructuring of China distribution activities and associated costs in the period as we focus on a far smaller portfolio of third-party brands
· Reduction in Group’s adjusted EBITDA losses by 10% vs prior year and good progress made towards goal of monthly breakeven
David Hampstead, Chief Executive Officer of Samarkand Group, commented: “Our strategic shift to focus on growing our owned, proprietary brands and taking a more selective approach to distributing 3rd party brands gathered pace in the first half. We are delighted with the growth momentum behind our owned brands and the acquisition of Optimised Energetics has strengthened our portfolio of meaningfully different premium health and healing brands and improved our competitive position with the addition of flexible manufacturing services.
Reaching monthly profitability remains our top priority and I’m pleased to report this strategy is bearing fruit with September bringing a profit of c.£40k at adjusted EBITDA level, a material improvement on previous months. This, together with the significant improvement in our owned brands and ongoing restructuring of our China operations, is moving us closer to that goal. I am confident in the future potential of our brands.”
For more information, please contact:
Samarkand Group plcDavid Hampstead, Chief Executive OfficerEva Hang, Chief Financial Officerhttp://samarkand.global/info@samarkand.globalGuild Financial Advisory LimitedRoss AndrewsTomas Klaassen+44 (0) 7973839767+44 (0) 7834458095
November 4, 2024
Ninth Edition
This month we announced another new client Bowleven plc, with 2 more to go live very shortly. We have a number of new clients announce this month to go live in November. We highly anticipate the budget, to see what will happen and how this will affect the investment landscape in both public and private markets.
We are delighted to announce the following new admissions to JP Jenkins:
Bowleven plc (JPJ:BLVN) announces its shares have been admitted to trade on JP Jenkins share dealing platform. Shareholders wishing to trade these securities can do so through their stockbroker. Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer. The indicative pricing for the ordinary shares (ISIN: GB00B04PYL99), as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/).
Eli Chahin, CEO of Bowleven plc commented:
To read the full announcement, please use the link here:
Issuer news – Check out the latest updates, awards and news from our clients:
Released their interim results for the last 6 months. CSS is a leading supplier of value-added, people-based solutions to the UK’s largest brands. Their shares are currently trading on JP Jenkins, to learn more please visit www.jpjenkins.com
Released their 2024 half year results.
Highlights Include:
£75m funding to accelerate rooftop solar for UK schools and businesses
£1m invested in two community-owned wind turbines
25-year extension to our Beochlich hydro project
£30k in funding for community buildings
Shares are trading on JP Jenkins via a monthly auction, with the indicative price sitting at £2.15 per share. The share price rose just shy of 18% following the last auction. Read about the full results with the link below: https://lnkd.in/eS58dyci
Opens their first new concept store – Athletic Essentials – at Westfield London shopping mall. Superdry shares are trading on JP Jenkins, to learn more please visit https://lnkd.in/eyKCh9qV
Their CEO, Julian Dunkerton, said:
Prax:
celebrated their 25th anniversary! The Prax Group has evolved into a globally recognised leader with full integration across the oil value chain – from upstream to midstream and downstream.Well done to all the team! Prax has two lines of Deffered Consideration Units (DCU) trading on JP Jenkins, to learn more, please visit www.jpjenkins.com
Announced Grumpy Mule’s brand-new look has officially landed in Waitrose. 100% Fairtrade coffee on the shelves of your local Waitrose & Partners, keep an eye out for the Mule. Cafédirect Group shares are trading on JP Jenkins, to learn more please visit www.jpjenkins.com
Trading – Check out the latest trading results from the past few weeks:
BiVicTrix PLC:
Date / Quantity / Mid. Price (GBX)
30/09/2024 – 50,000 – 11.50 GBX
18/10/2024 – 42,282 – 10.50 GBX
Superdry PLC:
Date / Quantity / Mid. Price (GBX)
10/10/2024 – 258,749 – 3.29 GBX
18/10/2024 – 137,451 – 3.29 GBX
Thrive Renewables PLC:
Monthly Auction (Sept)
Volume 500
Average price £2.15
Bowleven PLC (BLVN):
Date / Quantity / Mid. Price (GBX)
15/10/2024 – 14,500 – 0.28 GBX
LPM (LPM):
Date / Quantity / Mid. Price (GBX)
30/09/2024 – 6,298 – 40.00 GBX
Prax Exploration (DCU2):
Date / Quantity / Mid. Price (GBX)
08/10/2024 – 115,503 – 1.12 GBX
10/10/2024 – 12,579 – 1.68 GBX
17/10/2024 – 165,323 – 1.70 GBX
18/10/2024 – 165,323 – 2.00 GBX
Events – Check out the latest events and webinars:
Thank you all that attended our inaugural Liquidity Junction Event in Edinburgh! Paul Atkinson did a fantastic job at setting the scene and hosting us at the fantastic Green Room Wine Bar – Edinburgh. We are very focused on regional SMEs and growth companies across the UK, outside of the capital, who are looking for liquidity and trading for their shareholders.
The inaugural Stakeholderz Summit was a great success! Our Commercial Director – Veronika Oswald was delighted to attend and be on the panel discussing liquidity and exits for private companies.We want to thank the Stakeholderz team!
We had the pleasure of attending an insightful event hosted by Venari Security and co-hosted with Elixirr, centered around the important topic of Helping Boards Prepare for an Uncertain Digital Future in an AI World. The discussions were both engaging and enlightening, offering fresh perspectives on how AI is transforming the business landscape and what leaders can do to stay ahead of the curve. Huge thanks to Venari Security and Elixirr for hosting such a timely and impactful event!
Learning 101 with JP Jenkins – Check out our latest videos here on:
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
October 28, 2024
JP Jenkins Ltd
CAMBRIA AFRICA PLC Shares now trading on JP Jenkins
23-Oct-2024 / 13:27 GMT/BST
The issuer is solely responsible for the content of this announcement.
23rd Oct 2024
CMB:JPJ
ISIN: IM00B28CVH58
CAMBRIA AFRICA PLC
(“Cambria” or “the Company”)
Shares now trading on JP Jenkins
London, UK, 22nd Oct 2024 – CAMBRIA AFRICA PLC (CMB:JPJ), today announces its shares have been admitted to trade on JP Jenkins share dealing platform. Cambria’s registered offices are at Burleigh Manor, Peel Road, Douglas IM1 5EP, Isle of Man and is registered as a company in the Isle of Man under company number 001773V.
Cambria Africa Plc has actively invested and managed investments in Zimbabwe. Currently, its operations in Zimbabwe are limited to loan processing and payroll management. The company also owns the intellectual property of Paynet Systems, which successfully provided bulk payments and gross settlement services to nearly all Zimbabwean banks. The company is in the process of divesting assets, including Paynet’s corporate offices located in Mt. Pleasant Business Park. Management’s objective is to maximize value at the holding level and facilitate capital distributions to shareholders through dividends or a compulsory share redemption.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
Shareholders wishing to trade these securities can do so through their stockbroker. Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer. Trades can be conducted, and limits can be accepted, during normal business hours. Shareholders or potential investors can place limits via their existing UK regulated stockbroker. The indicative pricing for the ordinary shares (ISIN: IM00B28CVH58), as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/company/cambria-africa-plc/).
For further information, please contact:
CAMBRIA AFRICA PLC
Investor Relations
Tel. +44 (0) 203 287 8814
Email: info@cambriaafrica.com
JP Jenkins Ltd Veronika Oswald / Mason Doick
Tel. +44 (0) 207 469 0937
Email: info@jpjenkins.com
Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
October 24, 2024
Cambria Africa PLC
11 October 2024
Cambria Africa Plc
(“Cambria” or the “Company”)
Audited FY 2023 Results (“the Results”)
Earnings per Share of 0.03 US cents and NAV of 1.12 US cents (0.88p GBP)
Cambria Africa Plc (AIM: CMB) (“Cambria” or the “Company”) announces its audited results for the year ended 31 August 2023 (“FY 2023”). The Audited Financial Statements are available on the Company’s website (www.cambriaafrica.com) and will be sent to shareholders tomorrow. With the publishing of the Group`s FY 2023 and HY 2024 results, the suspension of the Company`s shares on the AIM will be lifted at 7.30am on 11 October 2024.
A loss attributable to Cambria Shareholders of $156,492 (0.03 US cents per share) was recorded for FY 2023. The Company’s subsidiaries in Zimbabwe continued to operate above or near breakeven EBITDA, with revenues
US $922,104 in FY 2023 comparable with US $920,047 million in FY 2022. The Company’s subsidiaries are expected to continue reporting at breakeven levels in FY 2024. The Company’s FY 2023 consolidated profits stem mainly from Tradanet, the 51% owned subsidiary of Paynet Zimbabwe with revenues of US$528,834.
Net Equity (NAV) increased by 6% from US $5.75 million (1.06 US cents per share) in FY 2022 to
$6.1 million FY 2023 (1.12 US cents per share). The increase is mainly attributable to receipt of “Legacy Debts” or “Blocked Funds” totalling $407,350 which had previously been written down offset by foreign currency translation losses of $226,000 related to the translation of the Zimbabwean operations.
· Net Equity (NAV) increased by 6% from US $5.75 million (1.06 US cents per share) to US $6.1 million
(1.12 US cents per share).
· Revenues were almost comparable with the prior year at $922,000 while operating costs decreased by 6% to $584,769.
· Consolidated EBITDA before exceptional items decreased by 13% to $298,000 from $344,000 in FY2022.
· Cambria’s central costs comprising the listing and associated operating costs decreased by 9% to $115,509 in
FY2023. Cambria’s CEO and Directors rendered services to Cambria without compensation during FY2023.
· The Statement of Comprehensive Income includes the receipt of $407,350 of the “Legacy Debts” or “Blocked Funds” registered with and received from the Zimbabwean Ministry of Finance during the year.
· Tradanet (Pvt) Ltd, Paynet Zimbabwe’s 51% owned subsidiary, continued to provide loan management services to CABS, the country’s largest building society. The persistent devaluation of the country’s currency led to an increase in salary-based loans. However, due to liquidity constraints in the banking sector, this increase was not in proportion to the depreciation of the currency.
· Autopay, Paynet Zimbabwe’s payroll processing division, performed as expected under a new management team with extensive payroll experience. Autopay established an independent contract relationship with payroll managers on a pure profit share basis.
Components to the decrease of NAV in 2023
The Group reported an increase in NAV to $6.1 million (1.12 US cents per share) at 31 August 2023, compared to
$5.75 million (1.06 US cents per share) at 31 August 2022. The net increase was due to the following material factors:
· Receipt of $407,350 of the “Legacy Debts” or “Blocked Funds” from the Zimbabwean Ministry of Finance. $1.2 million remains outstanding and represents the amounts owing by our Zimbabwean subsidiaries to their holding companies registered with the Ministry of Finance. These amounts were marked down to a negligible value in prior financial years. Accordingly any recovery of these Legacy Debts will represent an increase to the Group`s NAV upon receipt.
· Foreign currency translation adjustments (losses) of $226,000
· Profit after tax attributable to the owners of the Company $156,492
Components of NAV at 31 August 2023
The Group NAV of $6.1 million as at the end of FY 2023 includes the following material tangible and intangible assets:
Building and properties valued at $2.3 million – The Company`s real estate holding company, Lonzim Holdings Limited, has received multiple offers, with a transaction yet to be finalised.
Investment in Radar Holdings Limited – 9.74% or 4.98 million shares valued at US $1.743 million (net of minority interests) based on 35 US cents per equivalent Radar share. In the post balance sheet period, the sale of the Group`s 78.2% shareholding in A.F Philips (Pvt) Ltd (“AFP”) (which holds the Investment in Radar Holdings Limited) has been concluded with all conditions precedent to the deal being successfully completed. The purchasers have settled $1.1 million of the purchase price with the balance, which accrues interest at a rate of 10% per annum, expected to be settled by the end of the calendar year.
USD Cash and Cash Equivalents – US dollar cash totalling $1.498 million at the end of FY 2023.
Old Mutual and Nedbank shares – the Company holds 204,047 Old Mutual Limited shares and 2,692 Nedbank shares valued on its FY 2023 Statement of Financial Position at US $167,670 based on the closing price of shares on the Johannesburg Stock Exchange (JSE) at the year end. The Old Mutual Limited shares were suspended on the Zimbabwe Stock Exchange (ZSE) on 31 July 2020.
Goodwill – The Company has a goodwill value of $717,000 on its Statement of Financial Position relating to its investment in the Payserv group of Companies. The Company believes this is a fair assessment of the intangible asset despite the impact of the decisions made by Zimbabwe`s banking institutions against using its payment platforms. Turnaround opportunities are being explored, as evidenced by the recent granting to Multi-Pay Solutions (Pvt) Ltd (Multi-Pay Solutions) the exclusive rights to use, distribute, and operate Paynet Software in the Southern African Development Community (SADC). Payserv Africa will continue to operate Paynet outside of the SADC. Tradanet, in which the Company holds an effective 51% interest, processes microloans on behalf of CABS, Zimbabwe’s largest Building Society. At their peak in 2019, these microloans comprised about a third of the banks assets and the Directors believe that a return to those levels is fully conceivable. Accordingly, the Company continues to believe that Payserv’s intellectual property value and the amalgamation of the above exceeds the book value of the goodwill.
At this point in time, the Company’s investment proposition is underpinned by its realizable Net asset value (“NAV”) within the constructs of Zimbabwe’s current economic policy and its outlook. It is important to consider the components of NAV and the efforts of the Company to ensure that any disposal is realized at the holding Company level. We believe we are making significant progress in this regard.
Strategies to realise NAV
The Company continues to realize NAV at the holding company level by deploying the following strategies:
· Cash: As at the 2023 financial year end, the Group held cash reserves of US$1.55 million. As at 30 September 2024, in addition to Zimbabwe-held US dollar-denominated cash, shares and gold coins, the Company holds $2.6 million at the holding level.
· Recovery of Legacy Debts: The Company is actively pursuing the recovery of “Legacy Debts” or “Blocked Funds”
owed by our Zimbabwe subsidiaries to their holding companies. As at 31 August 2023, we’ve successfully recovered US$407,350, leaving an outstanding balance of $1.2 million held by the Ministry of Finance. These funds, initially held by the Reserve Bank in ZWL on a one-to-one basis with the USD, were marked down to a negligible value in previous financial years based on the annual official exchange rate.
· Listed Portfolio Value: We aim to realise the value of the 204,047 Old Mutual shares and 2,692 Nedbank shares by
transferring these shares to the South African register. The total value of this portfolio was $202,924 based on
Johannesburg Stock Exchange (JSE) closing prices on 30 September 2024.
· Asset Maximization at Holding Level: At the holding Company level, we intend to achieve approximately $4 million
from the sale of our indirect stake in Radar ($1.74 million) and properties ($2.3 million).
· Intellectual Property Value: We are committed to deriving maximum value from our intellectual property, both in
our current operations and future endeavours.
NAV Discussion
NAV increased by US$337,000 from 1.06 US cents per share to 1.12 US cents per share. As noted above, this excludes the balance of $1.2 million “Legacy Debt” due from the Zimbabwean Ministry of Finance.
The details of Cambria’s NAV components are as follows:
· Commercial Property – This is represented by the prominently located Mt. Pleasant Business Park Commercial Property valued at $2.3 million;
· Old Mutual and Nedbank Shares – The total value of Old Mutual and Nedbank shares based on JSE closing prices was $167,670 as at 31 August 2023. 204,047 Old Mutual shares are currently suspended on the Zimbabwe Stock Exchange (ZSE), and their fungibility is also halted. By way of an unbundling by Old Mutual in November 2021, the company received 2,692 Nedbank shares, which are still retained in Zimbabwe.
· Radar Holdings Limited – The Company has concluded the sale of its 78.2% shareholding in A.F. Philips (Pvt) Ltd (“AFP”) for a sum of US $1.74 million in cash. This amount is equivalent to the book value of its shareholding in AFP at 31 August 2023. All conditions precedent to the sale were met in June 2024 at which time the Company received US $800,000 of the sale price and subsequently a further $300,000 was received on 23rd September 2024. The balance accrues interest at a rate of 10% per annum and is expected to be settled before the end of the calendar year.
· Goodwill – Another component of NAV is the Company’s goodwill (intellectual property). Currently, intellectual property is driving the earnings in Tradanet – a significant contributor to the Company’s earnings. The 51% owned subsidiary of Paynet, processes microloans on behalf of CABS, Zimbabwe’s largest Building Society. At their peak in 2019, these microloans comprised about a third of the bank’s assets and the Directors believe that a return to those levels is fully conceivable. In June 2023, the Company announced its intention to license Paynet’s intellectual property to Multi-Pay which will attempt to provided bulk payment and clearing services to the banking sector in the SADC region, including Zimbabwe.
Continuing Operations
Tradanet – As mentioned in the discussion of our goodwill above, Tradanet, the 51%-owned subsidiary of Paynet Zimbabwe remains the Company’s most profitable operation. With greater reliance on the US Dollar for remuneration, Tradanet expects its ZWL earnings to transition to USD.
Other operations: Autopay and Millchem – These companies provide a modest revenue to the Group, primarily in ZWL. Their operations are beneficial in off-setting local expenses.
Cancellation of admission to trading on AIM of the Ordinary Shares
The Board undertook a review of the Company`s position and future prospects including the benefits and drawbacks to the Company retaining its admission on AIM. The Board concluded that it should recommend to Shareholders that a Cancellation is in the best interests of the Company and its Shareholders. In reaching this conclusion, the Board considered the following key factors:
· Permanent cost savings to be achieved by the Cancellation;
· Discount to NAV of the Company’s share price. As at 29 February 2024 (being the last trading day prior to its suspension) the Company’s share price was 0.225 pence per Ordinary Share, compared with an unaudited liquid NAV of 0.77 pence (as at 23 August 2024) and a potential recovery of 0.38 pence from illiquid assets (as at 23 August 2024).
· The free float of the Company is only c.30%, resulting in low trading volumes and significant illiquidity, preventing Shareholders from achieving the best value for their shares.
· The Company has not utilised its admission on AIM to raise fresh capital or issue paper consideration to fund acquisitions since 2018.
· The administrative, legal, and regulatory burden associated with maintaining the Company’s admission to trading on AIM is, in the Directors’ opinion, disproportionate to the benefits.
Under the AIM Rules, it is a requirement that a cancellation is approved by not less than 75 per cent of the votes cast, whether in person or by proxy at a general meeting of shareholders.
A circular to shareholders was issued on 23 September 2024 convening a general meeting to be held on 10 October 2024 to seek shareholder approval for the proposed Cancellation and to amend the Company’s Articles of Association. As the beneficial owner of 69.2% of the Company’s issued share capital via Encyclia Logistics Limited, I recused myself from voting in favor of the proposed delisting at the general meeting. As announced on 10 October 2024 all Resolutions were passed. Accordingly, cancellation of admission of the Company’s ordinary shares to trading on AIM will become effective at 7.00 a.m. on 22 October 2024.
The suspension of the Company’s Ordinary Shares has been lifted and as a result Shareholders will have one day to trade their Cambria Ordinary Shares on AIM, before the Company will again be suspended at 7.00am on 14 October 2024. As announced on 23 September 2024, the Company will cease to have a nominated adviser with effect from 8.00 a.m. on 14 October 2024. As a result, the Company will again be suspended as of 7:00 a.m. on 14 October 2024, pursuant to AIM Rule 1, for failing to retain a Nominated Adviser. As the Company have decided not to appoint a new Nominated Adviser the suspension will remain in place until the cancellation of admission of the Company’s ordinary shares to trading on AIM at 7.00 a.m. on 22 October 2024.
Posting of Annual Report
The Company has posted to shareholders copies of its annual report and financial statements for the year ended
31 August 2023.
A copy of the annual report and financial statements are available from the Company’s website www.cambriaafrica.com/investors.
This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended (“MAR”). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
Contacts Cambria Africa Plcwww.cambriaafrica.comSamir Shasha +44 (0)20 3287 8814WH Ireland Limitedhttps://www.whirelandplc.com/James Joyce / Sarah Mather+44 (0) 20 7220 1666Cambria Africa Plc Audited consolidated income statementFor the year ended 31 August 2023 Audited31-Aug-23 US$’000Audited31-Aug-22 US$’000Revenue922920Cost of sales(53)(22)Gross profit869898Operating costs(585)(623)Other income769Exceptionals13(212)Operating Profit304132Finance income3112Finance costs–(5) Net finance income317 Profit before tax335139Income tax(70)(144)Profit/(Loss) for the year265(5) Attributable to: Owners of the company156(178)Non-controlling Interests109173(Loss)/profit for the year265(5) Earnings/(Loss) per shareBasic and diluted earnings/(loss) per share (cents)0.03c(0.03c) Earnings/(Loss) per share – continuing operations Basic and diluted earnings/(loss) per share (cents)0.03c(0.03c) Weighted average number of shares544,576544,576Cambria Africa Plc Audited consolidated statement of comprehensive incomeFor the year ended 31 August 2023 Audited 31-Aug-23US$’000Audited 31-Aug-22US$’000 Profit/(Loss) for the year265(5) Other comprehensive income Items that will not be reclassified to Statement of Profit or Loss: Legacy debt recoveries407– Foreign currency translation differences for overseas operations(219)(424) Total comprehensive profit/(loss) for the year453 (429) Attributable to: Owners of the company344(602) Non-controlling interest109173 Total comprehensive profit/(loss) for the year453 (429)Cambria Africa Plc
Audited consolidated Statement of Financial Position
As at 31 August 2023
Audited Group 31-Aug-23 US$’000 Audited Group 31-Aug-22 US$’000RestatedProperty, plant and equipment23082306Goodwill717717Financial assets at fair value through profit and loss168155Total non-current assets3,193 3,178 Inventories–8Financial assets at fair value through profit and loss3428Trade and other receivables88142Cash and cash equivalents1,5521,263Total current assets1,674 1,441 Assets classified as held for sale2,228 2,228 Total assets7,095 6,847EquityIssued share capital7777Share premium account88,45988,459Revaluation reserve(190)(190)Foreign exchange reserve(10,940)(11,128)Non-distributable reserves2,3712,371Accumulated losses(73,688)(73,844)Equity attributable to owners of the company6,089 5,745 Non-controlling interests454425Total equity6,543 6,170 LiabilitiesDeferred tax liabilities153188Total non-current liabilities153 188Current tax liabilities104141Trade and other payables295348Liabilities directly associated with assets classified as held for sale – – Total current liabilities399 489 Total liabilities552 677 Total equity and liabilities7,095 6,847Cambria Africa Plc
Audited consolidated statement of cash flows
As at 31 August 2023
Audited 31-Aug-23 US$’000 Audited 31-Aug-22 US$’000Cash generated from operations 307495Taxation paid (142) (111)Cash generated from operating activities 165384Cash flows from investing activitiesProceeds on disposal of property, plant and equipment–17Purchase of property, plant and equipment(5)(6)Purchase of gold coins(31)–Interest received3112Dividends received6–Non-cash proceeds from scrip dividend–(33)Net cash generated from/(utilized in) investing activities 1 (10)Cash flows from financing activitiesDividends paid to non-controlling interests(56)(195)Legacy debt recoveries407Interest paid–(5)Loans repaid–(100)Net cash generated from/(utilized by) financing activities 351 (300) Net increase in cash and cash equivalents 51774Cash and cash equivalents at the beginning of the Period1,2631,656Foreign exchange(288)(467)Net cash and cash equivalents at 31 August 1,552 1,263 Cash and cash equivalents as above comprise the followingCash and cash equivalents attributable to continuing operations1,5521,263Net cash and cash equivalents at 31 August 1,552 1,263Annual Report
A copy of the annual report and financial statements will be made available on the Company’s website www.cambriaafrica.com/investors.
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
October 11, 2024
Eighth Edition
This month we announced another 3 new client’s, with 2 more to go live very shortly.
Sondrel, BiVictriX Therapeutics plc & 350 PPM LTD all went live over the last month! Congratulations all. We now have Bowleven plc to go live next Tuesday and another to go live the week after.
First and foremost, thank you to UHY Hacker Young for featuring us in their fantastic Capital Markets Outlook. Our Head of Corporate Mason Doick discusses the benefits to and experiences of current clients.
See below the full link to the document: https://lnkd.in/enmuCBp2
We are delighted to announce the following new admissions to JP Jenkins:
BiVictriX Therapeutics plc announced this month its shares are now trading on JP Jenkins. BiVictriX Therapeutics plc (JPJ: BVX), a drug discovery and development company applying an innovative, proprietary approach to develop a new class of highly selective, next generation cancer therapeutics, bispecific antibody drug conjugates (Bi-Cygni® ADCs), which exhibit superior potency, whilst reducing treatment-related toxicities.
The indicative pricing for the ordinary shares (ISIN: GB00BNXH3K91), as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/). To read the full announcement, please use the link here:
Sondrel (Holdings) PLC (JPJ: SND), announced this month it’s shares have been admitted to trade on JP Jenkins. Sondrel is a UK-based fabless semiconductor company specialising in high end, complex digital Application Specific Integrated Circuits (ASICs) and System on Chips (SOCs). It provides a full turnkey service in the design, prototyping, testing, packaging and production of ASICs and SoCs.
The indicative pricing for the ordinary shares (ISIN: GB00BJN54579), as well as the transaction history, will be available on the JP Jenkins website at (https://lnkd.in/e5NvtmyW).
To read the full announcement, please use the link here:
350 PPM LTD (JPJ: PPM), announced this month it’s shares have been admitted to trade on JP Jenkins. 350 PPM LTD is a UK-based company that incubates and accelerates early-stage environmental business with the aim of reducing the amount of carbon dioxide, or greenhouse gas equivalents, in the atmosphere.
The indicative pricing for the ordinary shares (ISIN: GB00BS4DJ926), as well as the transaction history, will be available on the JP Jenkins website.
To read the full announcement, please use the link here:
Coming Soon:
Bowleven plc announced its intention to leave AIM and move to JP Jenkins, for the trading of its Ord shares.
To learn more, see the full RNS below: https://lnkd.in/e5jABdpQ
Issuer news – Check out the latest updates, awards and news from our clients:
Sondrel announced Advanced Modelling Process for AI chip designs. Paul Martin, Sondrel’s Global Field Engineering Director, explained, “AI chips are extremely complex to design because of the huge amounts of data that have to flow round them between the heterogeneous processors, IO and the memory. There cannot be periods when the processors are stalled waiting for data, which is made more complicated when the chip has several different types of processors each with different data traffic requirements. This new Process enables us to analyse and balance the dataflow through the chip whilst executing the software workloads on the AI chip.”
Please read the full article here: https://lnkd.in/ePkpbWiG
Agronomics Limited was delighted to announce one of their portfolio companies, Formo, has secured EUR 50 million in Series B funding! Agronomics Limited also published their latest H2 newsletter. This edition looks at the significant technical, commercial and financial progress made throughout the portfolio, with a number of companies continuing to demonstrate notable and achieving multiple new financings.
You can read the full newsletter here: https://lnkd.in/enQjWYSm
Carlisle Support Services are hosting their Innovation lab conference due be held on Thursday 27th March 2025 at ExCeL London. Carlisle Support Services plans to have over 700 industry stakeholders and 50 exhibitors, an event not to be missed.
Please see more information here: https://lnkd.in/euAAwu5U
Trading – Check out the latest trading results from the past few weeks:
BiVicTrix PLC:
Date / Quantity / Mid. Price (GBX)
16/09/2024 – 250,000 – 11.00 GBX
Superdry PLC:
Date / Quantity / Mid. Price (GBX)
12/09/2024 – 46,251- 3.29 GBX
04/09/2024 – 100,000- 3.29 GBX
Thrive Renewables PLC:
Monthly Auction (July)
Volume 671
Average price £1.7
Prax Exploration (DCU2):
Date / Quantity / Mid. Price (GBX)
09/09/2024 – 11,878 – 1.12 GBX
04/09/2024 – 16,000 – 1.94 GBX
29/08/2024 – 34,238 – 2.03 GBX
27/08/2024 – 103,386 – 1.82 GBX
21/08/2024 – 6,479 – 1.6 GBX
Events – Check out the latest events and webinars:
Financial Services Innovator 2024 Finalist! Well done to all the team at InfinitX and JP Jenkins on achieving so much this past year since combining. Given the finalists, we are extremely proud to be nominated. Thank you to all the partners, advisors and companies that support JP Jenkins!
This week, our Head of Corporate Mason Doick attended the Enterprise Investment Scheme Association (EISA) – 30th Anniversary of the EIS. Thank you to the Institute of Directors (IoD) for hosting such a fabulous event.
A big thank you to Horizon37 who hosted the Money and
People Webinar this week, as our Commercial Director Veronika Oswald delve into actionable insights that bridge these critical domains.
Learning 101 with JP Jenkins – Check out our latest videos here on:
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
September 28, 2024
24th Sept 2024
JPJ: BLVN
ISIN: GB00B04PYL99
Bowleven plc (BLVN)
(“Bowleven” or “the Company”)
Shares now trading on JP Jenkins
London, UK, 24th Sept 2024 – Bowleven plc (JPJ:BLVN), is an oil and gas company, incorporated in Scotland in 2001 and has its registered office in Edinburgh, Scotland and its head office in London, UK today announces its shares have been admitted to trade on JP Jenkins share dealing platform. Bowleven plc (BLVN) is based at 50 Lothian Road, Festival Square, Edinburgh, Scotland, EH3 9WJand is registered as a company in England and Wales under Companies House, company number SC225242.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
Shareholders wishing to trade these securities can do so through their stockbroker. Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer. Trades can be conducted, and limits can be accepted, during normal business hours. Shareholders or potential investors can place limits via their existing UK regulated stockbroker.
The indicative pricing for the ordinary shares (ISIN: GB00B04PYL99), as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/).
Veronika Oswald, Commercial Director of JP Jenkins commented: “We are pleased to welcome Bowleven plc to JP Jenkins, the UK’s leading share dealing platform for unlisted companies. Following their transition from the London Stock Exchange’s AIM market, Bowleven shareholders will continue to have access to liquidity and trading opportunities. We look forward to supporting Bowleven as they focus on maximizing shareholder value and advancing their projects in Africa.”
Eli Chahin, CEO of Bowleven plc commented: “We are pleased to announce Bowleven’s move to JP Jenkins, ensuring continued access for our shareholders to trade and realize the value of their investments. This transition marks a key step in our journey as we remain focused on advancing our Ëtinde project and creating long-term value. JP Jenkins provides a platform that aligns with our commitment to maintaining liquidity and transparency for our shareholders. We look forward to this next chapter and remain committed to driving forward our strategic goals.”
For further information, please contact:
Bowleven plc (BLVN)
Eli Chahin, CEO
JP Jenkins
Veronika Oswald / Mason Doick
+44 (0) 207 469 0937
September 24, 2024
We’re delighted to announce that shares in 350 PPM Limited have been admitted to trade on JP Jenkins share dealing platform.
Veronika Oswald, Commercial Director at JP Jenkins, said: “JP Jenkins is proud to welcome 350 PPM, a pioneering investment firm focused on climate change and sustainable investment, to our share dealing platform.
“By joining JP Jenkins, 350 PPM will gain access to a broader investor base, enhancing liquidity and expanding its reach within the private investment community. This partnership reflects our shared commitment to supporting companies that drive positive environmental impact, and we look forward to seeing 350 PPM’s continued growth and success in the green economy.”
Shareholders wishing to trade these securities can do so through their stockbroker. Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer. Trades can be conducted, and limits can be accepted, during normal business hours. Shareholders or potential investors can place limits via their existing UK-regulated stockbroker.
The indicative pricing for the ordinary shares (ISIN: GB00BS4DJ926), as well as the transaction history, will be available on the JP Jenkins website.
Nick Dimmock, Chairman at 350 PPM said: “This is really an exciting time for us at 350 PPM. Whilst we have been trading for a number of years, with several successful exits already under our belt, we’ll be leveraging our relationship with JP Jenkins, and the widely used platform it provides, to step-change the growth of our own business and that of our clients to ensure we all make a meaningful contribution to climate action.”
JP Jenkins is a liquidity venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
September 5, 2024
Seventh Edition
This month we announced another new client – Destiny Pharma plc and we also have Sondrel going live this Thursday! We have Bowleven plc and BiVictriX Therapeutics plc going live in September.
We are delighted to announce the following new admissions to JP Jenkins:
Destiny Pharma plc (JPJ:DEST), announced it’s shares have been admitted to trade on JP Jenkins.
Destiny Pharma plc, a clinical stage biotechnology company focused on the development and commercialisation of novel medicines to prevent and cure life-threatening infections. Shareholders wishing to trade these securities can do so through their stockbroker. Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer.
To read the full announcement, please use the link below:
Veronika Oswald, Commercial Director of JP Jenkins said: “We would like to welcome another company from the pharmaceutical sector to JP Jenkins. We are delighted to be supporting Destiny Pharma in their transition and growth as a private company.”
BiVictriX Therapeutics plc announced its intention to leave AIM and move to JP Jenkins, for the trading of its Ord shares.
To learn more, see the full RNS below: https://otp.tools.investis.com/clients/uk/bivictrix_therapeutics_ltd/rns/regulatory-story.aspx?cid=2675&newsid=1853190
Bowleven plc announced its intention to leave AIM and move to JP Jenkins, for the trading of its Ord shares.
To learn more, see the full RNS below: https://lnkd.in/e5jABdpQ
Issuer news – Check out the latest updates and news from our clients:
Fulcrum Group – Annual Results
Fulcrum returns to profitability following major strategic turnaround Fulcrum Utility Services Limited “Fulcrum” or the “Group”, the leading multi-utility infrastructure and services provider announces its full year results for the period ending 31 March 2024.The Group is pleased to report growth and a return to profitability as part of its strategic turnaround, which is delivering sustainable, progressive improvements across its operating divisions.
Fulcrum shares are trading on JP Jenkins, to learn more please check out the page here: https://lnkd.in/e2GBCG4tPlease find the full results below: https://lnkd.in/eKFxwjpi
GS Verde Group – Management Buy Out Announcement:
We’re thrilled to announce the successful management buy-out of recruitment agency, NuStaff Recruitment, in a deal advised on by leading dealmakers GS Verde Group, with the support of the Development Bank of Wales!
GS Verde Group proudly advised Directors David Matthews and Paul Fletcher on the acquisition, marking a new chapter for the company, first established by the late John Scriven in 1993. Read the full story here: https://lnkd.in/d47qzfZY
Trading – Check out the latest trading results from the past few weeks:
Thrive Renewables PLC:
Monthly Auction (July)
Volume 30,000
Average price £1.925 GBP
Tende Energy:
Date / Quantity / Mid. Price (GBX)
31/07/2024 – 422,707 – 2.00 GBX
31/07/2024 – 500,000 – 2.00 GBX
31/07/2024 – 191158 – 2.00 GBX
31/07/2024 – 41263 – 2.00 GBX
31/07/2024 – 40,500 – 2.00 GBX
08/08/2024 – 14,203,264 – 2.00 GBX
8/08/2024 – 601,454 – 2.00 GBX
8/08/2024 – 1,049,534 – 2.00 GBX
Prax Exploration (DCU):
Date / Quantity / Mid. Price (GBX)
19/08/2024 – 1,745 – 1.6 GBX
30/07/2024 – 20,000 – 1.6 GBX
29/07/2024 – 310,774 – 1.6 GBX
23/07/2024 – 88,000 – 1.6 GBX
23/07/2024 – 9,000 – 1.6 GBX
Scirocco Energy:
Date 09/08/2024
Quantity 55,300
Mid. Price GBX 0.25 GBX
Events – Check out the latest events and webinars:
Money and People Webinar:
In today’s dynamic business landscape, success hinges on mastering two pivotal elements: Money and People. Join us for a collaborative webinar between Horizon37 and JP Jenkins as we delve into actionable insights that bridge these critical domains. The Money – led by Mason Doick, Head Of Corporate at JP Jenkins & The People – led by Katy Tuncer, Founder at Horizon37.
The Big Two: Money and People
19th September
12-1pm
OnlineRegister here: https://buff.ly/45HxQ3e
Charity:
Here at JP Jenkins we continue to support a number of charities, through personal commitments and monetary support. Each year, we continue to support charities like DEBRA UK, Tiny Tickers ‘The Tiny Hearts Charity’, GCHC (Glasgow Children’s Hospital Charity) & London’s Air Ambulance Charity London’s Air Ambulances campaign is required to replace two life‑saving helicopters and keep them flying for years to come
This is a charity close to our company, as Jonathan Jenkins, the CEO of London Air Ambulance, is the son of our founder John Jenkins – a well regarded city figure and fantastic man.
Learning 101 with JP Jenkins – Check out our latest videos here on:
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
August 28, 2024
RNS Number : 9863Z
BiVictriX Therapeutics PLC
12 August 2024
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
NOT FOR PUBLICATION OR RELEASE IN OR INTO THE UNITED STATES OR AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF IRELAND OR THE REPUBLIC OF SOUTH AFRICA, OR ANY PROVINCE OR TERRITORY THEREOF OR TO OR FOR THE ACCOUNT OF ANY NATIONAL, RESIDENT OR CITIZEN OF THE UNITED STATES OR ANY PERSON RESIDENT IN AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF IRELAND OR THE REPUBLIC OF SOUTH AFRICA.
BiVictriX Therapeutics plc
(“BiVictriX”, “BiVictriX Therapeutics” or the “Company”)
Proposed voluntary cancellation of admission of Ordinary Shares to trading on AIM
Proposed re-registration as a Private Limited Company
Adoption of New Articles
And
Notice of General Meeting
Alderley Park, 12 August 2024 – BiVictriX (AIM: BVX), a drug discovery and development company applying an innovative, proprietary approach to develop a new class of highly selective, next generation cancer therapeutics, bispecific antibody drug conjugates (Bi-Cygni® ADCs), which exhibit superior potency, whilst reducing treatment-related toxicities, today announces the proposed cancellation of the admission of its ordinary shares of £0.01 each (“Ordinary Shares“) from trading on AIM (the “Cancellation“) and the re-registration of the Company as a private limited company (the “Re-registration“).
A circular (“Circular“) will be sent to Shareholders today, setting out the background to and reasons for the Cancellation and the Re-registration. The Company is seeking Shareholder approval for the Cancellation and Re-registration at a general meeting, which has been convened for 11:30 a.m. on 29 August 2024 at the Company’s registered office, Mereside Alderley Park, Alderley Edge, Manchester SK10 4TG (“General Meeting“), notice of which is included in the Circular. The Company is also seeking Shareholder approval at the General Meeting for the adoption of new articles of association (the “New Articles“) to be effective on the Re-registration.
If the Cancellation Resolution is passed at the General Meeting, it is anticipated that the Cancellation will become effective at 7:00 a.m. on 11 September 2024. The Cancellation Resolution is conditional, pursuant to Rule 41 of the AIM Rules, upon the approval of Shareholders holding not less than 75 per cent. of the votes cast by Shareholders (whether present in person or by proxy) at the General Meeting.
The Company has received irrevocable undertakings from DBW Investments, Robert Keith, Alderley Park Ventures Limited, BioCity Investments Limited, Alden AS and those Directors who are also Shareholders, as set out below, representing in aggregate approximately 42.5 per cent. of the Company’s issued share capital, to vote in favour of the Resolutions set out in the Circular.
Tiffany Thorn, CEO of BiVictriX Therapeutics, said: “With a growing pipeline of novel, first-in-class bispecific Antibody Drug Conjugates (“bsADC”), together with a highly competitive platform in one of the most commercially attractive sectors across the entirety of the oncology drug development market, BiVictriX is well positioned to capitalise on its already strong foundations. To maintain our competitive advantage within this space, we intend to progress our pipeline and platform expeditiously, and after extensive review, the Board has concluded that this will be best achieved by the Company delisting from AIM and re-registering as a private company.
I’m immensely proud of everything BiVictriX has achieved to date. Yet the Board has concluded that the current public market valuation does not reflect the scale of our potential. The Directors believe that, as a private company, BiVictriX is likely to have access to a larger quantum of future funding, to enable the business to meet key value inflection points. We therefore believe the Cancellation is in the best interest of Shareholders and the future of our business as a whole.”
Proposed Cancellation and Re-registration
In view of the Company’s ambitions to move BVX001 into the clinic at pace, the Company has spent time considering a variety of funding options alongside its opportunities for early partnership of BVX001 and, consequently, has conducted an extensive review of the benefits and drawbacks to the Company retaining the admission of its Ordinary Shares to trading on AIM. The Directors believe that Cancellation and Re-registration is in the best interest of the Company and its Shareholders as a whole. In reaching this conclusion, the Directors have considered the following key factors:
· Challenges as a pre-clinical stage business in a difficult fundraising environment: Notwithstanding the Company’s positive momentum across BVX001 and BVX002 and positive initial FDA interactions regarding moving BVX001 into the clinic, the Company is at a pre-clinical stage of development and requires significant funds to be able to proceed towards a Phase I clinical trial and associated dose manufacturing. As at 30 June 2024, the Company had cash and cash equivalents of £1.7 million. The Board does not believe that its current market capitalisation, nor current equity market conditions, will support a sufficient fundraise (on terms acceptable to Shareholders, or at all) to enable the Company to progress these plans in the short term or potentially the medium term. The Directors believe that whilst a ‘top up raise’ may be possible (whilst the Ordinary Shares remain admitted to trading on AIM), due to the current market conditions, the Directors believe this is likely to be challenging and may not ultimately result in significant value creation. The Directors also believe the likely amount from any funding that may be accessible in the short to medium term (whilst the Ordinary Shares are admitted to trading on AIM) is unlikely to provide the Company with sufficient scale to allow further progression of BVX001 towards an IND submission or development of the Company’s broader portfolio, nor provide a strong capital base to support strategic discussions. On the contrary, Myricx Bio, a UK private company, announced on 8 July 2024 that it had raised £90 million to take their programmes into the clinic. The Directors note that Myricx Bio is at a similar stage to BiVictriX and believe this transaction illustrates the appetite for major investors to invest in this area.
· Market capitalisation not reflective of progress and prospects: In comparison to private companies operating in the ADC space, the Directors believe the current market capitalisation of the Company neither fully reflects the positive achievements nor the underlying prospects of the business and is a barrier to future growth, funding and potential partnership and licensing discussions.
· Current valuation impacting potential for partnerships and collaborations: The Company has continued to build key external relationships including with industry partners. Ongoing and further work with these key partners is expected to provide multiple opportunities for future manufacturing, clinical and commercialisation alliances to optimise the value potential of BiVictriX as a whole. However, the Directors believe that the Company’s profile and negotiating ability is severely constrained by the Company’s current market capitalisation, small scale and limited cash reserves.
· Identifying how best to benefit from market interest in ADCs: The Company notes that whilst there has been significant activity in the ADC space, the majority of ADC partnership and license opportunities occur either following initial clinical data on the asset in question or on earlier-stage assets being developed within well-capitalised, clinical stage companies. Many of the transactions occurring in the ADC space attract upfront payments which are multiples of the Company’s current market capitalisation. Whilst there is no guarantee that Cancellation will lead to the Company successfully completing a significant fundraise and/or partnership transaction (in BVX001 and/or other pipeline assets), the Directors believe the Company’s prospects of successfully completing such transactions will be significantly increased by obtaining early clinical proof-of-concept data on the wider platform. Currently the Board believe this would be best achieved through the further progression of BVX001 to IND and into the clinic, which, as noted above, will require a significant fundraise which the Board believe is more likely to be achieved successfully as a private company without the constraints of a public listing. The Company believes being a private company will facilitate a greater degree of flexibility in the Company’s strategy for delivering shareholder value.
· Need for greater diversity of investors: The Directors believe that as a private company, BiVictriX will have access to a greater pool of investors who are more likely to support clinical development, allowing more rapid development across its portfolio; and providing significant balance sheet strength whilst the Company continues its engagement with potential partners and collaborators. The Directors believe these factors, alongside an increase of scale of the business, have the potential to deliver increased opportunity for the creation of significant Shareholder value. This pool of investors is likely to include venture capital and specialist investors, who the Directors believe may have greater appetite for investing companies such as BiVictriX who do not have regular revenue streams and who are subject to research, development and clinical trial costs and risk.
· Seeking out opportunities for US investment bank engagement: The Company plans to engage a US healthcare investment bank with significant experience in the ADC space to assist the Company in securing additional capital to support its operations, although there can be no assurance that the Company will be successful in this regard.
· Assessing the best route for a significant fundraise: Whilst there is no guarantee that Cancellation and Re-registration will lead to the Company successfully completing a significant fundraise or licensing deal, the Directors believe its prospects of such a transaction will be significantly increased as a private company. The Board notes a number of recent examples of significant fundraises for pre-clinical private companies operating in the ADC space, including the recent £90 million raise for Myricx Bio noted above.
· Current challenges regarding liquidity: The Directors believe the current levels of liquidity in trading of the Company’s Ordinary Shares on AIM do not, in itself, offer investors the opportunity to trade in meaningful volumes or with frequency within an active market.
· Regulatory, financial and time burden related to AIM listing: The considerable cost of maintaining admission to trading on AIM, including fees payable to its professional advisers, including its nominated adviser and joint brokers, AIM fees payable to the London Stock Exchange as well as incremental legal, insurance, accounting and auditing fees, along with the considerable amount of management time and regulatory burden associated with maintaining the Company’s admission to trading on AIM are, in the Directors’ opinion, disproportionate to the benefits to the Company. The Directors believe the time and cost savings associated with the Cancellation and Re-registration could be better utilised for the benefit of the Company and value creation for its Shareholders. Subject to the Cancellation and excluding manufacturing and clinical trial costs for BVX001, the Company has sufficient funds for working capital into the second half of 2025.
· Support for delisting from largest shareholders: The Company has obtained irrevocable commitments for the Cancellation and Re-registration from its largest Shareholders representing in aggregate approximately 39.6 per cent. of the Company’s current issued share capital.
The Company is making arrangements for a Matched Bargain Facility to assist Shareholders to trade in the Ordinary Shares to be put in place from the date of the Cancellation, if the Resolutions are passed. The Matched Bargain Facility will be provided by JP Jenkins. JP Jenkins is an appointed representative of Prosper Capital LLP, which is authorised and regulated by the FCA.
A copy of this announcement and the Circular will be made available on the Company’s website later today at www.bivictrix.com.
Capitalised terms used but not defined in this announcement shall have the same meaning given to such term in the Circular.
For more information, please contact:
BiVictriX Therapeutics plcTiffany Thorn, Chief Executive OfficerMichael Kauffman, Non-Executive Chairman Email: info@bivictrix.com SP Angel Corporate Finance LLP (NOMAD and Broker)
David Hignell, Caroline Rowe (Corporate Finance)
Vadim Alexandre, Rob Rees (Sales and Broking) Tel: +44 (0) 20 3470 0470 Panmure Liberum Limited (Joint Broker)
Emma Earl, Freddy Crossley, Mark Rogers, Rupert Dearden Tel: +44 (0) 20 3100 2000 ICR Consilium Namrata Taak, Lucy Featherstone, Max Bennett, Emmalee Hoppe Tel: +44 (0) 20 3709 5700Email: Bivictrix@consilium-comms.com
About BiVictriX Therapeutics plc
BiVictriX (AIM: BVX) is an emerging biotechnology company leveraging clinical experience and its proprietary discovery engine to advance a new class of highly cancer-selective, next-generation precision cancer therapies in one of the fastest-growing markets in oncology. BiVictriX’s first-in-class Bi-Cygni® Antibody Drug Conjugates (“ADCs”) combine superior efficacy with substantially improved cancer-selectivity and safety to provide opportunities for prolonged dosing and greater efficacy in the clinic. The Company is advancing its pipeline to deliver the future of cancer care across a broad range of haematological and solid cancer indications in areas of high unmet medical need.
Find out more at www.bivictrix.com and connect with us on LinkedIn and Twitter @BiVictriX.
APPENDIX I
Extracts from the Circular
Background and Strategic Context
The Company’s Ordinary Shares have been admitted to trading on AIM since its initial public offering (“IPO“) in August 2021, and during this time the Company has raised gross proceeds of c.£9.6 million through equity fundraises to support the ongoing requirements and growth of the business.
Following the Company’s promising preclinical safety and efficacy data for its lead product, BVX001, and continued progression and expansion of the target discovery platform, the Directors have continued to consider the Company’s opportunities to generate Shareholder value and the optimal capital structure to deliver this. The Directors believe that having access to a larger quantum of funding than has historically been available to the Company through its AIM listing would allow it to pursue a greater number of opportunities to reach key value inflexion points. In particular, the Directors believe that the BVX001 data achieved to date supports progression of BVX001 into the clinic, subject to significant funding requirements. The Company is also mindful that the optimal opportunity for a significant license/partner deal for BVX001 and/or other pipeline assets will be with a strengthened balance sheet, a higher valuation and potentially on the back of initial clinical efficacy data.
Notwithstanding the Company’s current intention to progress BVX001 into the clinic, the Board will continue to review all opportunities available to it to create Shareholder value.
The Directors believe that as a private company, BiVictriX may have access to a wider range of investors which could include specialist investors in the US with the potential opportunity to raise funds at a higher valuation than the current market capitalisation of the Company. The Directors have based this decision on a combination of factors, including: the Company’s current market capitalisation, the difficult equity market conditions for pre-revenue companies, the low trading liquidity of its Ordinary Shares, as well as the Group being at pre-clinical stage. These factors combined mean that the opportunity for significant value creation is currently tempered, and accordingly the Directors believe that the Cancellation is in the best interests of Shareholders. Further details as to the reasons for the Cancellation are set out in Paragraph 3 of this Part I below.
Following the Cancellation and Re-registration, the Company will continue to review the structure and composition of the business, the Board and the executive management team, to ensure the optimal corporate structure is in place to support the long-term success of the Company.
Process for, and principal effects of, the Cancellation
The Directors are aware that certain Shareholders may be unable or unwilling to hold Ordinary Shares in the event that the Cancellation is approved and becomes effective. Such Shareholders should consider selling their interests in the market prior to the Cancellation becoming effective. However, should the Cancellation become effective, the Company intends to implement a Matched Bargain Facility with a third party which would facilitate Shareholders buying and selling Ordinary Shares on a matched bargain basis following Cancellation.
Under the AIM Rules, the Company is required to give at least 20 clear Business Days’ notice of the Cancellation. Additionally, the Cancellation will not take effect until at least five clear Business Days have passed following the passing of the Cancellation Resolution. If the Cancellation Resolution is passed at the General Meeting, it is proposed that the last day of trading in the Ordinary Shares on AIM will be 10 September 2024 and that the Cancellation will take effect at 7:00 a.m. on 11 September 2024.
If the Cancellation becomes effective, SP Angel will cease to be the nominated adviser of the Company and the Company will no longer be required to comply with the AIM Rules.
Under the AIM Rules, it is a requirement that the Cancellation must be approved by Shareholders holding not less than 75 per cent. of votes cast by Shareholders at the General Meeting. Accordingly, the Notice of General Meeting, set out in at the end of the Circular, contains a special resolution to approve the Cancellation.
The principal effects of the Cancellation will include the following:
· as a private company, there will be no formal market mechanism enabling Shareholders to trade Ordinary Shares (other than any limited off-market mechanism provided by the Matched Bargain Facility), and no price will be publicly quoted for the Ordinary Shares;
· it is possible that, following the publication of this announcement, the liquidity and marketability of the Ordinary Shares may be significantly reduced, and their value adversely affected (however, as set out above, the Directors believe that the existing liquidity in the Ordinary Shares is, in any event, limited);
· the Ordinary Shares may be more difficult to sell compared to shares of companies traded on AIM (or any other recognised market or trading exchange);
· in the absence of a formal market and quoted price, it may be difficult for Shareholders to determine the market value of their investment in the Company at any given time;
· the regulatory and financial reporting regime applicable to companies whose shares are admitted to trading on AIM will no longer apply, albeit the Company will remain subject to the Takeover Code;
· Shareholders will no longer be afforded the protections given by the AIM Rules, such as the requirement to be notified of price sensitive information or certain events and the requirement that the Company seek shareholder approval for certain corporate actions, where applicable, including substantial transactions, reverse takeovers, related party transactions and fundamental changes in the Company’s business, including certain acquisitions and disposals;
· the levels of disclosure and corporate governance within the Company may not be as stringent as for a company quoted on AIM;
· the Company will no longer be subject to UK MAR regulating inside information and other matters;
· the Company will no longer be required to publicly disclose any change in major shareholdings in the Company under the Disclosure Guidance and Transparency Rules;
· SP Angel will cease to be nominated adviser to the Company;
· whilst the Company’s CREST facility will remain in place immediately post the Cancellation, the Company’s CREST facility may be cancelled in the future and, although the Ordinary Shares will remain transferable, they may cease to be transferable through CREST (in which case, Shareholders who hold Ordinary Shares in CREST will receive share certificates);
· stamp duty will be due on transfers of shares and agreements to transfer shares unless a relevant exemption or relief applies to a particular transfer; and
· the Cancellation and Re-registration may have personal taxation consequences for Shareholders. Shareholders who are in any doubt about their tax position should consult their own professional independent tax adviser.
The above considerations are not exhaustive, and Shareholders should seek their own independent advice when assessing the likely impact of the Cancellation on them.
For the avoidance of doubt, the Company will remain registered with the Registrar of Companies in England and Wales in accordance with, and subject to, the Companies Act, notwithstanding the Cancellation and Re-registration. The Resolutions to be proposed at the General Meeting include the adoption of the New Articles, with effect from the Re-registration. A copy of the New Articles can be viewed at www.bivictrix.com and is included at Appendix 1 to the Circular.
Transactions in the Ordinary Shares prior to and post the proposed Cancellation
Prior to the Cancellation
Shareholders should note that they are able to continue trading in the Ordinary Shares on AIM prior to the Cancellation.
Following the Cancellation
The Company is making arrangements for a Matched Bargain Facility to assist Shareholders to trade in the Ordinary Shares to be put in place from the date of the Cancellation, if the Resolutions are passed. The Matched Bargain Facility will be provided by JP Jenkins. JP Jenkins is an appointed representative of Prosper Capital LLP, which is authorised and regulated by the FCA.
Under the Matched Bargain Facility, Shareholders or persons wishing to acquire or dispose of Ordinary Shares will be able to leave an indication with JP Jenkins, through their stockbroker (JP Jenkins is unable to deal directly with members of the public), of the number of Ordinary Shares that they are prepared to buy or sell at an agreed price. In the event that JP Jenkins is able to match that order with an opposite sell or buy instruction, it would contact both parties and then effect the bargain (trade). Shareholdings remain in CREST and can be traded during normal business hours via a UK regulated stockbroker. Should the Cancellation become effective, and the Company puts in place the Matched Bargain Facility, details will be made available to Shareholders on the Company’s website at www.bivictrix.com.
The Matched Bargain Facility will operate for a minimum of six months after the Cancellation. The Directors’ current intention is that it will continue beyond that time, but Shareholders should note that it could be withdrawn and therefore inhibit the ability to trade the Ordinary Shares. Further details will be communicated to the Shareholders at the relevant time.
If Shareholders wish to buy or sell Ordinary Shares on AIM, they must do so prior to the Cancellation becoming effective. As noted above, in the event that Shareholders approve the Cancellation, it is anticipated that the last day of dealings in the Ordinary Shares on AIM will be 10 September 2024 and that the effective date of the Cancellation will be 11 September 2024.
Process for the Re-Registration
As set out above, following the Cancellation, the Directors believe that the requirements and associated costs of the Company maintaining its public company status will be difficult to justify and that the Company will benefit from the more flexible requirements and lower costs associated with private limited company status. It is therefore proposed to Re-register the Company as a private limited company. In connection with the Re-registration, it is proposed that the New Articles be adopted to reflect the change in the Company’s status to a private limited company. The principal effects of the Re-registration and the adoption of the New Articles on the rights and obligations of Shareholders and the Company are summarised in Part II of the Circular. A copy of the New Articles can be found at Appendix 1 to the Circular.
Under the Companies Act, the Re-registration and the adoption of the New Articles must be approved by Shareholders holding not less than 75 per cent. of votes cast by Shareholders at the General Meeting. Accordingly, the Notice of General Meeting set out at the end of the Circular contains a special resolution to approve the Re-registration and adopt the New Articles.
If the Cancellation Resolution and the Re-registration Resolution are approved at the General Meeting, an application will be made to the Registrar of Companies for the Company to be re-registered as a private limited company. Re-registration will take effect when the Registrar of Companies issues a certificate of incorporation on Re-registration. The Registrar of Companies will issue the certificate of incorporation on Re-registration when it is satisfied that no valid application can be made to cancel the Re-registration Resolution or that any such application to cancel the Re-registration Resolution has been determined and confirmed by the Court.
If the Resolutions are passed at the General Meeting, it is anticipated that the Re-registration will become effective before the end of September 2024.
Takeover Code
The Takeover Code applies to all offers for companies which have their registered offices in the United Kingdom, the Channel Islands or the Isle of Man if any of their equity share capital or other transferable securities carrying voting rights are admitted to trading on a UK regulated market or a UK multilateral trading facility or on any stock exchange in the Channel Islands or the Isle of Man.
The Takeover Code also applies to all offers for companies (both public and private) which have their registered offices in the United Kingdom, the Channel Islands or the Isle of Man and which are considered by the Panel to have their place of central management and control in the United Kingdom, the Channel Islands or the Isle of Man, but in relation to private companies only if one of a number of conditions is met, for example, if the Company’s shares were admitted to trading on a UK regulated market or a UK multilateral trading facility or on any stock exchange in the Channel Islands or the Isle of Man at any time in the preceding ten years.
If the Cancellation and Re-registration are approved by Shareholders at the General Meeting, the Company will be re-registered as a private company and its securities will no longer be admitted to trading on a regulated market or a multilateral trading facility in the United Kingdom. In these circumstances, the Takeover Code will only apply to the Company if it is considered by the Panel to have its place of central management and control in the United Kingdom, the Channel Islands or the Isle of Man. This is known as the “residency test”. In determining whether the residency test is satisfied, the Panel has regard primarily to whether a majority of a company’s directors are resident in these jurisdictions.
On the basis of the current composition and residency of the Directors, the residency test will be satisfied, therefore the Company is considered by the Panel to have its place of central management and control in the United Kingdom, the Channel Islands or the Isle of Man. Consequently, the Takeover Code will continue to apply to the Company following the Cancellation and the Re-registration subject to its terms until the later of:
· the date falling 10 years following the effective date of the Cancellation;
· the date falling 10 years after dealings and/or prices at which persons are willing to deal in any of the Ordinary Shares have been published on a regular basis for a continuous period of at least six months, whether via a newspaper, electronic price quotation system or otherwise;
· the date falling 10 years after any of the Ordinary Shares have been subject to a marketing arrangement as described in section 693(3)(b) of the Companies Act; or
· the date falling 10 years after the Company has filed a prospectus for the offer, admission to trading or issue of securities with the registrar of companies or any other relevant authority in the United Kingdom, the Channel Islands or the Isle of Man,
provided that, the Takeover Code may cease to apply earlier, if any changes to the composition of the Board results in the majority of the Directors not being resident in the United Kingdom, Channel Islands or Isle of Man.
Should the Takeover Code cease to apply to the Company in the future, Shareholders would not be afforded the protections provided by the Takeover Code. This includes the requirement for a mandatory cash offer to be made if either:
· a person acquires an interest in shares which, when taken together with the shares in which persons acting in concert with it are interested, increases the percentage of shares carrying voting rights in which it is interested to 30 per cent. or more; or
· a person, together with persons acting in concert with it, is interested in shares which in the aggregate carry not less than 30 per cent. of the voting rights of a company but does not hold shares carrying more than 50 per cent. of such voting rights and such person, or any person acting in concert with it, acquires an interest in any other shares which increases the percentage of shares carrying voting rights in which it is interested.
Before giving your consent to the Cancellation and the Re-registration, you may want to take independent professional advice from an appropriate independent financial adviser.
APPENDIX II
EXPECTED TIMETABLE OF PRINCIPAL EVENTS
Event Time and/or date(1)(2)Publication and posting of the Circular 12 August 2024Latest time for receipt of proxy appointments in respect of theGeneral Meeting 11:30am on 27 August 2024General Meeting 11:30am on 29 August 2024Announcement of result of General Meeting 29 August 2024Last day of dealings in Ordinary Shares on AIM 10 September 2024Cancellation of admission of the Ordinary Shares to trading on AIM 7:00am on 11 September 2024Matched Bargain Facility for Ordinary Shares commences 11 September 2024Expected re-registration as a private companyweek commencing 23 September 2024
Notes:
(1) All of the times referred to in this announcement refer to London time, unless otherwise stated.
(2) The timetable above assumes that the Resolutions set out in the Notice of General Meeting are passed. Events listed in the above timetable following the General Meeting are conditional on the Resolutions being passed at the General Meeting without amendment.
(3) Each of the times and dates in the above timetable is subject to change. If any of the above times and/or dates change, the revised times and dates will be notified to Shareholders by an announcement through a Regulatory Information Service.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom
. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
August 12, 2024
BiVictriX Therapeutics PLC
12 August 2024
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
NOT FOR PUBLICATION OR RELEASE IN OR INTO THE UNITED STATES OR AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF IRELAND OR THE REPUBLIC OF SOUTH AFRICA, OR ANY PROVINCE OR TERRITORY THEREOF OR TO OR FOR THE ACCOUNT OF ANY NATIONAL, RESIDENT OR CITIZEN OF THE UNITED STATES OR ANY PERSON RESIDENT IN AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF IRELAND OR THE REPUBLIC OF SOUTH AFRICA.
BiVictriX Therapeutics plc
(“BiVictriX”, “BiVictriX Therapeutics” or the “Company”)
Proposed voluntary cancellation of admission of Ordinary Shares to trading on AIM
Proposed re-registration as a Private Limited Company
Adoption of New Articles
And
Notice of General Meeting
Alderley Park, 12 August 2024 – BiVictriX (AIM: BVX), a drug discovery and development company applying an innovative, proprietary approach to develop a new class of highly selective, next generation cancer therapeutics, bispecific antibody drug conjugates (Bi-Cygni® ADCs), which exhibit superior potency, whilst reducing treatment-related toxicities, today announces the proposed cancellation of the admission of its ordinary shares of £0.01 each (“Ordinary Shares“) from trading on AIM (the “Cancellation“) and the re-registration of the Company as a private limited company (the “Re-registration“).
A circular (“Circular“) will be sent to Shareholders today, setting out the background to and reasons for the Cancellation and the Re-registration. The Company is seeking Shareholder approval for the Cancellation and Re-registration at a general meeting, which has been convened for 11:30 a.m. on 29 August 2024 at the Company’s registered office, Mereside Alderley Park, Alderley Edge, Manchester SK10 4TG (“General Meeting“), notice of which is included in the Circular. The Company is also seeking Shareholder approval at the General Meeting for the adoption of new articles of association (the “New Articles“) to be effective on the Re-registration.
If the Cancellation Resolution is passed at the General Meeting, it is anticipated that the Cancellation will become effective at 7:00 a.m. on 11 September 2024. The Cancellation Resolution is conditional, pursuant to Rule 41 of the AIM Rules, upon the approval of Shareholders holding not less than 75 per cent. of the votes cast by Shareholders (whether present in person or by proxy) at the General Meeting.
The Company has received irrevocable undertakings from DBW Investments, Robert Keith, Alderley Park Ventures Limited, BioCity Investments Limited, Alden AS and those Directors who are also Shareholders, as set out below, representing in aggregate approximately 42.5 per cent. of the Company’s issued share capital, to vote in favour of the Resolutions set out in the Circular.
Tiffany Thorn, CEO of BiVictriX Therapeutics, said: “With a growing pipeline of novel, first-in-class bispecific Antibody Drug Conjugates (“bsADC”), together with a highly competitive platform in one of the most commercially attractive sectors across the entirety of the oncology drug development market, BiVictriX is well positioned to capitalise on its already strong foundations. To maintain our competitive advantage within this space, we intend to progress our pipeline and platform expeditiously, and after extensive review, the Board has concluded that this will be best achieved by the Company delisting from AIM and re-registering as a private company.
I’m immensely proud of everything BiVictriX has achieved to date. Yet the Board has concluded that the current public market valuation does not reflect the scale of our potential. The Directors believe that, as a private company, BiVictriX is likely to have access to a larger quantum of future funding, to enable the business to meet key value inflection points. We therefore believe the Cancellation is in the best interest of Shareholders and the future of our business as a whole.”
Proposed Cancellation and Re-registration
In view of the Company’s ambitions to move BVX001 into the clinic at pace, the Company has spent time considering a variety of funding options alongside its opportunities for early partnership of BVX001 and, consequently, has conducted an extensive review of the benefits and drawbacks to the Company retaining the admission of its Ordinary Shares to trading on AIM. The Directors believe that Cancellation and Re-registration is in the best interest of the Company and its Shareholders as a whole. In reaching this conclusion, the Directors have considered the following key factors:
· Challenges as a pre-clinical stage business in a difficult fundraising environment: Notwithstanding the Company’s positive momentum across BVX001 and BVX002 and positive initial FDA interactions regarding moving BVX001 into the clinic, the Company is at a pre-clinical stage of development and requires significant funds to be able to proceed towards a Phase I clinical trial and associated dose manufacturing. As at 30 June 2024, the Company had cash and cash equivalents of £1.7 million. The Board does not believe that its current market capitalisation, nor current equity market conditions, will support a sufficient fundraise (on terms acceptable to Shareholders, or at all) to enable the Company to progress these plans in the short term or potentially the medium term. The Directors believe that whilst a ‘top up raise’ may be possible (whilst the Ordinary Shares remain admitted to trading on AIM), due to the current market conditions, the Directors believe this is likely to be challenging and may not ultimately result in significant value creation. The Directors also believe the likely amount from any funding that may be accessible in the short to medium term (whilst the Ordinary Shares are admitted to trading on AIM) is unlikely to provide the Company with sufficient scale to allow further progression of BVX001 towards an IND submission or development of the Company’s broader portfolio, nor provide a strong capital base to support strategic discussions. On the contrary, Myricx Bio, a UK private company, announced on 8 July 2024 that it had raised £90 million to take their programmes into the clinic. The Directors note that Myricx Bio is at a similar stage to BiVictriX and believe this transaction illustrates the appetite for major investors to invest in this area.
· Market capitalisation not reflective of progress and prospects: In comparison to private companies operating in the ADC space, the Directors believe the current market capitalisation of the Company neither fully reflects the positive achievements nor the underlying prospects of the business and is a barrier to future growth, funding and potential partnership and licensing discussions.
· Current valuation impacting potential for partnerships and collaborations: The Company has continued to build key external relationships including with industry partners. Ongoing and further work with these key partners is expected to provide multiple opportunities for future manufacturing, clinical and commercialisation alliances to optimise the value potential of BiVictriX as a whole. However, the Directors believe that the Company’s profile and negotiating ability is severely constrained by the Company’s current market capitalisation, small scale and limited cash reserves.
· Identifying how best to benefit from market interest in ADCs: The Company notes that whilst there has been significant activity in the ADC space, the majority of ADC partnership and license opportunities occur either following initial clinical data on the asset in question or on earlier-stage assets being developed within well-capitalised, clinical stage companies. Many of the transactions occurring in the ADC space attract upfront payments which are multiples of the Company’s current market capitalisation. Whilst there is no guarantee that Cancellation will lead to the Company successfully completing a significant fundraise and/or partnership transaction (in BVX001 and/or other pipeline assets), the Directors believe the Company’s prospects of successfully completing such transactions will be significantly increased by obtaining early clinical proof-of-concept data on the wider platform. Currently the Board believe this would be best achieved through the further progression of BVX001 to IND and into the clinic, which, as noted above, will require a significant fundraise which the Board believe is more likely to be achieved successfully as a private company without the constraints of a public listing. The Company believes being a private company will facilitate a greater degree of flexibility in the Company’s strategy for delivering shareholder value.
· Need for greater diversity of investors: The Directors believe that as a private company, BiVictriX will have access to a greater pool of investors who are more likely to support clinical development, allowing more rapid development across its portfolio; and providing significant balance sheet strength whilst the Company continues its engagement with potential partners and collaborators. The Directors believe these factors, alongside an increase of scale of the business, have the potential to deliver increased opportunity for the creation of significant Shareholder value. This pool of investors is likely to include venture capital and specialist investors, who the Directors believe may have greater appetite for investing companies such as BiVictriX who do not have regular revenue streams and who are subject to research, development and clinical trial costs and risk.
· Seeking out opportunities for US investment bank engagement: The Company plans to engage a US healthcare investment bank with significant experience in the ADC space to assist the Company in securing additional capital to support its operations, although there can be no assurance that the Company will be successful in this regard.
· Assessing the best route for a significant fundraise: Whilst there is no guarantee that Cancellation and Re-registration will lead to the Company successfully completing a significant fundraise or licensing deal, the Directors believe its prospects of such a transaction will be significantly increased as a private company. The Board notes a number of recent examples of significant fundraises for pre-clinical private companies operating in the ADC space, including the recent £90 million raise for Myricx Bio noted above.
· Current challenges regarding liquidity: The Directors believe the current levels of liquidity in trading of the Company’s Ordinary Shares on AIM do not, in itself, offer investors the opportunity to trade in meaningful volumes or with frequency within an active market.
· Regulatory, financial and time burden related to AIM listing: The considerable cost of maintaining admission to trading on AIM, including fees payable to its professional advisers, including its nominated adviser and joint brokers, AIM fees payable to the London Stock Exchange as well as incremental legal, insurance, accounting and auditing fees, along with the considerable amount of management time and regulatory burden associated with maintaining the Company’s admission to trading on AIM are, in the Directors’ opinion, disproportionate to the benefits to the Company. The Directors believe the time and cost savings associated with the Cancellation and Re-registration could be better utilised for the benefit of the Company and value creation for its Shareholders. Subject to the Cancellation and excluding manufacturing and clinical trial costs for BVX001, the Company has sufficient funds for working capital into the second half of 2025.
· Support for delisting from largest shareholders: The Company has obtained irrevocable commitments for the Cancellation and Re-registration from its largest Shareholders representing in aggregate approximately 39.6 per cent. of the Company’s current issued share capital.
The Company is making arrangements for a Matched Bargain Facility to assist Shareholders to trade in the Ordinary Shares to be put in place from the date of the Cancellation, if the Resolutions are passed. The Matched Bargain Facility will be provided by JP Jenkins. JP Jenkins is an appointed representative of Prosper Capital LLP, which is authorised and regulated by the FCA.
A copy of this announcement and the Circular will be made available on the Company’s website later today at www.bivictrix.com.
Capitalised terms used but not defined in this announcement shall have the same meaning given to such term in the Circular.
For more information, please contact:
BiVictriX Therapeutics plcTiffany Thorn, Chief Executive OfficerMichael Kauffman, Non-Executive Chairman Email: info@bivictrix.com SP Angel Corporate Finance LLP (NOMAD and Broker)About BiVictriX Therapeutics plc
BiVictriX (AIM: BVX) is an emerging biotechnology company leveraging clinical experience and its proprietary discovery engine to advance a new class of highly cancer-selective, next-generation precision cancer therapies in one of the fastest-growing markets in oncology. BiVictriX’s first-in-class Bi-Cygni® Antibody Drug Conjugates (“ADCs”) combine superior efficacy with substantially improved cancer-selectivity and safety to provide opportunities for prolonged dosing and greater efficacy in the clinic. The Company is advancing its pipeline to deliver the future of cancer care across a broad range of haematological and solid cancer indications in areas of high unmet medical need.
Find out more at www.bivictrix.com and connect with us on LinkedIn and Twitter @BiVictriX.
APPENDIX I
Extracts from the Circular
Background and Strategic Context
The Company’s Ordinary Shares have been admitted to trading on AIM since its initial public offering (“IPO“) in August 2021, and during this time the Company has raised gross proceeds of c.£9.6 million through equity fundraises to support the ongoing requirements and growth of the business.
Following the Company’s promising preclinical safety and efficacy data for its lead product, BVX001, and continued progression and expansion of the target discovery platform, the Directors have continued to consider the Company’s opportunities to generate Shareholder value and the optimal capital structure to deliver this. The Directors believe that having access to a larger quantum of funding than has historically been available to the Company through its AIM listing would allow it to pursue a greater number of opportunities to reach key value inflexion points. In particular, the Directors believe that the BVX001 data achieved to date supports progression of BVX001 into the clinic, subject to significant funding requirements. The Company is also mindful that the optimal opportunity for a significant license/partner deal for BVX001 and/or other pipeline assets will be with a strengthened balance sheet, a higher valuation and potentially on the back of initial clinical efficacy data.
Notwithstanding the Company’s current intention to progress BVX001 into the clinic, the Board will continue to review all opportunities available to it to create Shareholder value.
The Directors believe that as a private company, BiVictriX may have access to a wider range of investors which could include specialist investors in the US with the potential opportunity to raise funds at a higher valuation than the current market capitalisation of the Company. The Directors have based this decision on a combination of factors, including: the Company’s current market capitalisation, the difficult equity market conditions for pre-revenue companies, the low trading liquidity of its Ordinary Shares, as well as the Group being at pre-clinical stage. These factors combined mean that the opportunity for significant value creation is currently tempered, and accordingly the Directors believe that the Cancellation is in the best interests of Shareholders. Further details as to the reasons for the Cancellation are set out in Paragraph 3 of this Part I below.
Following the Cancellation and Re-registration, the Company will continue to review the structure and composition of the business, the Board and the executive management team, to ensure the optimal corporate structure is in place to support the long-term success of the Company.
Process for, and principal effects of, the Cancellation
The Directors are aware that certain Shareholders may be unable or unwilling to hold Ordinary Shares in the event that the Cancellation is approved and becomes effective. Such Shareholders should consider selling their interests in the market prior to the Cancellation becoming effective. However, should the Cancellation become effective, the Company intends to implement a Matched Bargain Facility with a third party which would facilitate Shareholders buying and selling Ordinary Shares on a matched bargain basis following Cancellation.
Under the AIM Rules, the Company is required to give at least 20 clear Business Days’ notice of the Cancellation. Additionally, the Cancellation will not take effect until at least five clear Business Days have passed following the passing of the Cancellation Resolution. If the Cancellation Resolution is passed at the General Meeting, it is proposed that the last day of trading in the Ordinary Shares on AIM will be 10 September 2024 and that the Cancellation will take effect at 7:00 a.m. on 11 September 2024.
If the Cancellation becomes effective, SP Angel will cease to be the nominated adviser of the Company and the Company will no longer be required to comply with the AIM Rules.
Under the AIM Rules, it is a requirement that the Cancellation must be approved by Shareholders holding not less than 75 per cent. of votes cast by Shareholders at the General Meeting. Accordingly, the Notice of General Meeting, set out in at the end of the Circular, contains a special resolution to approve the Cancellation.
The principal effects of the Cancellation will include the following:
· as a private company, there will be no formal market mechanism enabling Shareholders to trade Ordinary Shares (other than any limited off-market mechanism provided by the Matched Bargain Facility), and no price will be publicly quoted for the Ordinary Shares;
· it is possible that, following the publication of this announcement, the liquidity and marketability of the Ordinary Shares may be significantly reduced, and their value adversely affected (however, as set out above, the Directors believe that the existing liquidity in the Ordinary Shares is, in any event, limited);
· the Ordinary Shares may be more difficult to sell compared to shares of companies traded on AIM (or any other recognised market or trading exchange);
· in the absence of a formal market and quoted price, it may be difficult for Shareholders to determine the market value of their investment in the Company at any given time;
· the regulatory and financial reporting regime applicable to companies whose shares are admitted to trading on AIM will no longer apply, albeit the Company will remain subject to the Takeover Code;
· Shareholders will no longer be afforded the protections given by the AIM Rules, such as the requirement to be notified of price sensitive information or certain events and the requirement that the Company seek shareholder approval for certain corporate actions, where applicable, including substantial transactions, reverse takeovers, related party transactions and fundamental changes in the Company’s business, including certain acquisitions and disposals;
· the levels of disclosure and corporate governance within the Company may not be as stringent as for a company quoted on AIM;
· the Company will no longer be subject to UK MAR regulating inside information and other matters;
· the Company will no longer be required to publicly disclose any change in major shareholdings in the Company under the Disclosure Guidance and Transparency Rules;
· SP Angel will cease to be nominated adviser to the Company;
· whilst the Company’s CREST facility will remain in place immediately post the Cancellation, the Company’s CREST facility may be cancelled in the future and, although the Ordinary Shares will remain transferable, they may cease to be transferable through CREST (in which case, Shareholders who hold Ordinary Shares in CREST will receive share certificates);
· stamp duty will be due on transfers of shares and agreements to transfer shares unless a relevant exemption or relief applies to a particular transfer; and
· the Cancellation and Re-registration may have personal taxation consequences for Shareholders. Shareholders who are in any doubt about their tax position should consult their own professional independent tax adviser.
The above considerations are not exhaustive, and Shareholders should seek their own independent advice when assessing the likely impact of the Cancellation on them.
For the avoidance of doubt, the Company will remain registered with the Registrar of Companies in England and Wales in accordance with, and subject to, the Companies Act, notwithstanding the Cancellation and Re-registration. The Resolutions to be proposed at the General Meeting include the adoption of the New Articles, with effect from the Re-registration. A copy of the New Articles can be viewed at www.bivictrix.com and is included at Appendix 1 to the Circular.
Transactions in the Ordinary Shares prior to and post the proposed Cancellation
Prior to the Cancellation
Shareholders should note that they are able to continue trading in the Ordinary Shares on AIM prior to the Cancellation.
Following the Cancellation
The Company is making arrangements for a Matched Bargain Facility to assist Shareholders to trade in the Ordinary Shares to be put in place from the date of the Cancellation, if the Resolutions are passed. The Matched Bargain Facility will be provided by JP Jenkins. JP Jenkins is an appointed representative of Prosper Capital LLP, which is authorised and regulated by the FCA.
Under the Matched Bargain Facility, Shareholders or persons wishing to acquire or dispose of Ordinary Shares will be able to leave an indication with JP Jenkins, through their stockbroker (JP Jenkins is unable to deal directly with members of the public), of the number of Ordinary Shares that they are prepared to buy or sell at an agreed price. In the event that JP Jenkins is able to match that order with an opposite sell or buy instruction, it would contact both parties and then effect the bargain (trade). Shareholdings remain in CREST and can be traded during normal business hours via a UK regulated stockbroker. Should the Cancellation become effective, and the Company puts in place the Matched Bargain Facility, details will be made available to Shareholders on the Company’s website at www.bivictrix.com.
The Matched Bargain Facility will operate for a minimum of six months after the Cancellation. The Directors’ current intention is that it will continue beyond that time, but Shareholders should note that it could be withdrawn and therefore inhibit the ability to trade the Ordinary Shares. Further details will be communicated to the Shareholders at the relevant time.
If Shareholders wish to buy or sell Ordinary Shares on AIM, they must do so prior to the Cancellation becoming effective. As noted above, in the event that Shareholders approve the Cancellation, it is anticipated that the last day of dealings in the Ordinary Shares on AIM will be 10 September 2024 and that the effective date of the Cancellation will be 11 September 2024.
Process for the Re-Registration
As set out above, following the Cancellation, the Directors believe that the requirements and associated costs of the Company maintaining its public company status will be difficult to justify and that the Company will benefit from the more flexible requirements and lower costs associated with private limited company status. It is therefore proposed to Re-register the Company as a private limited company. In connection with the Re-registration, it is proposed that the New Articles be adopted to reflect the change in the Company’s status to a private limited company. The principal effects of the Re-registration and the adoption of the New Articles on the rights and obligations of Shareholders and the Company are summarised in Part II of the Circular. A copy of the New Articles can be found at Appendix 1 to the Circular.
Under the Companies Act, the Re-registration and the adoption of the New Articles must be approved by Shareholders holding not less than 75 per cent. of votes cast by Shareholders at the General Meeting. Accordingly, the Notice of General Meeting set out at the end of the Circular contains a special resolution to approve the Re-registration and adopt the New Articles.
If the Cancellation Resolution and the Re-registration Resolution are approved at the General Meeting, an application will be made to the Registrar of Companies for the Company to be re-registered as a private limited company. Re-registration will take effect when the Registrar of Companies issues a certificate of incorporation on Re-registration. The Registrar of Companies will issue the certificate of incorporation on Re-registration when it is satisfied that no valid application can be made to cancel the Re-registration Resolution or that any such application to cancel the Re-registration Resolution has been determined and confirmed by the Court.
If the Resolutions are passed at the General Meeting, it is anticipated that the Re-registration will become effective before the end of September 2024.
Takeover Code
The Takeover Code applies to all offers for companies which have their registered offices in the United Kingdom, the Channel Islands or the Isle of Man if any of their equity share capital or other transferable securities carrying voting rights are admitted to trading on a UK regulated market or a UK multilateral trading facility or on any stock exchange in the Channel Islands or the Isle of Man.
The Takeover Code also applies to all offers for companies (both public and private) which have their registered offices in the United Kingdom, the Channel Islands or the Isle of Man and which are considered by the Panel to have their place of central management and control in the United Kingdom, the Channel Islands or the Isle of Man, but in relation to private companies only if one of a number of conditions is met, for example, if the Company’s shares were admitted to trading on a UK regulated market or a UK multilateral trading facility or on any stock exchange in the Channel Islands or the Isle of Man at any time in the preceding ten years.
If the Cancellation and Re-registration are approved by Shareholders at the General Meeting, the Company will be re-registered as a private company and its securities will no longer be admitted to trading on a regulated market or a multilateral trading facility in the United Kingdom. In these circumstances, the Takeover Code will only apply to the Company if it is considered by the Panel to have its place of central management and control in the United Kingdom, the Channel Islands or the Isle of Man. This is known as the “residency test”. In determining whether the residency test is satisfied, the Panel has regard primarily to whether a majority of a company’s directors are resident in these jurisdictions.
On the basis of the current composition and residency of the Directors, the residency test will be satisfied, therefore the Company is considered by the Panel to have its place of central management and control in the United Kingdom, the Channel Islands or the Isle of Man. Consequently, the Takeover Code will continue to apply to the Company following the Cancellation and the Re-registration subject to its terms until the later of:
· the date falling 10 years following the effective date of the Cancellation;
· the date falling 10 years after dealings and/or prices at which persons are willing to deal in any of the Ordinary Shares have been published on a regular basis for a continuous period of at least six months, whether via a newspaper, electronic price quotation system or otherwise;
· the date falling 10 years after any of the Ordinary Shares have been subject to a marketing arrangement as described in section 693(3)(b) of the Companies Act; or
· the date falling 10 years after the Company has filed a prospectus for the offer, admission to trading or issue of securities with the registrar of companies or any other relevant authority in the United Kingdom, the Channel Islands or the Isle of Man,
provided that, the Takeover Code may cease to apply earlier, if any changes to the composition of the Board results in the majority of the Directors not being resident in the United Kingdom, Channel Islands or Isle of Man.
Should the Takeover Code cease to apply to the Company in the future, Shareholders would not be afforded the protections provided by the Takeover Code. This includes the requirement for a mandatory cash offer to be made if either:
· a person acquires an interest in shares which, when taken together with the shares in which persons acting in concert with it are interested, increases the percentage of shares carrying voting rights in which it is interested to 30 per cent. or more; or
· a person, together with persons acting in concert with it, is interested in shares which in the aggregate carry not less than 30 per cent. of the voting rights of a company but does not hold shares carrying more than 50 per cent. of such voting rights and such person, or any person acting in concert with it, acquires an interest in any other shares which increases the percentage of shares carrying voting rights in which it is interested.
Before giving your consent to the Cancellation and the Re-registration, you may want to take independent professional advice from an appropriate independent financial adviser.
APPENDIX II
EXPECTED TIMETABLE OF PRINCIPAL EVENTS
Event Time and/or date(1)(2)Publication and posting of the Circular 12 August 2024Latest time for receipt of proxy appointments in respect of theGeneral Meeting 11:30am on 27 August 2024General Meeting 11:30am on 29 August 2024Announcement of result of General Meeting 29 August 2024Last day of dealings in Ordinary Shares on AIM 10 September 2024Cancellation of admission of the Ordinary Shares to trading on AIM 7:00am on 11 September 2024Matched Bargain Facility for Ordinary Shares commences 11 September 2024Expected re-registration as a private companyweek commencing 23 September 2024Notes:
(1) All of the times referred to in this announcement refer to London time, unless otherwise stated.
(2) The timetable above assumes that the Resolutions set out in the Notice of General Meeting are passed. Events listed in the above timetable following the General Meeting are conditional on the Resolutions being passed at the General Meeting without amendment.
(3) Each of the times and dates in the above timetable is subject to change. If any of the above times and/or dates change, the revised times and dates will be notified to Shareholders by an announcement through a Regulatory Information Service.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
August 12, 2024
The Group is pleased to report growth and a return to profitability as part of its strategic turnaround, which is delivering sustainable, progressive improvements across its operating divisions.
Financial highlights
*Adjusted EBITDA is Operating Profit excluding the impact of exceptional items, other net gains, fair value gains on derivatives, depreciation, amortisation and equity-settled share-based payment charges.
Operational highlights
The Group’s turnaround has been delivered following a comprehensive strategic review of the organisation and its four operating divisions, Dunamis, Maintech Power, Fulcrum (Multi-Utility Operations) and Fulcrum (AssetOwnership):
The Group’s turnaround and positive progress continues to be supported by its Major Investors, with the existing Facility Agreement amended and extended in the year. The Group is grateful for this ongoing support whilst it continues on its path of profitable growth.
Divisional overview and performance
Dunamis reports significant growth as it strengthens position in renewable energy sector
Growing demand for Maintech Power’s specialist expertise delivers improved profitability
Positive progress and recurring revenue opportunities for multi-utility operations and asset ownership divisions
Outlook
The Group is delighted with the positive progress made in the year and these results provide a stronger platform for continued, sustainable growth.
The Group offers specialist services with increasing demand in markets mandated for growth, which is accelerating development, performance, and access to future opportunities. The renewable energy industry, in particular, is providing significant opportunities as the UK drives towards net-zero. This, combined with the advent of a new government with an ambitious housebuilding agenda, and the resurrection of onshore wind farm developments, presents significant and exciting opportunities for the Group.
The Group is focused on its core strengths in sectors where it is very experienced and has increased the efficiency of its central operations. This has been fundamental to the Group’s success and will be central to the delivery of its five-year strategy of growth and profitability.
Commenting on the full year results, Lindsay Austin, Fulcrum CEO, said:
The Group’s leadership team is exceptionally proud of the turnaround we’ve achieved, and the contribution made by our excellent people, that has delivered a return to profitability.
The strong, collaborative approach we have brought to the Group, with the full support of our highly engaged major shareholders, has ensured the outcomes of the strategic review were successfully implemented and have set us on a path to sustainable, progressive improvements.
We have optimised the expertise within the Group, delivered cost improvements and efficiencies through streamlined processes and allowed our divisions the autonomy to pursue and secure new relationships and build on long-term partnerships.
The Group is operating in booming, high-growth markets, offering in-demand specialist services, which is accelerating their growth and access to future opportunities.
August 8, 2024
Released : 01/08/2024 07:00
RNS Number : 6863Y
BiVictriX Therapeutics PLC
01 August 2024
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
BIVICTRIX THERAPEUTICS PLC
(“BiVictriX” or “the Company” or “the Group”)
Interim Results for the Six Months Ended 30 June 2024
Alderley Park, 1 August 2024 – BiVictriX Therapeutics plc (AIM: BVX), a drug discovery and development company applying an innovative, proprietary approach to develop a new class of highly selective, next generation cancer therapeutics, bispecific antibody drug conjugates (Bi-Cygni® ADCs), which exhibit superior potency, whilst reducing treatment-related toxicities, today announces its unaudited interim results for the six months ended 30 June 2024.
Highlights, including post period:
· Safety data supports progression of BVX001 into the clinic. Data compares favourably to approved ADCs with same linker and cytotoxic payload and informs clinical dose selection ahead of final IND-enabling studies
· BVX001 granted Orphan Drug Designation by the FDA for the treatment of AML, providing commercial and regulatory benefits
· Positive INTERACT meeting with the FDA for BVX001, providing efficient route forward for IND submission
· Innovate UK grant provides non-dilutive capital to accelerate BVX002, our second drug candidate which targets solid tumours
· Continued progression and expansion of target discovery platform with Bi-Cygni® target pairs discovered in over ten different cancer types, including lung, breast and bladder cancer
· Cash and cash equivalents of £1.7 million as at 30 June 2024 (£1.9 million at 30 June 2023)
Tiffany Thorn, Chief Executive Officer of BiVictriX Therapeutics plc, commented: “In the first half of the year, BiVictriX has continued to execute on its strategy of discovering and developing novel, potentially best-in-class bispecific ADCs targeting multiple cancer types. Our lead product, BVX001, has now shown positive preclinical safety and efficacy data in multiple in vivo models, highlighting its potential for improved efficacy and superior cancer selectivity compared with existing AML agents. I am pleased with our initial interaction with the FDA, as we look to progress BVX001 into the clinic. Furthermore, we have made significant progress in the solid tumour space through the identification of a lead for our solid tumour programme, BVX002, together with the expansion of our target discovery library to include some of the largest commercial cancer types, including lung and breast cancers.”
For more information, please contact:
BiVictriX Therapeutics plcTiffany Thorn, Chief Executive OfficerMichael Kauffman, Non-Executive Chairman Email: info@bivictrix.com SP Angel Corporate Finance LLP (NOMAD and Broker)About BiVictriX Therapeutics plc
BiVictriX (AIM: BVX) is an emerging biotechnology company leveraging clinical experience and its proprietary discovery engine to advance a new class of highly cancer-selective, next-generation precision cancer therapies in one of the fastest-growing markets in oncology. BiVictriX’s first-in-class Bi-Cygni® Antibody Drug Conjugates (“ADCs”) combine superior efficacy with substantially improved cancer-selectivity and safety to provide opportunities for prolonged dosing and greater efficacy in the clinic. The Company is advancing its pipeline to deliver the future of cancer care across a broad range of haematological and solid cancer indications in areas of high unmet medical need.
Find out more at www.bivictrix.com and connect with us on LinkedIn and Twitter @BiVictriX.
Chairman’s Statement
I am pleased to report on our encouraging progress in the first half of 2024, as we continue our path to becoming a clinical stage biotech company with a novel and differentiated therapeutic pipeline of bispecific Antibody Drug Conjugates (“ADCs”) with enhanced selectivity for tumour over normal cells.
The BiVictriX team continues to expand our potential with a growing portfolio of proprietary bispecific ADCs targeting both solid and liquid tumours. Our unique approach with our proprietary Bi-Cygni® platform enables us to target novel cancer-specific twin antigen fingerprints, with bespoke tuneable, ADC therapeutics.
Our lead programme and primary focus, BVX001, targets Acute Myeloid Leukaemia (“AML”), the most aggressive form of adult leukaemia, a disease with dismal clinical outcomes and poor survival rates.
During the period, we reported further positive preclinical safety and efficacy results in established in vivo models and using AML cells directly from patients. Our data package strongly supports the progression of BVX001 into the clinic, and we believe we have an emerging profile that could be best-in-class targeting neoplastic cells whilst sparing normal myeloid cells, including disease-fighting neutrophils. This has been further supported by initial positive interactions with the FDA and with the recent grant of Orphan Drug Designation for BVX001.
Consistent with our identification of BVX002 for the treatment of ovarian cancer, our wider platform has the ability to address over ten different cancer types. We have recently expanded our proprietary twin-antigen target library to include novel, cancer-specific target pairs across a number of commercially meaningful indications, including lung, breast and bladder cancer, areas of significant and growing commercial interest.
During the reporting period and aligned with our focus, we have prioritised our Research & Development (“R&D”) capabilities, with the Company investing £1.2 million in the first half of the year.
Outlook
Looking ahead, with the strong fundamentals BiVictriX has built, we plan to expand our Intellectual Property portfolio and target discovery activities to build a robust library of commercially attractive novel therapeutic leads, while continuing to progress BVX001 and BVX002 towards the clinic.
The Directors believe BiVictriX has one of the leading platforms in the bispecific ADC space and needs to be able to maintain competitiveness in a rapidly expanding landscape by moving BVX001 as expeditiously as possible into the clinic and demonstrating anti-leukemic activity and tolerability, as well as to progress our other programmes at a competitive rate.
With recent precedents in AML for granting accelerated / conditional approval, we believe there is a substantial opportunity to generate additional shareholder value. As such, the Directors will continue to assess the various commercial and strategic business development opportunities available to them with regards to both the future funding and growth of the Company.
Conclusions
In summary, we have made encouraging progress with our R&D pipeline. These accomplishments, coupled with the promising in vivo safety and efficacy data on BVX001 and the development of our lead drug candidate in our solid tumour programme, BVX002, have established a solid foundation for BiVictriX, setting us up to take advantage of future opportunities.
I would like to extend my gratitude to Tiffany Thorn, our CEO, for her leadership and to the entire team for their diligent work over the past six months, which has been instrumental in establishing BiVictriX as a prominent biotech company. In addition, I’d like to thank the BiVictriX Board for their diligence in helping the Company advance. I also express my appreciation to our shareholders for their continued support, and I eagerly look forward to updating the shareholders on our progress in the year ahead.
Michael Kauffman, M.D., Ph.D.
Chairman of BiVictriX Therapeutics plc
Chief Executive Officer’s Report
The year to date has been a period of significant progress towards advancing our lead assets towards the clinic and establishing BiVictriX as a global leader in the bispecific ADC space. We have once again met our challenging R&D milestones and delivered highly compelling data across our lead AML and solid tumour assets whilst prudently managing our capital. We have placed an increased and significant emphasis on our corporate activities during the period, to take advantage of the continuing global commercial interest in novel ADC approaches by large pharma and other biotech companies, as our technology gains greater visibility and appreciation.
Our R&D activities have centred upon the progression of BVX001 towards clinical readiness, accelerating our path to the clinic for BVX002, and scaling our drug discovery platform to address a wider range of solid tumours. We continue to strengthen and maintain our Intellectual Property portfolio and are very encouraged by our initial positive interactions with the FDA and leading Key Opinion Leaders (“KOLs”) in the AML space, highlighting a clear path forward for BVX001. I continue to work closely with our executive team, internal R&D teams and Board to achieve key value-enhancing milestones for our business, with a key focus on value creation for our shareholders.
Meaningful scientific progress
Over the past six months, we have continued to execute on our development plan for our lead therapeutic asset, BVX001. We have met several key preclinical milestones which are essential for progressing this molecule towards the clinic.
Since nominating our clinical candidate in June 2023, based on a positive in vivo efficacy profile in murine models of disease, we have been able to further demonstrate the potential efficacy of this therapeutic across a panel of primary samples from patients with AML. The preclinical profile thus far observed with BVX001 is consistent with the potential to result in deeper and more durable regressions with markedly reduced activity against normal infection-fighting white blood cells, thereby offering the possibility of reducing potentially fatal toxicity for patients with AML and related diseases.
Further to this, in June of this year, we reported data for BVX001 showing an in vivo safety profile in an established rodent model of toxicity supporting progression to final IND-enabling studies and towards clinical studies. This repeat dose finding preclinical study assessed the tolerability, toxicity and toxicokinetics of BVX001 at 10, 30 and 55mg/kg given intravenously, and studied the effects on standard behavioural and clinical endpoints (including haematology and serum chemistry) and macro/microscopic changes in a number of organs and tissues. BVX001 was tolerated across the dose-range with adverse clinical and anatomic pathology changes primarily observed only at the high dose level, far in excess of doses required for anti-leukaemic activity as discussed below. Ocular toxicity was not observed at mid to low doses, and affects at higher doses were graded as minimal with no severe pathological changes seen at all doses tested.
Importantly, if converted to human equivalent doses, the doses tested here were up to 11-times higher than equivalent doses used in a mouse xenograft study that showed significant tumour regressions (up to 97% versus control) in a hard-to-treat AML tumour model, as we reported in 2023. These data provide us with further confidence in the tolerability of this drug candidate at doses that confer marked anti-leukemic activity in the preclinical models. Together, they highlight the clear benefits of the Bi-Cygni® platform versus the de facto (single antigen) ADC approach, where the safety window for killing tumour versus normal cells reported is typically minimal.
We are greatly encouraged by these data as they round out our comprehensive preclinical package. These data will be submitted for formal presentation at forthcoming medical meetings, as part of our strategy to showcase our data to a wider audience.
In total, our preclinical studies demonstrate the significant potential of BVX001 as an effective treatment for AML with a potentially higher therapeutic window as compared to existing therapeutic options and support our plans to progress BVX001 into the clinic. In addition, progress with our lead bispecific ADC validates the wider Bi-Cygni® platform approach to offer the ability for improved cancer cell-specific targeting leading to the potential for reduced serious side effects across a broad range of cancer indications.
Expanding and accelerating our BiVictriX Solid Tumour pipeline
Solid tumours represent the largest commercial opportunity for ADC therapeutics, which aligns to BiVictriX’s increased activities in this space during 2023 to 2024. Our lead solid tumour asset, BVX002, is progressing well, and we were delighted to receive an Innovate Grant from the UK Government in recognition of the drug’s potential in the ovarian cancer setting. This grant of c. £0.4 million enables us to perform key preclinical work as we progress our plans towards filing an IND for BVX002.
Additionally, we have expanded our Bi-Cygni® target pair library with the identification of novel and proprietary, cancer-specific antigen pairs across ten different cancer types, including breast and lung cancers which represent some of the largest commercial opportunities. Our plans are to develop our solid tumour pipeline to provide the Company with future partnership opportunities.
Positive initial FDA interactions
During the first half of 2024, we concluded our first successful interactions with the FDA, the key regulatory body in the United States, where we recently received confirmation of grant of Orphan Drug Designation status for BVX001, providing significant potential patent exclusivity and regulatory benefits to BiVictriX as we progress the candidate towards clinical studies. Further to this, we have also received positive feedback from the FDA via the INTERACT meeting, providing initial support for our plans for an efficient path to IND for BVX001. We now head towards our IND filing for BVX001 with increasing confidence.
Business development
We have continued to build key external relationships over the period, with an aim of establishing and maintaining a network of connections with academia, KOLs, other clinicians, regulators and industry partners. There has been much activity across all these fronts in 2024 to date, as we benefit from the increasing acceptance of ADCs as a key component of cancer therapy in the future. Ongoing and further work with these key partners will provide multiple opportunities for future manufacturing, clinical and commercialisation alliances to optimise the value potential of our entire business.
We have attended major international scientific and investor conferences to continue building on this network and to highlight our next-generation precision ADC approach. Notably, we attended the European Hematology Association (EHA) meeting in May 2024, securing meetings with many global leaders in the AML space. These relationships are key to optimise our clinical trial design and ensure we are working with leading physicians to bring our product to patients.
Financial performance
The Groups’s loss after tax for the period was £1.3 million (H1 2023: £1.2 million), reflecting investment in R&D of £1.2 million (H1 2023: £1.1 million) and administrative expenses of £0.4 million (H1 2023: £0.3 million).
The Group closed the period with a cash balance of £1.7 million at 30 June 2024 (30 June 2023: £1.9 million). Excluding the manufacturing and clinical trial costs for BVX001, the Company currently has sufficient capital to funds its working capital requirements into Q2 2025.
Summary and outlook
BiVictriX is at a key juncture having achieved much success from our novel technology with prudent capital utilisation. We are proud of our progress in bringing our lead asset all the way from concept to “IND ready”, at a fraction of the cost of our peers, prioritising R&D expenditure towards key data that will drive value in BiVictriX. As we move towards obtaining clinical data across our portfolio, we believe we are well placed to scale our activities to broaden our pipeline further. The increasing breadth of BiVictriX and the ongoing interest in ADCs as a therapeutic class provides a significant tailwind for our business.
I am encouraged by the continued progress made in the period, showcasing the advantages of our novel therapeutic approach and believe that the progression of our lead asset to reach early clinical efficacy data will help to ensure the Company is well placed to feature on the global ADC stage, as a future driver of this technology. Over the next period and beyond, I remain fully committed to our key business goals, including identifying opportunities to accelerate the Company’s growth through partnerships and alliances, and I look forward to achieving the next key value-enhancing milestones, with a primary focus on the acceleration of BVX001 into clinical trials in AML and related conditions, as well as expansion into the solid tumour space initially with BVX002.
I would like to thank the entire BiVictriX team and Board for their hard work in 2024 to date and express my gratitude to all of our existing shareholders for their continued support, belief and confidence in BiVictriX’s future as a global leader delivering next generation, highly targeted cancer therapeutics.
Tiffany Thorn,
Chief Executive Officer and Founder of BiVictriX Therapeutics plc
BiVictriX Therapeutics plc
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
Statement of Comprehensive Income
Notes6 Months Ended30 Jun 2024£’0006 Months Ended30 Jun 2023£’000Year Ended31 Dec 2023£’000 UnauditedUnauditedAuditedOther income366––Research and development(1,186)(1,051)(2,047)General and administrative(424)(293)(904)Share based compensation5(65)(46)(74)Total operating expenses(1,675)(1,390)(3,025)Operating loss(1,609)(1,390)(3,025)Finance income16–22Loss on ordinary activities before taxation(1,593)(1,390)(3,003)Taxation296219458Loss for the period(1,297)(1,171)(2,545) Basic loss per share (pence)4(1.79)(1.77)(3.50)Diluted loss per share (pence)4(1.79)(1.77)(3.50)BiVictriX Therapeutics plc
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
Statement of Financial Position
30 June 2024£’00030 June 2023£’00031 Dec 2023£’000 UnauditedUnauditedAuditedAssets Non-current assets Property, plant and equipment390655476Total non-current assets390655476Current assets Trade and other receivables210224144Current tax receivable692674396Cash and cash equivalents1,6891,9043,279Total current assets2,5912,8023,819Total assets2,9813,4574,295Liabilities and equity Current liabilities Trade and other payables473214496Lease liabilities116195128Total current liabilities589409624Non-current Liabilities87216134Total Liabilities676625758Equity Ordinary shares825661825Share premium13,93912,05213,939Share based compensation397397425Warrant reserve737373Merger reserve(2,834)(2,834)(2,834)Retained (deficit)/profit(10,095)(7,517)(8,891)Total equity attributable to equity holders of the parent2,3052,8323,537Total liabilities and equity2,9813,4574,295BiVictriX Therapeutics plc
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
Consolidated Statement of Changes in Equity
Ordinary shares£’000SharePremium£’000Merger reserve£’000Share based compensation£’000Warrant reserve £’000sRetained deficit£’000 Total£’000Balance at 31 December 202266112,052 (2,834)35173 (6,346)3,957Total comprehensive expense for the period––––– (1,171)(1,171)Transactions with owners Share option grant–––46– –46Total transactions with owners–––46– –46Balance at 30 June 202366112,052(2,834)39773 (7,517)2,832Total comprehensive expense for the period––––– (1,374)(1,374)Transactions with owners Share issue – cash1641,969––––2,133Expense of share issue–(82)––––(82)Share based compensation–––28– –28Total transactions with owners–––28– –28Balance at 31 December 202382513,939(2,834)42573 (8,891)3,537Total comprehensive expense for the period––––– (1,204)(1,204)Transactions with ownersShare based compensation–––65– –65Share based compensation – lapsed options–––(93)– –(93)Total transactions with owners–––(28)– –(28)Balance at 30 June 202482513,939(2,834)39773 (10,095)2,305BiVictriX Therapeutics plc
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
Statement of Cash Flows
Period ended 30 Jun 2024 £’000Period ended 30 Jun 2023 £’000Year ended 31 Dec 2023 £’000 UnauditedUnauditedAuditedCash flows from operating activitiesLoss before taxation(1,593)(1,390)(3,003)Depreciation and amortisation9076165Share based compensation6546 74Finance costs(9)–(8)(1,447)(1,268)(2,769)Changes in working capital (Increase)/decrease in trade and other receivables(66)–80Increase/(decrease) in trade and other payables(23)45213Cash used in operations(89)45293Taxation received––516Net cash used in operating activities(1,536)(1,223)(1,960)Cash flows (used in)/generated from investing activities Acquisition of tangible fixed assets(4)(160)(5)Interest received16–22Net cash (used in)/generated from investing activities12(160)17Cash flows from financing activities Proceeds from issue of shares––2,133Issue costs––(82)Repayment of lease liabilities(66)–(116)Net cash generated from financing activities(66)–1,935Movements in cash and cash equivalents in the period(1,590)(1,383)(8)Cash and cash equivalents at start of period3,2793,2873,287Cash and cash equivalents at end of period1,6891,9043,279BiVictriX Therapeutics plc
Notes to the financial information
1. Company Information
BiVictriX Therapeutics plc (BiVictriX’ or ‘the Company’) is a public limited company incorporated in England and Wales. The address of its registered office is Mereside, Alderley Park, Alderley Edge, Macclesfield, England, SK10 4TG and the registered company number is 13470690.
The principal activity of the Company is research and experimental development of pharmaceutical products.
2. Significant Accounting Policies and Basis of Preparation
The consolidated financial statements have been prepared in accordance with United Kingdom International Financial Reporting Standards (‘IFRS’) as adopted by the UK, IFRIC interpretations and the Companies Act 2006 applicable to companies operating under IFRS.
These interim financial statements do not include all the information required for a complete set of financial statements prepared in accordance with IFRS Standards. However, selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the Group’s financial position and performance since the last annual consolidated financial statements.
The financial information provided for the six-month period ended 30 June 2024 is unaudited, however, the same accounting policies, presentation and methods of computation have been followed in these interim financial statements as those which were applied in the preparation of the Group’s annual consolidated financial statements for the year ended 31 December 2023.
These unaudited interim financial statements were authorised for issue by the Company’s Board of Directors on 31 July 2024.
The financial statements are presented in Sterling (£) and rounded to the nearest £000. This is the predominant functional currency of the Group and is the currency of the primary economic environment in which it operates. Foreign transactions are accounted in accordance with the policies set out below.
The nature of the Group’s operations mean that recorded financial performance is not seasonal or cyclical in nature.
Going concern
In the normal course of business, the Directors regularly review rolling cash flow forecasts. The review of financial forecasts and cash flows looking at least 12 months from approval of these financial statements includes levers and controls which could be applied, if necessary.
The Board has considered ongoing international conflicts and the impact that they may have on worldwide supplies; together with foreign exchange risk and the reducing inflationary outlook. These risks are closely monitored as part of controlled, defined expenditure to meet business objectives.
Operational cashflows focus on planned research and development activities to advance the Group’s lead and pipeline programmes. The timing and quantum of this expenditure is under the control and direction of management with oversight provided by the Board.
After considering cash flow forecasts and associated risks, the Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing these unaudited financial statements.
At 30 June 2024, the Group had cash and cash equivalents of £1.7 million (30 June 2023: £1.9 million).
Standards, interpretations and amendments to published standards not yet effective
The Directors have considered those standards and interpretations, which have not been applied in these financial statements, but which are relevant to the group’s operations, that are in issue but not yet effective and do not consider that they will have a material effect on the future reported performance, position of disclosure of the Group.
Government grants
UK government grants are for named projects and provide reimbursement of specific costs incurred on these projects. The grants are paid after each reporting period when the claim is submitted. The administering body has the right to request information on any items included in each grant claim and to request an Independent Auditor’s report.
There are no clawback provisions relating to the grants as they are not paid until after the relevant expenditure has been incurred and agreed, and this is the only condition.
Revenue-based grants have been credited to the statement of comprehensive income in the period to which they relate and reported as other income.
Research and development expenditure
Expenditure on pure and applied research are charged to the profit and loss account in the year in which it is incurred. Development costs are charged to the profit and loss account unless it can be demonstrated that the costs represent an intangible asset which meets all the criteria for capitalisation set out in para 57 of IAS38. As BiVictriX’s lead programme is in the early stages of clinical development, all costs are expensed to the income statement.
Share–based compensation
The Group has issued share options to certain employees and Directors. Warrants have been issued to certain external third parties. Such equity-settled share-based payments are measured at fair value at the date of grant and expensed on a straight-line basis over the vesting period, along with a corresponding increase in equity.
At each reporting date, the Group revises its estimate of the number of equity instruments expected to vest as a result of the effect of non-market based vesting conditions. The impact of any revision is recognised in the Consolidated Statement of Comprehensive Income, with a corresponding adjustment to equity reserves.
Share based payment charges
In the period, share options were issued to certain employees and a Black-Scholes model was used to calculate the share-based payment charge.
The calculation involves estimates and judgements to establish the appropriate inputs to be entered into the model, including interest rate, dividend rate, exercise restrictions and behavioural considerations.
The total charge in the period was £65,392 (H1 2023: £46,239).
3. Other Income
Other operating income of £66,107 (H1 2023: Nil) was derived from the first quarter of a £0.4 million Innovate UK grant, which was awarded on 4 June 2024.
4. Loss per Share
Basic loss per share is calculated by dividing the loss for the period attributable to equity holders by the weighted average number of ordinary shares outstanding during the year.
For diluted loss per share, the loss for the period attributable to equity holders and the weighted average number of ordinary shares outstanding during the period is adjusted to assume conversion of all dilutive potential ordinary shares.
At 30 June 2024, the Group had 10,533,616 (30 June 2023: 8,804,184) share options, warrants and subscriptions outstanding.
The calculation of the Group’s basic and diluted loss per share is based on the following data:
Period ended30 Jun2024£‘000Period ended30 Jun2023£’000Year ended31 Dec2023£’000Loss for the period attributable to equity holders for basic loss and adjusted for the effects of dilution(1,297)(1,390)(2,545)Period ended30 Jun2024 Period ended30 Jun2023 Year ended31 Dec2023 Weighted average number of ordinary shares for basic loss per share72,645,07566,115,17172,645,075Effects of dilution:Share options – – –Weighted average number of ordinary shares adjusted for the effects of dilution72,645,07566,115,17172,645,075Period ended30 Jun2024£Period ended30 Jun2023£Year ended31 Dec2023£Loss per share – basic and diluted(1.79)(1.77)(3.50)The loss and the weighted average number of ordinary shares for the period ended 30 June 2024 and 30 June 2023 used for calculating the diluted loss per share are identical to those for the basic loss per share. This is because the outstanding share options would have the effect of reducing the loss per ordinary share and would therefore not be dilutive under the terms of International Accounting Standard (‘IAS’) No 33.
5. Share option grants
The Group operates an Enterprise Incentive (EMI) share option plan and an Employee Related Share (ERS) scheme for employees, together with a non-employee share option plan. Options are granted for nil consideration and are exercisable at a price which is determined on the date of the grant.
Directors and employees hold options to subscribe for shares in BiVictrix Therapeutics plc in accordance with the rules of the Group share option plans. The maximum number of Ordinary shares which may be issued under the Group’s share option plans is 12,245,050. At 30 June 2024, this share option pool represented 14.8 per cent of the issued share capital in BiVictrix Therapeutics plc.
In addition to the Company share option pool of 12,245,050 share options, Tiffany Thorn holds 2,023,500 share options arising from pre-existing share options which were exchanged at Admission in August 2021, for new options over ordinary shares in BiVictriX Therapeutics plc.
At 30 June 2024, the Company had 9,283,334 share options under grant. The number of shares subject to options, the periods in which they were granted and the period in which they may be exercised are given below:
Exercise priceAt 31 Dec2023GrantedLapsedAt 30 Jun2024Date from which exercisableExpiry date0.117365,295––365,29511 Aug 20213 Aug 20310.2003,290,875–(408,170)2,882,70511 Aug 20213 Aug 20310.2002,449,000––2,449,00009 Feb 20223 Aug 20310.2001,632,680–(1,632,680)–11 Aug 20213 Aug 20310.250846,334–846,33406 Jun 202312 Dec 20320.20540,000–(40,000)–14 Sep 202313 Sep 20320.17050,000––50,00022 Dec 202321 Dec 20320.15070,000(30,000)40,00010 May 20249 May 20330.1175–2,650,000–2,650,00027 Mar 202526 Mar 20348,744,184 9,283,334Of the 9,283,334 options in issue at 30 June 2024, 8,483,334 were issued to employees including 4,036,334 options granted under the EMI scheme and 4,447,000 granted under the ERS. Option grants under the non-employee share option plan were 800,000.
The total charge in the period relating to share based compensation was £65,392 (H1 2023: £46,239).
6. Post balance sheet events
There were no post balance sheet events to report.
7. Copies of the interim report
Copies of the interim report are available on the Company’s website at www.bivictrix.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom
. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
August 1, 2024
Sixth Edition
No Summer Holidays Here.
This month we announced another new client – Superdry (Well done to all the team), alongside this we saw the announcements from Sondrel, i(x) Net Zero and Destiny Pharma Limited who intend to join JPJ very soon.
We are delighted to announce the following new admissions to JP Jenkins:
Superdry PLC (JPJ: SDRY)
Superdry announced its shares have been admitted to trade on JP Jenkins. Superdry plc designs, produces, markets, and sells clothing, footwear, and accessories primarily under the Superdry brand for men and women in the United Kingdom and internationally. It operates through Retail and Wholesale segments. The Company operates through stores, concessions, various Internet sites, multi-brand independents and distributors, franchise, and license stores.It operates 213 owned, and 410 franchised and licensed stores; and 18 international websites. The company was formerly known as SuperGroup Plc and changed its name to Superdry plc in January 2018. Superdry plc was founded in 1985 and is headquartered in Cheltenham, the United Kingdom.
Julian Dunkerton, Co-Founder & CEO of Superdry PLC said,
Veronika Oswald, Commercial Director of JP Jenkins Ltd commented:
The indicative pricing for the ordinary shares (ISIN: GB00B60BD277), as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/).
To read more, please see the full EQS below:https://lnkd.in/eaR2t4b9
Destiny Pharma (AIM:DEST)
Announced its intentions to join JP Jenkins to trade its ord shares, post the AGM if approved. Please see the full RNS below:
Sondrel (AIM:SND)
Announced its intentions to join JP Jenkins to trade its ord shares, post the AGM if approved. Please see the full RNS below:
https://ir.sondrel.com/investors/news/archive/2024/220724
Issuer news – Check out the latest updates and news from our clients:
Cafédirect PLC (JPJ: CDR):
Cafe Direct recently released Progress Report. In 2023, they doubled in size overnight with the purchase of Bewley’s UK. One new roastery. Two new coffee brands. Hundreds of venues selling our coffee across the UK. Millions of farmers earning enough to feed their families. Take a look at some of their highlights from last year below.
Read the full report here: https://lnkd.in/eGEci-kK
e-therapeutics PLC (JPJ: ETX):
Earlier this month, e-therapeutics PLC announced its completion of a £28.9Million fundraise.
e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, is pleased to announce that it has completed its £28.90 million fundraise by way of a subscription by funds managed by M&G Investment Management Limited and Richard Griffiths and his controlled undertakings, both existing shareholders of the Company. The Subscription by M&G was conditional upon clearance under the National Security and Investment Act 2021, which is now complete.
To read more, please see the full EQS below:https://lnkd.in/emAfSZzf
Redx Pharma (JPJ: RED):
Redx Pharma released their latest update – “Redx Reports Encouraging Zamaporvint (RXC004) Phase 2 Combination Data in MSS mCRC at ESMO GI Congress Supporting Genetic Selection Hypothesis in Hard-to-Treat GI Cancers”
To read the full report, please click the link below: https://lnkd.in/e2GY6BpJNatalie
Liquidity Lens UK Business Angels Association
Our Head of Corporate Mason Doick took part in a Friday Focus session webinar with UKBAA to discuss – ‘Are secondary markets a pathway to Liquidity for Early-Stage Investors?’.
With first-time funding rounds at an all-time low, early-stage investors are increasingly seeking exits so that they can recycle capital back into the UK’s high-potential innovators.
It was a very enjoyable and interesting session, with tens of questions from the 60+ audience that attended the live seminar. The recording is on the UKBAA centre of excellence for their members.
UKBAA Annual Awards Dinner
Some of the JP Jenkins team attended the UKBAA awards this year, delighted to meet and catch up with friendly faces from across the industry in capital markets and the private sphere.
Well done to all the winners and runners up!
CISI events:
JP Jenkins took part in a three part series with CISI talking all things liquidity. Last week was our last session with them, focusing on the admission process for Issuers / companies joining the platform and the importance of ESG / Investor Relations featuring Veronika Oswald (Commercial Director at JP Jenkins).
Charity:
Last week our team here at JP Jenkins, helped with donating prizes to a sponsored charity raffle, raising over £700, to raise funds for Glasgow Children’s Hospital Charity.
Learning 101 with JP Jenkins – Check out our latest videos here on:
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
July 28, 2024
Lexington Gold (AIM: LEX), the gold exploration and development company with projects in South Africa and the USA, is pleased to announce that the Company’s existing unlisted 10 pence warrants expiring on 20 July 2026 (the “2026 Warrants”).
JP Jenkins provides a securities matching venue for unlisted or unquoted assets in companies, thereby enabling, inter alia, warrant holders to buy and sell their warrants on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited which is an Appointed Representative of Prosper Capital LLP (FRN453007).
Holders of the 2026 Warrants who wish to trade their securities can do so and place limits via their stockbroker with trades conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer during normal business hours.
Indicative pricing for the 2026 Warrants (ISIN: BMG5479L1155), as well as a transaction history, will be made available on JP Jenkins’ website.
Ed Nealon, Lexington Gold’s Non-Executive Chairman, commented: “We are delighted to announce that the warrants issued as part of our July 2023 fundraise will now be capable of being traded on JP Jenkins’ platform. This facility provides our warrant holders with an efficient and accessible venue to potentially trade their securities. The JP Jenkins platform provides transparency and convenience such that our warrant holders can trade with confidence.”
To learn more, read the full RNS here.
July 20, 2024
Fifth Edition
This month we announced another new client (Lexington Gold Warrants), saw the announcement of Superdry PLC joining JPJ and lots of celebratory drinks / awards. Hoorah!
We are delighted to announce the following new admissions to JP Jenkins:
Lexington Gold (JPJ: LEXW):
LEX announces its Warrants (https://lnkd.in/dCnT99cx) have been admitted to trade on JP Jenkins securities matching venue.Lexington Gold, the gold exploration and development company with projects in South Africa and the USA, is pleased to announce that the Company’s existing unlisted 10 pence warrants expiring on 20 July 2026 (the “2026 Warrants”).
To learn more, read the full RNS below:https://lnkd.in/dCnT99cx
Issuer news – Check out the latest updates and news from our clients:
Cafédirect PLC (JPJ: CDR):
Cafedirect released an announcement this week that shares can be bought and sold on JP Jenkins. They have gone live on our venue and the shares are tradable electronically, with CREST settlement. To see the full post, click here: https://lnkd.in/eGBSdQ8g
e-therapeutics PLC (JPJ: ETX):
e-therapeutics PLC released their audited results for the year ended 31 January 2024 and provided an update on recent pipeline progress.
Post period operational highlights:
Please find the full results below:https://www.etherapeutics.co.uk/news-and-media/press-releases/e-therapeutics-announces-pipeline-updates-and-final-year-results-year-end-january-2024/
Thrive Renewables PLC (JPJ: THRV):
Our client Thrive Renewables has just released their 2023 Annual Results. They run regular monthly auctions on JPJ, transacting every month and providing shareholders with pivotal liquidity and reporting.
Please see the full report below: https://www.thriverenewables.co.uk/news/2024/05/thrive-announces-13-6-million-operating-profit-for-2023-with-12-3-million-of-capital-allocated-to-build-new-clean-energy-projects
Sportech (JPJ: SPO):
One of our clients, Sportech (JPJ:SPO) released their FY 2023 Pre-Results Announcement, with the Full Annual Results coming on the 5th July 2024. Sportech, an international betting and hospitality business is pleased to announce a pre-close trading update in respect of the financial year ended 31 December 2023 (‘FY 2023’).
Full release below:https://lnkd.in/dAEdFQwR
Carlisle Support Services (JPJ: CSS):
Our client Carlisle Support Services enjoyed their latest event this month – Rail Safety Week! Carlisle Support Services is a leading supplier of outsourced workforce solutions to chosen niche markets. They provide Security, Cleaning, Events and Retail Merchandising services across the UK and Ireland. Carlisle shares are trading on JP Jenkins, if you are looking to sell or buy shares please get in touch with your broker.
Liquidity Junction
This month was the JP Jenkins Liquidity Junction Summer Drinks! Bringing together the advisors, lawyers, accountants, registrars and many more great companies we work with to support and help our clients. Lovely to see everyone and thank you for all who attended – we look forward to seeing you at our next event
EISA Awards
The JP Jenkins team enjoyed the EISA Awards 2024 this year. Congratulations to all those shortlisted and those who won. Our team thoroughly enjoyed the drinks on the terrace of the House of Lords tonight. We were nominated as Best Newcomer (InfinitX) post our acquisition.
CISI events:
Exciting times ahead for private asset trading! At our recent webinar with CISI we explored recent innovations, regulatory changes, and the future of private markets. From electronic connections for UK brokers to the evolving market infrastructure.
Great to attend and our CEO Mike McCudden enjoyed being one of the main speakers alongside Colin Anderson. If you missed it, watch it on-demand via CISI TV next week if you are a member here: https://lnkd.in/e5eENn6E
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
Learning 101 with JP Jenkins – Check out our latest videos here on:
June 28, 2024
Fourth Edition
This month we announced four new clients, saw trading volumes tick up and more brokers connect. Hoorah!
We are delighted to announce the following new admissions to JP Jenkins:
Molecular Energies (JPJ:MEN): Molecular Energies has four primary business divisions – an innovation arm focussing on the development of sustainable aviation fuel and other green energy solutions; ongoing receipts from the sale of its oil production operations in Argentina; a c18% holding in AIM-quoted ATOME plc, a green fertiliser project developer; and a 75% holding in Green House Capital Group, a carbon removal business focussed on biomass to biochar projects.
RedX Pharma (JPJ:REDX): Redx is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, targeted medicines for the treatment of fibrotic disease, cancer and the emerging area of cancer-associated fibrosis. Peter Collum, Chief Financial Officer, Redx Pharma said,
E-therapeutics (JPJ:ETX): e-therapeutics combines computation and RNAi to discover and develop life-transforming medicines. The computational platform allows ETX to discover better medicines faster through generation of novel insights and increased automation across all stages of drug development. The Company is progressing a pipeline of highly differentiated RNAi therapies across a variety of therapeutic areas with high unmet need.
Scirocco Energy PLC (JPJ:SCIR): Scirocco Energy (“Scirocco”) is an investing company targeting attractive production and development opportunities within the European transition energy market. Scirocco Energy’s strategy is to acquire a diverse portfolio of direct and indirect interests in attractive production and development opportunities within the European transition energy market.
Issuer news – Check out the latest updates and news from our clients:
RedX Pharma: This month Redx Pharma’s CFO, Peter Collum, acquired 59,614 ordinary shares of the company at an average price of 20.87 pence per share, increasing his stake to 0.04% of the issued share capital.
Thrive Renewables: A solar panel business has secured £75m in funding from Bristol-based energy firm Thrive Renewables. Eden Sustainable, which operates around the UK including in Exeter and London, said the deal would accelerate the roll out of private wire solar power purchase agreement (PPA) projects for schools, businesses and organisations across the country.
Agronomics: Portfolio company Solar Foods Oy (“Solar Foods”) has raised an additional EUR8 million in funding via Finnish investment organiser Springvest Oyj.
Ienergizer: Air India augments customer care with 5 new centres globally. Partners with Concentrix and iEnergizer to provide 24/7 assistance for customers
Delistings
This month has been a month for delistings, not only in London but Europe too, where it was described by Euronews as ‘The Great Delisting’. A company delisting and moving onto JP Jenkins means its shareholders and future investors are still able to have shares bought and sold by UK regulated brokers and their price transparency and governance is maintained, albeit at a fraction of the cost.
We don’t actively seek delistings from the main markets, as we support companies on the path to IPO and those choosing to remain private too, but in the event a company does delist and comes over to JP Jenkins we like to consider ourselves as a safety net for capital. We hope that by providing a facility for private liquidity in the UK, we might impede capital outflow to the likes of the US or act as a holding bay in case those companies that are delisting decide to relist in the future.
CISI events:
Our first event with The Chartered Institute for Securities & Investment ( CISI) as part of a three webinar series begins on 22 May. We will be focusing on the evolving world of private securities. Earn CPD hours and learn about access to JP Jenkins as well as the private market environment both here and globally. Sign up here.
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
Learning 101 with JP Jenkins – Check out our latest videos here on:
May 28, 2024
April 18, 2024
3# Newsletter April 2024
Since going live on the 5th March 2024 for electronic trading and a shift to digital-first operations, we have significantly modernised our venue for trading unquoted securities. Our team is proving the thesis that seamless electronic connection brings more liquidity and greater transparency. We’re encouraged to see JP Jenkins maintain its position as the first choice Matched Bargain Facility.
Trading volumes continue to exceed expectations and we continue to offer a liquidity venue for companies that are waiting to IPO or seeking to remain private. We now have a combined market capitalisation / valuation across our admitted private company clients of circa £1.3bn. This represents an increase of over 100% growth in the 12 months. In the first month anniversary of us going ‘live’ with electronic trading, the team has completed over £10m+ in consideration of trading and over 400m+ shares being traded.
Last week we saw Cafedirect PLC and Loopup Group PLC shares admitted to our platform.
Steve Flavell, LoopUp co-CEO said “We are delighted to be able to support our shareholders and future investors by being part of JP Jenkins. The venue gives us continued structural features similar to public markets, such as transparency and investor access, and will enable us to continue to grow our multinational cloud telephony business while supporting our existing shareholder base with price transparency and the ability to buy and sell shares.”
John Steel, Cafedirect’s CEO said “We are delighted to be able to offer buyers and sellers of Cafedirect shares a platform to execute transactions via matched bargain on a secondary market”.
We have three more going live in Lexington Gold (Warrants), Red X Pharma PLC and Molecular Energies PLC.. The team is also in talks with over 20+ delistings to support a move to our venue and away from the public markets where it doesn’t seem necessary to maintain a listing.
Latest News:
In the latest article SmallCap RoundUp from The Armchair Trader we saw two companies that are intending to join us very shortly.
Molecular Energies PLC [LON:MEN] topped the board, up 60%. Whilst the stock has had a tough ride in recent months, yesterday’s confirmation that the business would move its listing from AIM to the JP Jenkins private venue has offered some clarity, allowing the share price to post a meaningful recovery as a result.
Redx Pharma [LON:REDX] was second, up 22%. This is a business that has elected to leave the main market and migrate to the JP Jenkins private venue. That process is still playing out, but the stock continues to gain ground from the losses posted in the immediate reaction to the news a couple of weeks back.
Please see the full article here: https://www.thearmchairtrader.com/smallcap-round-up-molecular-energies-redx-pharma-seed-innovations
Iress Partners with InfinitX, JP Jenkins for Unlisted Security Trading
Iress today announces that it has partnered with InfinitX to enable its clients to trade unlisted securities through Iress’s EMS Trader and IOS+ platforms. This fully electronic integration with JP Jenkins, the liquidity venue for unlisted assets, enables private companies to allow trading in their shares on a matched bargain basis. Any client using Iress’s Order Management System is able to connect directly to the JP Jenkins venue and submit expressions of interest to buy or sell shares. See full article here: https://lnkd.in/eyNw4mCd
At the same time as lots of new onboardings and trading, our team was round the city running events, panels and presentations. Head of Corporate, Mason Doick took to the panel at UK Fintech Week to discuss more around JP Jenkins’ ambitions and responsible innovation both in terms of meaningful fintech collaborations and positive outcomes for shareholders.
Client News:
Last week one of our clients, Carlisle Support Services, provided the Grand National festival with a comprehensive service including Security and Stewarding at Aintree Racecourse including Security Officers on the Merseyrail train stations. Well done to Carlisle Support Services and all their team!
One of our clients, Agronomics Limited has its Warrant’s trading on JP Jenkins and just released their latest Q1 update for 2024 here: https://www.youtube.com/watch?v=6r1urFCA9rg
Events
Fintech Scotland hosted an event this month at Scotland House as part of London Fintech Week around responsible innovation for financial technology. We were honoured to have Mason Doick deliver a message around how transparency, liquidity and access are supporting financial technology growth companies and providing a bridge to London based capital.
We are working with The Chartered Institute for Securities & Investment (The CISI) hosting three webinars focusing on the evolving world of private securities. Earn CPD hours and learn about access to JP Jenkins as well as the private market environment both here and globally. Sign up here. The first one is on 22 May.
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
Learning 101 with JP Jenkins – Check out our latest videos here on:
April 18, 2024
Iress today announces that it has partnered with InfinitX to enable its clients to trade unlisted securities through Iress’s EMS Trader and IOS+ platforms. This fully electronic integration with JP Jenkins, the liquidity venue for unlisted assets, enables private companies to allow trading in their shares on a matched bargain basis. Any client using Iress’s Order Management System is able to connect directly to the JP Jenkins venue and submit expressions of interest to buy or sell shares.
Iress’s Head of UK Trading, Debbie Kaye, said “Iress has been at the forefront of retail investment in listed equities for many years, and this move means that we can give our clients access to a wider array of investment options. It also means our clients benefit from a more streamlined market access, and the automation of a historically manual process, making it far easier for them to trade.”
InfinitX’s Founder, Andrew Foster, commented, “We have been working hard with both the broker community and other capital market infrastructure providers to ensure we can fully automate our trading processes. Working with Iress has hugely accelerated our plans, thanks to its market reach and expertise in the space. This is another significant milestone in our journey and fully validates the hard work of our team of developers in creating world class trading technology that connects seamlessly with capital market infrastructure and accelerates our goal of driving access, transparency and liquidity in the unquoted space.”
https://www.marketsmedia.com/iress-partners-with-infinitx-jp-jenkins-for-unlisted-security-trading/
April 16, 2024
10th April 2024
JPJ: CDR
CafeDirect PLC
Shares now trading on JP Jenkins
10th April 2024 – Shares in Cafedirect PLC (https://www.cafedirect.co.uk/) have been admitted to trade on JP Jenkins share dealing platform. Cafedirect PLC is based at 115 George Street, Edinburgh, Scotland, EH2 4JN and is registered as a company in England and Wales under Companies House, company number SC141496.
Cafedirect plc is a British coffee company established in 1991 that is driven by a passion for fairness and sustainability. They are known for their commitment to ethical sourcing, focusing on fair trade and direct relationships with coffee farmers. Cafedirect sources their coffee beans from various regions around the world, including Latin America, Africa, and Asia. They work directly with small-scale farmers, ensuring fair prices and sustainable practices.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
Shareholders wishing to trade these securities can do so through their stockbroker. Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer. Trades can be conducted, and limits can be accepted, during normal business hours. Shareholders or potential investors can place limits via their existing UK regulated stockbroker.
The indicative pricing for the ordinary shares (ISIN: GB00B0M0J665), as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/company/cafedirect/).
Veronika Oswald, Commercial Director of JP Jenkins said: “Congratulations to CafeDirect PLC for joining our securities trading venue. We are delighted to extend our warmest welcome to another fantastic growth company that joins our consistently expanding community. This admission allows CafeDirect shareholders the opportunity to trade their shares with many of the UK regulated brokers and access a comprehensive secondary market.”
John Steel, Cafedirect’s CEO said “we are delighted to be able to offer buyers and sellers of Cafedirect shares a platform to execute transactions via matched bargain on a secondary market”
For further information, please contact:
JP Jenkins Limited
Veronika Oswald (Commercial Director)
Tel: +44 (0) 207 469 0937
April 10, 2024
Second Edition
This month we announced a major shift towards digital-first operations, significantly modernising our venue for trading unquoted securities. This transformation was marked by the full digital integration of many UK brokers into its system. This move towards automation aims to enhance liquidity, transparency, and scalability, accommodating a growing number of issuers and traded volumes. Our parent company and technology provider, InfinitX, allows for seamless connectivity and order gathering from any regulated broker.
This transition to a wholly digital approach represents a strategic leap forward and sets the new standard for the trading of private securities which will in turn attract more companies and higher trading volumes. By streamlining the process and making it super efficient, we are ready to facilitate greater liquidity and investment in private securities, marking 2024 as a pivotal year for private company trading venues.
Trading update:
Within the first week of going live with our electronic trading we received over 128 live orders resulting in a trading consideration of £7.4m, with much more to follow. There are lots of private companies now looking to utilise a private venue for trading and many looking to delist for better utilisation of trading and valuations off public markets.
Issuer news – Check out the latest updates and news from our clients
Thrive Renewables, a clean energy investment company, announced they have completed three major projects that were delivered in February. Invested £1 million into a 1MW community-owned, agreed a 25 year life extension for one of our Scottish hydro projects and switched on our largest battery project to date in Bristol. Thrive is now recruiting two Non-Executive Directors (NEDs) with experience at a senior level to join the Board. For full job spec and to apply: https://lnkd.in/errxFRwr. Thrives shares are trading on JP Jenkins via our auction service, to learn more please visit: https://jpjenkins.com/company/thrive-renewables-plc
GS Verde Group has recently marked its entry into the JP Jenkins trading venue following a seven-figure funding round the company reported deal activity and revenue growth, establishing itself as the most active dealmaker in Wales, according to Experian MarketIQ, which named the GS Verde Group the most active M&A advisors of Q3 2023. Full Article here: https://www.gsverde.group/news/gs-verde-group-lead-manda-rankings-for-another-year. GS Verde Groups shares are trading on JP Jenkins, to learn more please visit – https://jpjenkins.com/company/gs-verde-group/
Prax Group have been doing lots of work volunteering around the country with colleagues from their Weybridge office dedicating their time at the Hounslow Community FoodBox packing Easter hampers for the families in the local community. Prax has also been a long supporter of SchoolBreakfastWeek, highlighting the importance of a nutritious school breakfast in fuelling students for success. They currently fund breakfasts at a number of local schools striving to ensure that no child is too hungry to learn. Learn about what Prax Group do and how they conduct our business here: www.prax.com. Prax Groups DCU’s (Deferred Consideration Units) are trading on JP Jenkins, to learn more please visit: https://jpjenkins.com/company/prax-exploration-production-plc-dcu-2/
Agronomics Limited is delighted to announce that their portfolio company Meatly has created the world’s first cans of pet food that use cultivated chicken as a protein source. The product was created in collaboration with Meatly’s first brand partner Omni Pet Ltd (“Omni”), a fast-growing novel protein pet food company in the UK, founded by veterinarian Dr Guy Sandelowsky. Once its product has been granted regulatory approval, Meatly-produced pet food will be made available in shops across the country through partnerships with retailers and manufacturers like Omni. As an early investor in Meatly, Pets at Home Limited plans to be the first retailer to offer these products in its stores. Agronomics Warrants are trading on JP Jenkins, to learn more please visit: https://jpjenkins.com/company/agronomics/
Carlisle Support Services were one of the few established event partners at one of the UK’s most iconic venues. The highly trained staff members ensured visitors had a pleasant and safe experience as the extraordinary racing and the priceless moments returned to the Cheltenham Racecourse. Carlisle Support Services shares are trading on JP Jenkins, to learn more please visit: https://jpjenkins.com/company/carlisle-support-services-group-limited/
Learning 101 with JP Jenkins – Check out our latest videos here on:
March 28, 2024
March 11, 2024
46 UK brokers now accessing unlisted assets
London, March 5th, 2024 – JP Jenkins (www.jpjenkins.com), the liquidity venue for unlisted assets, has this morning announced that more than 40 UK brokers are now accessing the platform, including 16 who have completed a full digital integration, allowing for buy and sell orders to now be lodged on a fully automated basis. This coincides with a move by the company to now prioritise electronic dealing to ensure maximum liquidity, transparency and scalability for the venue as it looks to harness a significant uptick in both issuer numbers and volumes traded.
Mike McCudden, CEO of JP Jenkins, commented:
“For the past 12 months, the team at JP Jenkins has been working hard with both the broker community and capital market infrastructure providers to ensure we can fully automate our trading processes. Following the completion of this, I am delighted to announce that as from today, we are now a digital-first platform where any regulated broker or other financial institution can connect into our venue, enabling them to view indicative prices and lodge buy or sell orders against relevant securities.”
Although automation has been a popular theme in financial markets for decades, it required the deployment of specialist applications from FinTech provider InfinitX to migrate JP Jenkins from voice based services to a wholly digital approach. In addition to being able to connect via a direct API, brokers can also access JP Jenkins’ issuers via their existing connections to Order Management Systems providers IRESS and Winterflood Securities.
Andrew Stanclife, Head of Execution Services at Winterflood Securities, added:
“2024 is now on course to be a pivotal year for venues catering to the liquidity needs of private companies. This week HM Treasury is expected to launch a consultation starting this week into the role these disruptors can play in helping to reinvigorate London’s position as a booming capital market. Winterflood looks forward to supporting JP Jenkins and InfinitX in their mission to facilitate greater liquidity in private companies”
The brokers now connected on an automated basis to the JP Jenkins platform include IG, Jarvis, AJ Bell, Charles Stanley, James Sharpe, Hargreaves Lansdown, Investec, Kyte, Rathbone, Ramsey Crookall, Interactive Investor, ITI, Intrinsic, Albert E Sharpe, Killik, Raymond James, FIS Global, Winterflood Securities and Shore Capital
Media contact
Tony Cross
Monk Communications
Tel +44 (0) 7973 284 749
About JP Jenkins
Founded in 1991, JP Jenkins is the liquidity venue for unlisted assets. The company provides an efficient platform for privately held and unlisted businesses who are seeking a liquidity solution for holders of their securities. JP Jenkins was acquired by the innovative FinTech provider InfinitX in 2023, enabling the display of real-time pricing with any registered broker or financial institution, who can then connect, execute and settle with JP Jenkins over existing market infrastructures.
March 6, 2024
Moves off market show London is innovating, not dying. The decline of London as a financial hub has been a theme in recent commentary, but a run of companies pulling their stock listings points to the city evolving, not dying. The tsunami of moves off-market — including private equity market buyouts — is a sign of how innovation will always unite investorschasing returns with companies that need capital. Below the radar is a fascinating sub-story at play as disruptors like JP Jenkins look to find ways to accommodate the liquidity needs of issuers who are no longer willing to squeeze themselves into the straitjacket of rules now tying up traditional capital markets.
Policy makers have been making an effort to find more progressive solutions, but events so far are moving faster, especially in high-growth areas the politicians are keen to attract. Alternative trading venues are nothing new. But with daily reports of major companies such as ARM, CRH and Flutter taking their primary or secondary listings abroad, or going back into private ownership, it seems timely to serve up a reminder that the city already has many right-sized options closer to home. JP Jenkins provides a stepping stone for the high-growth businesses of tomorrow. Less onerous reporting rules mean lower overall costs both for the initial admission and then to meet ongoing obligations, offering a genuine alternative to opting for a trade sale.
Critically, this approach also allows early-stage investors the choice of realising some value immediately, while still retaining a degree of ownership. And don’t forget that with the current levels of uncertainty, there’s no shortage of businesses who may be looking wistfully at an IPO but don’t want to take the plunge just yet. Alternative routes like JP Jenkins, allow for companies to take their time in the IPO preparation phase, obtain a registrar and start to act like a public company. These companies can feel comfortable in an environment away from volatility and wide bid/offer spreads. This takes us back to the core point, which is how, in capital markets, one size will never be a good fit for every business or security.
Indeed, back in the late 1990s, amid the unprecedented frenzy that led up to the dot.com bubble and heightened levels of market turmoil, the alternative London venue OFEX saw a significant surge in popularity as many investors accepted that the certainty that had been previously provided by the main board could no longer be relied upon. Capital markets never stop evolving. Technology has been a driving force here in recent years, but so is the exceptionally high quality of talent. London’s recent delistings show the tide is turning on how companies want to raise capital. It does not show that confidence is flowing out of the market. The City continues to act as a beacon when it comes to innovation. Some forms of capital allocation will brighten as others grow dim. In a fast evolving world it is difficult to see London’s shining light ever being extinguished.
To learn more about JP Jenkins and how we are helping scaling growth companies in the UK. Please email our team on info@jpjenkins.com or call 0207 469 0937.
February 28, 2024
Moves off market show London is innovating, not dying. The decline of London as a financial hub has been a theme in recent commentary, but a run of companies pulling their stock listings points to the city evolving, not dying. The tsunami of moves off-market — including private equity market buyouts — is a sign of how innovation will always unite investorschasing returns with companies that need capital. Below the radar is a fascinating sub-story at play as disruptors like JP Jenkins look to find ways to accommodate the liquidity needs of issuers who are no longer willing to squeeze themselves into the straitjacket of rules now tying up traditional capital markets.
Policy makers have been making an effort to find more progressive solutions, but events so far are moving faster, especially in high-growth areas the politicians are keen to attract. Alternative trading venues are nothing new. But with daily reports of major companies such as ARM, CRH and Flutter taking their primary or secondary listings abroad, or going back into private ownership, it seems timely to serve up a reminder that the city already has many right-sized options closer to home. JP Jenkins provides a stepping stone for the high-growth businesses of tomorrow. Less onerous reporting rules mean lower overall costs both for the initial admission and then to meet ongoing obligations, offering a genuine alternative to opting for a trade sale.
Critically, this approach also allows early-stage investors the choice of realising some value immediately, while still retaining a degree of ownership. And don’t forget that with the current levels of uncertainty, there’s no shortage of businesses who may be looking wistfully at an IPO but don’t want to take the plunge just yet. Alternative routes like JP Jenkins, allow for companies to take their time in the IPO preparation phase, obtain a registrar and start to act like a public company. These companies can feel comfortable in an environment away from volatility and wide bid/offer spreads. This takes us back to the core point, which is how, in capital markets, one size will never be a good fit for every business or security.
Indeed, back in the late 1990s, amid the unprecedented frenzy that led up to the dot.com bubble and heightened levels of market turmoil, the alternative London venue OFEX saw a significant surge in popularity as many investors accepted that the certainty that had been previously provided by the main board could no longer be relied upon. Capital markets never stop evolving. Technology has been a driving force here in recent years, but so is the exceptionally high quality of talent. London’s recent delistings show the tide is turning on how companies want to raise capital. It does not show that confidence is flowing out of the market. The City continues to act as a beacon when it comes to innovation. Some forms of capital allocation will brighten as others grow dim. In a fast evolving world it is difficult to see London’s shining light ever being extinguished.
To learn more about JP Jenkins and how we are helping scaling growth companies in the UK. Please email our team on info@jpjenkins.com or call 0207 469 0937.
February 20, 2024
This week Pitchbook demonstrated that more companies are choosing to remain private. A Bloomberg report shows that the number of companies trading in London has contracted by 25% over the past decade. So where there are fewer companies currently choosing to go public, there are also public companies seeking to go private.
We’re thrilled to act as a bridging solution to underscore our position as a venue for private companies as the UK public markets consolidate their position. Most recently we have successfully facilitated the delisting of two companies.
Our commitment to providing a seamless and efficient venue for companies seeking alternative liquidity options supports this. What does this mean for companies seeking a private alternative and why does JP Jenkins stand out as the preferred solution?
A Tailored Delisting Process: We understand that each company’s journey is unique. Our team works closely with listed companies and their advisers to navigate the delisting process with a tailored approach, ensuring a smooth transition.
Enhanced Liquidity Options: Companies listed on JP Jenkins benefit from customised liquidity options, providing them with the flexibility to manage their financial strategies effectively. This is crucial for those seeking a strategic exit or looking to either diversify or support their shareholder base.
Access to a Robust Distribution Network: By joining JP Jenkins, companies gain access to a diverse and robust community actively participating in supporting private companies. This expanded reach opens up new opportunities for companies to attract potential investors and partners.
Transparency, Visibility and Trust: JP Jenkins prides itself on maintaining the highest standards of transparency and trust. Our venue provides a secure environment for companies and intermediaries, fostering confidence in the delisting process and subsequent transactions and we provide visibility akin to capital market environments through a dedicated news service.
Efficient and Cost-Effective Solution: Going private on JP Jenkins is not only efficient but also cost-effective. We understand the financial implications of such decisions, and our venue is designed to minimise costs while maximising value for all parties involved.
In conclusion, the continued success of delistings on JP Jenkins reaffirms our status as the go-to liquidity and secondary market venue for unquoted assets. For listed companies navigating the delisting journey and considering their strategic options in 2024, JP Jenkins offers a positive and reliable solution
Feel free to reach out if you have any questions or if your company or client is considering going private – we’re here to guide you every step of the way!
February 6, 2024
December 31, 2023
InfinitX, the new technology powering JP Jenkins, has received a flurry of commendations in the final quarter of 2023. These plaudits reflect the growing demand for next generation solutions as capital markets continue to fragment and shift away from their traditional structures.
By using InfinitX, JP Jenkins can now integrate seamlessly with the existing capital market ecosystem. This allows any broker or other regulated financial intermediary the abilityto access prices and place orders using their standard trading terminal. The assets remain unquoted, but accessibility is dramatically improved for buyers and sellers alike.
Recently, InfinitX has received the following recognitions:
Leading Innovators in Private Trading Technology 2023, UK by Innovation in Business. Innovation in Business’ Technology Innovator Awards 2023 provided a platform for companies like InfinitX to showcase their groundbreaking solutions, game-changing innovations, and positive impact on the business landscape.
Finalist for Private Trading Technology 2023 with FF Awards. More than 250 entries were received and over 6,000 votes were cast by the public, before the final decisions were made by a judging panel of industry experts.
Business Cloud awarded InfinitX 2nd place in the UK’s Most Innovative Tech Creators 2023, where it climbed up from number 37 of 50 in 2022 to be second amongst a number of recognised leading financial service providers.
December 7, 2023
In the latest move highlighting the pressure asset owners are feeling when it comes to making disposals, the Nordic private equity fund manager EQT announced earlier in October that dysfunction in IPO markets was forcing it to look for other options to crystalise value in its private asset holdings.
EQT is looking at holding a series of private auctions to enable monetisation without having to opt for a full-scale IPO. An Financial Times article highlighted that a slowdown in dealmaking and poor IPO prospects had seen fund managers embrace more creative financial engineering techniques in order to return capital..
As EQT’s CEO stated in the FT article, “As long as the price is set in a fair way at a fair market value, it doesn’t really matter that the transaction is private. Why go public if we actually don’t need to?”
Full article below:
https://www.ft.com/content/8a354b8c-ccb9-44e6-82f6-1499b3f9681e
That very much aligns with the ethos adopted by JP Jenkins with its private market venue, now powered by market leading software from InfinitX. Working from the ethos that companies shouldn’t be forced into a trade sale or a badly timed IPO to enable early stage investors or employees with vested shares to unlock capital, the JP Jenkins proposition continues to gain traction. with the collective value of member companies on the platform having doubled during the year to date.
To find out more about how JP Jenkins can help your company unlock the value held in its equity, contact Mason Doick – Md@jpjenkins.com.
October 30, 2023
JP Jenkins is pleased to announce that Prax Exploration & Production PLC have been admitted onto its matched bargain trading platform. Deferred Consideration Units (“DCUs”), following the acquisition of Hurricane Energy plc (“Hurricane”), have been admitted to trade on JP Jenkins’.
Further information on the DCUs as well as the acquisition of Hurricane can be found on the Prax microsite at www.prax.com/dcu/.
The indicative pricing for the instruments, as well as the transaction history, will be available on the JP Jenkins website at jpjenkins.com.
Alessandro Agostini, Head of Exploration and Production at Prax said:
“We are pleased that trading on JP Jenkins’ matched bargain facility has commenced, enabling investors to acquire the DCUs and provide those DCU holders who wish to monetise their DCUs the ability to do so.”
Full announcement here – https://lnkd.in/e6r-ZKUB
October 10, 2023
JP Jenkins is pleased to announce that Prax Exploration & Production PLC have been admitted onto its matched bargain trading platform. Deferred Consideration Units (“DCUs”), following the acquisition of Hurricane Energy plc (“Hurricane”), have been admitted to trade on JP Jenkins’.
Further information on the DCUs as well as the acquisition of Hurricane can be found on the Prax microsite at www.prax.com/dcu/.
The indicative pricing for the instruments, as well as the transaction history, will be available on the JP Jenkins website at jpjenkins.com.
Alessandro Agostini, Head of Exploration and Production at Prax said:
“We are pleased that trading on JP Jenkins’ matched bargain facility has commenced, enabling investors to acquire the DCUs and provide those DCU holders who wish to monetise their DCUs the ability to do so.”
Full announcement here – https://lnkd.in/e6r-ZKUB
October 10, 2023
Hurricane Energy Deferred Consideration Unit Payment
29 September 2023: Prax Exploration & Production Plc is pleased to provide its first update to Deferred Consideration Unit (“DCU”) holders under the terms of the agreement dated 8 June 2023, based on the performance of Prax Upstream Limited (formerly Hurricane Energy Plc) and its subsidiaries (“Prax Upstream”) in the four month period from 1 March 2023 to 30 June 2023.
The DCUs confer an entitlement for holders to receive 17.5% of all future net revenues earned by Prax Upstream from 1 March 2023 until 31 December 2026, including from both the Lancaster Oil Field and from any acquisitions made by Prax Upstream, capped at a total of 6.48 pence per DCU (being c.£129.1 million in aggregate). The DCU payments will be paid biannually in arrears, approximately 90 days after the end of each 6 month period (those periods ending on 30 June and 31 December each year).
Production from the Lancaster Oil Field, the only producing asset currently in Prax Upstream, resulted in sales of 539,244 barrels of oil during the four months from 1 March 2023 to 30 June 2023.
Gross revenues for the period were $45,801,204.35, with net revenues being $43,903,875.95 after the related costs for transportation, freight, port, inspection, testing and marketing charges are adjusted for. The Deferred Payment for the period based on 17.5% of net revenues equates to £6,150,478.94 which in turn equates to a payment of £0.00309 (0.309p) per DCU. The Deferred Payment Calculation Statement can be viewed in full here. The payments will be paid to Prax DCU II Holders on 30 September 2023.
Prax Upstream continues to pursue upstream acquisition opportunities and will provide an update to DCU holders when definitive progress is made.
DCU II Holders will receive the payment via their Crest account or, if holding share certificates, via cheque in the post.
DCU I Holders will receive loan notes in the post.
Alessandro Agostini, Head of E&P – Europe and Africa at the Prax Group said:
“Following the completion of the acquisition of Hurricane Energy in June, we are very pleased to deliver the first payment tranche to DCU holders. In line with previous guidance, the Lancaster Oil Field production continues to follow its natural decline. We had a successful turnaround during the month of August and current production is around 7,000 bopd. The transition of ownership has been smooth and we are pleased to have welcomed numerous Hurricane employees into the Group.
As has been stated previously, our goal is to participate in further deals in the UK North Sea in order to continue to deliver value to the DCU holders. Any significant progress made in this regard will be announced to the market via the Prax website.”
For further information on the DCUs and to sign up for future press releases in relation to the DCUs, please visit the Prax Group’s website: https://www.prax.com/information-for-holders-of-dcus/
Enquires: 2
Camarco Public Relations Adviser to Prax Billy Clegg / Violet Wilson / Hugo Liddy +44 (0) 20 3757 4980 prax@camarco.co.uk
September 29, 2023
Hurricane Energy Deferred Consideration Unit Payment
29 September 2023: Prax Exploration & Production Plc is pleased to provide its first update to Deferred Consideration Unit (“DCU”) holders under the terms of the agreement dated 8 June 2023, based on the performance of Prax Upstream Limited (formerly Hurricane Energy Plc) and its subsidiaries (“Prax Upstream”) in the four month period from 1 March 2023 to 30 June 2023.
The DCUs confer an entitlement for holders to receive 17.5% of all future net revenues earned by Prax Upstream from 1 March 2023 until 31 December 2026, including from both the Lancaster Oil Field and from any acquisitions made by Prax Upstream, capped at a total of 6.48 pence per DCU (being c.£129.1 million in aggregate). The DCU payments will be paid biannually in arrears, approximately 90 days after the end of each 6 month period (those periods ending on 30 June and 31 December each year).
Production from the Lancaster Oil Field, the only producing asset currently in Prax Upstream, resulted in sales of 539,244 barrels of oil during the four months from 1 March 2023 to 30 June 2023.
Gross revenues for the period were $45,801,204.35, with net revenues being $43,903,875.95 after the related costs for transportation, freight, port, inspection, testing and marketing charges are adjusted for. The Deferred Payment for the period based on 17.5% of net revenues equates to £6,150,478.94 which in turn equates to a payment of £0.00309 (0.309p) per DCU. The Deferred Payment Calculation Statement can be viewed in full here. The payments will be paid to Prax DCU II Holders on 30 September 2023.
Prax Upstream continues to pursue upstream acquisition opportunities and will provide an update to DCU holders when definitive progress is made.
DCU II Holders will receive the payment via their Crest account or, if holding share certificates, via cheque in the post.
DCU I Holders will receive loan notes in the post.
Alessandro Agostini, Head of E&P – Europe and Africa at the Prax Group said:
“Following the completion of the acquisition of Hurricane Energy in June, we are very pleased to deliver the first payment tranche to DCU holders. In line with previous guidance, the Lancaster Oil Field production continues to follow its natural decline. We had a successful turnaround during the month of August and current production is around 7,000 bopd. The transition of ownership has been smooth and we are pleased to have welcomed numerous Hurricane employees into the Group.
As has been stated previously, our goal is to participate in further deals in the UK North Sea in order to continue to deliver value to the DCU holders. Any significant progress made in this regard will be announced to the market via the Prax website.”
For further information on the DCUs and to sign up for future press releases in relation to the DCUs, please visit the Prax Group’s website: https://www.prax.com/information-for-holders-of-dcus/
Enquires: 2
Camarco Public Relations Adviser to Prax Billy Clegg / Violet Wilson / Hugo Liddy +44 (0) 20 3757 4980 prax@camarco.co.ukSeptember 29, 2023
UK boat and yacht rental marketplace Borrow A Boat has today announced its intent to admit its shares to London trading venue, JP Jenkins, in a move that reflects the continuing growth of the business.
The company went through a streamlining and restructuring earlier in 2023 when it de-merged one previous acquisition, and optimised the business for scalable and purely tech-driven growth which has put the business poised to achieve profit in 2024 and beyond as the company continues to grow internationally.
Borrow A Boat delivered over 2,500 charters over summer 2023 from day hires, to sailing holidays and luxury crewed superyacht charters – from the 45,000 boats on offer on the platform. In addition, new future bookings made over the summer were up by 30% compared to 2022.
Now, with one eye on future growth and having recently raised a further round of capital, it is pushing forward for a profitable year in 2024 and will be listing to the London share trading venue, JP Jenkins, in late 2023. In a first-of-its-kind for the industry, the admission will allow investors globally to trade shares via their stock brokers.
Following the restructuring process undergone in early 2023, Borrow A Boat is now owned by The Boat Engine Ltd since the company was acquired into a new entity by founder Matt Ovenden and a consortium of supportive investors. Ovenden has since brought the original crowdfunding investors (numbering close to 2000) across to the new entity, although there was no obligation to do so he believed it was “the right thing to do”. In the process, the business has returned shares worth £2.4 million to the crowd.
Founder, Matt Ovenden, said, “We are leaner and meaner than ever, and growing at a rate still – we successfully delivered over 2,500 charters during summer 2023 as part of this exponential growth, representing the strength of the boat and yacht rental market globally. The next step in our journey is the exciting admission of our shares to JP Jenkins, in what is set to be a strong end to 2023 and start to 2024”.
The Borrow A Boat team are exhibiting this week at Southampton Boat Show, and are celebrating a successful summer, offering a 10% boat show discount on any charter booked at the show
September 15, 2023
September 5, 2023
Fulcrum Utility Services Ltd
21 August 2023
FULCRUM UTILITY SERVICES LIMITED
(“Fulcrum”, the “Company”) or “the Group”)
Proposed cancellation of admission of Ordinary Shares to trading on AIM
Adoption of Amended and Restated Memorandum and Articles of Association
and
Notice of General Meeting
The Company announces the proposed cancellation of admission to trading on AIM of its ordinary shares of 0.1p each (“Ordinary Shares“) (the “Cancellation“), and the adoption of amended and restated memorandum and articles of association (the “Amended Articles“) (together, the “Proposals“).
The Directors have undertaken a review to evaluate the advantages and disadvantages to the Company and its Shareholders of retaining the admission to trading on AIM of the Company’s Ordinary Shares. This review has included, amongst other matters, the Company’s limited prospects of raising additional equity financing on AIM given its current investor base, the limited trading in the Company’s Ordinary Shares, the significant cost associated with maintaining the Company’s admission to trading on AIM and the management time and the legal and regulatory burden associated with being a quoted company. As a result, the Directors have concluded that the Proposals are in the best interests of the Company and its Shareholders as a whole. Further details of the background and reasons for the Proposals are set out in Appendix 1 to this announcement.
The Proposals are subject to Shareholder approval and accordingly, a circular will be sent to Shareholders and will be made available on the Company’s website today, setting out the background to and reasons for the Proposals (the “Circular“) and which will contain a notice convening a general meeting (the “General Meeting“) at which Shareholders will be invited to consider and, if thought fit, approve the resolutions to implement the Proposals. Extracts of the Circular can be found in Appendix 1 to this announcement.
To be passed, Resolution 1 (the “Cancellation Resolution“) requires, pursuant to AIM Rule 41 of the AIM Rules, the consent of not less than 75 per cent. of votes cast by the Company’s shareholders at the General Meeting. Resolution 2, to approve the adoption of the Amended Articles is a special resolution and as such requires a vote of not less than two thirds of Shareholders who vote in person or by proxy at the General Meeting. The Resolutions are inter-conditional, meaning that each of the Resolutions is conditional on the other Resolution being passed.
As of today’s date, the Company has received irrevocable undertakings from certain shareholders representing approximately 57.31 per cent. of the Company’s issued share capital, to vote in favour of the Resolutions.
The General Meeting will be held at the offices of Addleshaw Goddard, Milton Gate, 60 Chiswell Street, London EC1Y 4AG on 26 September 2023 at 11.30am.
To facilitate future Shareholder transactions in Ordinary Shares, JP Jenkins has been appointed to provide a Matched Bargain Facility, which is expected to be available from 4 October 2023. Shareholders wishing to trade these securities can do so through their stockbroker. Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer. Trades can be conducted, and limits can be accepted, during normal business hours. Shareholders or potential investors can place limits via their existing UK regulated stockbroker.
A copy of the Circular and the Amended Articles will be made available later today on the Company’s website at https://investors.fulcrum.co.uk
Announcement of the proposed Cancellation pursuant to AIM Rule 4121 August 2023Posting of the Circular to Shareholders21 August 2023Time and date of General Meeting11.30 a.m. on 26 September 2023Anticipated date to announce results of the General Meeting26 September 2023Last day of dealings in the Ordinary Shares on AIM3 October 2023Cancellation of admission of the Ordinary Shares to trading on AIM7.00 a.m. on 4 October 2023Matched Bargain Facility for Ordinary Shares commences4 October 20231All times are references to London times. Each of the above times and dates is based on the Company’s expectations as at the date of this announcement. If any of the above times and/or dates change, the revised times and/or dates will be notified to Shareholders by an announcement through a Regulatory Information Service
Unless otherwise stated, capitalised terms in this announcement have the meanings ascribed to them in Appendix II of this announcement.
Enquiries:
Fulcrum Utility Services LimitedJonathan Jager, Chief Financial Officer Cenkos Securities plc (Nominated adviser and broker)Camilla Hume / Callum Davidson (Nomad) / Michael Johnson (Sales) +44 (0)114 280 4150 +44 (0)20 7397 8900Notes to Editors:
Fulcrum is a multi-utility infrastructure and services provider. The Group operates nationally with its head office in Sheffield, UK. It designs, builds, owns and maintains utility. https://investors.fulcrum.co.uk
August 21, 2023
From growing a global FinTech disruptor from scratch to how this stands to help with the UK’s levelling up agenda, InfinitX CEO Mike McCudden spoke with Peter Higgins from Conkers3 on the Investing Matters podcast.
The market for investing in private companies is acknowledged as being a multi-trillion dollar opportunity and whilst great strides have been made in enabling better access in places such as the USA, in the discussion, Mike explains how InfinitX technology can be deployed anywhere in the globe, providing much needed liquidity and financing for businesses of all sizes. That might sound somewhat ambitious, but financial democratisation like this can also play an instrumental role in helping push concepts such as the UK’s levelling up agenda.
As Mike notes, there’s a lot more that can be done to support early stage businesses in the UK and further afield. InfinitX is keen to play a central role in that. It’s all about making sure that the money flow is there to help support these underlying young growth businesses. After all, they act as the backbone of economies worldwide, providing jobs and creating ideas to underpin the success stories of tomorrow.
Listen to the full podcast here. https://open.spotify.com/episode/1XpuelLsY1iDXB94FlTDm4
August 10, 2023
If you want to give employees a stronger connection to your company’s ‘big picture’, and encourage them to share their goals, there’s no greater motivator than company shares.
Let’s face it, salary only stretches so far in terms of encouragement, and pension pots aren’t what they used to be. But if luck is on their side (and yours), their shares could convert into a life-changing monetary sum.
And the business benefits are manifold. From collaboration and engagement to motivation and accountability, sharing equity encourages positive behaviours among staff that management teams can only dream of.
Motivation lies in value
However, granting team members an equity stake in the company can fall short if there’s no real way of understanding what it’s worth – or the route to ‘cashing in’ their shares.
If an employee isn’t aware of the company’s current value, how can they estimate the potential future value of their vested shares? If there are no opportunities to liquidate their shares (or other perks like dividends), then what’s the point in having them?
Vestd, the UK’s original share scheme and equity management platform, has helped thousands of business owners unlock the power of equity. So they know a thing or two about share schemes, including the best way to set one up, design a fair scheme and crucially maximise employee engagement.
Too often share certificates are stashed away in a drawer never to be seen again. There’s no reminder of their worth, which is hardly motivating or inspiring. That’s why a digital platform is arguably the best means to set up a share scheme and manage it.
With Vestd, shareholders can access their own personalised dashboard, view recent valuations and use scenario modelling tools to project future value. This accessibility not only promotes transparency but boosts engagement, as they can see a visual representation of the true value of their shares.
And if they’re option holders, they can exercise their options (that is convert them into shares) through the platform too.
It’s easier than you think
What’s more, using the intuitive scheme designer, business owners can clearly outline what exactly will happen in the event of an exit and set specific milestones to meet before employees’ shares vest or before they can do anything meaningful with them, incentivising them to earn their stake while protecting existing shareholders’ interests.
Vestd also offers an array of CoSec tools too, to take the friction out of company admin. The two-way integration with Companies House means customers can issue shares, update their cap table and shareholder register, file confirmation statements and much more, seamlessly.
So companies who are considering giving shares to employees but are doubting the tangibility of the incentive can rest assured that meaningful options exist which allow recipients to understand the value they are generating.
And for employees to see the full benefit of such an initiative, company owners owe it to them to ensure there’s a transparent mechanism in place to allow them to trade out of any such position.
Speaking of, that’s where solutions like JP Jenkins come in. Powered by InifinitX, their secure platform supports private companies looking for a way to let their shareholders match their shares.
July 4, 2023
UHY Hacker Young hosted JP Jenkins and CFO Centre at their London office this week, providing an insightful and valuable event for all who attended, with excellent presentations, followed by networking and canapés.
There is an urgent need for liquidity in unquoted companies and growing SME’s. JP Jenkins provides a perfect solution for companies to access a wider investor audience without the need to IPO just yet; tighten their cap table; showcase a visible price and build on their valuation.
Any private/unquoted company looking for a venue for their shares or building in plans to IPO in the coming years, please get in touch: info@jpjenkins.com
February 9, 2023
All share exchange acquisition gives London’s oldest private equity market significant tech boost
London, January 26th, 2023 – CrowdX (www.crowdx.co.uk), the FinTech platform providing marketplaces and liquidity solutions for private companies, has this morning announced the acquisition of J P Jenkins (JPJ) as a wholly owned subsidiary. Founded in 1991, JPJ has built a strong reputation in helping private companies engage with shareholders and allowing early-stage investors to realise a return on their paper wealth.
Mike McCudden CEO of CrowdX commented:
“This acquisition comes at a critical time, not only in the growth story of CrowdX but also as the UK’s future as a capital market of choice is very much in the spotlight. Our proven technology will afford J P Jenkins clients’ access to a cutting edge venue, which any broker or institution can connect into using a standard API. This greater accessibility to an enlarged number of investment opportunities improves liquidity, generates more accurate valuations and in turn delivers a tangible boost to transparency.”
In addition to boosting accessibility for the secondary trading already offered by JPJ, the integration CrowdX technology will also deliver a platform to facilitate the primary issuance of both debt and equity instruments.
Veronika Oswald, Commercial Director of J P Jenkins, commented:
“CrowdX have already developed some great technology and protocols which are designed to power the next generation of capital markets. We are truly excited as to what the future may hold, not only for the existing cohort of J P Jenkins members, but also when it comes to the positive impact this will have in bolstering London’s position for securities issuance and trading on a global basis.”
CrowdX is currently in advanced stages of negotiations with a number of other financial institutions who are looking to deploy its technology. This will allow them to power their own venues, improving management of investment portfolios and preserving asset valuations without needing to resort to trade sales.
Ends
Media contact
Tony Cross
Monk Communications
tony@monkcommunications.com
Tel +44 (0) 7973 284 749
About CrowdX
CrowdX is a Financial Technology company, delivering bespoke, private venues which act like public markets. These highly configurable solutions are deployed by financial institutions and enable a curated network to connect using industry standard APIs, delivering both primary issuance and secondary market functionality.
In 2022, CrowdX was shortlisted in Business Cloud’s FinTech 50 rankings as one of the most innovative financial technology creators in the UK.
https://www.realwire.com/releases/j-p-jenkins-becomes-part-of-crowdx-group
January 9, 2023
November 28, 2022
The need for liquidity in private markets is becoming more crucial than ever before, with private equity investments at an all-time high.
The continuing evolution of private equity itself and especially its explosive growth in the last few years, has made the development of a robust private market both necessary and inevitable.
The last decade has seen rapid growth in unquoted securities as investors seek the legendary gains available from investing in private companies.
At the same time, there is huge pent-up demand for the selling of shares in private companies from EIS/SEIS investors, crowd funding investors and employees at companies who were rewarded shares in the earlier stages.
Where’s the exit?
In the absence of an IPO or trade sale, there is no practical way for early stage investors to exit. An increasing number of exciting private companies are seeking, rather than choosing the traditional public markets, to raise growth funds from investors directly.
The Numbers:
Since the S/EIS scheme’s were established, circa 35,000 companies have received £26bn of funding.
A vast army of private companies exist in the UK, employing 15.5 million people, generating combined revenues of over £1.8 trillion.
Paper Wealth Unlocked
Increasingly investors in unquoted companies are looking to trade their investment portfolios more freely and frequently in what is mostly an illiquid market. More and more investors are looking to free up capital they have had locked up in previous investments.
Thousands of private companies funded via EIS/SEIS structures eventually reach “end of life”. Very few have IPO or trade sale based exits in place and early stage investors have no reasonable or practical mechanisms through which to monetise their stakes.
October 9, 2022
26 August 2022
Firestone Diamonds plc
(“Firestone”, “Company” or the “Group”)
2021 ANNUAL REPORT NOTIFICATION
Firestone Diamonds plc’s Annual Report for the 2021 financial year is now available on the Company’s
website.
For more information please visit: www.firestonediamonds.com or contact:
Firestone Diamonds plc +44 (0)20 3319 1690
Rob de Pretto
Grant Ferriman
Background information on Firestone
Firestone is an international diamond mining company with operations in Lesotho. Liqhobong is owned
75% by Firestone and 25% by the Government of Lesotho. Lesotho is one of Africa’s significant new
diamond producers, hosting Gem Diamonds’ Letšeng Mine, Firestone’s Liqhobong Mine, Namakwa
Diamonds’ Kao Mine and Lucapa’s Mothae Mine
August 26, 2022
Ep. 49 of the EIS Navigator #podcast out now: Developing secondary markets for venture capital investments | Mason Doick of JP Jenkins
One of the challenges that venture capital investors have to accept is that there probably won’t be liquidity for their shares until the company exits. Several companies have been trying to change that, not entirely without success, with JP Jenkins one of the longest standing. Its Head of Corporate Development, Mason Doick, comes onto the podcast to discuss the state of play and prospects for things getting better.
We talk about the challenges for improving matters. Mason gives good perspectives on the lack of liquidity, as we dig into why it’s so hard. He compares the UK and the US, which has been doing better, and we discuss what lessons we can learn here to improve matters.
We also get into the challenges of getting appropriate information flows – how some private companies don’t understand the long-term benefits of getting those flows right. Mason also talks about the typical companies that achieve successful secondary markets and how companies can start preparing facilities for their investors when the time is right.
April 19, 2022
Avanti’s financial debt has been reduced from $810 million to $260 million. This significantly strengthens Avanti’s financial position moving ahead as we continue to build our business and strive to meet our customers’ needs.
Funds (or subsidiaries of such funds) and/or accounts managed, advised or controlled by HPS Investment Partners LLC or affiliates/subsidiaries thereof ($80 billion leading global investment firm) and Solus Alternative Asset Management LP (leading US registered investment advisor specialising in corporate recapitalisations) will become the principal shareholders.
Avanti will continue business as usual, but with a stronger balance sheet. There will be no change to the Avanti team or Avanti’s business activities, assets, and technical capabilities.
Kyle Whitehill, Avanti CEO, said “Today’s completion of our planned financial recapitalisation marks a major milestone in Avanti’s transformation as a business. Achieving this significant reduction in our legacy debt burden leaves us in a strong position to continue the growth of our business and to deliver our mission of connecting the unconnected across Europe, the Middle East & Africa through our HYLAS fleet of Ka-band satellites.”
For further information contact public relations:
THREESIXTY Communications
avanti@threesixtycomms.com
April 13, 2022
Mason Doick, Head of Corporate Development at JP Jenkins sat down with Proactive London to talk about exactly what his company does. JP Jenkins is a trading facility for private companies and has worked with Premier League Clubs
and Weetabix to name a few. Mason Doick adds that the UK is generally 10-15 years behind the US in the secondary market, but expects to see a huge flurry of business over the next decade
April 9, 2022
The company is engaging between many private companies in a variety of sectors seeking to make their securities electronically compatible for purchase or sale in order to cover fundraising capabilities.
We have significant experience with high yield, investment grade and convertible notes offerings, including financing for leverage acquisitions.
SBS Group has since been introduced to numerous companies and intends to sign them up through this mechanism which will be linked to Bloomberg via a central custodian which will allow both a platform and avenue for their stock to be executed.
The electronic platform is rapidly growing and is capable of operating worldwide and therefore we are not restricted to the UK for our customer base.
We seek to engage through a specialist company to enable Crest and Euroclear functionality and the portal access via Bloomberg, the global giant, covered under a dedicated arrangement specifically for this purpose
SBS Groups global insight is invaluable. It helps to manage complex cross border transactions and aids compliance with regulatory frameworks.
March 27, 2022
Sama Resources Québec Completed a 1,494 line-km HELITEM2 Survey at the Lac Brulé Nickel-Copper Project in the Province of Québec outlining several high conductivity zones.
Highlights:
A 1,494 line-km HELITEM2 survey outlined several high conductivity-thickness (CTP) zones characterised with elevated conductivity levels near the discovered gossan and along an interpreted 10 km-long folded amphibolite unit.
Based on these excellent results, a large exploration program is planned for summer 2022 at the Lac Brulé and Lac Brennan properties. Exploration works will include geological mapping and sampling, ground geophysical survey aimed at drilling priority targets by the fall of 2022. An existing vast network of forestry roads and bridges will greatly facilitate access for all our exploration works.
Montréal, Quebec, March 22, 2022 – Sama Resource Inc. (“Sama” or the “Company”) (TSX-V: SME | OTC-PK: SAMMF) is pleased to report that Sama Resources Québec Inc. (“SRQ”) a fully owned subsidiary of the Company has announced the completion and interpretation of a HELITEM2 electromagnetic and magnetic helicopter geophysical survey of 1,494 line-kilometres (line-km) at the new Lac Brulé nickel-copper property in the Province of Québec, Canada (Figure 1).
As a follow-up on the new gossan discovered in May 2021 (see Press Release 2021-06-16)*1,SRQ commissioned Xcalibur Multiphysics (MPH) Canada Inc. for a HELITEM2 electromagnetic survey supplemented by a high-sensitivity cesium magnetometer. One block of claims (390 claims) was flown between December 5 and December 14, 2021. The survey coverage consisted of 1,374 km of traverse lines flown with a spacing of 200 and 100 metres (“m”) and 119 km of tie lines with a 2000 m spacing.
Figures 2 to 5 show Xcalibur’s final compilation outlining several high conductivity-thickness-product (“CTP”) areas grading 5 to 6 on the Conductivity Grade scale (Table1). Highest Conductivity Grade and CTP, outlined by the late off-time channel/gates (Figures 2 & 5), are located next to the discovered gossan. Figure 6 shows the rooted EM response down to 600 m from surface. Detailed Interpretation and targets modeling will be performed by M. Joel Simard, P. Geol./Geoph based in St-Donat, Quebec province, Canada.
*1(Gossans are highly ferruginous rock which is the product of the oxidation by weathering and leaching of a sulfide body: Elsevier Mineral Exploration 2013)
“While we are fully committed at exploring and developing our Ivorian Samapleu Ni-Cu-PGM assets with our partner Ivanhoe Electric, Sama is demonstrating its ability at finding new highly prospective grounds worldwide in totally virgin territories.” said Marc-Antoine Audet, Ph.D, P.Geo and CEO of Sama Resources Inc. Dr. Audet is continuing by saying “SRQ’s 100% owned Lac Brulé project is only 5 hours driving north of Montreal, Québec Province, which greatly facilitate our upcoming explorations programs”
No historical prospecting or ground exploration had been reported from the Lac Brulé area prior to SRQ. The past-producing Renzi nickel-copper mine is the closest mining activity with historical information available. The Renzi mine is located 48 km east-southeast of the Lac Brulé property. The Company is targeting possible accumulations of Ni and Cu mineralisation at Lac Brulé that could be of similar nature to that at the Renzy mine, Voisey Bay Ni-Cu mine and at other well-known Ni-Cu deposits in Canada and worldwide.
Geophysical HELITEM2 electromagnetic Program
The HELITEM2 system is composed of a 40 m cable to which is attached the transmitter loop. The receiver platform and the receiver coil are located at the centre of the 35 m diameter transmitter loop approximately 0.1 m above the centre of the transmitter plane. The real time navigation GPS antenna is on the tail boom of the helicopter. The barometric altimeter, radar altimeter, laser altimeter, video camera and data recorder are all installed in the helicopter. GPS antennae are attached to the transmitter loop to give positional information and transmitter orientation.
The survey used a 7.5 Hertz (“Hz”) one half cycle of the HELITEM2 system is made up of a square pulse (on-time) of approximately thirty-four milliseconds in duration followed by approximately thirty-four milliseconds of off-time before the pulse is repeated with the opposite polarity. After acquisition the measured data are windowed into twenty-five ranges called “gates”. Gate widths increase as time after turn-off increases because as the energy from the transmitter decays a wider sample must be taken to get a valid average. The position of the first off-time gate is selected after examining several flights of data and is as close to the transmitter turn off as possible. The power of the pulse causes eddy currents in the system after the turn off and the first off-time gate cannot start until these have died away. The earliest data has had less time to penetrate the subsurface and so contains information from the near surface. Detailed technical information on the survey is available on Sama’s website.
Xcalibur MPH selected electromagnetic (“EM”) anomalies automatically using proprietary software from both X and Z components using the fourth off-time gate and a threshold of 100 nT/s. These automatically generated anomalies were then examined in profile form for each line against the X & Z EM responses, decay information, magnetic responses, altimeter readings and flight path videos removing those not considered valid and adding additional anomalies missed by the threshold. For each anomaly the conductor type was interpreted and assigned to each anomaly. After reviewing all anomalies, the following parameters were associated with each anomaly using the data for the fourth off-time gate and where applicable: conductivity-thickness-product (CTP) (Table 1), amplitude of EM response, last off-time channel with an anomalous response, time constant, apparent depth and dip.
Table 1: Xcalibur’s MPH (proprietary) EM Anomaly characterisation (Conductor Grade and CTP)
(fourth off-time gate and a threshold of 100 nT/s)
2022 Exploration Program
SRQ will continue surface exploration at the Lac Brulé and Lac Brennan properties. Exploration works will include geological mapping and sampling, ground geophysical survey aiming at drilling priority targets by the fall of 2022. An existing vast network of forestry roads and bridges will greatly facilitate access for all our exploration works.
Readers are invited to view the updated Corporate Presentation showing exploration progress at all our properties : https://samaresources.com/i/pdf/Sama_Corporate_Presentation.pdf
The technical information in this release has been reviewed and approved by Dr. Marc-Antoine Audet, Ph.D geology, P.Geo and President and CEO of Sama, and a ‘qualified person’, as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects.
ABOUT SAMA RESOURCES INC.
Sama is a Canadian-based mineral exploration and development company with projects in West Africa and now in Canada.
In Côte d’Ivoire only, Sama, has a strategic partnership to develop the Samapleu-Yepleu nickel-copper-palladium project with Ivanhoe Electric (previously HPX) of which mining entrepreneur Robert Friedland is a significant stakeholder. For more information about Sama, please visit Sama’s website at http://www.samaresources.com.
FOR FURTHER INFORMATION, PLEASE CONTACT:
SAMA RESOURCES INC./RESSOURCES SAMA INC.
Dr. Marc-Antoine Audet, President and CEO
Tel:(514) 726-4158
OR
Mr. Matt Johnston, Corporate Development Advisor
Tel: (604) 443-3835
Toll Free: 1 (877) 792-6688, Ext. 5
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
Certain of the statements made and information contained herein are “forward-looking statements” or “forward-looking information” within the meaning of Canadian securities legislation. Forward-looking statements and forward-looking information such as “plan”, “evidence”, “potential”, “appears”, “seems”, “suggest”, are subject to a variety of risks and uncertainties which could cause actual events or results to differ from those reflected in the forward-looking statements or forward-looking information, including, without limitation, the availability of financing for activities, risks and uncertainties relating to the interpretation of drill results and the estimation of mineral resources and reserves, the geology, grade and continuity of mineral deposits, the possibility that future exploration, development or mining results will not be consistent with the Company’s expectations, metal price fluctuations, environmental and regulatory requirements, availability of permits, escalating costs of remediation and mitigation, risk of title loss, the effects of accidents, equipment breakdowns, labour disputes or other unanticipated difficulties with or interruptions in exploration or development, the potential for delays in exploration or development activities, the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, commodity price fluctuations, currency fluctuations, expectations and beliefs of management and other risks and uncertainties.
In addition, forward-looking statements and forward-looking information are based on various assumptions. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking information or forward-looking statements. Accordingly, readers are advised not to place undue reliance on forward-looking statements or forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking statements or forward-looking information, whether as a result of new information, future events or otherwise.
March 22, 2022
We are pleased to confirm that the highly progressive vehicle and commercial company is participating in a significant funding increase in its business plan, primarily through its vehicle rental subsidiary. This planned funding will operative within the LCP Financial Ltd 4% 2027 existing qualified security bonds, listed and traded on the Vienna Stock Exchange and on the Bloomberg Platform
A composite arrangement of secured debt free vehicles combined with a progressive and added fleet from within its own portfolio, together with planned purchased fleets of varying vehicles, will provide the security under the bond conditions.
Significant revenue streaming and increasing capability for the growth of the business in this highly profitable sector will be provided by a series of placings through both high-net-worth groups and institutional funders alike.
With an initial allocation of up to £20,000,000 on terms that have been agreed, this will establish a clear platform for the group to enter the next phase of its development as a major countrywide force in this fast-growing sector.
We have made clear to the group, a combination of equity growth and bond funding as well as specialist instruments dedicated solely to their needs, is available to them with immediate effect.
Due diligence and compliance requirements within the overall strategy are being progressed with all practical speed. A further update will be available as soon as the target steps are achieved.
Work is progressing expeditiously on the overall order flow and further updates as each target date is achieved.
February 27, 2022
Montreal, Quebec, February 28, 2022 – Sama Resources Inc. (“Sama” or the “Company”) (TSX-V SME) (OTC-PF: SAMMF) is pleased to announce, subject to regulatory acceptance, that the Company has granted an aggregate total of 2,145,000 incentive stock options to certain officers, employees and consultants, subject to certain vesting provisions. These options will be exercisable at a price of $0.22 per common share and will expire on February 28, 2032.
ABOUT SAMA RESOURCES INC.
Sama is a Canadian-based mineral exploration and development company with projects in West Africa and now in Canada. On March 19, 2021, Sama formalised a Joint Venture Agreement with Ivanhoe Electric Inc, a private mineral exploration company in which mining entrepreneur Robert Friedland is a significant stakeholder, in order to develop its Ivorian Nickel-Copper and Cobalt project in Côte d’Ivoire, West-Africa.
For more information about Sama, please visit Sama’s website at http://www.samaresources.com.
FOR FURTHER INFORMATION, PLEASE CONTACT:
SAMA RESOURCES INC./RESSOURCES SAMA INC.
Dr. Marc-Antoine Audet, President and CEO
Tel: (514) 726-4158
OR
Mr. Matt Johnston, Corporate Development Advisor
Tel: (604) 443-3835
Toll Free: 1 (877) 792-6688, Ext. 5
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
February 27, 2022
February 15, 2022
Hole GR-04 at the newly discovered Grata deposit in Ivory Coast returned 6.40 m grading 1.05% nickel, 1.24% copper and 0.48 gpt palladium within a wider mineralized zone of 141 m grading 0.38% nickel, 0.37% copper and 0.25 gpt palladium. Ivanhoe Electric to continue Earn-In on the Ivory Coast projects
2021 Highlights
Montreal, Quebec, January 25, 2022 – Sama Resources Inc. (“Sama” or the “Company”) (TSX-V: SME OTC-PK: SAMMF) is pleased to announce drilling results from our 2021 drilling campaign. Sama drilled a total of 20 drill holes for 8,768 meters (“m”) in 2021, including 5 holes at Yepleu for 2,766 m, 7 holes at the Samapleu deposit, including hole S-312 returning a combined 17.50 m at 1.87% nickel (“Ni”), 1.05% copper (“Cu”) and 1.64 grams per tonne (“gpt”) of palladium (“Pd”), and 7 holes at the Grata discovery for 2,921 m. Hole GR-04 drilled at the Grata discovery intersected 141m of continuous mineralization including near surface intervals of 6.40 m and 6.60 m grading 1.05% Ni -1.28% Cu & 0.48 gpt Pd and 0.73% Ni – 0.38% Cu & 0.30 gpt Pd respectively. Table 1 summarizes results for all these holes. Assays results for GR-05 to GR-09 are still pending.
“Sama was very pleased with hosting the Ivanhoe Electric Inc. (“IVNE”) – Sama Technical Meeting at the project site in Ivory Coast in mid-January. IVNE reviewed and acknowledged the large potential of the entire project especially with our high-quality intersections at the new Grata zone. The IVNE-Sama joint exploration program for 2022 should include between 5,000 m to 10,000 m of diamond drilling at the Grata, Samapleu and Yepleu deposits” stated Dr. Marc-Antoine Audet, President & CEO of Sama Resources Inc.
Dr. Audet added “Sama also proposes flying a new generation of helicopter-borne Electro-Magnetic survey to further refine the electromagnetic response of target zones identified in 2013 on PR 838 as well as to cover the newly acquired Zoupleu permit (PR 837). Additional funds should also be allocated for pursuing technical studies for the future open pit operation at the Samapleu deposit.”
Grata: Latest discovery in the Yacouba Intrusive Complex
In September 2021, Sama announced the Grata discovery located 5 kilometers (“km”) east of the Samapleu deposit.
The discovery hole, GR-03, drilled in June 2021, returned a 310 m sequence of pyroxenite and gabbro containing a 147 m interval of disseminated sulfides and several intersections of semi-massive sulphide mineralization. The second hole GR-04 confirmed the width of the mineralized zone, with a 141 m mineralized intersection including 6.40 m and 6.60 m intervals grading 1.05% Ni, 1.28% Cu & 0.48 gpt Pd and 0.73% Ni, 0.38% Cu & 0.30 gpt Pd respectively (see Figures 1 to 5 and Table 1). All measurements are core length.
The mineralization at Grata is similar in composition to the Samapleu deposit but shows a larger proportion of chalcopyrite and therefore a higher copper to nickel ratio. This relationship between copper and nickel is particularly evident in the GR-06 mineralized zones (Figures 3 & 4).
The Company is looking at increasing mineral resources at Samapleu and Grata for a future surface mining operation as well as searching for massive sulphide veins and lenses that could have accumulated at depth in traps and embayments along the feeder system of the Yacouba Intrusive Complex.
Yepleu: Dynamic magmatic system
At the Yepleu mineralized zone, hole YE-19 returned 45m of disseminated and semi-massive sulphide mineralization including 1.15m @ 1.40% Ni. Hole YE-20 drilled 600 m to the north-northeast returned 16m @ 0.49%Ni including 4.25 m @ 1.01% Ni (Figures 5 & 6).
Following the completion of hole YE-23 in mid-2021, which aimed at testing the strong electromagnetic conductor target with a 20,000 conductivity-thickness (“CT”), the Company decided to perform a wedge from the YE-23 hole. The wedged hole is aiming at the centre of the 20,000 CT target. However, due to delays in obtaining equipment and heavy rains during the last four months of 2021, the start of the wedging operation is now planned for the end of this month.
Yepleu is the centre of the intrusive feeder system with evidence of multiple magma injections generating a large volume of host rock assimilation.
At Yepleu and Grata, all newly intersected mineralization is characterized by aggregates of the nickel, copper and iron sulphides – pentlandite, chalcopyrite and pyrrhotite, respectively. Pentlandite occurs together with pyrrhotite, while the chalcopyrite is either mixed with the pentlandite and pyrrhotite or occurs as millimetric to centimetric sulphide veins/accumulations. The textures of the sulphide mineralization vary from disseminated to semi-massive and massive.
Table 1: Summary of 2021 drilling program at Samapleu, Grata and Yepleu
Core logging and sampling was performed at Sama’s Samapleu and Yepleu field facilities. Sample preparation was conducted at the Bureau Veritas Mineral Laboratory in Abidjan. Sample pulps were delivered to Activation Laboratories Ltd, Ancaster, Thunder Bay, Canada, for assaying. All samples were assayed for Ni, Cu, Co, Pt, Pd, Au, Fe and S.
The technical information in this release has been reviewed and approved by Dr. Marc-Antoine Audet, P.Geo and President and CEO of Sama, and a ‘qualified person’, as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects.
ABOUT SAMA RESOURCES INC.
Sama is a Canadian-based mineral exploration and development company with projects in West Africa and now in Canada.
On March 19, 2021 Sama formalised a Joint Venture Agreement Ivanhoe Electric Inc, a private mineral exploration company in which mining entrepreneur Robert Friedland is a significant stakeholder, in order to develop its Ivorian Nickel-Copper and Cobalt project in Côte d’Ivoire, West-Africa. For more information about Sama, please visit Sama’s website at http://www.samaresources.com.
ABOUT IVANHOE ELECTRIC INC.
Ivanhoe Electric Inc. is a privately-owned company focused on making technology-enabled metals discoveries for the electrification of everything. The Company deploys proprietary and disruptive technology that de-risks mineral and water discoveries. Ivanhoe Electric is focused on “electric metals” (copper, nickel, gold and silver) mining assets for the electric revolution. For further information, please visit www.ivanhoeelectric.com.
FOR FURTHER INFORMATION, PLEASE CONTACT:
SAMA RESOURCES INC./RESSOURCES SAMA INC.
Dr. Marc-Antoine Audet, President and CEO
Tel: (514) 726-4158
OR
Mr. Matt Johnston, Corporate Development Advisor
Tel: (604) 443-3835
Toll Free: 1 (877) 792-6688, Ext. 5
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
Certain of the statements made and information contained herein are “forward-looking statements” or “forward-looking information” within the meaning of Canadian securities legislation. Forward-looking statements and forward-looking information such as “will”, could”, “expect”, “estimate”, “evidence”, “potential”, “appears”, “seems”, “suggest”, are subject to a variety of risks and uncertainties which could cause actual events or results to differ from those reflected in the forward-looking statements or forward-looking information, including, without limitation, the ability of the company to convert resources in reserves, its ability to see through the next phase of development on the project, its ability to produce a pre-feasibility study or a feasibility study regarding the project, its ability to execute on its development plans in terms of metallurgy or exploration, the availability of financing for activities, risks and uncertainties relating to the interpretation of drill results and the estimation of mineral resources and reserves, the geology, grade and continuity of mineral deposits, the possibility that future exploration, development or mining results will not be consistent with the Company’s expectations, metal price fluctuations, environmental and regulatory requirements, availability of permits, escalating costs of remediation and mitigation, risk of title loss, the effects of accidents, equipment breakdowns, labour disputes or other unanticipated difficulties with or interruptions in exploration or development, the potential for delays in exploration or development activities, the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, commodity price fluctuations, currency fluctuations, expectations and beliefs of management and other risks and uncertainties.
In addition, forward-looking statements and forward-looking information are based on various assumptions. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking information or forward-looking statements. Accordingly, readers are advised not to place undue reliance on forward-looking statements or forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking statements or forward-looking information, whether as a result of new information, future events or otherwise.
January 27, 2022
Q3 Update
Investor Briefing & Quarterly Update
This quarter our team focussed primarily on the partnerships that we strive to build with angel groups, S/EIS funds and investment firms. We continued the momentum from early in the year by adding many new potential companies to the pipeline for use of a matched bargain facility for their shares. We still believe that the early stage investment eco system requires capital to be recycled from various static companies that were formerly purchased through tax efficient investment schemes.
Partnerships
Our team have been working with both Stakeholderz and Innvotec,two established, predominantly EIS private equity firms. From the initial investment, we then provide shareholder liquidity for these companies and their prospective investors. Our service provides a clear oversight over price, value and company reporting. This in turn provides more credibility to both the company and its shareholders who are engaged and informed of the ongoings of these businesses.
Our community is growing fast, reaching over 10,000+ signed up members. In regard to our social channel followers and website users, we have seen a significant increase.
Future Outlook
As we enter Q4, we aim to complete a number of admissions to our Traditional facility. We expect to have a number of new companies join the platform towards year end.
· Operational Delivery – We continue to review our CRM system and also the technology behind our matching facility.
· Admissions Target – Albeit a revised target, it still stand to be a strong foundation for the new year.
· Suite of Services – Our expanding team will now allow us to initiate our other exciting services for both cross border listings, private SPACs and our uniques swaps vehicle for expired S/EIS shareholders.
· Investors / Buy Side – We continue to speak with syndicates, angel groups and EIS funds to assist companies that require new liquidity or assistance in selling pre-existing shares.
· Second Market Eco-System – We hope to have a number of new partnerships signed up to add to our already strong eco-sysetm of collaborative partners.
· Secondary Partnerships – Joint venture opportunities are key to our success and we look forward to the potential doors this may open.
As psychical events return and meetings are once more face to face, the JPJ team have enjoyed getting back into the swing of things. We are continuously growing in clients, investors and liquidity. The influx of new scaling SMEs and early stage businesses endorses our longterm believes and validates that private markets have come of age.We look forward to updating you further with our Christmas message.
Mason Doick
Head of Corporate Development
November 11, 2021
1st September saw two events for RGH our first partner, Ani Jackson, made her first placement, and our latest partner, Vernon Rose, brought his first baby into the world! These momentous occasions coincided with our inaugural Collaboration Event, the first of a series of get togethers for our global team.
Having launched RGH on 1st March 2020, and immediately having to pivot as a result of the global reaction to the Covid-19 crisis, we have engaged 24 recruitment and people focused partners and businesses across 5 jurisdictions and multiple disciplines.
Our DNA of collaborating with each other to create shared value kicked off with a Global Zoom with a brief update on progress and the chance for everyone to meet each other wherever they are UK, Africa, Singapore, Philippines, India and even on the hard-shoulder somewhere in Sussex all came on line.
Later, for those who were able to join us in London; we had an informal gathering on the amazing roof terraces of 1 St Katherine’s Way overlooking the sights of London to both the East and West. We were joined by the MD of JP Jenkins, Veronica Oswald and RGH chairman, Cameron Parry, for drinks, an Indian finger buffet and the opportunity to meet in person. Out of shot is our new Environmental partner, Jon Pyke, closing his first collaborative deal with our FinTech and Energy partners.
October 20, 2021
FullGreen Limited
Admission Statement
JP Jenkins is pleased to announce the admission of FullGreen Limited and its shares to trading on its dealing platform.
Launched in October 2015, Fullgreen introduced a globally patented technology to make innovative, long-life plant-based productswithout the need for any preservatives. Operating through two trading subsidiaries, the “Group” sells in approx9,000 major retailers across the UK and US, and exports to Europe, South EastAsia and the Middle East.
Fullgreen provide vegetable-based products that are healthy, low-carb alternatives to traditional rice & grains for people looking to eat less carbs, add more vegetables to their meals, or to manage health issues such as obesity and diabetes. With the growing trend for Plant-based eating, as well as the staggering economic cost of tackling Diabetes & Obesity (UK spend £50 billion & US economic cost is approx. $500 billion per year), we believe our products will continue to increase in relevance in the future.
Fullgreen is the only long-life, riced vegetable brand on the rice & grains shelves today -with up to 89% fewer carbs & calories; and 2 servings of veg per pouch.
Originally founded as “Cauli Rice”, in January 2018 rebranded to Fullgreen Ltd to expand into other vegetable innovations other than cauliflower.
In 2019 we opened our second production line based in the USA. By end 2020 Fullgreen products could be found in all major multiples in the UK; major US supermarkets incl. Walmart, Kroger,Target, Wholefoods Market; as well as exported around the world. The Group finished 2020 with £5.4m revenue –growing from £3.9m in 2019. Estimated revenue for 2021 is £6.5-£7 million.
Mason Doick, Head of Corporate Development of JP Jenkins said: “We would like to welcome FullGreen to our unique share trading platform. A disruptor in the food industry with its long lasting rice vegetables pushing sustainability to the forefront. With such a wide consumer base globally, it will be a great opportunity for investors to be part of their journey.”
How to trade:
Should shareholders/investors wish to trade, they can do so through our online trading platform (https://jpjenkinsdirect.rizdex.com/)
The indicative price and transaction history are available on J P Jenkins’s website (www.jpjenkins.com).
For more information, please call +44 (0) 20 7469 0937.
Risk Disclosure:
Investing in unlisted securities involves a high level of risk that investors should be prepared to bear. The information shown is for information only purposes and does not constitute an invitation, offer or recommendation to buy, sell or otherwise deal in any investment.
October 20, 2021
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION.
If you are in any doubt about the contents of this Document or about what action to take, you are
recommended immediately to seek your own professional advice from your stockbroker,
solicitor, accountant or other financial adviser duly authorised for the purposes of the
Financial Services and Markets Act 2000 (as amended) who specialises in advising upon
investments in shares and other securities.
If you have sold or otherwise transferred all of your ordinary shares in CAP Energy Plc, you
should send this document, together with the accompanying Form of Proxy, at once to the
purchaser or transferee or to the stockbroker, bank or other agent through whom the sale
or transfer was effected, for onward delivery to the purchaser or transferee.
CAP ENERGY PLC
(Registered in England & Wales with Company No. 5351398)
Directors
Guy Hustinx
Lina Haidar
Alexander Haly
05 August 2021
Registered Office
2nd Floor
20 Berkeley Square
London W1J 6EQ
United Kingdom
Dear Shareholder,
Introduction
The purpose of this letter is to provide you with a brief summary and explanation of the
resolutions proposed by Cap Energy Plc (“Cap” or the “Company”) as set out in the attached
notice convening an Annual General Meeting (“AGM”) of the Company at 11.00 am on
Friday, 27 August 2021 (the “Notice of AGM”).
The Company would like to propose the following Ordinary Resolutions at the AGM:
Resolution 1
Resolution 1 is to defer the Company’s financial statements and the report of the directors
and auditors for the year ended 31 December 2020 until a later date. Shareholders will have
a reasonable opportunity at the AGM to ask questions and comment on these reports and on
the business and operations of the Company.
Resolution 2
Resolution 2 deals with the re-appointment of directors. Guy Hustinx retires in accordance
with the Articles of Association (“Articles”) and, being eligible, offers himself for reappointment as a director.
Resolution 3
Resolution 3 is to re-appoint Crowe UK LLP as auditors of the Company to hold office from the
conclusion of the AGM to the conclusion of the next AGM at which accounts are laid before
the Company at a remuneration level to be determined by the directors.
Resolution 4
Resolution 4 authorises the Board to allot and issue shares in the Company or grant rights to
subscribe for or to convert any securities into shares in the Company up to an aggregate
number of equity securities not to exceed 31,551,719 shares, being 100% of the Company’s
issued ordinary share capital as at the date of this notice, such authority to expire at the next
AGM or fifteen months after the passing of this resolution, whichever date is the earlier.
The Company is also proposing the following Special Resolution at the AGM:
Resolution 5
The Companies Act 2006 (the “Act”) requires that any equity securities issued for cash must
first be offered to existing shareholders pro rata to their holdings unless approval is obtained
by special resolution to disapply this requirement. It is proposed that this authority also be
renewed for the same period as the authority under Resolution 4. In order to retain flexibility
to raise further capital quickly in order to meet its funding requirements under its current
exploration projects as well as to be able to take advantage of prospective exploration
projects, the Company is seeking disapplication of pre-emption rights up to an aggregate
number of equity securities not exceeding 20,508,617 shares, being 65 % of the Company’s
ordinary issued share capital as at the date of this notice.
All Shareholders registered as holding ordinary shares of the Company at 6.00 pm on Thursday
26 August 2021 or, if adjourned, 6.00 pm on the day that is the second day prior to the date
of the adjourned AGM (not including any day that is not a business day) shall be (unless
otherwise entitled to do so) entitled to attend the AGM and vote on the Resolutions
proposed.
Action to be taken by Shareholders
Attached to the Notice of AGM accompanying this letter is a Proxy Form for use by
Shareholders. All Shareholders are invited and encouraged to attend the AGM or, if they are
unable to attend in person, to complete, sign and return the Proxy Form to the Company.
Lodgement of a Proxy Form will not preclude the Shareholder from attending and voting at
the AGM in person.
Shareholders can either deliver the Proxy by hand, by mail, or as an attachment by email in
accordance with instructions on the Proxy Form.
Yours sincerely,
Lina Haidar
Chairman
NOTICE OF ANNUAL GENERAL MEETING
CAP ENERGY PLC
(Incorporated in England and Wales with registered no 05351398)
(the “Company”)
NOTICE IS HEREBY GIVEN that the Annual General Meeting of the Company will be held at the
Company’s Registered Office, 2nd Floor, 20 Berkeley Square, London W1J 6EQ at 11.00 am on
Friday, 27 August 2021, for the purposes of considering and, if thought fit, passing the
following resolutions, of which resolutions 1 – 4 will be proposed as ordinary resolutions and
resolution 5 will be proposed as a special resolution:
ORDINARY RESOLUTIONS
August 5, 2021
11 May 2021
Ritorno plc
(“Ritorno” or “the Company”)
Acquisition of Intellectual Property Rights of the Billion Dollar Draw
Ritorno is pleased to announce the acquisition of the entire issued share capital of MHL Invest No 1 Limited (“MHL”) from Mesh Holdings plc. MHL owns all existing and in-development intellectual property rights of the Billion Dollar Draw. The consideration for the acquisition of MHL is £4,000,000 which has been satisfied by the issue of 888,888,888 new ordinary shares in the Company at a price of 0.45p per share credited as fully paid. Following the issue of those shares Mesh holds 925,000,000 ordinary shares representing 26.6% of Ritorno’s enlarged issued share capital.
In 2016 Chris Akers developed the innovative idea to raise at least US$1 billion for charity through an annual global blockchain raffle initiative, which would give participants the chance to win US$2 billion in prize money including the world’s first $1 billion jackpot prize. A total of 1 billion unique tickets would be sold to participants over 18 years of age at US$5 each. Approximately 50% of the Billion Dollar Draw’s proceeds would be allocated to a dedicated number of high impact social and environmental projects in close collaboration with various leading charities and other organisations. The intention is for the initiative to be supported proactively by multiple leading global brands and influential individuals from all walks of life. Various high-profile campaigns would be curated and delivered around the world throughout the year.
Chris Akers, Chairman of Ritorno and founder of the Billion Dollar Draw said: “Ritorno’s vision for the Billion Dollar Draw is intended to empower the ESG sector on a global basis. The project has been designed to enable people around the world and from all walks of life to proactively contribute to positive and progressive social development.”
Following the issue of the 888,888,888 new ordinary shares as consideration for the acquisition of MHL and the Billion Dollar Draw intellectual property assets, the Company has 3,476,066,912 ordinary shares in issue.
Contact details
Chris Akers: Chairman, Ritorno plc
Email: chris.akers@srgplc.com
Nearly 2.5 billion people or over one-third of the worldwide population live on less than US$1.90 a day, and more than 1 billion suffer from chronic hunger. 1 billion children worldwide are multi-dimensionally poor – without access to education, health, housing, nutrition, sanitation or water. An estimated 356 million children live in extreme poverty.
This number continues to grow as the COVID-19 pandemic, humanitarian disasters, natural catastrophes, conflict zones, global displacements, climate change and political turmoil create newly poor groups. According to UNICEF 150 million additional children have been plunged into multidimensional poverty due to COVID-19.
Respect for human rights, meeting basic human needs and more equitable distribution of wealth are clear priorities for the eradication of poverty.
It is Ritorno’s belief that authentic audience engagement together with smart and relevant technology can play an important role to drive these types of initiatives forward, contributing to the creation and delivery of a sustainable global human economy.
May 11, 2021
25 March 2021
Ritorno plc is pleased to announce that the Company has raised £162,500 through a placing to a new investor of 36,111,112 new ordinary shares (the “Placing Shares”) at a price of 0.45 pence per Placing Share (the “Placing Price”) (the “Placing”).
The placing price of 0.45 pence per represents a premium of 80% to the prevailing middle market price of the shares on JP Jenkins at the close of business on 18 January 2021.
The funds raised pursuant to the Placing will be used for general working capital and further investment into Low6 Group Limited.
The Placing Shares, which will be issued credited as fully paid and which will rank pari passu in all respects with the existing Ordinary Shares, represent approximately 1.4% of the Company’s enlarged issued share capital.
As a result of the Placing the enlarged number of shares in issue will be 2,587,178,024. The Board intends to recommend a share consolidation in Q1 2021 on the basis of one share for every 100 shares in issue.
The Directors of the Company accept responsibility for the contents of this announcement.
-ENDS-
March 25, 2021
December 10, 2019
J P Jenkins is the oldest established trading platform in UK for unlisted or unquoted companies which enables shareholders and prospective investors to trade shares on a matched bargain basis.Should shareholders wish to trade their shares they can do so through their stockbroker.
The indicative price and transaction history are available on J P Jenkins’s website at: www.jpjenkins.com. For more information please call +44 (0) 20 7469 0937.
Veronika Oswald, Director of J P Jenkins, said: “Shareholders in Sirius Petroleum now have a platform to trade in the Company’s shares on a matched bargain basis whilst it undergoes the period leading to its eventual relisting in London.”
Jack Pryde, Chairman of Sirius Petroleum Plc, said: “Whilst we continue to work towards an eventual relisting of the Company’s shares in London, the J P Jenkins share dealing platform provides trading solution for shareholders, albeit it on a matched bargain basis, during the intervening period.
It remains our clear intention to relist the Company’s shares in London.If shareholders have not already registered for future news updates you can register for updates via email by sending a ‘register for updates’ email to: :ir@siriuspetroleum.com
Ends.
July 10, 2020